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Abstract 
The amphidinolide compounds represent an extensive array of marine natural products, 
a number of which demonstrate potent anti-cancer bioactivity in vitro. Amphidinolide C 
represents an attractive synthetic target due to a combination of potent bioactivity and 
complex molecular architecture. 
This project deals with a modular 
and convergent total synthesis 
approach to amphidinolide C from 
which two synthetic fragments of 
similar size and complexity, termed 
‘northern’ and ‘southern’, were 
synthesised in a stereoselective fashion. The stereochemical commonality between the 
branched chains of the 2,5-trans tetrahydrofuran systems found within both fragments, 
led to the conclusion that a keystone common intermediate could be applied to the 
synthesis of each. Previous efforts within the group have shown that 2,5-trans 
tetrahydrofuran-3-ones could be prepared through a diastereoselective rearrangement 
of a free or metal-bound oxonium ylide generated from a metal carbenoid.  
  
This thesis details the scalable preparation of the intermediate tetrahydrofuranone 
through tandem oxonium ylide and [2,3]-sigmatropic rearrangement. Subsequent 
discussions show the applicability of the intermediate to forming the C-(18)—C-(34) 
fragment of amphidinolide C and the C-(18)—C-(29) fragment of amphidinolide F, 
through the use of palladium cross-coupling methodology; alternative methods found to 
prepare the ‘northern’ fragment are also discussed. Additionally, the C-(1)—C-(8) 
fragment was prepared from the common intermediate system, the key steps in this 
synthesis involved introduction of the C-(4) methyl group through homogeneous 
catalytic hydrogenation and Luche reduction to afford the C-(7) alcohol. 
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1 Marine Natural Products and Total Synthesis 
The genesis of life on the Earth is proposed to have begun between 3.9 to 3.5 billion 
years ago in the primordial oceans of the early planet, leading over time from simple 
prokaryotic beginnings to the complex biodiversity that is seen in our world today.1 The 
success and permanency of marine organisms over this timeframe, in conjunction with 
evolutionary requirements for intra-species molecular signalling and the essential toxins 
required for both offensive and defensive purposes, have led to a plethora of complex 
chemical entities present within the marine environment.  
In contrast to terrestrial creatures whose messenger pheromones are by necessity of air 
transmission relatively simple, low-weight and therefore volatile, marine organisms can 
extrude much more complex structures into their saline surroundings with the only 
caveats being the requirement for solubility and potency towards their target. These 
drug-like attributes of biological potency and aqueous solubility, in addition to the 
volume of unique chemical structures, have led to the pursuance of marine natural 
products as possible ligands for receptors associated with human disease states. 
Since the completion of the Human Genome Project in 2004,2 the current consensus is 
that of the approximate 30,000 proteins coded by the human genome, around 3,000 are 
designated as disease modifying genes, while only 10% of the total genome is considered 
‘druggable’ i.e. susceptible to binding orally bioavailable ligands.3 The overlap between 
disease modifying and druggable genes provides a targetable genome of between 600 to 
1500 proteins that are amenable to small molecule therapy. The application of natural 
products as both drugs and lead compounds for drug development is a well-established 
process within the pharmaceutical industry, and has led to wide-spread screening of 
numerous marine natural compounds in the challenging search for the drugs of 
tomorrow.4 
As of 2012, the structures of approximately 22,000 individual marine natural products 
have been published of which eight have overcome the hurdles of clinical trials to attain 
drug approval by US and European regulatory authorities, with numerous others in 
various phases of clinical development.5 These compounds span a broad range of 
structural classes, modes of action and have utilities ranging from anti-cancer to pain 
relief. Due to the number and array of compound types isolated from the marine 
environment thus far, combined with the relatively small genomic locus associated with 
disease states and current capabilities in high‐throughput screening, it is axiomatic that 
marine natural products will continue to play an important role in the pharmaceutical 
industry as both drugs and lead compounds in the foreseeable future.  
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Due to the efforts required to isolate relatively small quantities of pure compound from 
substantial amounts of natural resources, in combination with the necessity of providing 
a regular supply of bioactive material, modern synthetic techniques are required to 
supply sufficient quantities of these potentially precious materials for pharmaceutical 
testing. 
2 Amphidinolides: Isolation, Bioactivity and Structure 
The amphidinolides are a set of 34 distinct macrolide compounds, harvested from the 
microalgae amphidinium sp. a symbiont found within the inner cells of the flatworm 
amphiscolops sp., native to the coral reefs of the Okinawan archipelago in southern 
Japan. Isolation and characterisation of these complex polyoxygenated natural products 
has been accomplished entirely by Kobayashi and co-workers who have disclosed a 
structurally diverse range of macrolactones exhibiting, in certain cases, excellent 
cytotoxic efficacy against tumour cell lines.6 
Initial assays of amphidinium metabolites were conducted using crude extract mixtures 
and demonstrated promising anti-neoplastic effects against two distinct cell lines, 
namely mouse lymphoma L1210 and human epidermoid carcinoma KB. The encouraging 
cytotoxic activity observed (70–90% inhibition at 3 μg mL−1) led to large-scale harvesting 
of various microalgae strains and separation of the molecular components by HPLC. The 
Y-5 strain of amphidinium sp. has proved to be the richest source of amphidinolide 
macrolides with no less than 15 individual compounds isolated, of which amphidinolides 
N, B and C (6, 2 and 3) have proven to be amongst the most bioactive members.6a To 
date the cytotoxic mode of action of the amphidinolides remains undetermined though 
amplified cytotoxicity is more prevalent amongst those macrolides composed of 25 to 27 
atoms, as illustrated in Table 1.  
Structurally, the macrolactone systems of the amphidinolides vary in size from 12 
membered, in the case amphidinolides Q7 and W,8 through to the largest known 29 
membered amphidinolide M.9 Despite overall structural differences present within the 
group, several common features such as multiple sites of unsaturation, the presence of 
1,1-disubstituted alkenes and the occurrence of oxacycles (e.g. epoxides, 
tetrahydrofurans and pyrans) within the macrolactone ring, are manifest throughout the 
family (Figure 1).
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  Cytotoxicity  (IC50, μg mL
−1) 
Amphidinolide 
Macrolactone 
Size 
Murine Lymphoma 
L1210 
Human Epidermoid 
Carcinoma KB 
A 1 20 2.0 5.7 
B 2 26 1.4×10−4 4.2×10−3 
C 3 25 5.8×10−3  4.6×10−3 
D  26 1.9×10-2  0.08 
E  19 2.0 10 
F  25 1.5 3.2 
G  27 5.4×10−3  5.9×10−3  
H 4 26 4.8×10-4 5.2×10−4  
J  15 2.7 3.9 
K  19 1.7 2.9 
L 5 27 9.2×10−2 0.1 
M  29 1.1  0.4 
N 6 26 5.0×10−5  6.0×10−5 
O  15 1.7 3.6 
P  15 1.6 5.8 
Q  12 6.4  >10 
R  15 1.4 0.7 
S  16 4.0 6.5 
T1 7 19 18 >20 
U 8 20 12 >20 
V  14 3.2 7 
W 9 12 3.9 >10 
X  16 0.6 7.5 
Y  17 0.8  8.0 
Table 1 
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Figure 1 
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3 Amphidinolide C and Related Compounds 
3.1 Discovery, Bioactivity and Structure 
Amphidinolide C 3 was the earliest 25-membered macrolide isolated from amphidinium 
sp. by Kobayashi et al. in 1988.10 Originally obtained as a component of the Y-5 strain of 
the microalga it was later also found in Y-26, Y-56 and Y-71 strains leading to significant 
isolable quantities of material that were used subsequently to determine the structure 
and absolute stereochemistry.6a 
The novel macrolide was tested against both murine lymphoma L1210 and epidermoid 
carcinoma KB cell lines, exhibiting IC50 values of 5.8×10
−3 and 4.6×10−3 μg mL−1 
respectively.10  Interestingly, a brief remark also described the ability of amphidinolide 
C to activate rabbit skeletal muscle actomyosin ATPase activity.11 
On the assignment of the absolute stereochemistry, again by Kobayashi et al., 
amphidinolide C was shown to a be structurally complex natural product comprising a 
core 25-membered macrolactone ring, which contains two embedded 2,5-trans 
substituted tetrahydrofurans and a C-(25)—C-(34) exocyclic tail unit.12 The macrolactone 
possesses eleven stereocentres, three of which are secondary hydroxyl groups, two 
ketone units and a diene system between C-(9)—C-(11) bearing an exocyclic 1,1-
disubstituted olefin. The tail fragment accommodates an (E,E)-diene system, a doubly 
allylic alcohol at the C-(29) position as well as the compound’s second 1,1-disubstuted 
alkene unit, located at C-(30) (Figure 2).12 
The core macrolide of amphidinolide C is shared by three closely related congeners 
C2,13 C314 and F15 shown in Table 2. The apparent structural similarity between these 
compounds does not translate into comparable in vitro bioactivity, the significant 
difference in biological activity between amphidinolides C, C2 and C3, and the chain-
truncated amphidinolide F, lies within the tail region of the compound. The doubly 
allylic alcohol of C-(29) confers potent bioactivity but in its absence, or the removal of 
the H-bond donor capacity by acetylation, the activity of the parent compound is 
reduced by approximately 1000 fold. This surprisingly tight SAR illustrates the key 
importance of the tail region of the compound but does not provide insight into the 
requisite functionality of the macrolactone in binding to the as yet unknown target 
receptor. This observation suggests that edited portions of amphidinolide C, particularly 
those around the northern hemisphere and tail of the compound, may elicit a response 
in cytotoxicity assays. 
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Figure 2 
  Cytotoxicity  (IC50, μg mL
−1) 
Amphidinolide R 
Murine Lymphoma 
L1210 
Human Epidermoid 
Carcinoma KB 
C10 3 
 
5.8×10−3 4.6×10−3 
C2 10 
 
0.8 3.0 
C3 11 
 
7.6 10 
F 12 Me 1.5 3.2 
Table 2. 
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4 Synthetic Efforts Towards the Total Synthesis of 
Amphidinolide C and Congeners 
4.1 General Remarks  
The potent in vitro cytotoxic activity displayed by amphidinolide C in vitro, in 
combination with the complex molecular architecture of the compound, and the 
relatively small quantities of material available for study, have made it an attractive 
target for total synthesis. Due to the high degree of structural overlap between 
congeners of the amphidinolide C and amphidinolide F, efforts towards the synthesis of 
both compounds are of interest when reviewing the current state of literature regarding 
these fascinating targets.  
Numbering of the amphidinolide C family begins at the carboxy unit of the macrolactone 
ester C-(1) and continues in a counter-clockwise fashion terminating in the terminal 
carbon of the exocyclic tail unit, C-(29) in the case of amphidinolide F and C-(34) in 
that of amphidinolide C. Retrosyntheses of these particular natural products tend 
towards two very specific starting disconnections, the first along the macrolactone bond 
and the second on either of the flanking bonds of the C-(18) ketone. These 
disconnections lead to what will subsequently be described as ‘northern’ and ‘southern’ 
fragments, for the sake of generality. 
The majority of syntheses have focussed on the construction of the 2,5-trans 
tetrahydrofuran units embedded within the macrolide system as a basis for building 
outwards towards more developed intermediate fragments. To date, no total synthesis 
of amphidinolide C, C2 or C3 has been disclosed, though a total synthesis of 
amphidinolide F has been published recently. The ensuing sections detail the work on 
the synthesis of both ‘northern’ and ‘southern’ fragments of amphidinolide C and F. 
Where a single group has published on both sections the work is discussed in 
conjunction. 
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4.2 The Roush Group  
4.2.1 Synthesis of C-(11)—C-(29) Fragment of Amphidinolide F 
 
Figure 3 
Roush and co-workers envisaged the retrosynthetic analysis of amphidinolide F shown in 
Figure 3.16 Disconnection across the lactone bond and the C-(9)—C-(10) diene system led 
to a structurally complex C-(10)—C-(29) fragment from which the forward connections 
were predicted to be achievable through Yamaguchi macrolactonisation and Heck 
coupling respectively.  
The group’s interest in chelate controlled [3+2] annulation reactions between chiral 
allylic silanes and aldehydes, led to the belief that the 2,5-trans stereochemistry of the 
northern tetrahydrofuran could be formed using this methodology. The synthesis of 
tetrahydrofuran 15 was accomplished through tin activation of ethyl glyoxylate and 
treatment of the complex with allylsilane 13. The desired [3+2]-annulation proceeded 
in good yield and excellent diastereoselectivity to afford the desired 2,5-trans 
tetrahydrofuran 15, shown in Scheme 1, the stereochemical outcome of the reaction is 
guided by the syn-synclinal intermediate 14.17 
Reduction of the ester functionality was followed by two-step conversion of the alcohol 
product to alkyl iodide 16 which upon iodide displacement, protiodisilation of the C-Si 
bond and functional group interchange afforded aldehyde 17. 
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Scheme 1 
The synthesis was completed in a further six steps beginning from the boron mediated 
aldol condensation of the aldehyde with methylketone 18 which proceeded under 
Felkin-Anh control. The yield and diastereomeric ratio of the addition proved to be 
excellent, allowing progression of the route through an Evans-Tishchenko reduction of 
the resultant β-hydroxy ketone.18 After further manipulation of functional groups, vinyl 
iodide 21 was ultimately cross-coupled to a stannane under Stille conditions to afford 
the C-(11)—C-(29) carbon framework of amphidinolide F (Scheme 2). 
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Scheme 2 
4.2.2 Synthesis of the C-(1)—C-(9) Fragment of Amphidinolides C and F 
Encouraged by the success of their tin mediated [3+2] annulation in forming the key C-
(20)—C-(23) tetrahydrofuran of the Northern fragment of amphidinolide F, Roush and 
co-workers subsequently focussed on the application of the same methodology to the C-
(1)—C-(9) Southern fragment of the macrolactone ring.19 The greater molecular 
intricacies of this section of the target, particularly regarding the exocyclic C-(35) 
methyl group, provided complications in the observed diastereocontrol of the 
annulation reaction when aldehydes other than ethyl glyoxylate were used (Scheme 3). 
Although aldehyde 25 was prepared in eleven steps from the 2,5-trans tetrahydrofuran 
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24, the route was considered to be too long and low yielding for practical use in a total 
synthesis. An alternative method was sought. 
 
Scheme 3 
Prior work conducted by Kobayashi and co-workers towards evaluation of the absolute 
stereochemistry of amphidinolide C, used a stereocontrolled intramolecular oxa-Michael 
reaction to construct the C-(3)—C-(6) tetrahydrofuran unit.12b  
Roush and co-workers employed an analogous methodology when developing a second 
generation synthesis of their target tetrahydrofuran (Scheme 4). The α,β-unsaturated 
ester 26 was prepared by Still-Genari olefination of isopentyl ketal glyceraldehyde 
thereby providing a chiral-pool starting point for the synthesis. Acid-catalysed ketal 
deprotection and lactonisation was followed by stereoselective hydrogenation of the 
endocyclic double bond with Pearlman’s catalyst, TBS protection of the extant hydroxyl 
gave the lactone 27 as a single diastereoisomer. Reduction of the lactone group 
delivered an aldehyde which upon treatment with (carbethoxymethylene)-
triphenylphosphorane yielded α,β-unsaturated ester 28, the precursor compound 
required to deliver the 2,5-trans tetrahydrofuran. Treatment of the intermediate with 
TBAF led to intramolecular cyclisation of the compound in good yield and with a high 
degree of stereocontrol.12b  
 
 
Scheme 4 
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The high ratio of 2,5-trans tetrahydrofuran formation over the cis diastereomer is 
largely controlled by the steric effect of the C-(35) methyl group on the preferred 
conformer of compound 28 generated through 1,3-allylic strain, as illustrated in Figure 
4. The stereocontrolled installation of the C-(7)—C-(8) diol was accomplished through 
the application of Brown’s γ-borylallylborane20 and was followed by a Tamao-Fleming 
oxidation. Overall the sequence illustrated in Scheme 4 provided a shorter and 
higher-yielding synthesis than that of the [3+2] annulation methodology discussed in 
Scheme 3. 
 
Figure 4 
4.3 The Mohapatra Group 
4.3.1 Synthesis of the C-(19)—C-(34) Fragment of Amphidinolide C 
The initial disconnections in Mohapatra’s strategy for the synthesis of amphidinolide C, 
were analogous to those previously exploited in Roush’s disconnection of amphidinolide 
F, leading to a target C-(19)—C-(34) fragment highlighted in Figure 5.21  
Scheme 5 shows the forward synthesis of the 2,5-trans tetrahydrofuran ring system. 
Generally, syntheses of the 2,5-trans tetrahydrofuran functionality of amphidinolide C 
are conducted in a diastereoselective fashion, unusually Mohapatra’s group decided to 
pre-form the enatiopure C-(20) and C-(23) stereocentres and combine both through a 
regioselective, copper triflate catalysed ring opening of the allylic oxirane 33.22  
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Figure 5 
In forming diene 34, the desired stereochemistry at C-(20), C-(23) and C-(24) was 
introduced early in the synthesis through inexpensive chiral starting materials. The 
terminal olefins were united by means of metathesis, catalysed by Grubbs second 
generation catalyst, and the resultant endocyclic olefin reduced by hydrogenation.  
 
Scheme 5 
Further manipulation of the compound afforded aldehyde 37 which was olefinated with 
phosphonate ester 40, thereby permitting access to the unsaturated E:E diene ester 38. 
The synthesis was completed in a further three reactions, the key step of which was the 
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Nozaki-Hayama-Kishi coupling of the intermediate aldehyde with vinyl iodide 41, 
providing the C-(19)—C-(34) fragment 39 as a 1:1 mixture of separable C-(29) 
diastereomers. 
4.4 The Armstrong Group 
4.4.1 Synthesis of the C-(18)—C-(29) Fragment of Amphidinolide F 
2009 saw the publication by Armstrong and co-workers of their work concerning the 
synthesis of the northern fragment of amphidinolide F, comprising a short synthesis of 
the 2,5-trans tetrahydrofuran system, and unification of the formed fragment with the 
C-(26)—C-(29) truncated tail section through Wittig olefination.23 These workers also 
reflected on the possibility of expanding the C-(18)—C-(29) northern construct of 
amphidinolide F to enable synthesis of the C-(29)—C-(34) tail of amphidinolide C.  
 
 
Figure 6 
Armstrong’s retrosynthetic analysis of amphidinolide F followed the prevalent 
convention of disconnection at the macrolactone bond and adjacent to the C-(18) 
ketone, in this case between the C-(17)—C-(18) bond, leading to the C-(18)—C-(29) 
fragment 42, shown in Figure 6.  
Synthesis of fragment 42 commenced using the oxidation-olefination procedures of 
Graham et al.24 from which dienoate 44 was isolated in acceptable yield with good E:Z 
selectivity. Attention subsequently turned to the development of methodology for the 
selective monodihydroxylation of the diene and subsequent oxa-Michael cyclisation used 
to form the 2,5-trans tetrahydrofuran 46. In the absence of base, the major product 
isolated from the Sharpless asymmetric dihydroxylation of 44 was diol 45, but in the 
presence of NaOH the cyclisation reaction proceeded to afford tetrahydrofuran 46. 
Although the cyclisation reaction occurred in poor yield and with a low diastereomeric 
ratio, no 6-exo trig cyclisation was reported. Isolation of diol 45 and base mediated 
cyclisation of the purified material was attempted but no discernible improvement in 
the diastereomeric ratio of cis and trans isomers was observed. Iodo etherification of 
alkene 45 did not provide a markedly better diasteromeric ratio of iodotetrahydrofuran 
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47 (trans:cis 3:1) but did allow for enrichment of the desired enantiomer by means of 
product recrystallization. 
 
Scheme 6 
Following several transformations, including radical deiodination, the carbon framework 
of the C-(18)—C-(29) fragment of amphidinolide F was completed following Wittig 
olefination of aldehyde 48. A two-step conversion of the ester into dithiane 42 provided 
the final compound of the sequence. Attempts to extend the potential utility of diene 
49 for the synthesis of amphidinolide C were realised through the provision of a 
synthetic handle on the C-(29) position. As shown in Scheme 7, selenium mediated 
allylic oxidation afforded the desired allylic alcohol 50 in 70% yield. 
Chapter 1: Introduction 
17 
 
 
Scheme 7 
4.5 The Spilling Group 
4.5.1 Synthesis of the C-(18)—C-(34) Fragment of Amphidinolide C 
Spilling’s retrosynthetic analysis of the macrolactone ring of amphidinolide C adhered to 
the standard disconnection strategy leading to the C-(18)—C-(34) fragment 51.25 
Construction of the 2,5-trans tetrahydrofuran ring was envisaged as the result of an 
intramolecular, palladium-catalysed cyclisation of an allylcarbonate with a suitably 
functionalised alcohol, while introduction of the C-(25)—C-(26) diene by use of 
phosphonate olefination chemistry was expected. The applicability of HWE olefination 
to the functionalization of various aldehydes was noted as a potential route towards 
accessing a number of synthetic analogues, including that of the abbreviated tail region 
of amphidinolide F. Introduction of the extended C-(29)—C-(34) side chain was 
anticipated to be performed by Nozaki–Hiyama–Kishi coupling of a suitable vinylic iodide 
with the appropriate C-(29) aldehyde, in an identical approach to that used by 
Mohapatra.21 
 
Figure 7 
Forward synthesis began from epoxide 52, formed in three steps from 3-buten-1-ol and 
resolved from the racemic epoxide by use of Jacobsen’s methodology.26 Ring opening 
with allylmagnesium chloride provided a terminal alkene, which on metathesis with 
enantiomerically pure phosphonoallylic carbonate 57 using Grubbs’ second generation 
catalyst yielded E-olefin 53. Palladium catalysed decarboxylation of the allylcarbonate 
led to intramolecular cyclisation through the C-(20) secondary hydroxyl group, thereby 
forming the 2,5-trans tetrahydrofuran diastereomer 54 preferentially. The resultant E-
vinylphosphonate underwent hydroboration-oxidation with diboron pinacol ester and 
sodium perborate to afford a 1:1 mixture of C-(24) secondary alcohols, which upon TPAP 
oxidation provided the β-ketophosphonate 55 in good yield. 
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Scheme 8 
With the β-ketophosphonate in hand, attention turned to synthesis of an aldehyde 
coupling partner and optimisation of the coupling methodology. Prior to construction of 
the C-(26)—C-(34) segment of amphidinolide C, the group decided to test the viability of 
using HWE olefination to construct the C-(25)—C-(26) bond by fashioning the northern 
fragment of amphidinolide F from commercially available 3-methyl-crotonaldehyde 58. 
A number of ineffective conditions, in which various solvent-base combinations were 
employed, were examined before the optimal system comprising caesium carbonate and 
anhydrous isopropanol, permitted access to the desired dieneone. Felkin-Anh controlled 
1,2-reduction of the C-(24) ketone functionality was then accomplished by use of L-
selectride, providing the C-(18)—C-(29) northern fragment of amphidinolide F 56 as a 
single diastereoisomer. 
The success of the HWE protocol channelled subsequent efforts into the synthesis of an 
aldehyde that would form the backbone of the C-(26)—C-(34) tail of amphidinolide C. 
Nozaki-Hiyami-Kishi coupling of aldehyde 59 and vinyl iodide 41 afforded a racemic 
mixture of doubly allylic alcohol 60 in good yield, the PMB ether was further 
manipulated to afford the germane aldehyde for provision of the C-(25)—C-(26) 
bond-forming olefination reaction. Application of the previously optimised HWE 
conditions allowed for high-yielding formation of an intermediate dieneone 62 and 
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subsequentby L-selectride reduction afforded the desired C-(18)—C-(34) fragment of 
amphidinolide C. 
 
Scheme 9 
4.5.2 Synthesis of the C-(1)—C-(9) Fragment of Amphidinolides C and F 
Spilling’s synthesis of the C-(1)—C-(9) fragment of amphidinolides C and F harnessed the 
power of a nickel catalysed, homoallylic addition reaction of a 1,3-diene to an 
aldehyde, in order to provide the precursor framework of the southern 3-methyl 2,5-
trans tetrahydrofuran fragment of the natural product.27 As shown in the retrosynthesis 
(Figure 8), access to the 2,5-trans tetrahydrofuran was viewed as being possible through 
an intramolecular oxa-Michael addition of α,β-unsaturated ester 65, analogous to that 
previously employed by Kobayashi12b and Roush.19 
 
Figure 8 
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The synthesis commenced from the commercially available lactone 66, which 
underwent DIBAL-H reduction to hemiacetal 67, thereby providing a masked aldehyde 
bearing the required C-(7)—C-(8) diol stereochemistry of the natural product, for the 
key homoallylation step (Scheme 10).  
 
Scheme 10 
Isoprene underwent stereoselective addition to form 68 through the application of 
catalytic Ni(acac)2 and stoichiometric  triethylborane, to afford a 3:1 mixture of C-
(6),C-(7) anti products in favour of the undesired diastereoisomer. The C-(1)—C-(9) 
fragment 70 was obtained from the isolated minor isomer through cross metathesis of 
the alkene 68 with methyl acrylate, followed by an oxa-Michael addition to the α,β-
unsaturated ester. Stereocontrol of the cyclisation reaction was, as previously 
discussed, induced by the presence of the C-(35) methyl group (cf. Figure 3). 
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4.6 The Pagenkopf Group 
4.6.1 Synthesis of the C-(18)—C-(34) Fragment of Amphidinolide C 
The disconnections employed by Pagenkopf and Mora, illustrated in Figure 9, followed 
the orthodox macrolactone and C-(17)—C-(18) bond breakages to provide the C-(18)—C-
(34) fragment 71 bearing suitable protecting groups.28 The disconnection between the 
2,5-trans tetrahydrofuran and tail region was envisioned to be the result of a 
stereoselective alkynylation reaction between an aldehyde and an enyne which would 
be followed by propargylic reduction, while formation of the central tetrahydrofuran 
was viewed as the product of the intramolecular, cobalt catalysed, oxidative radical 
cyclisation.  
 
Figure 9 
This synthesis is one of the more succinct routes to access the northern fragment of 
amphidinolide C allowing for an extremely rapid access to the 2,5-trans tetrahydrofuran 
using inexpensive starting materials, through an efficient cobalt(II) mediated cyclisation 
reaction which proceeds with remarkable stereoselectivity (Scheme 11). The same 
authors have recently reported on the utility of the cobalt cyclisation methodology for 
the preparation of the C-(3)—C-(6) tetrahydrofuran of the southern fragment of 
amphidinolide C.29  
The construction of enyne 82 was accomplished through the nine step sequence 
detailed in Scheme 12. Installation of the C-(29) stereochemistry was accomplished 
through reagent controlled reduction, using the (S)-enantiomer of the Corey-Bakshi-
Shibata reagent of an intermediate enone system, to provide allylic alcohol 78 in good 
yield and enantiomeric excess. Manipulation of the silyl protecting groups and formation 
of the propargylic ester 79 yielded a substrate that was amenable to the copper 
mediated 1,4-addition of a methyl group, affording the synthetic equivalent of the C-
(40) methyl of the natural product. The C-(25)—C-(34) carbon backbone of the tail 
region of amphidinolide C was completed in a further four steps utilising Corey-Fuchs 
methodology to afford enyne 82. 
 
Chapter 1: Introduction 
22 
 
 
Scheme 11 
 
Scheme 12 
The stereoselective addition of lithiated alkyne 84 to aldehyde 77 was accomplished, 
after painstaking optimisation, to afford the C-(23)—C-(24) 1,2-anti diastereomer 85 as 
the sole product, in 93% yield (Scheme 13). Mitsunobu inversion of the C-(24) hydroxyl 
group was followed by treatment with Red-Al, leading to reduction of both the 4-
nitrobenzoate group and the propargylic alcohol to form the required 2E,4E-dienol 71. 
This sequence was reported to allow rapid access to gram scale quantities of the C-
(18)—C-(34) fragment of amphidinolide and provides a concise sequence for construction 
of the 2,5-trans tetrahydrofuran core using cobalt catalysis.  
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Scheme 13 
4.7 The Ferrié Group 
4.7.1 Synthesis of the C-(1)—C-(9) Fragment of Amphidinolides C and F 
2010 saw the publication of Ferrié and Figadére’s route towards the C-(1)—C-(9) 
fragment of the macrolide core of amphidinolide C.31 The disconnection at the lactone 
bond and at the C-(9)—C-(10) diene locus suggested vinyl stannane 87 as the synthetic 
goal of the project. Integration of the C-(1) methyl ester was envisaged as the product 
of C-glycosylation of an acylated hemiacetal, whilst the required 1,2-anti relationship of 
the C-(6) and C-(7) stereocentres was expected to result from a stereoselective 
Mukaiyama aldol reaction of a siloxyfuran and a suitably protected enatiopure aldehyde. 
 
Figure 10 
The approach taken towards the target 87 began from the TMS triflate catalysed aldol 
reaction of oxyfuran 89 and D-glyceraldehyde acetonide 88, Scheme 14. The separable 
diastereomers resulting from the addition reaction, both provided the required 1,2-anti-
relationship associated with the C-(7)—C-(8) diol, but were formed in a 3:1 mixture of 
C-(6) isomers. Hydrogenation of the endocyclic alkene bond from the least hindered 
face generated the required C-(35) methyl stereochemistry, whilst the acidic solvent 
system led to removal of both the acetonide and TMS groups. Threefold reprotection of 
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the resultant triol 92 with TBS chloride afforded lactone 93, which upon reduction and 
acetylation provided a protected hemiacetal precursor to the key TiCl4 facilitated C-
glycoslation reaction. Treatment of the intermediate with the titanium enolate of 
oxazolidinone 95 resulted in stereoselective access to the desired C-(3) isomer 
corresponding to the natural product.  
 
Scheme 14 
The completion of the synthesis was instigated through cleavage of the terminal TBS 
ether, partial oxidation of the resulting alcohol and homologation of the resultant 
aldehyde using the Bestmann-Ohira reagent to provide the alkyne 94 in good yield. The 
conversion of the alkyne into a synthetic handle for future assembly of the C-(9)—C-(10) 
bond was accomplished by formation of vinyl stannane 85 through regioselective, 
molybdenum catalysed hydrostannylation.32 
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Scheme 15 
4.8 The Carter Group 
4.8.1 Total Synthesis of Amphidinolide F 
2012 saw publication by Carter and Mahapatra on the total synthesis of amphidinolide F, 
the first member of this sub-family of the amphidinolides to be synthesised.33 The 
elegant methodology disclosed in the paper, built upon the solid foundations of a 
preceding publication in which the stereoselective construction of the C-(7)—C-(20) 
fragment of the macrolactone ring system was described.34 The prior paper had 
excluded the construction of the 2,5-trans tetrahydrofuran ring systems, in favour of 
defining methodology for the synthesis of the C-(9)—C-(11) diene system, which they 
noted was difficult to prepare through conventional palladium cross-coupling 
methodology.35  
The key strategic aspect of the total synthesis lay in the realisation that both the C-(3)—
C-(6) and C-(20)—C-(23) tetrahydrofuran systems bore identical stereochemistry, and 
comparable functionalization on their neighbouring branched chains. This observation 
suggested that a common intermediate could be used as a keystone compound for the 
preparation of both northern and southern fragments, thereby reducing both the 
timeframe and cost of synthesis. The retrosynthesis of amphidinolide F, shown in Figure 
11, details the requisite northern and southern fragments, in addition to the 
intermediate 100 that was hoped would be the antecedent to both. 
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Figure 11 
4.8.1.1 Synthesis of Common Intermediate  
The approach adopted to synthesise the common intermediate began from enyne 100, 
prepared in seven steps from D-malic acid 101. Sharpless asymmetric dihydroxylation of 
the E-olefin provided diol 103 as a single diastereoisomer, thereby establishing what 
would later become the C-(6) and C-(23) stereocentres of the natural product. 
Treatment of the propargylic alcohol with a sub-stoichiometric quantity of silver 
tetrafluoroborate, in refluxing benzene, resulted in the the [3,3]-sigmatropic 
rearrangement of the intermediate silver complex 104 (Scheme 16). The initial 
stereochemistry and suprafacial shift of the benzoyl ester provided transfer of 
stereogenicity to the allenyl intermediate 105 allowing for a stereospecific 5-endo-trig 
cyclisation to the desired dihydrofuran 106. On protection of the secondary alcohol and 
methanolysis of the benzoyl ester, 2,5-trans tetrahydrofuranone  100 was isolated as a 
single diastereoisomer. 
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Scheme 16 
4.8.1.2 Diversification of Common Intermediate to the C-(15)—C-(29) Northern 
Fragment 
Synthesis of the C-(15)—C-(25) backbone of the Northern fragment began with deletion 
of the C-(21) carbonyl group. This transformation was achieved through reduction of the 
group to give a mixture of diastereomeric alcohols followed by radical deoxygenation of 
the thiocarbamates produced from the alcohols to afford tetrahydrofuran 107 (Scheme 
17). Further manipulation of functionality led to aldehyde 108 which underwent Wittig 
olefination in excellent yield, providing the required diene 98 with the C-(25)—C-(28) 
(E,E)-stereochemistry found in the natural product.  
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Scheme 17 
4.8.1.3 Diversification of Common Intermediate to the C-(1)—C-(14) Southern 
Fragment  
Installation of the C-(35) methyl group was achieved through Mannich reaction of the 
lithium enolate of 100 with Eschenmoser’s salt, and stereoselective hydrogenation using 
Wilkinson’s catalyst thereby affording intermediate 110. Deletion of the superfluous 
carbonyl functionality was again achieved through the use of radical hydride 
substitution methodology (Scheme 18).  
 
Scheme 18 
The C-(9)—C-(14) vinylic iodide 112, prepared using chemistry developed within the 
group previously,34 was activated through lithium-halogen exchange and added to 
aldehyde 111. Alcohol 113, bearing the required C-(8) stereochemistry was fashioned 
through Felkin-Anh controlled addition and protected as a TBS ether. Further 
functionalization of compound 114 led to alkyl iodide 99, the electrophilic coupling 
partner required for the key C-(14)—C-(15) sulfone alkylation step. 
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Scheme 19 
4.8.1.4 Union of Northern and Southern Fragments and Completion of Synthesis 
Alkylation of sulfone 98 with alkyl iodide 99 proceeded in good yield to provide the C-
(1)—C-(29) fragment 115. However, subsequent oxidative desulfurisation, although 
leading to the clean formation of the C-(18) ketone, afforded a mixture of C-(1) pivaloyl 
ester protected and deprotected products 116 and 117. Independent manipulation of 
both compounds to form the pertinent carboxylic acid, was followed by C-(24) TES 
deprotection setting the stage for a Yamaguchi macrolactonisation which afforded 118 
in 65% yield. The synthesis of amphidinolide F 12 was completed in a further three 
operations comprising the removal of the C-(15) ethoxyethyl ether, oxidation of the 
resultant secondary alcohol and universal cleavage of the extant TBS ethers.   
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5 Carbenes and Metal Carbenoids 
5.1 Carbene Structure 
Carbenes have been postulated as reaction intermediates since the early days of organic 
synthesis, when the decomposition of relatively simple precursors led to products that 
were explainable only through invocation of such transient species. At the most basic 
level carbenes are divalent carbon species containing a neutral carbon atom bearing 
two unshared valence electrons.36 Methylene, the simplest member of the family, is a 
highly reactive and difficult to control reactive intermediate that was first definitively 
identified and studied in the early 1960s.37 Subsequent studies of functionalised 
carbenes, have led to a greater understanding of the reactivity of this unique species 
and have even led to the isolation and study of so-called persistent carbenes. Carbenes 
can exist in one of two possible electronic structures, namely the singlet and triplet 
states, shown in Figure 12.38 
 
Figure 12 
The triplet state contains two unpaired electrons within the σ and p orbitals and 
resembles a diradical carbon centre in which the dihedral angle between the R groups is 
generally within the range of 130 to 150°. The triplet state exists when the energy gap 
between the σ and p orbitals is small allowing for an electron to remain unpaired and 
inhabit each of the orbitals in accordance with Hund’s rule of maximum multiplicity. By 
virtue of the unpaired nature of electrons in the triplet state, carbenes of this type are 
paramagnetic and can be identified by ESR spectroscopy, provided the lifetime of the 
species is sufficiently long lived.38 
In contrast, if the energy gap between the σ and p orbitals is large the electrons will 
pair within the σ orbital leading to singlet carbenes. This paired configuration of 
electrons provides a neutral carbon centre of ambiphilic character (i.e. exemplified by 
the ability to exhibit both carbocationic and carbanionic behaviour) due to the s orbital 
lone pair and the vacant p orbitals. The singlet state is generally of higher energy and is 
therefore of greater reactivity than the triplet state. The increased energy cost of 
pairing electrons can be mitigated through the ability of the empty p orbital to accept 
electron density from adjacent electronegative atoms, as illustrated in Figure 13, 
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thereby perturbing the originally degenerate orbitals on the carbon centre and 
stabilising the singlet carbene.39 
 
Figure 13 
5.2 The Generation of Carbenes 
Carbenes are generally prepared by base induced α-elimination of haloalkanes or 
through controlled decomposition of nitrogen from a stabilised intermediate. 
Historically, carbenes were postulated as plausible reaction intermediates based upon 
experimental observations. Butlerov’s experiments concerning the reaction of copper 
with methyl iodide afforded ethylene, which was considered to be the result of the 
dimerization of methylene.40 As early as 1862, Geuther proposed that the basic 
hydrolysis of chloroform provided dichloromethylene,41 a result that has since been 
substantiated to proceed via an α-elimination mechanism, as shown in Scheme 21.42 
Trihalomethanes generally provide the best precursor compounds for this type of 
reaction providing dihalocarbenes as the intermediates. Chloroform can be used to form 
dichlorocarbene using hydroxide as the base, but formation of alkyl carbenes from alkyl 
halides requires a more powerful base such as t-BuLi due to the possibility of alkene 
formation through β-elimination.43 
 
 
Scheme 21  
The early years of the 20th century saw work published by Buchner44 and Staudinger45 on 
the decomposition of diazo compounds and reactions of the intermediate carbene 
species. Diazo groups can be liberated in the form of nitrogen gas from suitable starting 
materials through thermolysis and photolysis (Scheme 22). The inherent instability of 
alkyl diazo groups, and the safety issues associated with their explosive potential and 
carcinogenicity,46 led to work on more stable precursors such as diazirines47 and sulfonyl 
hydrazine salts48 which can also undergo photolytic and thermolytic decomposition to 
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form carbenes. Upon formation, free carbenes are promiscuous in their behaviour 
towards various functional groups which limits their application in useful synthesis to all 
but the most simple of compounds. 
 
Scheme 22 
5.3 Metal Carbenoids 
The potential of carbenes to accomplish various synthetically valuable procedures was 
realised in the early days of organic synthesis, but it was not until the 1960’s when 
Fischer49 and Schrock50 independently stabilised carbenes within the coordination 
spheres of metal centres, that carbene chemistry became of significant practical use. 
Metal carbenoids, or metallocarbenes, are reactive intermediates formed by the 
nucleophilic attack of a diazo compound into the empty orbital of Lewis acidic 
transition metal centre as shown in Figure 14. Loss of nitrogen from the complex results 
in a transient metallocarbene species, which is stabilised by back donation from the d-
orbitals of the metal centre to the vacant p-orbitals of the carbon centre. Despite 
exhibiting corresponding reactivity, metal carbenoids have fully tetravalent carbons and 
cannot therefore be described absolutely as carbenes. In the presence of electron-rich 
substrates (S:) a reaction proceeds whereby a new carbon—substrate bond is formed and 
the metal-ligand complex returned to the catalytic cycle.51 
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Figure 14 
The high reactivities of metal carbenoids means that they are transient species, 
generally formed within the reaction and used in situ to form the desired products. 
However, 2001 saw the publication of work by Hofmann in which the relatively long-
lived copper carbenoid 123 was prepared and detected in solution by NMR 
spectroscopy.52 In the same year a stable rhodium carbenoid was isolated by the groups 
of Snyder and Arduengo and was analysed by X-ray crystallography, providing the first 
incontrovertible proof of metallocarbene structure.53 
 
Figure 15 
5.4 Diazo compounds as Metal Carbenoid Precursors 
5.4.1 Electronic character of Metal Carbenoids 
The electrophilicity of metallocarbene intermediates has been shown to be of key 
importance in controlling the chemo-, regio- and stereoselective outcomes of reactions, 
particularly those involving C-H insertion. The electrophilic character of the 
intermediate species is determined partly from the ligands used on the metal catalyst 
and partly from the substituents of the parent diazo compound.54 Metallocarbenes 
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possesing low electrophilic character display inferior reactivity in comparison to their 
more electron-poor analogues, but superfluous electrophilicity can lead to significant 
side-product formation. The mesomeric effect of flanking electron-withdrawing groups 
offers stabilisation to diazo compounds, thereby providing viable synthetic 
intermediates for subsequent transformations.55 The dinitrogen of the diazo 
functionality is easily liberated by application of photo or thermolytic excitation, and is 
decomposed readily in the presence of acid catalysis. In the case of alkyl diazo 
compounds, such as diazomethane, this facile decomposition presents significant safety 
risks and hence α-diazo carbonyl substrates are the preferred option for the generation 
of metal carbenoids due to their improved safety profile.56 Modern synthetic techniques 
tend towards the preparation of α-diazo carbonyl compounds as a means of both 
stabilising the diazo group and tuning the electrophilicity of the compounds to deliver 
useful reactivity. Metallocarbenes derived from these types of compounds can be 
subdivided into three categories:  
1. Acceptor substrates containing an electron-withdrawing group. Generation of metal 
carbenoid intermediates can be achieved by reaction of various metal catalysts with 
diazo compounds of the type shown in Figure 16. The general trend of decreasing 
reactivity of metallocarbenes derived from these types of compounds progresses from 
α-diazoacetates 124, through α-diazoketones 125 to α-diazoacetamides 126.57 
Extrusion of nitrogen from these compounds can be achieved using a variety of metals 
to provide moderate electrophilicity in the resulting metal carbenoid, and hence high 
degrees of reactivity are noted within this class of compound. 
 
 
Figure 16  
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2. Acceptor-acceptor substrates containing two electron-withdrawing groups. 
Metallocarbenes derived from compounds of the type shown in Figure 17 demonstrate 
enhanced stability, due to the presence of two electron-withdrawing groups flanking 
the carbenoid centre. The presence of two electron-withdrawing groups deactivates 
these compounds towards forming metallocarbenes, hence there is a requirement for 
highly reactive metal complexes in order to decompose the diazo functionality. The 
highly electrophilic nature of the resultant species provides increased reactivity when 
compared to those generated from a single acceptor substrate.58 
 
 
Figure 17 
3. Those containing an electron-withdrawing group and an electron-donating group 
(acceptor-donor substrate)  
The third category of metallocarbenes is that covering intermediates derived from α-
diazo compounds of type 131 and 132. These compounds remained relatively 
unexplored until the work of Davies in 1997, when the first example of C-H insertion 
was reported using these reagents.59 The stabilising influence of the electron-
withdrawing group when combined with the resonance donation of an adjacent π-
system provides a push-pull system which affords a stabilised metallocarbene. Due to 
the increased stability of the starting materials, highly reactive metal catalysts are 
required to convert the diazo functionality into metallocarbenes, but the reactivity of 
the formed intermediate is moderated, leading to greater chemoselectivity in 
subsequent transformations.60  
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Figure 18 
5.5 Formation of α-Diazo Compounds 
5.5.1 Diazomethane Formation and Application to α-Diazoketone Formation 
In order to access the key diazo functionality, required for the preparation of metal 
carbenoids, several methods have been developed to introduce the moiety into 
synthetically useful compounds. The simplest alkyl diazo compound is diazomethane 
138 which was traditionally prepared by the base mediated decomposition of N-nitroso-
N-methylurea 133 through the method of von Pechmann.61  
 
Figure 19 
The instability of this precursor to shock and temperatures greater than 20 °C led to the 
development of Diazald® 134 (N-Methyl-N-(p-tolylsulfonyl)nitrosamide) as a more stable 
alternative.62 The mechanism of diazald decomposition to diazomethane 138, and its 
subsequent use for the synthesis of α-diazocarbonyl compounds, is shown in Scheme 23. 
Diazomethane is toxic and explosive, although the risk can be minimised by confining 
the decomposition reaction within specialised glassware and co-distilling the product 
with diethyl ether.63 Diazomethane is never isolated pure, but is instead used as a dilute 
ethereal solution in subsequent transformations. In the case of α-diazo carbonyls 139, 
this routinely involves the introduction of an activated acetyl group, typically an acid 
chloride or mixed anhydride, into the bulk solution of diazomethane.  
 Chapter 1: Introduction 
 
38 
 
 
Scheme 23 
5.5.2 Diazotisation of Amines 
Diazo groups can be accessed by treatment of amines with nitrous acid, normally 
generated through reaction of nitrite salts and aqueous acid at low temperature 
(Scheme 24).   
 
Scheme 24 
In the presence of flanking electron-withdrawing groups the resultant diazonium salt 
can undergo elimination of the acidic proton leading to formation of an α-diazo carbonyl 
species. Curtius prepared ethyl diazoacetate from glycine ethyl ester hydrochloride 
using this method as early as 1883.64 Alternatively, alkyl nitrite reagents can be used to 
produce α-diazo carbonyl compounds in cases where an organic soilvent is preferred 
over the traditional aqueous solvent systems.65 
5.5.3 Decomposition of Hydrazones and Oximes 
The Bamford-Stevens reaction is a method for the preparation of diazo compounds from 
corresponding ketones and aldehydes. The preliminary step in the sequence, shown in 
Scheme 25, requires the formation of a tosyl hydrazone 145 which upon exposure to 
base decomposes to form the diazo compound 121, through deprotonation and 
elimination of the p-toluenesulfinate ion. The Bamford-Stevens reaction is generally 
conducted at elevated temperature and so only stabilised diazo compounds, such as 
those bearing adjacent aryl substitutions, can be isolated from this reaction. Non-
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stabilised alkyl diazo intermediates undergo thermal decomposition, leading to a 
carbene based rearrangement of the compound to form olefins.66 
 
Scheme 25 
Oxidation of hydrazones offers an alternative route for the preparation of the diazo 
functionality (Scheme 26). Initially this reaction was reported by Curtius in 1889 using 
mercuric oxide in the preparation.67 Subsequent work demonstrated that other heavy 
metal salts such as Pb(OAc)4,
68 MnO2
55 and AgO69  can promote the same transformation. 
A less toxic variant, in which Swern oxidation conditions are employed, was recently 
published by Brewer and Javed.70 
 
Scheme 26 
An associated reaction is the Forster Reaction in which an oxime is treated with 
chloroamine to afford the intermediate 148, which readily decomposes to the related 
diazo compound (Scheme 27). Although diazomethane can be prepared from 
formaldehyde by this method it has not found widespread applicability.71  
 
Scheme 27 
5.5.4 Regitz Diazo Transfer 
Arenesulfonyl azides were shown by Regitz to transfer diazo functionality to suitably 
activated carbonyl systems (Scheme 28).72 This methodology is limited to compounds 
such as malonates and β-ketoesters where the α-protons are sufficiently acidic for the 
reaction to proceed. The scope of the Regitz methodology can be augmented through 
the use of an aldehyde as the second activating group, in which case deacetylation 
leads to α-diazo compounds of type 152.73  
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Scheme 28 
6 Metal Carbenoid Transformations  
The stabilising influence of the metal-ligand complex in metallocarbenes has led to a 
proliferation of their synthetic uses over the course of the last thirty years. The three 
major transformations in which they have been used are cyclopropanation, insertion 
reactions and in the formation of ylides coupled with their subsequent rearrangement 
chemistry. 
6.1 Carbenoid Mediated Cyclopropanation 
Addition of a carbene species to olefin has long been known to afford a cyclopropane, a 
recurrent motif amongst natural products occurring in plant defence and in synthetic 
insecticides. In 1958, Simmons and Smith described the reaction of methylene 
carbenoid, generated by reaction of diiodomethane and a zinc-copper couple, adding to 
various alkenes to provide cyclopropanes.74 Subsequent advances in metal carbenoid 
formation, through decomposition of diazo compounds with chiral metal complexes, has 
led the way to both enatio- and diasteroselective transformations but a thorough review 
of which remains outwith the scope of this narrative. Various metals, including Cu, Rh, 
Ru, Mo, Fe, Co, Ir and Pd have been shown to generate metal carbenoids from diazo 
compounds,75  which subsequently undergo cyclopropanation in the presence of alkenes, 
or cyclopropenation when reacted with alkynes. Additionally, numerous ligands have 
been developed which can impart chiral information to these reactions leading to 
enantioselective transformations in both inter and intramolecular fashion.  
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 As shown in Figure 20, upon formation of the metal carbenoid and introduction to an 
olefin, the complex undergoes concerted [2+1] cycloaddition to afford the cyclopropane 
system with regeneration of the catalyst.51, 76 Palladium complexes can also be used to 
decompose diazo compounds to form palladium carbenoids, which although undergoing 
cyclopropanation reactions, do so through an alternative mechanism involving a formal 
[2+2] addition of the carbenoid across the alkene, followed by reductive elimination of 
the metal centre.77  
 
Figure 20  
The use of metal carbenoid catalysed cyclopropanation is widespread within literature 
due to the many applications of the methodology in the total syntheses of natural 
products. A good example of the synthetic utility of this reaction is Martin’s total 
synthesis of (+)-ambruticin S 155, an antibiotic derived from Polyangium cellulosum. 
The central divinyl cyclopropane unit of the synthetic product was prepared through an 
intramolecular, asymmetric dirhodium carboxamide catalysed, cyclopropanation of 
alkene 153 (Scheme 29).78 
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Scheme 29 
6.2 Carbenoid Insertion Reactions 
The ability of a carbenoid to insert into R-H bonds (R = C, S, Si, O, N) is a long 
recognized phenomenon in the field.79 Early work on carbene C-H insertion reactions 
focussed on the ability of the carbenes methylene and dichloromethylene to react with 
simple aliphatic acyclic and cyclic systems. These reactions were found to be 
chemoselectively and regioselectively uncontrollable, leading to the comment by 
Doering that "methylene must be classified as the most indiscriminate reagent known in 
organic chemistry".80 The relative stability of metal carbenoids has circumvented this 
promiscuous behaviour resulting in more controllable reactivity and synthetic utility, in 
which specific bonds are activated for insertion.79 Classical C-H insertion reactions were 
traditionally carried out using copper activation, but the advent of dirhodium complexes 
as catalysts for the formation of metal carbenoids has led to advances in both the regio- 
and stereocontrol of this reaction.  
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Doyle suggested a mechanism for C-H insertion, in which overlap of the p-orbitals of the 
metal bound centre of the carbenoid with the σ-orbital of the activated C-H bond 
initiates a three- or four-membered cyclic transition state. The dissociation of the 
carbenoid-stabilising metal proceeds with concerted migration of the hydrogen atom 
thereby providing the insertion product and regenerating catalyst (Figure 21).81  
 
Figure 21 
C-H insertion reactions involving carbenoid intermediates are generally conducted 
intramolecularly on systems bearing restricted molecular geometry, in order to control 
the diastereoselectivity of the reaction. C-H Insertion reactions tend towards the 
formation of five-membered cyclic systems through a pseudo-chair transition state first 
propose by Taber and co-workers (Figure 22).82  
 
Figure 22 
6.3 Ylide Formation 
In the presence of Lewis bases, metallocarbenoids have been shown to form ylides or 
ylide-like intermediates that are prone to undergo subsequent rearrangement 
chemistry.83 Ethers, sulfides, tertiary amines, carbonyls and imines have all been shown 
to provide non-bonding electrons for formation of these short lived intermediates 
(Figure 23).84  
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Figure 23 
7 Oxonium Ylides 
At the most basic level, oxonium ylides are a species bearing a positively charged 
oxygen atom adjacent to negatively charged carbon atom. Unlike their ammonium and 
sulfonium counterparts, oxonium ylides are a short lived species which have never been 
isolated and whose existence is imputed only through isolation of the products they 
form. Recent years have seen great interest in oxonium ylides as transient synthetic 
species through the simplified methodologies used in their generation and a better 
understanding of the synthetic outcomes of their use.83 
7.1 Formation of Oxonium Ylides 
7.1.1 Generation of Oxonium Ylides from Oxonium Salts 
Two profoundly different methods have been used for the generation of oxonium ylides 
from readily accessible starting materials, the most prevalent being treatment of a 
metal carbenoid with an ether. An alternative methodology which gave the earliest 
verifiable example of oxonium ylide formation, results from the manipulation of simple 
oxonium salts. Olah reported in the early 1980’s that trimethyloxonium 
tetrafluoroborate 157 could be deprotonated using sodium hydride to yield 
methoxyethane 159, the result of a [1,2]-shift of a methyl group from the oxonium 
centre. This result, combined with the isolation of a product mixture consistant with 
the transient formation of the oxonium ylide 158, provided evidence of the putative 
intermediate species (Scheme 30).85 
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Scheme 30 
Supplementary work on the fluoride mediated decomposition of α-silated oxonium salts 
160 provided further evidence for the short-lived oxonium ylide species.85 The synthetic 
utility of the methodology was, however, severely limited by the restricted functional 
group tolerance and the high reactivity of the starting materials towards the 
methylation of nucleophiles. 
7.1.2 Generation of Oxonium Ylides from Metal Carbenoids 
The oxygen atom of an ether group, by virtue of its non-bonding electrons, acts as a 
weak Lewis base. Within the confines of conventional chemistry this limits the potential 
of ethers as nucleophiles, but within the sphere of metallocarbenoid chemistry, ether 
lone pairs are effective in forming oxonium ylide intermediates. The interaction 
between the two species is believed to be weak, with the equilibrium lying towards the 
discrete ether and metallocarbenoid pair (Figure 24).86 This is corroborated by the 
ability of metal carbenoids to undergo both cyclopropanation and insertion reactions in 
ethereal solvents.87 
 
Figure 24 
Although the intermolecular formation of oxonium ylides is usually disfavoured with 
repect to competitive pathways, the intramolecular formation of cyclic ylide systems, 
especially when subsequent rearrangement reactions are efficient, can push the 
equilibrium towards product formation. This type of transformation can be tuned by the 
choice of both metal and ligand in the carbenoid species.88 
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7.2 Reactivity of Oxonium Ylides 
Upon formation, oxonium ylides can undergo a synthetically useful [2,3]-sigmatropic 
rearrangement or [1,2]-shift (Stevens rearrangement) in the presence of suitable 
migrating functionality. Side reactions such as β-hydride elimination and deoxygenation 
of epoxides are also possible. When combined with the competitive reactivity of the 
parent metal carbenoid, the disadvantages of employing this methodology are evident. 
However, despite these apparent limitations, valuable studies concerning oxonium ylide 
chemistry published by several groups, have led to the methodology becoming a useful 
tool in modern organic synthesis. 
7.2.1 Deoxygenation of Epoxides 
Wittig and Schlosser described the deoxygentation of phenyloxirane to form styrene 
using a copper generated carbene in 1962.89 Subsequent work by Martin and Ganem 
established a more robust deoxygenation reaction for conversion of epoxides into their 
associated alkenes using a carbenoid generated from dimethyl diazomalonate and 
Rh2(OAc)4, or alternatively Rh2(Piv)4. The decomposition of ephemeral oxonium ylide 
162, illustrated in Scheme 31, provided good isolated yields of isomerically pure olefins 
163 in the presence of labile functionalities such as halides, ketones, acetates and TMS 
ethers but without secondary cyclopropanation occurring.90 
 
Scheme 31 
7.2.2 β-Hydride Elimination of Oxonium Ylides 
Several significant migratory reaction pathways can be followed upon the formation of 
an oxonium ylide. The first of these, β-hydride elimination, results in the degradation of 
the parent ylide 166 to form an ether 167 and an olefin 168, a generalised sequence 
for which is illustrated in Scheme 32. This reaction was first reported by Franzen and 
Fikentscher from the reaction of methylene with diethyl ether.91  
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Scheme 32 
7.2.3 Stevens Rearrangement of Oxonium Ylides 
A more synthetically useful reaction of an oxonium ylide is the Stevens rearangement, 
which involves the formal [1,2]-shift of an alkyl group adjacent to the ylide. The net 
result of the Stevens rearrangement is equivalent to the insertion of a carbene into a 
C-O ether bond (Scheme 33). The reaction was originally discovered in 1928, during 
Stevens’ work on ammonium ylides.92 
 
Scheme 33 
The Stevens Rearrangement is a high-energy, symmetry-forbidden process under the 
rules of Woodward and Hoffmann93 and hence mechanistic explanations have 
traditionally tended towards rationalisations involving radical pairs.94 CIDNP analysis of 
the reaction by Iwamura suggested that a singlet radical pair is formed through 
homolytic degradation of the transient ylide species 171, followed by a recombination 
of the radicals within the solvent cage to afford the [1,2]-shift product 174.95 
Use can be made of the [1,2]-shift reaction of oxonium ylides in forming oxo-bridged 
ring systems, as has been demonstrated by West and co-workers (Scheme 34).96 Use of 
rhodium dimers in generating the metal carbenoid intermediate from α-diazoketone 
175 led predominantly to C-H insertion products, in preference to oxonium ylide 
formation. Conversely, Cu(hfacac)2 afforded the oxo-bridged system 177, through [1,2]-
shift of oxonium ylide 176, with retention of starting material stereochemistry. This 
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stereochemical result was ascribed to the rapid recombination of the putative radical 
species during rearrangement.  
 
Scheme 34 
7.2.4 Competitive [1,2]-Stevens Rearrangement and [2,3]-Sigmatropic 
Rearrangement  
Although most alkyl groups can migrate in the [1,2]-shift of oxonium ylide systems, 
benzyl groups have found widespread use as migrating functionality in Stevens 
rearrangement reactions. West conducted a study, summarised in Scheme 35, on the 
effect of catalyst selection on the outcome of oxonium ylide rearrangement, in which 
both the [1,2]-shift of a benzyl group and the [2,3]-sigmatropic rearrangement of an 
allylic ether function were possible.97 The study showed that there is a defined 
preference for formation of the five-membered oxonium ylide 179, where rhodium 
dimers and Cu(hfacac)2 are used for the formation of the metal carbenoid. In these 
cases, formation of tetrahydrofuranone 181 resulted from [1,2]-shift of the benzyl 
group, but generation of the metal carbenoid with Cu(tfacac)2 afforded the six-
membered pyranone 182 preferentially. This result is suggestive of an equilibration 
between five and six-membered oxonium ylides 179 and 180, which allows for 
formation of the pyranone preferentially when the migratory group facilitates rapid 
rearrangement.  
 Chapter 1: Introduction 
 
49 
 
 
Scheme 35 
The preference for the rhodium catalysts for the formation of the furanone system was 
attributed towards to either, a shift in equilibrium through a stabilisation of the five-
membered ylide by the metal centre or a lack of preference towards migrating group 
where rhodium carbenoids are involved. The differences in reactivity observed through 
changes to both the metal and ligand in the catalyst suggest that the metal centre is 
associated with the transient oxonium ylide species. 
7.2.4.1 Asymmetric Induction of [1,2]-shifts of Oxonium Ylides 
The use of chiral ligands to influence the stereochemical outcome of the [1,2]-shift of 
oxonium ylides has been explored. Inspired by the moderately enantioselective, 
intermolecular oxonium ylide ring expansion reactions of Nozaki,98 Katsuki and co-
workers investigated the asymmetric ring expansion of oxetanes, to form 
tetrahydrofurans. Bipyridine ligand 187 was applied to the copper-catalysed reaction of 
t-butyl diazoacetate with oxetane 183 and subsequent intermolecular oxonium ylide 
formation.99 
Use of racemic 183 (Scheme 32, entry 1) was expected to result in the kinetic 
resolution of one enantiomer, yet the ratio of trans 185 and cis products 186 was 
essentially equimolar. The high degree of enantiomeric excess obtained for each 
product suggested that the catalyst was interacting in a stereodivergent fashion with 
each enantiomer of the starting material resulting in a highly enantioselective 
transformation upon [1,2]-shift. Use of chiral (R)-oxetane (entry 2) led to 
diastereoselective formation of the trans product with high levels of enatioselectivity, 
equally use of the (S)-oxetane resulted in preferential formation of the cis 
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diastereomer, with a correspondingly remarkable level of asymmetric induction 
(entry 3).  
 
Entry R dr 
185:186 
ee (%)  
trans 
ee (%)  
cis 
ee (%) 
recovered oxetane 
1 Ph 59:41 75 81 5 
2 (R)-Ph 89:11 92 16 87 
3 (S)-Ph 25:75 11 93 87 
Scheme 36 
The catalyst was believed to induce the formation of a chiral oxonium ylide which 
underwent [1,2]-rearrangement before oxonium inversion could occur. The group would 
later apply their ring-expanding [1,2]-shift to a total synthesis of trans-whiskey lactone 
188.100 
 
 
 
 
 
 
 
 Chapter 1: Introduction 
 
51 
 
Doyle et al. reported the desymmetrisation of acetonide 189 using the chiral rhodium 
carboxylate dimer Rh2(4S-MPPIM)4 191. High yields of the [1,2]-shift product 190 were 
reported, with an enantiomeric excess of 81%. Small quantities of C-H insertion side 
products were also produced (Scheme 37).101 
 
Scheme 37 
The stereoselective [1,2]-shift of an oxonium ylide formed from an acetal, was also 
explored by Zercher and co-workers in their studies concerning the synthesis of complex 
bridged bicyclic acetals. Reaction of α-diazo-β-ketoester 192 with Rh2(OAc)4 resulted in 
the formation the desired [1,2]-shift product 193, which the group noted was the core 
carbon structure found in the zaragozic acid family of natural products. Employment of 
Cu(hfacac)2 to generate the oxonium ylide resulted in both the required Stevens 
rearrangement product as well as the undesired [2,3]-sigmatropic rearrangement 
product, diene 194.102 
 
  Yield (%) 
Entry Catalyst Temp. (°C) 193 194 
1 Rh2(OAc)4 80 64 - 
2 Cu(hfacac)2 25 42 20 
Scheme 38 
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7.3 [2,3]-Sigmatropic Rearrangements of Oxonium Ylides 
As discussed briefly in the preceding section, when oxonium ylides are formed in the 
presence of an allylic function, [2,3]-sigmatropic rearrangement of the intermediate 
can occur. The initial report of this transformation, by Kirmse and Kapps in 1968, 
described the intermolecular reaction between allyl ether and the copper derived 
carbenoid of diazomethane. The major product of the reaction was the mono 
cyclopropanated adduct, with [2,3]-rearrangement providing the minor side product.103 
The synthetic utility of such rearrangements came to the fore in 1986 when Johnson and 
Pirrung independently reported the intramolecular cyclisation of allylic ethers bearing 
α-diazo carbonyl group when treated with rhodium acetate. Formation of furanones and 
pyranones were demonstrated to be achievable through rearrangements of oxonium 
ylides of type 196, as illustrated in Scheme 39.104  
 
Entry R n Yield 197 (%) 
1 CO2Me 1 91 
2 H 1 70 
3 CO2Me 2 53 
4 H 2 33 
Scheme 39 
The methodology was extended by Clark and co-workers during studies concerning both 
rhodium and copper catalysis, for the formation of 2,6-tetrahydropyran-3-ones and 
larger ring systems.105 Initial studies, based upon the reaction of α-diazoketones of type 
198 with various catalysts, demonstrated that tandem oxonium ylide formation and 
[2,3]-sigmatropic rearrangement was best facilitated by the use of electrophilic copper 
catalysts, in particular Cu(hfacac)2. Scheme 40 shows that use of rhodium carboxylate 
dimers and less electrophilic copper complexes promoted formation of the C-H insertion 
by-products 200. Application of the optimal copper catalyst to chain extended 
diazoketone precursors allowed an oxepane-3-one (entry 7) and an oxocan-3-one 
(entry 8) to be formed, albeit with attendant C-H insertion (entry 7) and in modest yield 
(entry 8). 
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Entry n Catalyst Solvent Temp. Yield 199 
(%) 
Yield 200 
(%) 
1 1 Rh2(OAc)4 CH2Cl2 rt 37 22 
2 1 Rh2(OAc)4 THF reflux 58 12 
3 1 Cu(acac)2 CH2Cl2 reflux 61 12 
4 1 Cu(tfacac)2 CH2Cl2 reflux 78 0 
5 1 Cu(hfacac)2 CH2Cl2 reflux 83 0 
6 2 Cu(acac)2 CH2Cl2 reflux 18 61 
7 2 Cu(hfacac)2 CH2Cl2 reflux 76 3 
8 3 Cu(hfacac)2 CH2Cl2 reflux 40 - 
Scheme 40 
The [2,3]-sigmatropic rearrangement of oxonium ylides does not occur on allylic 
functionality exclusively, Johnson and Pirrung demonstrated the applicability of the 
methodology to the formation tetrahydrofuranones bearing a pendant allene, the result 
of the [2,3]-rearrangement of a propargylic ether (Scheme 41).104 
 
Scheme 41 
 Chapter 1: Introduction 
 
54 
 
Doyle subsequently reported on the application of the [2,3]-sigmatropic rearrangement 
reaction of propargylic ethers to the formation of allene bearing macrocycle 206 using 
copper catalysis (Scheme 43). Reaction of rhodium(II) acetate with diazoester 205 led 
to selective cyclopropenation of the alkyne in a clear example of the importance of 
catalyst choice in the face of competing reactions.106 
 
   Product Distribution 
Entry Catalyst 
Combined 
Yield (%) 
206 207 208 
1 Cu(MeCN)4PF6 61 75 0 25 
2 Rh(OAc)4 62 0 96 4 
Scheme 42 
7.4 Diastereoselectivity of Intramolecular [2,3]-Sigmatropic 
Rearrangements 
7.4.1 Application to 2,5-trans tetrahydrofuran-3-one Formation 
Johnson and Roskamp’s initial report of intramolecular cyclisation reactions through 
transient oxonium ylides demonstrated that, upon formation of 2,5-tetrahydrofuran-3-
ones the 2,5-trans diastereomer predominated when dirhodium acetate was employed 
as the catalyst (Scheme 43, entry 1).104b Clark later reported that copper catalysts could 
be used in analogous transformations providing both higher yields of the desired 
products, as well as improved diastereocontrol in forming the 2,5-trans diastereoisomer 
210 (entries 2 and 3).107 
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Entry R Catalyst 
Combined 
Yield (%) 
dr 
210:211 
1 Me Rh2(OAc)4 65 92:8 
2 i-Pr Cu(acac)2 85 >97:3 
3 i-Pr Cu(acac)2 83 >97:3 
Scheme 43 
7.4.2 Application to 2,6-trans Tetrahydropyran-3-one Formation 
Studies by Clark, the results of which were published in 2003, explored the effect of 
catalyst choice on the stereoselectivity of 2,6-tetrahydropyran-3-one formation from 
diazoketones of type 210 (Scheme 44).108  
 
Entry Catalyst R 
Yield (%) 
213+214 
dr 
213:214 
Yield (%) 
215 
1 Cu(acac)2 Me 28 92:8 4 
2 Cu(acac)2 i-Pr 40 96:4 7 
3 Cu(tfacac)2 i-Pr 64 94:6 9 
4 Cu(hfacac)2 i-Pr 65 76:24 13 
5 Rh2(OAc)4 i-Pr 17 21:79 0 
Scheme 44 
Copper catalysis was again found to promote the formation of oxonium ylides and 
provide the desired 2,6-trans tetrahydropyran-3-one systems upon [2,3]-sigmatropic 
rearrangement. The catalyst of choice for 2,5-trans tetrahydrofuran-3-one formation, 
Cu(acac)2, afforded good stereoselectivity when applied to diazoketones of type 212  
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providing the 2,6-trans diastereomer 213 as the major product albeit in a low yield 
(entries 1 and 2). Increasing the electrophilic character of the metal carbenoid resulted 
in increased product yields, augmented formation of the 2,6-trans diastereomer and 
slightly increased formation of the [1,4]-rearranged side-product 215 (entries 2 and 3), 
whereas use of a rhodium dimer catalyst reversed the ratio of products to favour the 
2,6-cis isomer over the trans diastereomer (entry 5).  
7.4.3 Rationalisation of Diastereomeric Outcome 
Two models exist to explain the diastereoselectivity of the rearrangement reactions of 
the oxonium ylides, based on models of a free oxonium ylide, under which [2,3]-
rearrangement occurs in a classical fashion and an alternative in which the ylide is 
associated with the metal-ligand complex of the parent carbenoid.  
 
Figure 25 
Although the possibility exists for attack of the metal carbenoid 216 through either of 
the diastereotopic ether lone pairs, in practise one predominates to form the energy 
minimised transition state, in which the R substituent and migrating allylic functionality 
are located in equatorial positions (Figure 25). The diastereoselectivity of the 
rearrangement product is believed to originate from migration occurring on the least 
hindered face of the transition state i.e. that opposite to the bulky R substituent. 
Preferential formation of the 2,6-trans product suggests [2,3]-sigmatropic 
rearrangement occurs swiftly upon formation of the oxonium ylide. Furthermore, the 
trans to cis ratio variation with catalyst system implies that the oxonium ylide is 
associated to some degree with the metal centre. The stereochemical outcome can be 
envisaged as proceeding via one of the two possible pathways illustrated. Pathway A 
shows attack through an etheric lone pair onto the newly formed metal carbenoid and 
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the resulting metal associated product then rapidly rearranges with concomitant loss of 
the associated metal-ligand centre. The nature of metal association and stabilisation is 
not well understood and could derive from either the carbon-metal bond of 217 or the 
metal enolate 218.  
A second possibility exists in which the metal-ligand centre is lost completely to provide 
a free chiral oxonium ylide 219. Rapid rearrangement of the chiral oxonium system 
would follow along pathway B to provide the identical kinetic product gained through 
pathway A. Inversion of an oxonium centre is a phenomenon that is describe within the 
literature109 and provides the possibility of isomeric chiral oxonium ylides, which upon 
thermodynamic equilibration would afford diasteromeric product mixtures. The 
equilibrium between the oxonium ylide and its parent compounds (Figure 24), in 
addition to the product distributions obtained from intramolecular cyclisation reactions 
tending towards the predominance of a single diastereoisomer, means that the metal 
associated model is more likely than formation of a free oxonium ylide. However 
progression via pathway B and a free oxonium ylide cannot, as yet, be completely 
discounted. 
7.4.4 Application of Diastereoselective [2,3]-Rearrangements to Total 
Synthesis 
West’s studies on the formation of trans-fused polycyclic ethers, of the type found in 
marine natural products such as gambierol, led to the publication of an iterative 
approach to the formation of polyethers (Scheme 45).110 Diazoketone 221 was treated 
under optimised conditions to afford a diasteromeric mixture of oxabicycles 219 and 
223, resulting from the formation of an oxonium ylide and subsequent [2,3]-sigmatropic 
rearrangement, as well as the C-H insertion product 224. Epimerisation of ketones 222 
and 223 was followed by stereoselective reduction of the carbonyl group to afford the 
alcohol 225. Stepwise modification of the pendant groups afforded diazoketone 226, a 
precursor to a second tandem oxonium ylide-rearrangement sequence, providing access 
to tricyclic ketone 226. 
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Scheme 45 
The Clark group demonstrated the efficacy of the [2,3]-rearrangement reaction of 
oxonium ylides in total synthesis by using the reaction to construct of the 2,6-trans 
tetrahydrofuran-3-one core of  (±)-decarestrictine L 232 (Scheme 46).111 
 
Scheme 46 
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7.5 Bicyclic Ring Formation through Stereoselective [2,3]-
Sigmatropic Rearrangment  
The creation of bicyclic ring systems from suitably fashioned cyclic ethers can be 
accomplished through use of a tandem oxonium ylide formation/rearrangement 
strategy. Pirrung demonstrated an efficient route for the preparation of an eight-
membered bicyclic ketone 234 from the 2,5-trans tetrahydrofuran 230 (Scheme 47).104a  
 
Scheme 47 
An early example of the utility of this ring expansion reaction was published by Clark, 
who used the methodology to prepare the core bicyclic structure of neoliacinic acid 
240.112 The reaction sequence, shown in Scheme 48, used two key carbenoid 
transformations in the preparation of strategic oxacyclic intermediates. The primary 
transformation involved the Rh2(hfacac)4 catalysed C-H insertion of diazoketone 235 to 
form a 2,5-cis tetrahydrofuran-3-one, which was treated with methylmagnesium 
chloride to afford alcohol 236. After further manipulation of the pendant groups, the 
stage was set for the second carbenoid transformation, the copper-catalysed oxonium 
ylide formation and subsequent [2,3]-sigmatropic rearrangement reaction of 
diazoketone 237. Application of Cu(hfacac)2 to 237 afforded a mixture of the [1,2]-shift 
product as well as the desired [2,3]-sigmatropic rearrangement, albeit as a mixture of 
both E and Z isomers 238ab. The 2,6-cis stereochemistry of the bridgehead protons 
results from the spatial orientation of the nucleophilic centre with respect to the 
pendant allylic groups in the transition state (Figure 26). Nucleophilic attack of the 
allylic group, during the [2,3]-rearrangement is achieved from the proximal position of 
the six-membered oxonium system, leading to the formation of the cis isomer 
preferentially. 
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Scheme 48 
Both olefin isomers are produced as a consequence of the capacity of the oxonium ylide 
to rearrange through either of the oxonium ylides 242 or 243 shown in Figure 26. The 
3:2 ratio of E and Z isomers is suggestive of a small energy difference in the equilibrium 
of the transition states that is easily overcome. Subsequent work by Clark on the 
cladiellin family of natural products showed that the choice of metal and ligand in the 
carbenoid species is of prime importance in determining the outcome of olefin 
geometry in this type of transformation, providing evidence of metal association 
adjacent to the site of oxonium ylide formation.113 Following isolation of the products, 
conversion of the E olefin into the more stable Z isomer was found to be achievable 
using mercaptoethanol and a radical initiator. A similar oxonium ylide rearrangement 
strategy was also utilised in Clark’s synthesis of the tricyclic core 247 of labiatin A 
(Scheme 49).114 
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Figure 26 
 
 
Scheme 49 
In an elegant example of convergent total syntheses, a recent paper by Clark and co-
workers demonstrated how the ratio of E/Z isomers could be tuned through the 
judicious selection of solvent, temperature and most importantly catalyst. Reaction of 
Rh2(O2CCPh3)4 with diazoketone 248 afforded practical quantities of E-olefin 250 which 
was used to prepare eight members of the cladiellen family of natural products, the 
skeleton of which (252) is shown in Scheme 50.113  
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Entry Catalyst Solvent Yield (%) Z:E ratio 
1 Cu(hfacac)2 THF 74 6.9:1.0 
2 Rh2(O2CCPh3)4 1,2-dichloroethane 56 1.0:6.3 
Scheme 50 
The use of electrophilic ligands in copper catalysis has allowed the fine tuning of the 
oxonium ylide formation and rearrangement reaction to afford primarily the Z-olefin 
249, previously employed by Clark and co-workers in their synthesis of vigulariol 251.115 
These examples distinctly illustrate the effect of the metal centre on the 
diastereoselectivity of the reaction and provide further substantiation to a metal 
associated oxonium ylide intermediate. 
7.6 Stereochemistry of [2,3]-Rearranged Allylic Substituents 
A study on the transition states generated through oxonium ylide generation and [2,3]-
rearrangement of substituted olefins was conducted by Clark and co-workers in 2004.116 
The formation of 2,5-tetrahydrofuran-3-ones, as has been seen, was a well-studied 
reaction within the group, but the generation of stereochemistry in the allylic 
substituent through the [2,3]-rearrangement of the ephemeral oxonium ylide was 
relatively unexplored. An understanding of the nature of the rearrangement transition 
state, either endo or exo, was therefore of key importance in delivering the desired 
stereochemistry to the allylic position. In order to access the required stereochemistry 
of the product, the E-crotyl ether starting material 253a would have to rearrange 
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through the endo transition state shown in Scheme 51, alternatively the Z crotyl ether 
253b would have to pass through an exo transition state.  
 
Scheme 51 
To evaluate the course of the tandem oxonium ylide formation and [2,3]-sigmatropic 
rearrangement reaction, the E and Z-crotyl ethers 253a and 253b were prepared and 
treated independently with Cu(acac)2. As discussed previously, the cyclic oxonium ylide 
formed from allylic ethers such as 253 rearrange preferentially to afford 2,5-trans 
tetrahydrofuran-3-ones and this diastereoselective outcome was again observed from 
the experiments conducted. Rearrangement of Z-crotyl ether 253b afforded the 
unwanted diastereomer 254b in good yield and excellent diastereoselective control 
(75%, dr 95:5), indicating an endo transition state predominated the transformation. 
The desired isomeric product 255a was prepared in both excellent yield and with a high 
diastereomeric ratio from the E crotyl ether starting material 253a (88%, dr >92:8). 
Again, this outcome supported the occurrence of an endo transition state during the 
rearrangement reaction.  
The work of Hodgson and co-workers concerning the total synthesis of hyperolactone, 
an anti-HIV agent, relied upon a similar type of rearrangement reaction to afford the 
desired stereochemistry at the allylic position. Initial studies on model systems, shown 
in Scheme 52, supported the preference for an endo transition state in the [2,3]-
rearrangement of cyclic oxonium ylides, thereby affording tetrahydrofuranones of type 
258 in good yield and diastereoselective ratio.117 Optimisation of the reaction 
conditions for the one-pot process was subsequently allowed for an enantioselective 
preparation of  (−)-hyperolactone.118 
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Entry Alkene 
Yield  
(%) 
dr 
258:259 
1 
 
49 94:6 
2 
 
79 90:10 
3 
 
63 98:2 
4  82 98:2 
Scheme 52 
7.7 Asymmetric Induction of Tandem Oxonium Ylide Formation and 
[2,3]-Rearrangement 
The field of asymmetric induction in carbene reactions has been of intense interest to 
researchers for many years. Although both cyclopropanation and C-H insertion reactions 
have been well studied, the application of asymmetric induction in the case of oxonium 
ylide formation and rearrangement has only advanced within the last two decades. 
Several reports emerged in the early 1990’s regarding enantio-induction in the [2,3]-
sigmatropic rearrangement reaction of chalcogen ylides, particularly those of sulfur and 
selenium, by means of chiral rhodium, copper and cobalt complexes.119 Work on 
oxonium ylides, by comparison, has been sparser. 
7.7.1 Intramolecular Enantioselective Transformations 
McKervey published the first report of a [2,3]-sigmatropic rearrangement of the 
oxonium ylide derived from α-diazo-β-ketoesters of type 261a using the binol-phosphate 
dirhodium(II) complex 263. This reaction afforded 90% isolated yield of the [2,3]-
rearranged product 262a with a moderate 30% ee (Scheme 53, entry 1).120 Both the 
yield and enantio-induction of the reaction were improved by using the rhodium dimer 
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264, the ligand of which was derived from D-tert-leucine.121 Augumented 
stereoselectivity, through the use of chiral complexes, provides supplementary evidence 
for the transitional species being a metal-bound oxonium ylide in which the chiral 
ligands are proximal to the reacting centre. Aromatic α-diazo-β-keto esters, of type 
261, have proved to be suitable substrates for comparative studies of enantioselective 
oxonium ylide and [2,3]-sigmatropic rearrangements, and have been used in several 
experiments.  
Doyle had previously observed that rhodium(II) carboxamide dimers, despite being 
inferior substrates, apropos diazo decomposition, delivered higher degrees of 
asymmetric induction in subsequent reactions when compared to rhodium complexes 
bearing carboxylate ligands.101 The improved stereochemical outcomes from application 
of these catalysts were understood to be the result of the closer proximity of the 
reacting metal centre to the chiral appendages of the ligand, as illustrated by the 
generalised rhodium carboxamide carbenoid 260.  
 
Figure 27 
Inspired by these findings, the group of Moody prepared several chiral rhodium(II) 
carboxylates, such as 263 and 264, designed to facilitate the rapid decomposition of 
the diazo moiety to the metal carbenoid, but which secured the pendant chiral ligands 
in a comparable spatial position to those of carboxamide ligands. Scheme 53 (entries 4 
and 5) shows that these ligands provided good conversion of the starting material into 
the oxonium ylide resulting in the formation of the [2,3]-rearranged product, albeit 
with low levels of enantioinduction.122 Hodgson established that enantiomeric excesses 
of 62% could be achieved by the employment of Rh2[(R)-DDBNP]4 265 as a catalyst 
(entry 3),123 whilst the work of Hashimoto and co-workers led to the development of 
Rh2[(S)-PTTL]4 catalyst 268 (entry 6) which afforded 262a in 76% ee when the reaction 
was conducted at low temperature.124 
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Entry Catalyst R Solvent Temp. Yield (%) ee (%) 
1 263 Me CH2Cl2 reflux 92 30 
2 264 H Hexane 20 °C 96 60 
3 265 H Benzene 25 °C 46 62 
4 266 Me CH2Cl2 reflux 92 13 
5 267 Me CH2Cl2 reflux 92 12 
6 268 Me Toluene −10 °C 54 76 
Scheme 53 
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Calter and Sugathapala demonstrated that an enantioselective rearrangement of an 
allylic acetal, to form bicyclic ether 270, could be accomplished in moderate yield and 
with modest ee when performed using Davies’ Rh2[S-TBSP]4 complex 271 as the catalyst 
(Scheme 54).125 Hashimoto subsequently performed an analogous transformation using 
the Rh2(S-TFPTTL)4 dimer 272 as the catalyst, thereby improving dramatically both the 
yield and enantioselectivity of this novel transformation.126 
 
Entry Catalyst Solvent Temp. Yield (%) ee (%) 
1 271 Benzene reflux 34 34 
2 272 Toluene 0 °C 93 93 
Scheme 54 
The stereoselective formation of cis-macrocyclic structure 274 was achieved by Doyle in 
1998.127 Application of chiral bis-oxazoline ligand 275 and a copper(I) salt, to achiral 
α-diazoester 273 provided chemoselective oxonium ylide formation and [2,3]-
rearrangement, the only notable by-product being cyclopropanation of the olefin bond 
(Scheme 55). Although the reaction proceeded in low yield, the levels of 
enantioselectivity are notable for a poly-oxygenated system. Replacement of the copper 
catalyst with a chiral rhodium dimer was ineffective, resulting only in formation of 
trace amounts of 274. 
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Scheme 55 
In a rare example of copper-catalysed enantioselective tandem oxonium ylide formation 
and [2,3]-sigmatropic rearrangement, Clark established that tetrahydrofuran-3-ones 
could be constructed asymmetrically through decomposition of diazoketone 276, using a 
catalyst formed in situ from Cu(MeCN)4PF6 and diimine ligand 280, to afford 277 in 
reasonable yield and enantiomeric excess (Scheme 56).128 The modest induction of 
asymmetry in aliphatic substrates was also observed when the same catalyst system was 
applied to aromatic substrate 278. Although a higher yield of benzofuranone 279 was 
achieved, a decrease in enantiomeric excess was also observed when compared to the 
non-aromatic substrate 276. The variance in asymmetric induction between substrates 
was attributed to differences in the reaction pathways, from which high enantiomeric 
excess was ascribed to a significant metal association with the oxonium ylide, whilst low 
induction was thought to result from a transition state whose structure corresponded to 
a free ylide from which partial oxonium inversion occurred. 
 
Scheme 56 
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7.7.2 Intermolecular Stereoselective [2,3]-Rearrangements 
Although intramolecular cyclisation reactions involving oxonium ylides have been well 
studied in terms of reaction outcome and stereochemistry, the intermolecular variant of 
this type of reaction has, by comparison, received limited attention. The 
Rh2(OAc)4-catalysed decomposition of ethyl diazoaceate in the presence of either the 
cis or trans isomer of cinnamyl methyl ether was investigated by Doyle et al. in 1988. 
The outcome of the resultant tandem oxonium ylide formation and [2,3]-sigmatropic 
rearrangement reaction, illustrated in Scheme 57, provided evidence that the geometry 
of the alkene starting material translates into a preference for the 1,2-anti or 1,2-syn 
product.129  
 
Scheme 57 
In the case of trans cinnamyl methyl ether 281 the major product is the 1,2-anti 
diastereomer 282, whereas the reaction employing the cis isomer 283 results 
predominantly in the 1,2-syn isomer 284; the major side product of the reaction was 
the competitive cyclopropanation of the olefin. Doyle rationalised the highly 
diastereoselective nature of the reaction through application of the transition state 
models illustrated in Figure 28. 
 
Figure 28 
The highest energy transition states are those in which an eclipsed conformation exists 
between the ester group and that of the methyl group, hence transition states B and D 
are energetically disfavoured over A and C.  The cis cinnamyl methyl ether (R1=Ph, 
R2=H) reacts preferentially to form the 1,2-syn product through transition state A due to 
the minimised steric clash between the ester and phenyl groups, whereas in the case of 
the trans olefin (R1=H, R2=Ph), the 1,2-anti diastereomer is formed preferentially where 
transition state C is energetically minimised.   
 Chapter 1: Introduction 
 
70 
 
In 2006 Quinn et al. published a paper in which stereoselective three-carbon ring 
expansion of trans divinyl epoxides was accomplished using a [2,3]-sigmatropic 
rearrangement of an intermolecularly formed oxonium ylide.130 Scheme 58 illustrates 
that the C2-symmetry of the epoxide 285, when converted to an intermediate ylide 
species 287 allows for stereospecific rearrangement to dihydropyran 288 only. 
 
Scheme 58 
Recent attempts by Njardarson and co-workers, to follow the ring expansion chemistry 
established by Quinn, demonstrated that oxonium ylides formed intermolecularly from 
variously sized, asymmetric oxygen containing heterocycles of type 289 and ethyl 
diazoacetate, did not efficiently undergo [2,3]-rearranged ring expansion, but instead 
provided a mixture of the desired rearrangement products 290 and the [1,2]-shift 
products 291.131 Moreover, epoxides (entry 1) underwent preferential 
carbenoid-mediated deoxygenation to afford diene 292 (Scheme 59). 
 
    Product Distribution 
Entry n Ar 
Combined Yield (%) 
290+291 
290 291 
1 1 4-MePh 26 1 1.2 
2 2 Ph 72 1 
2.5 
(3:1, trans:cis) 
3 3 Ph 74 6 
1  
(trans only) 
Scheme 59 
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Despite the disappointing results of their ring expansion chemistry, the group refocused 
their attention on the reactivity of ylides generated from symmetric allylic ether 293 
(Scheme 60). In accordance with the results of Doyle129 the trans stereochemistry of the 
olefin bonds translated into the preferential formation of the anti diastereomer 295 
upon [2,3]-sigmatropic rearrangement of the transient ylide. Both rhodium and 
copper-catalysed decomposition of diazo acetophenone resulted in the the formation of 
oxonium ylides and [2,3]-rearrangement to afford the anti diastereomer preferentially. 
However, the optimal combination of yield and diastereomeric ratio was found to result 
from the use of Cu(tfacac)2 as the catalyst. The group introduced this reaction as the 
first stage of their two-step, one-pot, stereoselective formation of dihydropyran 296. 
 
Scheme 60 
8 Overview 
Metal carbenoid chemistry has, over the past three decades, added a set of highly 
controllable reactions to the toolkit of organic chemists. The application of a range of 
metal catalysts, particularly copper and rhodium complexes, for the controlled 
decomposition of diazo compounds has paved the way towards tuneable reactivity in 
three key areas, namely cyclopropanation, insertion and ylide formation.  
Oxonium ylide formation, and the attendant [1,2]-shift and [2,3]-sigmatropic 
rearrangement reactions of the short-lived intermediate, have shown excellent 
practical application to the diastereoselective formation of oxygen-containing 
hetereocycles; of particular note is the formation of 2,5-trans tetrahydrofuran and 2,6-
trans tetrahydropyran systems, which are motifs common to a number of isolated 
natural products. 
One such example is amphidinolide C, a structurally complex marine natural product, 
which shows promising anti-cancer bioactivity. Several groups have published syntheses 
of fragments of the natural product, in which various methodologies have been used to 
construct the two, 2,5-trans tetrahydrofurans embedded within the macrolactone 
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system. However, until recently the application of oxonium ylide rearrangement 
towards this target has not been explored. 
9 Addendum 
Subsequent to completion of this manuscript, a number of papers were published 
detailing partial and total syntheses of amphidinolides C and F. Primarily, Carter and 
Mahapatra used methodology analogous to that successfully applied to their synthesis of 
amphidinolide F to afford the first total synthesis of amphidinolide C.224  
September 2013 saw the publication by Fürstner and co-workers on the second total 
synthesis of amphidinolide F.225 Forsyth and Wu have also published details of their work 
on the preparation of the C-(1)–C-(14) and C-(15)–C-(25) fragments of amphidinolide 
C.226 
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10 Clark Group Approach to the Total Synthesis of 
Amphidinolide C 
Since the inception of this project in 2009, the approach towards the synthesis of 
amphidinolide C within the Clark group has been designed to be both modular and 
convergent. In common with Carter and Mahapatra’s approach, our strategy took into 
account the ‘hidden symmetry’ of the macrolide-embedded 2,5-trans tetrahydrofuran 
rings. The key feature of our strategy is the use of a common intermediate for the 
construction of both ‘northern’ and ‘southern’ hemisphere fragments in order that rapid 
construction of the macrocyclic skeleton could be achieved. The initial retrosynthetic 
analysis developed by the group, and shown in Figure 29, commences with the two 
almost ubiquitous disconnections across the lactone bond of the macrolactone and the 
C-(17)—C-(18) bond adjacent to the ketone of C-(18), thereby affording ‘northern 
hemisphere’ fragment 297 and ‘southern hemisphere’ fragment 298. Both resultant 
fragments are of similar size and complexity leading to a highly convergent synthesis. 
Forward connection would be facilitated firstly at C-(17)—C-(18) through a dithiane 
alkylation of 297 with alkyl iodide 298 and followed by Yamaguchi macrolactonisation. 
The northern hemisphere fragment 297 was further disconnected across the C-(26)—
C-(27) bond, with forward connection envisaged through a Heck or Stille coupling 
reaction, to afford vinyl iodide 300 and a vinyl organometallic reagent 299. Further 
disconnection of the iodide leads to a strategy involving Negishi carboalumination of 
alkyne 301. A Stille reagent of type 299 can be envisaged as being derived from 
hydrostannylation of a propargylic group, which itself is preparable through nucleophilic 
attack of a suitable alkyne onto an aldehyde at the C-(24) position. An aldehyde of this 
type can be prepared through various fuctional group interchanges on 2,5-trans 
dihydrofuran-3-one 306 which is the product of a copper-catalysed formation and 
rearrangement reaction of an oxonium ylide, or metal-bound ylide intermediate, 
formed from α-diazoketone 307, a reaction well studied within the group.
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Figure 29
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Southern hemisphere fragment 298 was developed from the same dihydrofuran-3-one 
through disconnection of the C-(10)—C-(11) alkene bond to afford a putative Horner-
Wadsworth-Emmons intermediate 302 and methyl ketone 303. The β-ketophosphonate 
was disconnected along the protected diol C-(7)—C-(8) bond and the methyl appendage 
of the furan ring at C-(4), again providing the 2,5-trans dihydrofuranone substrate 306 
as the key intermediate in the synthesis. The ketone coupling partner for the HWE 
reagent was disconnected along the C-(14)-C-(15) bond and can be seen as an advanced 
intermediate derived from a stereoselective aldol coupling of intermediates 304 and 
305. 
11 Preparation of a Common Intermediate 
11.1 Acetonide Protected Target 
An early candidate for a common intermediate system, incorporating the simplified 
introduction of the required C-(24) stereochemistry, was acetonide 309; this compound 
was believed to be accessible from the early stage enantiopure glyceraldehyde 88. The 
use of this starting material would allow, upon tandem oxonium ylide formation and 
[2,3]-sigmatropic rearrangement of α-diazoketone 308, access to the desired 
diastereomer from an inexpensive chiral pool starting material at an early stage in the 
synthesis. In addition to the early establishment of the C-(24) stereochemistry, facile 
oxidative cleavage of the deprotected diol would afford an aldehyde, which upon 
manipulation could deliver the foundation of the C-(7)—C-(8)-anti diol subunit of the 
macrolactone core. 
 
Figure 30 
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11.1.1 Formation of β-hydroxyester Intermediate - Reduction Methodology 
The starting material for this synthetic pathway was 1,2;5,6-diisopropylidene-D-
mannitol 310, an easily accessible derivative of D-mannitol (Scheme 61). The bis-
acetonide protection of the two terminal 1,2-diol units of D-mannitol was accomplished 
using 2,2-dimethoxypropane and catalytic tin(II) chloride in refluxing 1,2-
dimethoxyethane according to the methods of Schmid and co-workers.132 The reaction 
afforded the required 1,2;5,6-diacetal 312 in 58% isolated yield in addition to the 1,2-
monoacetal product 311 and the triacetalated material 313 in 9% and 17% yields, 
respectively. Upon isolation, the diol 312 was subjected to oxidative cleavage, using 
sodium periodate, to afford the enantiopure (R)-glyceraldehyde acetonide 88. As the 
procedures became standardised, isolation of the aldehyde, through vacuum 
distillation, routinely afforded the required compound in yields of up to 87%, with 
analysis consistant with that described in the literature.132  
 
 
Scheme 61 
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(R)-Glyceraldehyde acetonide is known to have poor stability and is prone to 
polymerisation even at low temperatures under a nitrogen atmosphere. In addition to 
the polymerisation problems, it is also known to form a highly water soluble hydrate in 
the presence of moisture, resulting in overall loss of material if not handled or stored 
correctly.132 Generally, subsequent reactions were performed with freshly distilled 
material to minimise the potential for loss of aldehyde on prolonged storage. 
Attainment of sufficient quantities of aldehyde 88 allowed investigations to turn to 
construction of the 2,5-trans tetrahydrofuran-3-one system 309, for which we required 
the precursor α-diazoketone 308. Introduction of the ester functionality required for 
formation of the required α-diazoketone began by reaction of aldehyde 88 with ethyl 
diazoacetate in the presence of a Lewis acid, to provide β-ketoester 314a. Various 
Lewis acids have been shown to be useful in achieving this type of C-H insertion 
reaction, including BF3∙OEt2,
133 SnCl2
134 and NbCl5;
135 alternative approaches to effecting 
this transformation have used Cu(II) and Rh(III) exchanged clays136 and zeolite 
catalysts.137 Initial efforts to effect the formation of 314a employed BF3∙OEt2 as the 
catalyst afforded complex reaction mixtures from which the desired β-ketoester was 
isolated in an unsatisfactory 16% yield. The 1H NMR spectrum of the isolated product 
showed an equilibrium mixture of β-ketoester 314a and tautomeric enol form 314b. A 
transformation using stannous chloride as the catalyst, as described originally by 
Roskamp and Holmquist,134 resulted in a cleaner reaction and a much improved isolated 
yield of 81%. 
 
Scheme 62 
In order to introduce the required C-5 R-stereochemistry to the target, 2,5-trans 
tetrahydrofuran-3-one 309, the ketone functionality of 314 was required to undergo 
stereoselective reduction. Pleasingly, Chikashita and co-workers had previously 
described an identical reduction reaction in 1989. Their work detailed the low 
temperature application of L-selectride [LiBH(sec-Bu)3] for the stereoselective reduction 
of a series of β-ketoesters, one of which resulted in the attainment of 1,2-syn 
diastereomer 315a in moderate yield and with excellent diastereocontrol.138 The 
mechanistic rationale for the stereoselective reduction relied on chelation of the 
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lithium cation with both the carbonyl and the β-ether groups of the acetonide, allowing 
preferential attack from the less hindered si face. In this fashion, 1,2-syn diasteromer 
315a is formed as the major product, whereas coordination through the α-ether and 
reduction from the re face results in the undesired 1,2-anti diastereomer 315b; both 
outcomes are illustrated in Figure 31. The results of Chikashita support the conclusion 
that high facial selectivity is engendered by use of reagents capable of chelation 
control, whilst reductants composed of poorly chelating metals, such as aluminium 
(DIBAL-H) and sodium (NaBH4) show only marginal preference for the 1,2-syn 
diastereomer. 
 
Figure 31 
In our hands, efforts to replicate these results were unsuccessful despite the use of 
various batches of L-selectride, solvents, temperatures and work-up conditions; a 
selection of results are illustrated in Table 3. Reductions using L-selectride and 
superhydride (entries 1 to 4 and entry 9 respectively) were monitored by TLC upon 
complete addition of the reductant, at the temperatures specified. In each case TLC 
analysis indicated consumption of the starting material and conversion to a more polar 
product. However, on work-up TLC analysis showed only a single spot of identical 
polarity to the starting material. 1H NMR analysis of isolated material showed that this 
was indeed the keto-enol 314, with no desired reduction having taken place. Increasing 
the concentration of reductant and variation of batch afforded no reaction nor did the 
extension of reaction time. Allowing the reaction to warm to ambient temperature 
(entry 3) led only to an intractable mixture from which the reduced product could not 
be isolated. The change in TLC profile observed during the reaction suggested that 
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coordination of the substrate and reductant was occurring, but was not followed by 
delivery of the hydride to the carbonyl group. 
 
Scheme 63 
Entry Reductant 
Eq. 
mol. 
Solvent 
Temp. 
(°C) 
Time 
(min) 
Yield (%) 
315a:315b 
dr 
315a:315b 
1 Li(sec-Bu)3BH 2.0 THF −78 180 — — 
2 Li(sec-Bu)3BH 2.0 THF −78 360 — — 
3 Li(sec-Bu)3BH 4.0 THF −78 to rt 300 Decomp. — 
4 Li(sec-Bu)3BH 3.0 Et2O −78 60 — — 
5 NaBH4 1.1 EtOH −78 30 95 56:44 
6 NaBH4 1.1 EtOH 0 30 94 50:50 
7 LiBH4 1.5 EtOH −78 30 90 50:50 
8 LiBH4 1.3 THF 0 30 — — 
9 LiBHEt3 1.1 THF −40 120 — — 
Table 3 
Less sterically encumbered reducing reagents were then applied to the system. As 
expected, NaBH4 delivered full reduction of the ketone but with no stereoselectivity 
even at low temperature (dr 56:44 syn:anti). LiBH4 in ethanol (entry 7) afforded no 
stereoselectivty in the reduction, but like NaBH4 fully reduced the starting material. 
Attempts to repeat the reduction in THF at 0 °C did not proceed most likely due to the 
poor solubility of the reductant (entry 9). Further attempts to pre-chelate the β-
ketoester with salts of lithium or zinc prior to reduction were unsuccessful in terms of 
diasteromeric outcome. 
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In an effort to advance the synthesis and test subsequent reactivity, efforts were made 
to isolate each of the diastereomeric β-hydroxyesters 315ab. During the course of 
purifying the products of reduction, attempts were made to separate the mixture by 
chromatography, but on each occasion attempted isolation was met with failure. It was 
found that derivatisation of the secondary alcohols as dimethylphenylsilyl ethers, as 
shown in Scheme 64, allowed for successful part-separation of the diastereomers on a 
100 mg scale. On isolation, the discrete products were treated with TBAF to regenerate 
the secondary alcohols and assignment of structure made by comparison to Herrera’s 
data for the 1,2-anti diastereomer 315b.139  
 
Scheme 64 
11.1.2 Formation of β-hydroxyester - Chiral Auxilliary Methodology 
Efforts to render formation of β-hydroxyester 315a stereoselective were undertaken 
using the chiral auxiliary procedures established by Sammakia and Zhang.140 Scheme 65 
illustrates the synthesis of the acetylated auxiliary unit 321, beginning from 
commercially available cysteine ethyl ester hydrochloride 317. Conversion of the 
starting material through reaction with carbon disufide allowed access to 
thiazolidinethione 318 in reasonable yield; an identical transformation was also 
accomplished with 1 1-thiocarbonyldiimidazole in a comparable 66% isolated yield.  
Tertiary alcohol 319 was formed by the addition of a methylcerium nucleophile, 
generated by combination of methyllithium and anhydrous cerium trichloride, a side-
step necessary due to epimerisation of the α-stereocentre through enolisation when 
using more basic nucleophiles. Addition of the cerium reagent to the ester group 
provided the required alcohol in 77% yield after recrystallisation from toluene. The 
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synthesis was completed by TES protection of the extant alcohol and acylation of the 
thiazolidinethione ring system.  
 
Scheme 65 
Attempts were made to accomplish the aldol addition of 321 to aldehyde 88 using 
dichlorophenylborane and (−)-sparteine to generate the enolate. Despite closely 
following the protocol of Sammakia, only complex reaction mixtures were obtained in 
each instance. Attempted purification of the reaction residues produced small amounts 
of material that, by 1H NMR analysis, contained the pertinent peaks of the product, as 
indicated by comparison to literature values, but also included many other artefacts 
that were inconsistent with the desired reactivity. Notwithstanding the disappointment 
of this initial result, a further attempt was made to effect the transformation using 
stannous triflate and N-ethylpiperidine to form the enolate at −78 °C, prior to addition 
of a freshly prepared batch of aldehyde. Analysis of an aliquot of reaction mixture 
showed only the presence of the auxiliary, the aldehyde appearing to have decomposed 
over a short period of time under the reaction conditions.  
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11.1.3 Subsequent Syntheses of the β-ketoester Intermediate 
As a quantity of the required β-hydroxyester 315a had been isolated cleanly through 
silyl ether derivitisation, efforts were made to allylate the free hydroxyl function using 
various procedures. Although treatment of alcohols with allyl bromide in the presence 
of silver(I) oxide has been used for the mild allylation of various diverse substrates 
including β-hydroesters,97 in our case no reaction was observed to occur when similar 
conditions were employed. An alternative approach, in which the allyl cation is 
generated in situ from allyl trichloroacetimidate in the presence of an acid catalyst has 
previously been used to form allylic ethers.141 Standard catalysts for this type of 
transformation include sulfonic acids, but in the case of compounds bearing acetal 
groups these conditions are too harsh, leading to loss of the protecting group. In related 
examples, Lewis acids have demonstrated useful reactivity in the formation of benzyl 
ethers from trichloroacetimidate precursors.142 It was hoped that treatment of alcohol 
315a with a freshly prepared batch of allyl trichloroacetimidate in toluene, using 
Sc(OTf)3 as the catalyst, would afford allyl ether 323. Disappointingly, on prolonged 
stirring the starting material remained unreacted.  
 
Scheme 66 
Allylation of the secondary alcohol was ultimately accomplished via palladium-catalysed 
generation of the allyl cation from allyl ethyl carbonate in degassed THF,143 as shown in 
Scheme 66. These conditions allowed high isolable yields of stereopure allyl ether 323 
to be obtained. When analogous conditions were applied to a diastereomeric mixture of 
 Chapter 2: Results and Discussion 
 
84 
 
β-hydroxyesters 315ab an isolated yield of 98% was achieved, but unfortunately the 
product diastereomers proved impossible to separate by chromatography.  
Attention subsequently turned to the conversion of the ethyl ester to an α-diazoketone 
via activation of carboxylic acid 324. Frustratingly, when ester 323 was exposed to 
hydrolysis using potassium hydroxide in alcohol, decomposition of the substrate ensued; 
the alternative use of potassium trimethylsilanolate as the nucleophile resulted in a 
sluggish reaction. At this stage, efforts to prepare an acetonide protected common 
intermediate were abandoned in favour a more practical route towards such an early 
stage intermediate. 
11.2 TBS and TBDPS Protected Targets 
The difficulties encountered during the attempted synthesis of 309, from the laborious 
preparation of aldehyde 88, through the non-stereoselective formation of desired β-
hydroxyester 315a and decomposition of the ester 323 on exposure to basic hydrolysis 
conditions had guided the project towards two significant conclusions. Firstly, the route 
used to introduce the stereochemistry, into what would become the C-5 position of the 
target 2,5-trans tetrahydrofuran-3-one, had to be amenable to scalable synthesis due to 
the early stage nature of the intermediate. Secondly, it was necessary to use a 
protecting group of greater stability than the originally chosen acetonide; in this case 
the use of silyl ethers was considered advantageous (Figure 32).  
 
Figure 32 
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The restructured synthetic route began from the commercially available chiral pool 
starting material D-malic acid, the enantiomer of which had proved to be a versatile 
starting material for a previous total synthesis project within the group.144 The keystone 
TBS-protected common intermediate 326a was prepared rapidly in seven steps from D-
malic acid 101 (Scheme 67). Bis-esterification of the carboxylic acids with methanol and 
thionyl chloride145 yielded D-methyl malate 325, the α-hydroxyester of which was 
selectively reduced using a combination of borane-DMS complex and sodium borohydride 
through the protocol of Saito and co-workers.146 The primary alcohol of the resulting 
diol 328, thus formed, was selectively protected using TBSCl, setting the stage for 
allylation of the secondary hydroxyl group.  
 
Scheme 67 
In the course of preparing a supplementary compound set, in which a TBDPS ether was 
used in place of the TBS protecting group, it had been found that allylation of this type 
of secondary alcohol could be achieved using the triflic acid catalysed activation of an 
allyl trichloroacetimidate (Scheme 68).147 Using this strategy, 2,5-trans tetrahydrofuran-
3-one 327b was prepared in seven steps and with an overall 36% yield.  
An initial attempt to convert TBS analogue 329a to allyl ether 330a, using triflic acid as 
the catalyst, led to a mixture of products through acidic cleavage of the TBS protecting 
group and non-selective allylation of the resultant diol 328. Further efforts employing 
CSA or PPTS as the catalyst did not furnish the desired allylated compound. However, 
high yields of 330a were obtained when the reaction was catalysed by triflic anhydride 
over the course of five days.148 An alternative allylation strategy, using the 
palladium-catalysed decomposition of allyl ethyl carbonate, afforded an inseparable 
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product mixture containing the desired material and a product that appeared to have 
resulted from migration of the silyl protecting group to the secondary hydroxyl group.  
 
Scheme 68 
Attempted hydrolysis of the methyl ester 330a by exposure to potassium 
trimethylsilanolate in THF, proved to be too sluggish for an acceptably reproducible 
procedure (Scheme 67). In contrast saponification using potassium hydroxide proceeded 
smoothly to afford the carboxylic acid 331a. Subsequent activation of the acid, either 
as the acid chloride or as a mixed anhydride, and treatment of the intermediate with 
freshly prepared diazomethane permitted access to the α-diazoketone 326a. The 
diazoketone was isolated as a green oil, indicating light absorbance in the visible 
spectrum, whilst the IR spectrum of the compound showed an intense absorbtion at 
2101 cm−1 corresponding to the diazo functionality.149 Both the 1H and 13C NMR spectra 
showed the presence of the newly formed CH=N2 group with signals at 5.34 and 55.5 
ppm respectively, thereby demonstrating the isolated material was the desired α-
diazoketone.  
As discussed in the previous chapter, α-diazocarbonyl compounds undergo extrusion of 
nitrogen to form metal carbenoids in the presence of metal catalysts. In cases of acyclic 
substrates where allylic ethers are present, these intermediates can then undergo 
oxonium ylide formation followed by a [2,3]-sigmatropic rearrangement, thereby 
forming oxygen-containing heterocycles in a highly diastereoselective fashion. In this 
case, α-diazoketone 326a, when exposed to Cu(acac)2 in refluxing THF, followed this 
pathway to afford 2,5-trans tetrahydrofuran-3-one 327a in excellent yield and as a 
single diastereomer (Scheme 69). As shown in Scheme 68, an analogous transformation 
was conducted to form the TBDPS protected substrate 327b and the NMR data of the 
compound again showed formation of a single diastereoisomer. Numerous examples 
within the group have shown that the rearrangement of oxonium ylides of this type 
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provide the desired 2,5-trans stereochemistry shown, the data for the isolated 
compound 327b was supported by these analyses and differed from data corresponding 
to the alternative 2,5-cis diastereomer.147 Further confirmation of the stereochemistry 
came from comparison of the data of advanced synthetic intermediates, to those of 
known compounds and will be discussed presently. 
 
Scheme 69 
While the benefits of forming 2,5-trans tetrahydrofuranones through the 
diastereoselective rearrangement of oxonium ylides is immediately apparent, the 
practical aspects of the synthesis require brief discussion. The safety hazards of 
diazomethane generation, both in terms of potential toxicity and explosive risk, require 
that distillation of the compound is conducted in a well-ventilated fume hood using 
apparatus with fire-polished jointed glassware. The glassware within our group limits 
the decomposition of Diazald to 100 mmol, which without loss would provide the 
equivalent molar concentration of diazomethane. The formation of diazoketone 326a 
from the mixed anhydride of 331a requires around 10 equivalent moles of 
diazomethane to maximise product yield, thereby limiting the scale of reaction to 10 
mmol scale, equating to 2.7 g of acid 331a as starting material. As 2,5-trans 
tetrahydrofuranone 327a is a relatively early stage intermediate in our process this 
scale issue constitutes an early bottleneck in the synthesis. The synthesis of diazoketone 
326a was typically conducted in duplicate, and the reactions combined for work up and 
purification prior to the tandem oxonium ylide and [2,3]-sigmatropic rearrangement 
reaction.  
The decomposition of diazoketone 326a, and rearrangement of the intermediate 
oxonium ylide to form the 2,5-trans tetrahydrofuran-3-one, generally occurred within 
thirty minutes if vigorous reflux was maintained throughout the course of the reaction. 
On occasion the reaction did not proceed, possibly due to inactive catalyst, but in such 
cases the starting α-diazoketone could be re-isolated almost quantitatively by column 
chromatography thereby showing the robust stability of 326a to thermolysis alone. The 
2,5-trans tetrahydrofuran-3-one 327a was isolated through simple concentration of the 
solution and direct purification of the residue; isolable yields of 85% to 95% were 
regularly achieved on reactions of up to 4 grams of α-diazoketone, with no observable 
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trace of the undesired 2,5-cis diastereomer. Although the possibility existed for a C-H 
insertion side reaction to form 332, or for an alternative six-membered oxonium ylide 
formation through 333, the products of neither outcome were observed (Figure 33). 
 
Figure 33 
12 Diversification of Common Intermediate  
12.1 Synthesis of C-(18)–C-(24) Fragment of Amphidinolide C — C-(21) 
Ketone Removal 
 
Figure 34 
12.1.1 Reductive Removal of C-(21) Ketone Functionality 
In differentiating the common intermediate 323a to provide the ‘northern’ construct 
297 (Figure 34), the immediate goal was deletion of the ketone group on what would 
become the C-(21) position of the natural product. Initial work on this problem was 
geared towards removal of the functionality through formation of the tosyl hydrazone 
followed by reduction of the intermediate species; an example of equivalent reactivity 
on tetrahydrofuranones was reported by McLaughlin in 2002.150 Although synthesis of the 
tosyl hydrazone 334 proved facile, reductive removal of the functionality using a 
number of reducing agents, including NaBH(OAc)3,
150 NaBH3CN,
151 and NaBH4,
152  proved 
impossible, leading only to intractable product mixtures in each case (Scheme 70). 
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Scheme 70 
12.1.2 Radical Deoxygenation of C-(21) Functionality 
An alternative approach to the problem was sought through the radical substitution 
methodology of Barton and McCombie153 whereby the ketone would be converted into a 
functional group that would undergo radical cleavage and hydride reduction. Initial 
anxieties concerning the possibility of cyclisation of the intermediate radical species 
with the pendant olefin in a 4-exo or 5-endo-trig fashion,154 would prove to be 
unfounded in practise (Figure 35). 
 
Figure 35 
Work on the sequence began with borohydride reduction of the ketone carbonyl group 
to form a diastereomeric mixture of alcohols on the C-(21) carbon. The diastereomers 
341a and 341b were separable by column chromatography and confirmation of absolute 
stereochemistry of the system was possible by comparison of the data for the 1,2-syn 
isomer 341a with that of a previously characterised sample prepared by Pagenkopf and 
Wang.155 Subsequent work on the compounds was conducted using the diastereomeric 
mixture of both alcohols. 
The alcohols were converted to their respective xanthate esters 342 by stepwise 
treatment with base, carbon disulfide and methyl iodide. This intermediate was not 
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purified but used directly in the subsequent deoxygenation step following work-up and 
concentration. Using tri-n-butyltin hydride and a radical initiator, both AIBN and ACHN 
proving germane, tetrahydrofuran 342 was deoxygenated smoothly to afford 343. 
Although the reaction proceeded cleanly to afford the required material, the compound 
could not be isolated by chromatography without the presence of a malodorous sulfur-
containing impurity.  
 
Scheme 71 
Isolation of unadulterated tetrahydrofuran substrate was accomplished by fluoride 
deprotection of TBS ether 343, column chromatography of the resultant alcohol 345 
allowing separation of the product from the foul-smelling impurity (Scheme 72). 
Although this alcohol was used in subsequent test reactions, alcohol 344 was the 
preferred and strategically required intermediate hence a consequent reprotection of 
the primary alcohol 345 was necessary, rendering this route synthetically superfluous. 
 
Scheme 72 
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As the impurity had been shown to be separable from the desired system by rendering 
the tetrahydrofuran compound more polar, a second approach involving direct 
transformation of the allyl functionality to primary alcohol 344 was investigated 
(Scheme 72). Preliminary attempts to effect this transformation involved 
dihydroxylation of the olefin, with subsequent oxidative cleavage of the intermediate 
1,2-diol and reduction of the resultant aldehyde affording alcohol 344 (Scheme 72). 
Disappointingly, formation of diol 346 failed possibly due to poisoning of the osmium, 
by the sulphur-based impurity, and so the reaction sequence was abandoned. An 
alternative approach, in which ozonolysis of the double bond was followed by 
borohydride reduction of the intermediate trioxolane, gratifyingly allowed access to 
alcohol 340 in 73% yield over four steps from ketone 327a (Scheme 71). The removal of 
the C-(21) oxygen substituent to form the desired tetrahydrofuran was confirmed by 
signals in the 1H NMR spectra at 2.11-2.02 and 1.63–1.53 ppm, integrating to one proton 
each for the newly formed CH2 group. A single peak in the 
13C NMR spectrum at 32.4 
ppm, showing HSQC correlation with both C-H signals confirmed the structure of the 
product.  
12.1.3 Orthogonal Protection of the C-(18)—C-(24) Fragment  
Masking of the primary alcohol of 344 was accomplished with two distinct protecting 
groups, namely TBDPS and PMB, in order to expand the potential late stage 
deprotection strategies for the C-(18) hydroxyl group. Upon protection of the pendant 
alcohol, the C-(24) TBS ether was removed selectively by means of CSA-catalysed 
deprotection in the case of bis-silyl ether 347, and by exposure to the fluoride anion in 
the case of PMB ether 349. 
 
Scheme 73 
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TBDPS ether 348 was used in the preliminary stages of construction of the C-(18)—C-
(34) fragment of the natural product, however the optimisation of an orthogonal 
protecting group strategy for this northern fragment would later require the 
exploitation of PMB protected ether 350. To this end, an alternative strategy towards 
the bulk synthesis of the fragment was investigated.  
12.1.4 Alternative Strategy in Forming C-(18)—C-(24) Fragment 
Due to the strictures of time at the final stages of the project, a more concise approach 
to the generation of the ‘Northern’ tetrahydrofuran 350 was sought which condensed 
the synthesis timeframes over those required for the previously discussed diazoketone 
rearrangement and Barton-McCombie deoxygenation steps. A variation on the procedure 
of Pagenkopf and Morra28 was used to form 350 in five steps from commercially 
available 1-buten-4-ol, as shown in Scheme 74. Protection of the alcohol with a PMB 
group proceeded in good yield and was followed by epoxidation of the alkene using 
standard m-CPBA methodology. Hydrolytic kinetic resolution of the racemic mixture, 
using the protocol of Jacobsen,26, 156 delivered the desired oxirane in a 39% yield, the 
data for which corresponded directly with that previously reported by Spilling and Roy.27 
Epoxide ring opening was achieved by the addition of allylmagnesium chloride, and the 
isolated compound again complemented literature data for the 5-hydroxypent-1-ene 
353.27 A diastereoselective, cobalt catalysed cyclisation then delivered the 2,5-trans 
tetrahydrofuran 350 in a 65% yield, the data for which matched precisely with that of 
the compound generated through the route involving tandem oxonium ylide and [2,3]-
sigmatropic rearrangement chemistry as previously discussed.    
 
Scheme 74 
Cobalt-catalysed cyclisations of this type had been investigated in the early 1990’s by 
Mukaiyama et al.157 In their original paper they reported an oxidative cyclisation of a 
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number of α-substituted 5-hydroxypent-1-ene starting materials 354, to form 2-
hydroxytetrahydrofurans 360 with varying C-5 substitutions (Figure 36). 
 
Figure 36 
The excellent stereocontrol of the reaction, affording exclusively the 2,5-trans product, 
was believed to derive from the minimised steric repulsion encountered between the α-
substituent at the 5–position of the radical intermediate 357 and the bound cobalt-
ligand complex in the cyclisation step. The NMM catalyst 366 used by Mukaiyama was 
improved by Pagenkopf by substitution of the NMM amide with NMP to give complex 
362. The diastereoselectivity of both catalysts were equivalent, but the NMP group was 
preferred due to the propensity of the tertiary amine to quaternarise in the presence of 
alkyl halides. The improved aqueous solubility of the quaternary amine facilitated 
removal of the catalyst system through simple extraction techniques.  
The catalyst was prepared, through the method of Pagenkopf, in three steps, beginning 
from formation of glyoxylate amide 364 through reaction of ethyl chlorooxoacetate 363 
and 1-methylpiperazine.158 The ester was subsequently reacted with the potassium 
enolate of pinacolone to afford ligand 365. Ligand exchange to form the cobalt(II) NMP2 
catalyst 362 was accomplished through reaction with cobalt(II) ethylhexanoate, the 
product being easily isolated by decanting off the mother liquor and washing the 
product with hexane (Scheme 75). 
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Scheme 75 
12.2 Synthesis of C-(18)—C-(26) Fragment — Introduction of C-(24) 
Stereochemistry 
12.2.1 Substrate Controlled Alkynylation 
With a range of tetrahydrofuryl alcohols in hand, attention turned to establishment of 
the C-(24) hydroxyl stereochemistry and the introduction of a synthetic handle to allow 
access to the C-(25)—C-(28) diene functionality. Formation of propargylic alcohol 363a 
was envisaged as a route towards creating this synthetic handle, as regio- and 
stereoselective hydrostannylation of the alkyne would permit test reactions to be 
conducted on future Stille cross-coupling methodology. 
Investigations into the creation of the desired C-(24) stereochemistry began by focussing 
on the ability of the aldehyde 366 to exert substrate control during the alkynylation 
through the α-chiral centre at the C-(23) position. It was hoped that through the use of 
chelation control, Figure 37, that the alkynylation would proceed to afford the desired 
C-(24) stereochemistry exclusively. To this end, magnesium and lithium acetylides were 
generated and added to aldehyde 366. 
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Scheme 76 
Entry Acetylide Additive 
Temp 
(°C) 
Solvent 
Yield 
(%) 
dr 
367a: 367b 
1 
 
— −78 
Et2O/ 
Et3N 
47 1:2 
2 
 
— −78 THF 68 1:2 
3 
 
— −78 THF 72 2:1 
4 
 
— 0 THF 72 2:1 
5 
 
MgBr2 −30 Et2O 71 1:1 
6 
 
MgBr2 −78 Et2O 71 1:2 
7 
 
ZnCl2 −78 — — — 
Table 4 
Frustratingly, no combination of reagent, additive, temperature or solvent system 
permitted stereoselective addition of the nucleophile to the aldehyde (Table 4). A 
single example of the addition of a structurally similar aldehyde to the lithium acetylide 
in THF at −78 °C afforded a dr of 9:1 in favour of the undesired stereochemistry, albeit 
in 38% yield; the reaction proved irreproducible when applied to aldehyde 366 (entry 
2). The use of a magnesium acetylide (entries 3 and 4) allowed marginal preference for 
the formation of the desired C-(23)—C-(24) 1,2-syn diastereomer. In contrast, attempts 
to pre-chelate the aldehyde and tetrahydrofuran ether with magnesium bromide did not 
provide the desired chelated intermediate for addition of the alkyne nucleophile 
(entries 5 and 6) and proceeded with a slight preference for the 1,2-anti diastereomer 
367b on addition of the nucleophile.  
Use of zinc chloride as a ligating additive did not afford either of the propargylic alcohol 
products, providing only unreacted aldehyde (entry 7). Pagenkopf and Morra would later 
report that stereoselective addition of a lithium acetylide to a similar aldehyde system 
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at −90 °C, using MTBE as solvent, offers a practical route towards the undesired C-(23)—
C-(24) 1,2-anti diastereomer, by Felkin-Anh controlled addition.159 
 
Figure 37 
12.2.2 Reagent Controlled Alkynylation Reaction 
The addition of zinc acetylides into aldehydes is a well-precedented reaction within the 
literature and has been rendered stereoselective through the use of numerous chiral 
ligands.160 Alkylzinc compounds have long been known to coordinate to the π-electrons 
of acetylenes, leaving the terminal hydrogen susceptible to deprotonation by weak 
tertiary amines. The nucleophiles thus formed can undergo stereoselective addition to 
carbonyl groups enabled by the ability of the zinc centres to coordinate to the chiral 
ligand, alkyne and the electrophile.161 
 
Figure 38 
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Carreira and co-workers eliminated the requirement for pyrophoric alkylzinc reagents, 
through replacement of the metal source with zinc triflate, and made the addition of 
the resultant zinc acetylide to aldehydes asymmetric through the use of N-
methylephedrine derived ligands.162 Tanaka et al would later apply Carreira’s 
methodology to the addition of zinc acetylides to 2-tetrahydrofuranaldehehydes, 
thereby synthesising propargylic alcohols of the type required for our total synthesis in a 
stereoselective manner.163 The proposed generalised asymmetric mechanism required to 
form the desired diastereomer is shown in Figure 38. 
 
Scheme 77 
Both primary alcohols 345 and 348 were used in the investigation of the reaction 
sequence shown in Scheme 77. Oxidation of the alcohol 348 to aldehyde 366 was 
accomplished in good yield using Dess-Martin periodinane as the oxidant. The analogous 
oxidation of 345 proceeded in 83% yield, with both compounds exhibiting the CHO 
proton signal at ~9.7 ppm in their respective 1H NMR spectra. Various attempts to effect 
the asymmetric introduction of trimethylsilyl acetylene using Carreira’s methodology 
failed, despite meticulous purification of reagents and intermediates, and careful drying 
of the zinc(II) triflate before use. Three separate batches of zinc(II) triflate were 
applied to the reaction, because disparities in results obtained from reagent batches 
was noted in the literature,164 but in each case the tested aldehyde always remained 
unreacted. 
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12.2.3 Stereoselective Reductions of Ynones 
An alternative approach was taken to generate the C-(24) secondary alcohol 
stereoselectively through the reduction of an ynone functionality. The reduction of two 
ynone substrates, TMS protected substrate 370 and deprotected analogue 372, were 
tested using a variety of reducing reagents. The TMS protected product was prepared 
easily through the Dess-Martin oxidation of diastereomeric mixtures of propargylic 
alcohols generated previously (Scheme 78).  
 
Scheme 78 
The second substrate 372 was formed by addition of commercially available 
ethynylmagnesium bromide to the Weinreb amide 371 (Scheme 79). This approach was 
found to be necessary because oxidation of propargylic alcohols lacking the terminal 
alkyne TMS group afforded difficult to resolve reaction mixtures; moreover, possible 
epimerisation of the adjacent C-(23) sterocentre could result from basic methanolysis of 
the TMS group of ynone 370. Weinreb amide 371 could also be used to prepare ynone 
370, providing an improved yield over the propargylic alcohol oxidation method 
illustrated in Scheme 78. 
 
Scheme 79 
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With ynone substrates 370 and 372 in hand, attention turned to the stereoselective 
reduction of the carbonyl functionality using a variety of reagents (Scheme 80). Use of 
chelating reducing reagents was expected to deliver the undesired 1,2-anti 
diastereomer through formation of the Cram chelate model, whereas non-chelating 
reductants under Felkin-Anh control should have allowed for preferential formation of 
1,2-syn product. A number of reductants were tested on both systems to assay the 
selectivity of the reduction; the results are shown in Table 5.   
 
Scheme 80 
The use of L-selectride on ynone 370, provided a marginal preference for the undesired 
1,2-anti diastereomer (Table 5, entry 1), however application to 372 yielded a mixture 
of products in a 1:1 ratio (entry 5). The use of Luche reduction conditions with both 370 
and 372 afforded a slight excess of the 1,2-syn product which corresponds to the Felkin-
Anh model of reduction (entries 2 and 6). This result was surprising when measured 
against a similar reduction applied to concurrent work on the ‘southern’ fragment, in 
which an analogous enone system was reduced with excellent levels of diastereocontrol; 
this work will be discussed subsequently (Section 12.5, Scheme 109). CBS reduction 
using both enantiomers of Corey’s methyl-oxazaborolidine ligands, which have 
previously demonstrated their usefulness in the stereoselective reduction of prochiral 
ynones,30 failed to deliver either diastereomer in good ratio (entries 3 and 4).  
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Entry Ynone Reductant Temp. Solvent 
Combined 
Yield (%) 
dr 
367a : 367b 
1 370 L-selectride −78 °C THF 82 2 : 3 
2 370 
NaBH4, 
CeCl3∙7H2O 
−78°C MeOH 90 3 : 2 
3 370 
BH3∙THF          
(R)-Me CBS 
ligand 
−78°C THF 94 1 : 2 
4 370 
BH3∙THF           
(S)-Me CBS 
ligand 
−78 °C THF 84 1 : 1 
      
dr 
378a : 378b 
5 372 L-selectride −78 °C THF 90 1 : 1 
6 372 
NaBH4, 
CeCl3∙7H2O 
−78 °C MeOH 95 3 : 2 
Table 5 
12.2.4 Resolution of Propargylic Alcohols 
Notwithstanding the disappointing results obtained when trying to control the C-(24) 
stereocentre, we had demonstrated that the C-(18)—(26) carbon backbone could be 
accessed through the chemistry discussed previously, albeit as an inseparable mixture of 
diastereomeric C-(24) alcohols; a methodology was subsequently sought to deliver the 
discrete compounds. 2001 saw publication of a paper by Gleason and Ajamianon on the 
use of a cobalt-mediated cycloisomerisation reaction in the formation of dihydrofuran 
systems.165 This paper proved to be of particular interest as it discussed the 
chromatographic isolation of intermediate dicobalt hexacarbonyl-alkyne complexes, the 
propargylic alcohols of which bore structural similarity to the diastereomeric mixture 
that we sought to separate.  
Treatment of a diasteromeric mixture of propargylic alcohols 367ab with dicobalt 
octacarbonyl in dichloromethane provided a mixture of separable brown oils, which 
upon independent oxidation of the complex with NMO allowed for recovery of the 
isolated compounds as single diastereomers. Curiously, this technique was found to be 
unsuccessful when applied to diasteromeric mixtures of propargylic alcohols 378ab in 
which the alkyne terminus was unprotected.  
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Scheme 81 
Assignment of the C-(24) hydroxyl stereochemistry was accomplished by analysis of the 
coupling constants between the C-(23) and C-(24) carbons, and comparison with the 
literature available for similar systems.166 The C-(23)—C-(24) syn coupling of the desired 
diastereomer 367a was measured at 3JHH=7.5 Hz, whereas that of the anti product 363b 
was determined to be 3JHH=3.3 Hz. In structurally similar α-tetrahydrofurylpropargylic 
alcohols, the erythro diastereomer exhibits vicinal coupling constants that are smaller 
(3JHH = 2-4 Hz) than that of the threo diastereomer (
3JHH=6-8 Hz).
167 A demonstrative 
example from the work of Gleason is shown in Figure 40.  
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Figure 39 
The Newman projections of compounds 367a and 367b, illustrated in Figure 39, 
demonstrate that the disparity in vicinal coupling constants is a product of the dihedral 
bond angle difference between the two protons.  
 
Figure 40 
12.3 Inversion of the 1,2-anti Diastereomer, Hydrostannylation and 
Attempted Stille Coupling 
With both C-(24) diastereomers in hand, attention turned to conversion of the alkyne 
functionality into a coupling partner for a palladium-catalysed coupling reaction. The 
original intention of the project was to use a Stille coupling reaction to connect the 
C-(26) and C-(27) carbons of amphidinolide C. This was originally envisaged as being 
achievable through transformation of the C-(25)—C-(26) terminal alkyne to a vinyl 
stannane through a palladium catalysed hydrostannylation. To this end, the TMS 
protecting group of 367a was cleaved from the alkyne under basic methanolysis 
conditions, affording propargylic alcohol 378a in excellent yield. In order to maximise 
the available quantity of alkyne 378a, the undesired stereochemistry of the 1,2-anti 
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diastereomer 367b was inverted through the protocol of Mitsunobu (Scheme 82).168 On 
work-up, the intermediate 4-nitrobenzoate 377 was not isolated but was instead 
treated with potassium carbonate and methanol to afford simultaneous cleavage of the 
terminal TMS and 4-nitrobenzoate groups. This two-pot three-step sequence proceeded 
in 88% yield to provide maximal quantities of alkyne 378a for subsequent work. 
 
Scheme 82 
Propargylic alcohol 378a was protected as a TES silyl ether and the alkyne converted 
into E-vinylstannane 380 through a palladium-catalysed hydrostannylation.169 The regio- 
and stereochemistry of vinylstannane 380 was confirmed by analysis of the 1H NMR 
spectrum, the vicinal coupling of the C-(25) and C-(26) alkene protons was measured at 
3JHH=19.1 Hz, indicating a trans alkene relationship.  
The vinyl iodide partner, required to afford the C-(18)—C-(34) fragment of 
amphidinolide C upon cross-coupling, had previously been synthesised by Yang but 
showed signs of instability on prolonged storage.170 It was decided at this stage to use 
the commercially available isocrotyl bromide to test the key Stille reaction. The benefit 
of this strategy extended beyond the safeguarding of precious stock of vinyl iodide 
precursor as it would also afford access to the C-(18)—C-(29) fragment 381 of 
amphidinolide F, if the cross-coupling methodology was effective (Scheme 83). 
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Scheme 83 
Initial attempts at the Stille cross-coupling of isocrotyl bromide and vinylstannane 380 
were entirely unsuccessful, resulting only in the recovery of starting material. Variation 
in palladium catalyst, as well as an attempted one-pot conversion of alkyne 379 directly 
into diene 381, in the presence of n-Bu3SnH and isocrotyl bromide,
169 afforded only 
unreacted vinylic stannane 380. 
12.4 Synthesis of C-(27)—C-(34) Fragment of Amphidinolide C  
The construction of the PMB protected tail fragment 382 of amphidinolide C was 
originally accomplished by Yang in six steps from hexanal.170 In the initial stages of the 
project, an orthogonal protection strategy was envisaged in which a PMB ether was to 
be used as the protecting group of choice for this C-(29) hydroxyl group and to this end 
a Lewis acid catalysed activation of PMB imidate was used to shield the allylic alcohol. 
Reports of problematic PMB deprotection of allylic alcohols in the presence of 
conjugated dienes,171 which would exist in the C-(25)—C-(29) locus of amphidinolide C, 
led us to subsequently explore alternative protecting groups for the C-(29) hydroxyl 
group. Nevertheless, palladium-catalysed methodologies were tested with this analogue 
in exploratory cross-coupling chemistry with alkyne 378a. 
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The route to PMB protected vinylic iodide 382 was replicated, with minor variation in 
step order and alteration of protecting group, to afford the TBS protected analogue 
386, as shown in Scheme 84.  
 
Figure 41 
Mannich methylenation of hexanal afforded enal 79 which upon treatment with the 
magnesium acetylide of trimethylsilylacetylene, yielded the racemic allylic alcohol 
80rac. Enantiopure 80 was then obtained via kinetic resolution of the racemate through 
Sharpless asymmetric epoxidation of the undesired C-(29) (R)-enantiomer.172 The highly 
conjugated secondary alcohol was protected as a TBS ether in excellent yield, affording 
intermediate 380.  
 
Scheme 84 
Removal of the terminal TMS group was accomplished under methanolysis conditions 
using potassium carbonate as base. Propargylic alcohol 385 was then converted into 
vinyl iodide 386 through the zirconium-catalysed carboalumination chemistry pioneered 
by Negishi et al.173 The water accelerated variant of this reaction described by Wipf174 
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was used in our case, providing methylated vinyl iodide 386 in poor yield. Although this 
conversion was reported by Yang to proceed with yields of up to 90%,170 these results 
proved impossible to duplicate despite numerous attempts. An alternative preparation 
of 386 from alkyne 385 using carbostannation/iodination procedures, as previously 
employed in Fürstner’s synthesis of amphidinolide B1,175 failed to deliver the required 
vinyl iodide (Scheme 85). 
 
Scheme 85 
12.5 Preparation of the C-(18)—C-(34) Fragment of Amphidinolide C: 
Sonogashira Cross-Coupling 
Our disappointment at the failure of Stille cross-coupling to effect the union of 
fragment 379 with isocrotyl bromide (Scheme 83) led us to explore alternative 
procedures to construct the C-(26)—C-(27) bond. Inspection of the intermediate 
components available to us, led to the conclusion that a possible palladium-catalysed 
cross-coupling could result from the direct reaction of vinyl halides and alkyne 379.  
In 1975, publications from Heck,176 Cassar177 and Sonogashira178 appeared concerning 
palladium-catalysed couplings of aryl and vinyl halides to terminal alkynes. Heck and 
Cassar showed that the cross-coupling reaction could occur in the absence of copper if 
elevated temperatures were employed for the transformation, while Sonogashira proved 
that the reaction is accelerated if a copper(I) co-catalyst is employed. The use of 
copper to couple alkynes was previously known from the Glaser179 and Cadiot-
Chodkiewicz180 reactions and was exploited by Sonogashira, in combination with the 
palladium catalytic cycle, to provide a powerful methodology to the organic synthesis 
community. The Sonogashira coupling, as we were to find, often suffers from the 
shortcoming of latent alkyne homo-coupling, affording dimeric side-products through 
the Glaser reaction. 
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Scheme 86 
The preliminary work progressed well, as shown in Scheme 86. A test coupling reaction 
of 7 mg alkyne 378a with the PMB protected vinyl iodide 382 delivered the desired 
enyne 387 in 64% yield, the coupling of the fragments was confirmed by 1H and 13C NMR 
analysis of the product. Although the NMR data was in accordance with the desired 
structure, the sample was visibly contaminated with brown residue, originating from 
either the palladium catalyst or copper(I) co-catalyst. The crude product was taken 
forward to the subsequent step, the Red-Al reduction of the propargylic alcohol, to 
afford the desired (E,E)-dienol 388 in 71% yield. Pagenkopf and Morra had previously 
demonstrated that this propargylic reduction was a feasible route to forming the C-
(25)—C-(28) dienol bonds of amphidinolide C.159  
A further batch of C-(29) PMB protected vinyl iodide 382 was prepared by Guang Yang 
and attempts to repeat the coupling on larger scale were undertaken. Unfortunately, 
the reaction did not proceed efficiently allowing only for recovery of starting alkyne 
378. The synthesis of 382, through Negishi carboalumination and subsequent PMB 
protection, was a delicate operation and isolation of the product hampered by the 
lipophilicity of the reaction residue on chromatography. Additionally, the instability of 
the vinyl iodide did not facilitate an easy transformation. Initially it was believed that 
residual PMB-trichloroacetimidate artefacts, resulting from the protection step, were 
responsible for poisoning the catalyst through coordination of the complex. In order to 
test this hypothesis, simultaneous Sonogashira couplings of alkyne 378a were 
undertaken with unprotected racemic and PMB protected enatiopure vinyl iodides. The 
desired coupling occurred with the unprotected species, albeit in a disappointing 29% 
yield, whilst the PMB protected intermediate failed to undergo cross-coupling. It was 
decided at this stage to move the strategy away from the use of the PMB protected vinyl 
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iodide towards a substrate bearing a protecting group with greater amenability to the 
synthesis, namely the TBS ether 386 described in Scheme 84.  
12.6 Synthesis of the C-(18)—C-(29) Fragment of Amphidinolide F: 
Palladium Cross-Coupling Methodology 
Although cross-coupling of alkyne 378a with vinyl iodide 382 had proved possible, the 
reaction sequence was largely irreproducible, varying from batch to batch of vinyl 
iodide. In an attempt to develop a more reproducible methodology, we turned our 
attention towards the cross-coupling of alkyne 378a with commercially available 
isocrotyl bromide. In this way, it was hoped that access to the northern fragment of 
amphidinolide F could be attained before employing the optimised methodology to 
couple alkyne 378a with the vinyl iodide fragment 386. The conditions previously 
illustrated in Scheme 83, demonstrate that Stille cross-coupling had failed to provide 
the C-(18)—C-(29) fragment of amphidinolide F, through reaction of isocrotyl bromide 
with a vinyl stannane. Despite this failure, it was hoped that palladium-catalysed alkyne 
cross-coupling could be used to effect an equivalent transformation. The resulting 
enyne intermediate would then undergo an equivalent C-(24) hydroxyl-controlled 
propargylic reduction, resulting in the formation of the (E,E)-dienol present in the 
natural product. 
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12.6.1 Amphidinolide F: C-(18)—C-(29) Fragment: Copper co-catalysed 
Palladium Cross-Couplings 
We anticipated that Sonogashira methodology would be an appropriate means of cleanly 
cross-coupling our alkyne and the commercially available isocrotyl bromide coupling 
partner. Significant problems with this methodology quickly became apparent, when 
initial test reactions resulted in alkyne dimerisation in the presence of Cu(I) salts and 
the desired cross-coupled product proved highly elusive at the early stages of the 
investigation. 
 
Scheme 87 
The initial reaction was undertaken using the standard Sonogashira conditions which 
resulted in cross-coupling of alkyne 378a to vinyl iodide 382 (Scheme 86). TLC analysis 
showed complete conversion of the alkyne to an unexpectedly more polar product when 
the reaction was conducted at ambient temperature, using a combination of Pd(PPh3)4 
and copper(I) iodide catalysts (Scheme 87, Table 6). Upon isolation and analysis of the 
newly formed product, it was found that the Glaser homo-coupled product 392 was the 
sole isolable material from the reaction (entry 1). Variation of catalyst loading, base 
and temperature were undertaken in accordance with diverse literature procedures 
(entries 2 to 6). Frustratingly, each adaptation failed to deliver the desired enyne 
system and the sole result of each of these experiments was, again, Glaser homo-
coupling of the starting alkyne. Characterisation of the unwanted product was 
signposted in the 1H NMR spectrum through loss of the terminal alkyne proton signal at 
2.24 ppm, whilst all other signals remained; disappearance of the corresponding alkyne 
C-H stretch in the FT-IR spectrum, previously observed at 3299 cm−1, further 
substantiated evidence of homo-coupling. The order of addition of reagents was 
explored, as was pre-stirring of the vinyl bromide with catalyst before slow addition of 
the alkyne in rigorously degassed solvents. The latter experiment did not result in any 
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reaction under an argon atmosphere, but on brief exposure to oxygen the homo-coupled 
dimer formed rapidly. Attempts to convert isocrotyl bromide 385 into the more reactive 
isocrotyl iodide 390, through treatment with sodium iodide in DMF at 160 °C following 
the procedures of Liu,181 did not deliver appreciable amounts of the cross-coupled 
product when the putative vinyl iodide was used in the 
Sonogashira reaction (Scheme 88). 
Entry Alkyne Catalyst System 
Solvent 
Base 
Temp. 
Yield (%) 
390 
 
Yield (%) 
392 
 
1 378a 
Pd(PPh3)4 [10 mol%] 
Cu(I)I [10 mol%] 
THF 
Et3N 
rt 0 84 
2 378a 
Pd(PPh3)4 [10 mol%] 
Cu(I)I [5 mol%] 
THF 
Et3N 
rt 0 
Not 
isolatedd 
3 378a 
Pd(PPh3)4 [10 mol%] 
Cu(I)Br [5 mol%] 
THF 
Et3N 
rt 0 
Not 
isolatedd 
4 378a 
Pd(PPh3)4 [10 mol%] 
Cu(I)I [5 mol%] 
THF 
Et3N 
50 °C 0 80 
5a 378a 
Pd(PPh3)4 [10 mol%] 
Cu(I)I [10 mol%] 
Benzene 
n-BuNH2 
rt 0 
Not 
isolatedd 
6b 378a 
Pd(PPh3)2Cl2 [10 mol%] 
Cu(I)I [5 mol%] 
i-Pr2NH rt 0 
Not 
isolatedd 
7c 378a Pd(PPh3)4  [5 mol%] Pyrrolidine 50 °C 75 N/A 
     
Yield (%) 
391 
 
Yield (%) 
393 
 
8 379 Pd(PPh3)4 [5 mol%] Pyrrolidine 50 °C 64 N/A 
For examples of similar conditions see; a. Burke et al;182 b. Echavarren et al;183 c. Linstrumelle et al;.184 d. 
Structure determined from analysis of the crude 1H NMR spectrum. 
Table 6 
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Scheme 88 
12.6.2 Amphidinolide F: C-(18)—C-(29) Fragment: Copper Free Palladium 
Cross-Couplings 
In order to remove copper from the cross-coupling protocols two procedures were 
investigated. Kumada-type cross-coupling185 did not result in reaction between 
TES-protected alkyne 379 and isocrotyl bromide (Scheme 89). We subsequently 
explored the application of the Heck alkynylation reaction, sometimes referred to in the 
literature as a ‘copper-free Sonogashira’ coupling.186  
 
Scheme 89 
A number of authors have shown that the cross-coupling of alkynes to aryl and vinyl 
halides can be accomplished in the presence of Pd0 catalyst and a judicious choice of 
base.186 The traditionally accepted mechanism for the copper-associated Sonogashira 
coupling is shown in Figure 41. The sequence comprises two catalytic cycles, the upper 
palladium cycle and the lower copper cycle.  
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Figure 42 
Activation of the alkyne is believed to result from the formation of a copper(I) π-
complex, which renders the terminal hydrogen more acidic, and therefore more labile 
to deprotonation by the ubiquitous amine base. Upon deprotonation and formation of 
the terminal copper acetylide, the intermediate can then undergo transmetallation with 
the active palladium complex, formed through oxidative insertion of the Pd0 catalyst 
into the aryl or vinyl halide starting material. Reductive elimination of palladium 
provides the cross-coupled compound and regenerates the palladium catalyst for further 
catalytic cycles. 
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Figure 43 
Various groups have demonstrated that the use of copper(I) is not necessary to afford 
equivalent reactivity and that cross-coupling can proceed in the presence of a Pd0 
catalyst and an amine alone.186 Jutand and co-workers studied the course of this cross-
coupling methodology and proposed two catalytic cycles that were dependent upon the 
ability of the amine to act as a ligand for the palladium centre, both cycles are shown in 
Figure 43.187 Pathway A occurs where the alkyne provides a better ligand to the 
palladium complex than the amine, resulting in an acetylide that can be deprotonated 
by the excess base and form the desired product upon reductive elimination. Pathway B 
is the result of the amine being able to act as a better ligand to the palladium(II) 
complex than the alkyne, thereby forming a more active intermediate that can 
accelerate the π-complexation of the alkyne. Deprotonation of the intermediate 
complex is followed by reductive elimination to form the cross-coupled product and 
regeneration of the catalyst. The pathway the reaction takes is determined by which 
complexation is faster, either that of the alkyne or amine, but the net result is the 
formation of the same cross-coupled product without the possibility of side reaction 
through Glaser coupling. 
Using the procedure of Linstrumelle et al,184 where pyrrolidine was employed as the 
reaction solvent and base, TES-protected alkyne 379 was successfully coupled to 
isocrotyl bromide 389 in 64% yield (Table 6, entry 8). The TES ether was shown to be 
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cleavable on short exposure to CSA to afford the desired, diastereomerically pure, 
propargylic alcohol 390 in 96% isolated yield. A further cross-coupling with the free 
hydroxyl propargylic alcohol 378 gratifyingly allowed direct access to the C-(18)—C-(29) 
carbon backbone of amphidinolide F 390 in 75% yield (entry 7). 
 
Scheme 90 
12.6.3 Amphidinolide F: Completion of C-(18)—C-(29) Fragment  
The stereospecific formation of (2E,4E)-dienol 395 was accomplished through the 
application of aluminium hydride reagents; both LiAlH4 at 30 °C and Red-Al at 0 °C 
provided the required compound in good yield and with excellent olefin geometry 
control (Scheme 91). The stereospecificity of this reduction is controlled by the 
proximal alcohol group, which upon chelation to the aluminium centre allows for 
transmetallation of the alkyne in a syn fashion.188 Upon hydrolysis of the vinylic 
aluminium intermediate, the complex decomposed to liberate the C-(25)—C-(26) trans 
alkene 395. Although in practice both reagents deliver the required dienol system the 
use of Red-Al was considered to be preferential in this sequence owing to the more 
facile work-up procedures employed for isolation of the product. The stereochemical 
assignment of (E)-alkene formation was ascribed based upon the C-(25)—C-(26) coupling 
constant (3JHH=15.2 Hz) and comparison of our data to that of previous literature data 
for compounds used in amphidinolide F fragment preparation.23, 25 
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Scheme 91 
With dieneol 395 in hand, test reactions were attempted in order to access C-(18) 
dithane target 400. MOM ether protection of the secondary alcohol was accomplished 
smoothly, as was the subsequent fluoride-mediated deprotection of TPDPS ether to 
afford primary alcohol 397. Partial oxidation of the alcohol yielded aldehyde 398, a 
potential C-(18) coupling partner for later syntheses. However, subsequent efforts to 
form dithiane 400 by treatment of the aldehyde with 1,3-propanedithiol, under Lewis 
acid catalysis, led to decomposition of the small amount of isolated material. The large 
loss of sample mass engendered by the removal of the TBDPS group, in conjunction with 
time limitations, meant that only a single attempt was made to prepare the dithiane 
400. 
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12.6.4 Amphidinolide C: C-(18)—C-(34) Fragment via Copper Free Cross-
Couplings 
The success of the pyrrolidine-aided cross-coupling reaction in preparing the ‘northern’ 
C-(18)—C-(29) fragment of amphidinolide F led us to apply the same methodology to the 
preparation of the C-(18)—C-(39) of amphidinolide C. Table 7 shows the results of the 
test reactions conducted on various alkyne analogues and vinyl iodide substrates in the 
preparation of Markush structure 402 (Scheme 92). 
 
Scheme 92 
Entry Alkyne R1 R2 
Yield (%) 
402 
1 378a H (rac)-OH 77 
2 379 TES (rac)-OH 71 
3 378a H (S)-OTBS 36 
Table 7 
As the racemic variant of the C-(29) unprotected vinyl iodide was readily available at 
the time of testing, two trial cross-couplings were conducted on this substrate. 
Application of the palladium-catalysed, pyrrolidine-solvated alkynylation methodology 
to the reaction of alkynes 378a and 379 with the racemic vinyl iodide afforded the 
cross-coupled product in good yield (Table 7, entries 1 and 2). Although the use of a 
racemic vinyl iodide initially seems to be of little synthetic value, the application of the 
methodology to the functionisation of TES-protected alkyne 379 (entry 2) potentially 
provided a substrate that, it was hoped, could be advantageously exploited through the 
reaction sequence shown in Scheme 93. A Corey-Bakshi-Shibata reagent-controlled 
stereoselective reduction of an analogue of the highly conjugated enone system 404 has 
precedent in the literature and it was hoped that this reaction would deliver the desired 
C-(29) stereochemistry.159 As discussed formerly (Section 10.4, Scheme 84), our route 
towards generating this stereocentre required removal of the undesired enantiomer of 
80rac by kinetic resolution, which resulted in substantial loss of potentially useful 
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material. Although the highly unsaturated ketone 404 was isolable from the oxidation of 
403 using manganese dioxide, the intermediate was prone to decomposition on 
standing, rendering it unusable for the proposed reduction.  
 
Scheme 93 
Synthesis of the C-(29) (S)-TBS protected vinyl iodide 381 was accomplished (section 
10.4, Scheme 85) and it was subjected to the cross-coupling under the copper-free 
conditions discussed previously (Table 6, entry 7). Although full consumption of the 
starting alkyne 374 was observed during the course of the reaction, the isolated yield of 
the cross-coupled product was only 36%. A second product, in which cross-coupling 
occurred but from which anomalous loss of the C-(29) OTBS group was also apparent, 
was also isolated; the structure of this by-product remains undetermined. Yang would 
subsequently demonstrate that slow addition of alkyne 378ab, facilitated by a syringe 
pump, to a heated solution of vinyl iodide 386, Pd(PPh3)2Cl2 and Cu(I) resulted in 
Sonogashira cross-coupling of the reactants in a yield of 82% (Scheme 94).170 
 
Scheme 94 
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12.7 Amphidinolide C: C-(18)—C-(34) Fragment via Alkynylation 
Methodology 
Although it had been established that palladium cross-coupling methods could be used 
to prepare the ‘northern’ fragments of both amphidinolides C and F, an alternative 
methodology was developed concurrently, involving alkynylation of a suitably 
functionalised tetrahydrofuran, to generate the C-(18)—C-(34) fragment of 
amphidinolide C.  
 
Figure 44 
We had previously discounted the use of a PMB ether to protect the C-(29) hydroxyl 
group, due to potential difficulties with removal of the group whilst adjacent to the 
C-(25)—C-(28) (E,E)-diene. A C-(29) hydroxyl protection as a TBS ether was an 
appropriate alternative, necessitating the use of a protecting group of greater lability 
on the C-(24) hydroxyl. This alteration was required as the C-(24) alcohol was required 
for Yamaguchi esterification at an advanced stage of the synthesis. As both silyl ethers 
were of inferior stability to the previously used C-(18) TBDPS group, it became 
strategically necessary to alter the C-(18) functionality to better enable selective 
deprotection of this key position; as shown previously the C-(18) PMB ether had been 
prepared from alcohol 344 (Section 10.1.3, Scheme 73). It was decided to use this 
compound, in the hope that its remoteness from the C-(25)—C-(28) (E,E)-diene would 
not cause unwanted reactivity during deprotection. The target compound 407 is shown 
in Figure 44. 
12.7.1 Amphidinolide C: Synthesis of the C-(25)—C-(34) Fragment 
Construction of the enyne C-(25)—C-(34) fragment was accomplished from the 
enatiomerically pure alkyne 80 (Scheme 95), an intermediate that had been prepared 
during the synthesis of vinyl iodide 386. The preliminary reaction in the sequence 
involved the mercury-catalysed hydrolysis of the terminal alkyne to afford α-hydroxy 
ketone 408. The possibility of acid-catalysed epimerisation of the adjacent secondary 
alcohol was a source of concern at this early stage, but other researchers had previously 
shown that the integrity of an α-chiral centre was preserved in hydrolysis reactions of 
this type.189 The methodology of Ley and co-workers in their synthesis of tetronasin was 
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applied to alkyne 80, allowing isolation of the enantiopure α-hydroxy ketone 408 in 
good yield.190 Although enolisation of the α-hydroxy stereocentre did not occur, the 
compound was not amenable to prolonged storage and was used in the following step 
immediately. 
 
Scheme 95 
The C-(29) hydroxyl required the protection of a TBS ether and so attempts were made 
to directly protect alcohol 408 using either TBS chloride or TBS triflate. However, this 
approach was found to be impractical through a combination of slow silation, possibly 
owing to steric factors, and the instability of the starting material. Protection of the 
secondary hydroxyl was deemed to be advantageous in the ensuing olefination step and 
so an alternative protecting group was sought. In contrast to the aborted TBS 
protection, we found that reaction of 408 with TES chloride resulted in full conversion 
of the starting material into the desired product in less than two hours and in excellent 
yield. 
Horner-Wadsworth-Emmons olefination of methyl ketone 409 with propargylic 
phosphanate ester 414,191 provided the desired enyne 410. Universal deprotection of 
the silyl groups was accomplished using a fluoride source and the integrity of the C-(29) 
hydroxyl stereochemistry was confirmed by Mosher ester analysis of compound 411.192  
Clean isolation of 411 was complicated by co-elution with triethysilyl fluoride during 
 Chapter 2: Results and Discussion 
 
120 
 
column chromatography but the impurity was found to be removable through protracted 
drying under high vacuum. As with the attempted TBS protection of 408, the conversion 
of alcohol 411 into target 412 did not progress with complete conversion. On stirring 
for three days under the indicated conditions, the desired TBS ether was isolated in an 
overall 77% yield with 14% recovery of the starting alcohol.  
12.8 Synthesis of C-(18)—C-(24) PMB Protected Tetrahydrofuran 
Electrophiles 
Two C-(24) electrophiles were prepared from alcohol 350 in order to explore the 
chemistry of the C-(18)—C-(34) fragment synthesis. Partial oxidation of the primary 
alcohol using Dess-Martin periodinane furnished aldehyde 415, which could be 
subjected to the direct addition of a metallated acetylide to afford the united fragment 
bearing a C-(24) alcohol. As an alternative, the intermediate aldehyde was further 
oxidised to the associated carboxylic acid, which upon treatment with N,O-
dimethylhydroxylamine hydrochloride in the presence of HBTU, yielded Weinreb amide 
416 as a stable intermediate. The highly conjugated ketone, resulting from coupling of 
this species to the metallated acetylide of 412, would subsequently be used to explore 
reductive methodology to deliver the desired C-(24) hydroxyl stereochemistry.  
 
Scheme 96 
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12.9 Amphidinolide C: Synthesis of C-(18)—C-(34) Fragment via 
Aldehyde Alkynylation 
Direct addition of the lithium acetylide to aldehyde 415 at −78 °C provided a 
diastereomeric mixture of C-(24) alcohols favouring of the undesired C-(24)—C-(25)-anti 
product. This result did not improve upon the stereoselectivity of acetylide addition 
reaction discussed previously (Section 10.2.1), but did accord with the previous 
observation of moderate preference for the undesired anti diastereomer (Scheme 97). 
 
Scheme 97 
12.10 Amphidinolide C: Synthesis of C-(18)—C-(34) Fragment via 
Weinreb Amide Alkynylation 
Addition of the lithium acetylide of enyne 412 to Weinreb amide 416 afforded the 
C-(24) ketone 418 in excellent yield (Scheme 98). The product was then subjected to 
various reducing agents to determine the diastereoselectivity of the 1,2-reduction 
reaction. Despite the previously unexceptional diastereomeric ratios gained through 
reduction of similar ynonic systems (Section 11.2.3, Scheme 80), results on a related 
dienone indicated that a stereoselective reduction of 418 might be possible (Section 
12.5, Scheme 109). 
The results of both the Luche and L-selectride reductions (Table 8, entries 1 and 2) 
were similar to those recorded previously for substrates 370 and 372 (Table 5). The 
direct introduction of Red-Al to ynone 418 was expected to result in the 1,2-reduction 
of the ketone with successive reduction of the consequential propargylic group affording 
(E,E)-dienol 419. When the reaction was conducted at 0 °C, a marginal preference for 
the C-(24)—C-(25)-syn diastereomer 419a was observed (entry 3). It was hoped that 
through reduction of reaction temperature, the diastereoselectivity of the reduction 
could be improved but the diastereomeric ratio remained constant and afforded only 
1,2-carbonyl reduction to the alcohol 417 as a mixture of isomers without the ensuing 
alkyne reduction. 
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Scheme 98 
Entry Reductant Solvent 
Temp. 
(°C) 
Yield 
(%) 
dr 
417a:417b 
1 
NaBH4 
CeCl3.7H2O 
MeOH −78 100 2:1 
2 L-selectride THF −78 66 1:1 
3 Red-Al Et2O 0 79 
2:1 
419a:419b 
4 Red-Al Et2O −78 87 2:1 
Table 8 
12.11 Amphidinolide C: Completion of C-(18)—C-(34) Fragment 
Although no diastereocontrol had been observed, in either addition of a lithium 
acetylide to aldehyde 415 or through reduction of ynone 418, significant quantities of 
both C-(24) diastereomers had been generated in the course of this work. Painstaking 
chromatography of the mixture allowed for the partial separation of a reasonable 
quantity of the unwanted 1,2-anti product 417b. Concurrent work on the ‘southern’ 
fragment had shown that the reduction of a C-5 enone system vicinal to a 2,5-trans 
tetrahydrofuran, could be accomplished under Felkin-Anh control using Luche reduction 
conditions  (Section 12.5, Scheme 109). The stereoselectivity of this reduction was in 
direct contrast to the reduction of ynonic systems, previously discussed in Schemes 80 
and 98, and suggested a possible solution to the generation of the desired C-(24) 
stereocentre. 
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Scheme 99 
Propargylic alcohol 417b was reduced with Red-Al to afford the stereopure (E,E)-dienol 
419b in good yield. Upon acquisition of the analysis for the C-(24) (S)-diastereomer, 
oxidation was accomplished using either Dess-Martin periodinane or MnO2, to provide 
dienone 420 in 87% or 83% yield depending upon the oxidation technique employed. The 
1,2-reduction of the carbonyl group proceeded in excellent yield and with high levels of 
diastereocontrol under Luche conditions, thereby providing the required (R)-
stereochemistry at the C-(24) stereocentre. This sequence was subsequently shown to 
be applicable to diasteromeric mixtures of 419a and 419b, thereby rendering the 
previous attempt to introduce the desired stereochemistry at an early stage in the 
synthesis entirely obsolete. Protection of the extant C-(24) secondary alcohol as a TES 
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ether was accomplished with TES triflate in 76% yield, after attempts to afford the same 
transformation with TES chloride met with incomplete conversion. 
With the fully protected C-(18)—C-(34) fragment 407 in hand, the stage was set for 
what we believed would be the simple removal of the PMB ether and introduction of a 
dithiane at the C-(18) position. Initial attempts to remove the PMB functionality using 
traditional single electron transfer reagents such as DDQ and CAN resulted in the 
decomposition of the precious starting material. It was believed that this type of 
deprotection strategy was incompatible in the presence of the C-(25)—C-(28) (E,E)-
diene system, a belief reinforced by similar observations by Iwasaki et al in their total 
synthesis of curacin A.193 Their observation that dienes of this type, even those remote 
from the PMB group, are incompatible with DDQ and CAN deprotection conditions led 
them to develop milder conditions to effect the desired transformation.194 Attempts to 
replicate Iwasaki’s conditions, using a combination of magnesium bromide diethyl 
etherate and dimethyl sulfide, resulted in decomposition of the C-(18)—C-(34) fragment 
407. Due to the paucity of late-stage material at this point in the project, in 
combination with the constrained time-frames no further attempts were made to 
remove the PMB ether from 407. 
 
 
 
 
 
 
 
 
 
 
 
 
 Chapter 2: Results and Discussion 
 
125 
 
13 Amphidinolide C: Synthesis of the C-(1)—C-(17) Fragment 
Early synthetic planning for the creation of the C-(1)—C-(17) fragment of the macrolide, 
proposed a disconnection between the C-(10) and C-(11) bonds, which would be 
constructed through Horner–Wadsworth–Emmons olefination of β-ketophosphonate 302 
and an appropriately functionalised methyl ketone. Initial work on this segment of the 
compound began in the belief that such a connection would be viable, and hence efforts 
were made to transform the common intermediate 327a into β–ketophosphonate 302, 
with emphasis on stereoselective formation of the C-(35) methyl group and introduction 
of the C-(7)—C-(8)-anti diol system. 
 
Figure 45 
13.1 Amphidinolide C: Synthesis of the C-(1)—C-(7) Fragment and 
Introduction of C-(4) Stereochemistry 
The primary goal of the synthesis was incorporation of the methyl group situated at 
C-(35) with the required C-(4) stereochemistry. To this end, the ketone of the common 
intermediate 327a was methylenated using a Wittig reaction and gratifyingly diene 423 
was afforded in quantitative yield on the first attempt, rendering the testing of 
alternative olefination methodologies redundant (Scheme 100). It was believed that 
introduction of the C-(4) stereochemistry could be facilitated by the application of 
homogeneous catalytic hydrogenation, facially directed by a C-(1)-positioned hydroxyl 
group. To form this intermediate, the pendant allylic group required conversion to the 
alcohol 426, without disruption to the newly formed 1,1-disubstituted olefin group 
(Scheme 100). Unlike the oxidative cleavage of the allyl group in the ‘northern’ 
fragment, compound 343, which was achieved through ozonolysis, transformation of 
diene 423 required a more selective approach; we believed that sequential 
dihydroxylation and periodate cleavage offered a suitable alternative methodology. 
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Examples in the literature of allylic mono-dihydroxylation in the presence of 1,1-dienes 
are sparse, with only two examples from the groups of Corey195 and Trost196 detailing 
equivalent reactivity. Nevertheless we considered that the less hindered allylic 
appendage should present the most accessible site for dihydroxylation in our case. A 
number of dihydroxylation experiments were undertaken, the first using Upjohn 
conditions197 and the second and third employing commercially available Sharpless 
asymmetric dihydroxylation reagents;156 the outcomes are summarised in Table 9.  
 
Scheme 100 
Entry Conditions Solvent Temp. 
Yield (%) 
424 
1 
OsO4 (2mol%) 
NMO (1.1 eq) 
THF, H2O rt 64 
2 AD-Mix α t-BuOH, H2O 0 °C 41 
3 AD-Mix β t-BuOH, H2O 0 °C 43 
4 
OsO4 (2 mol%) 
NaIO4 (2.1 eq) 
THF, H2O rt — 
Table 9 
Dihydroxylation using the standard Upjohn conditions (entry 1) afforded a 64% yield of 
the desired dihydroxylation product with a diastereomeric ratio of 1:1, as judged by 1H 
NMR spectroscopy, and 7% recovery of the starting diene. Under these conditions the 
reaction could not be forced to completion through the addition of further co-oxidant, 
without a concomitant drop in the isolated yield of the desired product. These results 
suggested bis-dihydroxylation was taking place in the presence of excess reagent, 
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leading to lower isolable quantities of the desired product. The use of Sharpless 
asymmetric dihydroxylation procedures (entries 2 and 3) provided diminished isolated 
yields of 424 in the case of both α and β mixtures. Application of the Lemieux-Johnson 
protocol198 in an attempt to directly access aldehyde 425, through a one-pot 
dihydroxylation and diol cleavage promoted by sodium periodate,  led to a complex 
reaction mixture from which none of the desired product was isolated.  
 
Scheme 101 
In an effort to maximise product recovery, we attempted to isolate the putative tetraol 
427 thought to be responsible for loss of material in the dihydroxylation step. Stripping 
of chromatography columns with dichloromethane and methanol, subsequent to 
isolation of the diol 424, afforded artefacts of the reaction, the complex 1H NMR 
spectrum of which contained signals corresponding to TBS and tetrahydrofuran groups. 
Attempts to oxidatively cleave the vicinal diols of the isolated material, thereby 
affording the dicarbonyl product 428, which it was hoped could be recycled back into 
the reaction sequence, gave a complex reaction mixture from which the desired 
material was not isolated (Scheme 101). 
 
Scheme 102 
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In an attempt to avaoid tetraol formation, the sequence of methylenation and 
dihydroxylation was reversed. Scheme 102 shows that although the dihydroxylation of 
alkene 327a was accomplished in excellent yield, subsequent Wittig olefination of the 
ketone was problematic, not only in terms of the moderate yield of the reaction, but 
also because partial epimerisation of the adjacent C-(3) tetrahydrofuranyl stereocentre 
was observed. At this stage we concluded that Upjohn dihydroxylation of diene 423 was 
a reasonable method for advancing the synthesis. The synthetic sequence was 
completed through oxidative cleavage of the 1,2-diol 424 and reduction of the 
intermediate aldehyde 425, providing C-(1) primary alcohol 426 (Scheme 100). 
13.2 Installation of C-(4) Methyl Stereochemistry through Asymmetric 
Hydrogenation 
With sufficient alkene 426 in hand, the stage was set to introduce the C-(4) 
stereochemistry, by means of a hydroxyl controlled reduction of the 1,1-disubstituted 
olefin. From the earliest stage of the project, Crabtree’s complex 430 was identified as 
the catalyst of choice for this transformation due to its ability to deliver stereoselective 
hydrogenation through chelation to carbonyl and alcohol groups.199 In our case, we 
believed that the pendant alkyl alcohol could act as a ligand for the catalyst, thereby 
delivering hydrogen from the corresponding face. 
 
Figure 46 
Early work proved positive with regard to the stereoselective outcome, but the reaction 
suffered from incomplete conversion. Previous reports had documented the 
deactivation of catalyst through the formation of a stable and inactive trimeric iridium 
complex on prolonged exposure to hydrogen (Figure 46).200 Assorted reaction conditions 
were assayed, including variation in the non-coordinating solvent employed, reaction 
concentration and the rigorous degassing of all solutions used in the transformation. It 
was found that briefly exposing the catalyst to a hydrogen atmosphere, prior to rapid, 
dropwise introduction of the olefin, allowed for complete conversion of the samples in 
less than two hours. The reaction was monitored through 1H NMR analysis of reaction 
aliquots, until disappearance of the olefin signals (5.01 and 4.44 ppm), and formation of 
the C-(4) methyl (doublet at 1.3 ppm) was observed.  
 Chapter 2: Results and Discussion 
 
129 
 
The catalyst loading in the preliminary reaction was 12 mol% but it was subsequently 
found that a loading of 7.5 mol% was as efficacious in terms of both stereoselectivity 
and yield. It is believed that further reduction in the amount of catalyst could afford 
equivalent reactivity, though this hypothesis remains untested.  In addition to the cost 
benefit of decreased catalyst loading, anomalous deprotection of the TBS group 
occurred during column chromatography of the products, where the sample was visibly 
contaminated with residual catalyst artefacts. Although initially problematic, this issue 
proved resolvable through minimisation of the required purification steps in the 
sequence between 426 and 435 (Scheme 103). Upon completion of the hydrogenation 
reaction, the extant alcohol was directly protected as a TBDPS ether in the same pot. 
Aqueous acidic work-up of bis-silyl ether 434 and CSA-catalysed deprotection of the C-
(7) TBS ether subsequently furnished alcohol 435, in a yield of 66% over three steps. 
 
Scheme 103 
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13.3 Installation of the C-(7)—C-(8) Diol through Dihydroxylation 
With alcohol 435 in hand, attention was turned to the formation of the β-
ketophosphonate retron 302 bearing the desired 1,2-anti diol in the C-(7)—C-(8) locus of 
the natural product (Figure 29). To this end, we planned to test the suitability of 
applying the Sharpless asymmetric dihydroxylation reaction to the (Z)-α,β-unsaturated 
ester 437. 
Oxidation of alcohol 435 to its associated aldehyde allowed access to olefin 437 
through either Wittig reaction with a phosphorane in an alcoholic solvent, or through 
the Still-Gennari modification of the Horner–Wadsworth–Emmons olefination. Exposure 
of (methoxycarbonyl)methylenetriphenylphosphorane to the intermediate aldehyde 
allowed for selective formation of the desired (Z)-isomer in good yield (Table 10, entry 
1).201 A one-pot reaction involving tandem oxidation and olefination in dichloromethane, 
led to a reversal in the stereoselectivity (entry 2),202 whereas application of the Still-
Genarri reagent203 to the pre-formed aldehyde gave the optimal ratio favouring the (Z)-
isomer 437 and the best yield over all three experiments. The (E) and (Z)-isomers 
proved sufficiently separable by column chromatography to allow access to pure 
samples of each. 
 
Scheme 104 
Entry Conditions 
Yield 
(%) 
Z:E  
1 
i.  Dess-Martin periodinane, CH2Cl2, rt 
ii. Ph3P=CHCO2Me, MeOH, rt 
70 95:5 
2 
Dess-Martin periodinane, Ph3P=CHCO2Me 
CH2Cl2, rt 
71 5:95 
3 
i. Dess-Martin periodinane, CH2Cl2, rt 
ii. (F3CCH2O)2POCH2CO2Me, THF, −78 °C 
77 99:1 
Table 10 
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Efforts to dihydroxylate (Z)-alkene 437, to generate the C-(7)—C-(8) 1,2-anti diol, 
began in the knowledge that Kishi’s empirical model of allylic dihydroxylation, Figure 
47, predicted that substrate control would deliver the wrong diastereomer as the major 
product.204 The model is based upon the least sterically encumbered, eclipsed 
conformation 438 being most kinetically accessible prior to, and during, the osmylation 
transition state.  
 
Figure 47 
In this case, the dihydroxylation reagent approaches the face opposite that of the allylic 
oxygen substituent, due to a minimisation of the electronic repulsion between reactant 
and substrate. It was hoped, in our case, that the use of the Sharpless’ ligands could 
override the substrate bias and deliver the desired diastereomer 440. The three 
reactions shown in Table 11 proceeded in good yield but with poor stereocontrol, 
dihydroxylation with  AD-mix β (entry 2) afforded a mild preference for the unwanted 
C-(7)—C-(8) (S, R)-diastereomer 441 while AD-mix α afforded equivalent amounts of the 
diastereomers (entry 1). Most surprisingly, Upjohn dihdroxylation (entry 3), which was 
expected to deliver the undesired product, according to the Kishi model of allylic 
substituent control, gave equivalent amounts of each diastereomer. The diastereomers 
were isolable by careful chromatography and the relative configurations assigned by 
reduction of the ester group to form triol 442. Comparison of the 1,2,3-triol with a 
sample of known absolute stereochemistry (sample preparation described in Section 
12.5, Scheme 110), as shown in Scheme 106, allowed for structural assignment of each 
of the products. 
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Scheme 105 
Entry Conditions Solvent 
Yield (%) 
440+441 
dr 
440:441 
1 AD-Mix α, MeSO2NH2 t-BuOH, H2O 71 1:1 
2 AD-Mix β, MeSO2NH2 t-BuOH, H2O 71 1:2 
3 OsO4, NMO THF, H2O 81 1:1 
Table 11 
In an effort to drive the synthesis forward towards the formation of β-ketophoshonate 
456, bis-PMB protection of diol 436 was attempted using PMB-trichloroacetimidate and 
PMB chloride alkylation techniques. Unfortunately both the acid and base mediated 
reactions afforded intractable mixture of products in each case.  
 
Scheme 106 
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13.4 Installation of the C-(7)—C-(8) Diol through Allylboration 
Following disappointing results when attempting to form the C-(7)—C-(8)-anti diol 437 
through dihydroxylation methodology, our attention briefly turned to effecting a similar 
transformation through allylboration procedures. Roush has described the application of 
γ-alkoxyallylboron reagents to deliver 1,2-anti silanols, which upon Tamao-Fleming 
oxidation afforded the associated 1,2-anti diol. An example from a 1991 paper inspired 
us to apply the methodology towards our synthesis of the C-(7)—C-(8) stereocentres.205 
 
Scheme 107 
Formation of chiral allylboronate 446 began with synthesis of allyl silanol 444 through 
the reaction of allyl chlorodimethylsilane 443 and cyclohexanol using the procedure of 
Cella (Scheme 107).206 Upon deprotonation of the allylic group using Schlosser’s base,207 
the solution was observed to turn from clear to orange-yellow indicating formation of 
the allylic anion. Subsequent sequential addition of triisopropylborane and 
(−)-diisopropyl D-tartrate was expected to deliver γ-alkoxyallylborane 446. In practice, 
1H NMR analysis of the reactions showed mixtures of allylsilane 444 and excess tartrate 
ester; trace peaks of the desired intermediate, identified by comparison to Roush’s 
data, were observed but were insubstantial components of the reaction mixtures. 
Variation of base, temperature, solvent and reaction time failed to deliver the desired 
product; where pertinent peaks were observed in the 1H NMR spectrum, addition of 
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aldehyde 436 was undertaken, on each attempt formation of the desired C-(7)—C-(8) 
silanol 448 was not observed. 
A variant of the procedure used in Scheme 107 was attempted in which 
allyltrimethylsilane was used as the source of the allyl functionality. Following 
equivalent deprotonation and boration procedures to those used previously, aldehyde 
436 was added to the reaction mixture. In this case two separable products were 
formed cleanly from the reaction. The 1H and 13C NMR spectra of the isolated 
compounds supports the formation of compound 452 and its diastereomer however the 
diastereoselectivity of the allylboration reaction was poor, yielding what was essentially 
an equivalent mixture of products. This sequence was not pursued further owing to the 
poor diastereoselectivity of the reaction; the relative stereochemistry of the products 
remains undetemined. Mechanistic considerations, whereby the reaction proceeds via a 
transition state of type 447, would suggest that the products are the C-(7)—C-(8)-anti 
diastereomers indicated (Scheme 108). 
 
Scheme 108 
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13.5 Installation of C-(7) Hydroxyl Stereochemistry 
The poor diastereoselectivity resulting from the preceding dihydroxylation and 
allylboration methodologies led us to explore stepwise introduction of the C-(7) and 
C-(8) stereocentres. This approach began with formation of enone 454 by addition of 
vinylmagnesium bromide to Weinreb amide 453, prepared in excellent yield by 
sequential step-wise oxidation of alcohol 435 and HBTU-facilitated coupling of the 
resultant carboxylic acid to N,O-dimethylhydroxylamine hydrochloride. This piecemeal 
sequence proved necessary as the alternative approach of vinylmagnesium bromide 
addition to the intermediate aldehyde 436, followed by an allylic oxidation of the 
diasteromeric mixture of allylic alcohols (dr 1:1), afforded mixtures that were difficult 
to purify and delivered significantly lower yields of enone 454 (45% over three steps). 
 
Scheme 109 
The efficacious, stereocontrolled introduction of the C-(7) hydroxyl group proved 
possible through Felkin-Anh reduction of enone 454 under Luche conditions.  Excellent 
isolated yields of allylic alcohol 455 were afforded along with exceptional levels of 
diastereocontrol. The absolute stereochemistry of the alcohol was determined by 
application of the modified Mosher protocol.192  
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The difference in stereoselectivity of this reduction reaction over that of the previously 
discussed ynone systems is difficult to rationalise as the two systems offer similar 
prochiral faces for the approach of a reducing reagent. Logically, if the enone confers 
greater stereocontrol to the reduction, the pendant olefin group must play a decisive 
role in the approach of the hydride ion. The C-C bond rotation between the carbonyl 
and olefin groups allows for several possible conformers to exist, the extremes of 
which, A and B, are illustrated in Figure 48. At low temperature, and under the Felkin-
Anh model, the lowest energy conformation is posited to be B, where the olefin is 
positioned to minimise allylic strain with the C-(6) β-tetrahydrofuranyl hydrogen. In this 
way, hydride approach from the si face is reinforced and stereocontrol is amplified over 
that of the Felkin-Anh modelled ynone system C. 
 
Figure 48 
Protection of the secondary alcohol was accomplished by Lewis acid catalysed 
activation of PMB-trichloroacetimidate with lanthanum(III) triflate, and the olefin was 
then dihydroxylated under Upjohn conditions (Scheme 110). As expected, under the 
allylic dihydroxylation model of Kishi discussed previously, the C-(8) hydroxyl was 
introduced stereoselectively to afford diol 457. The absolute stereochemistry of the 
C-(8) stereocentre was determined through selective TBS protection of the C-(9) 
primary alcohol and application of the modified Mosher protocol to the remaining 
secondary alcohol.192 Removal of the PMB ether by hydrogenolysis afforded triol 438, as 
shown in Scheme 106, allowing a determination of the absolute stereochemistry of the 
α,β-dihydroxyesters 440 and 441 prepared previously. Following protection of the C-(8) 
secondary alcohol and removal of the terminal TBS group, further steps could have 
progressed the synthesis towards advanced intermediates such as the β-
ketophosphonate 460 or the vinyl stannane 87 prepared by Ferrié31 (Scheme 15). By this 
stage in the project however, the proposal of forming the C-(9)—C-(11) diene 
functionality through Horner-Wadsworth-Emmons methodology had been beset by the 
failure of model reactions to accomplish the required coupling. 
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Scheme 110 
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13.6 Alternative Methodolgy Towards the Formation of C-(1)—C-(17) 
Fragment 
A revised synthetic plan required the creation of a fragment encompassing the 
necessary stereochemistry and diene geometry of the C-(9)—C-(17) locus of the natural 
product’s macrolide ring. The generation of a nucleophile from this fragment and 
addition to a suitably functionalised C-(1)—C-(8) fragment, was believed to be an 
appropriate method by which to access the desired C-(1)—C-(17) ‘southern’ component 
of amphidinolide C. The revised synthetic plan required the formation of an 
electrophilic moiety positioned at C-(8) and to this end, both aldehyde 461 and Weinreb 
amide 462 were prepared (Scheme 111).  
Aldehyde 461 was prepared through oxidative cleavage of the 1,2-diol 457 and was 
used immediately in the subsequent reaction with the C-(9)—C-(17) fragment 463 
prepared by Guang Yang. The Weinreb amide 462 was constructed through Pinnick 
oxidation of the intermediate aldehyde and condensation of the resultant carboxylic 
acid with N,O-dimethylhydroxylamine hydrochloride. Although compound 462 was 
isolated in good yield, partial epimerisation of the PMB protected C-(7) stereocentre 
was observed intermittently. The problematic reproducibility of this reaction 
necessitated reliance on aldehyde 461 as the electrophilic moiety required for 
formation of the C-(8)—C-(9) bond.  
 
Scheme 111 
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The completion of the C-(1)—C-(17) fragment 466, accomplished by Yang, is shown in 
Scheme 112 and commenced from the tin-lithium exchange of fragment 463. After 
formation of the nucleophile, through treatment of stannane 463 with t-butyl lithium, 
it was added to aldehyde 461. The reaction proceeded in good yield and with excellent 
levels of stereocontrol, but unfortunately the undesired C-(7)—C-(8) syn diastereomer 
464 predominated. The correct stereochemistry was subsequently introduced through 
oxidation of alcohol 464 to give ketone 465 followed by Luche reduction, under Felkin-
Anh control, to provide the C-(1)—C-(17) fragment of the macrolide core with the 
required stereochemistry. Although the reaction afforded the correct diastereomer, the 
slow rate of reduction led to a substantial loss of material through decomposition and 
resulted in a lower than anticipated isolated yield of 466. 
 
Scheme 112 
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14 Future Work 
Although the complexities of amphidinolide C have been largely addressed in the work 
described herein, a total synthesis of the natural product remains an elusive goal. The 
major difficulty at present lies within the realm of protecting group chemistry, 
particularly those associated with the C-(1), C-(13) and C-(15) positions. 
14.1 C-(1) Protection 
Presently, the choice of TBDPS on the C-(1) locus is impractical, owing to the increased 
stability of this functionality over the other silyl ethers within the two most advanced 
fragments 407 and 466. As the C-(1) position is destined to become the carboxylic acid 
precursor required for Yamaguchi cyclisation, it would be beneficial to have this locus 
protected in an equivalent oxidation state as early as possible to negate the 
requirement for oxidation at a later, more complex, stage in the synthesis. To this end, 
a suitable alternative could involve the formation of an oxazoline group at the C-(1) 
position, as shown in Scheme 113. This hetereocycle is stable against nucleophilic 
attack and generally requires forcing conditions of mineral acid and heat to restore the 
masked carboxylic acid. Removal of the group under mild conditions can be 
accomplished if an iminium salt is formed through reaction with an alkyl halide, and the 
salt treated with aqueous base; an example of this type of deprotection reaction has 
been used by the Kallmerten group during studies on the synthesis of nargenicins.208 
 
Scheme 113 
Although the current C-(7)-containing fragment 456 is protected as a PMB ether, it 
would be beneficial to test current methodologies where a TBS protecting group is used 
in its place. Elimination of PMB ethers from the synthesis may be highly advantageous to 
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negate the problematic reactivity associated with diene functionality of both ‘northern’ 
and ‘southern’ fragments. Protection of the C-(7)—C-(8) diol as bis TBS ethers would 
greatly assist in late-stage global deprotection. 
14.2 C-(13) and C-(15) Protection  
The 1,3-anti stereochemistry of the C-(13) and C-(15) hydroxyl groups was previously 
introduced using Evans Me4NHB(OAc)3 reagent,
209 but this generates a 1,3-diol which is 
difficult to protect in a selective fashion.170 An alternative approach would involve the 
C-(15) hydroxyl controlled Evans-Tishchenko reduction of ketone 470, an intermediate 
previously prepared by Guang Yang, which should afford the 1,3-anti product 
preferentially with the additional benefit of protecting the C-(15) position as an ester; 
this would allow for the subsequent differential protection of the C-(13) position. As the 
C-(15) position of amphidinolide C bears a ketone, the stereochemistry of this position is 
obsolete and hence this site could be protected as a ketal following oxidation of the 
secondary alcohol (Scheme 114).  
 
Scheme 114 
Upon combination of 475 and 469, formation of the desired C-(8) stereochemistry and 
protection of the secondary alcohol could be followed by selective cleavage of the 
C-(17) TBS ether. Conversion of the C-(17) hydroxyl into a leaving group would allow for 
subsequent formation of the C-(17)—C-(18) bond through dithiane alkylation. 
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Scheme 115 
14.3 C-(18) Protection 
Although the synthesis of the C-(18)—C-(34) fragment of amphidinolide C had been 
accomplished, we were unable to deprotect the PMB group of compound 407 using 
established SET reagents or a combination of MgBr2 and DMS. Although the literature 
abounds with methods for removal of PMB groups, the C-(24) and C-(29) hydroxyl 
protecting groups, in addition to the highly conjugated tail region renders the majority 
of methodologies unsuitable. A possible approach to effect this deprotection involves 
the use of Birch reduction, an example of this was reported by Bittman and co-workers 
in their synthesis of plasmalogens.210  
 
Scheme 116 
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Alternatively, as the primary strategy towards formation of the C-(17)—C-(18) linkage 
relies upon the alkylation of a dithiane, it may be possible to introduce this 
functionality early in the synthesis, thereby using it as both an alkylation precursor and 
the C-(18) protecting group. This change could be implemented at the ozonolysis stage 
through modification of the work-up from sodium borohydride to dimethyl sulfide to 
afford an intermediate aldehyde 478. Formation of the dithiane and deprotection of the 
C-(24) TBS group could be accomplished as shown in Scheme 116. Alteration of either of 
the existing routes, i.e. palladium cross-coupling or alkynylation of the C-(24) position, 
would afford the C-(18)—C-(34) construct 480; a caveat being amendment of the C-(24) 
alcohol oxidation protocols, from the current Dess-Martin procedure, to a more dithiane 
friendly alternative.   
14.4 Completion of Amphidinolide C Total Synthesis 
Alkylation of the dithiane 480 with 477 would set the stage for Yamaguchi lactonisation 
of the substrate, upon deprotection of the oxazoline and TES moieties. Fragmentation 
of the oxazoline group, as discussed previously, using a two-step process of alkyl 
iminium salt formation and mild treatment with aqueous base, would afford the C-(1) 
carboxylic acid. In our case, the application of methyl iodide to system 481 is likely to 
lead to concomitant loss of the C-(18) dithiane. On Yamaguchi macrolactonisation of the 
deprotected carboxylic acid with the C-(24) hydroxyl, the challenge would then be 
deprotection of the ketal and extant TBS ethers. Ketal hydrolysis could be accomplished 
by simple exposure of the moiety to catalytic acid and would be followed by universal 
removal of the remaining silyl ethers, using the Et3N∙3HF protocol adopted by Carter 
and Mahapatra in the final step of their synthesis of amphidinolide F (Scheme 117). 
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Scheme 117 
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15 Summary and Conclusions 
Methodology has been developed which has enabled access to two fragments comprising 
the complete carbon skeleton of amphidinolides C and F. This thesis has dealt 
specifically with the stereoselective synthesis of the C-(18)—C-(34) fragment of 
amphidinolide C 407, the C-(18)—C-(29) fragment of amphidinolide F 397 and the C-
(1)—C-(8) fragment 461 of the common macrolide ring system. A key point in the total 
synthesis work outlined was the employment of a modular synthesis, whereby the 
natural product was divided into two fragments of equivalent complexity, termed 
‘Northern’ and ‘Southern’. Each fragment was constructed through building outwards 
from a 2,5-trans substituted tetrahydrofuran, both ring systems of which were 
identified as being advanced synthetic products of an antecedent common 
intermediate. 
The synthesis of the common intermediate 327a was achieved in seven steps from the 
chiral pool starting material D-malic acid, in an overall 41% yield and with excellent 
diastereocontrol. The key step of this synthesis was the diastereoselective [2,3]-
sigmatropic rearrangement of an intermediate oxonium ylide, formed through the 
copper-catalysed decomposition of an α-diazoketone. The common intermediate 
provided the foundation for the construction of both ‘Northern’ and ‘Southern’ 
fragments through alteration of the 2,5-vicinal carbon chains and the C-3 positioned 
ketone.  
 
The C-(18)—C-(34) ‘Northern’ fragments were assembled in a further eleven linear steps 
from the common intermediate through two methodologies, namely palladium-catalysed 
cross-coupling of alkyne 378 or alkynylation of aldehyde 415. Transformation of 
intermediate 327a to either intermediate necessitated deletion of the C-(21) ketone 
moiety; this was accomplished through the application of radical deoxygenation 
techniques. 
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The vinylic iodide cross-coupling partner and alkynylation precursor were both derived 
from a common propargylic alcohol 80. The C-(29) stereochemistry of this intermediate 
was achieved through kinetic resolution of the racemic alcohol via the Sharpless 
asymmetric epoxidation protocol.  
 
Use of Sonogashira or Heck alkynylation cross-couplings between propargylic alcohol 
378 and vinyl iodide 386, or through alkynylation of aldehyde 415 using the lithium 
acetylide of 412, allowed access to systems of type 407, the carbon backbone of the 
C-(19)—C-(34) fragment of amphidinolide C. Heck alkyne cross-coupling of 378 with 
commercial isocrotyl bromide afforded access to the C-(18)—C-(29) carbon backbone of 
amphidinolide F. The desired C-(25)—C-(26) olefin geometry of both fragments was 
introduced through hydroxyl-controlled propargylic reduction, and the C-(24) 
stereochemistry of 407 established through Felkin-Anh controlled reduction of a C-(24) 
dienone. The deprotection of the C-(18) group has provided some problematic reactivity 
issues, which it is hoped can be resolved in future work. A recent publication from our 
group has discussed the use of palladium cross-couplings in forming these fragments of 
amphidinolide C and F.211  
 
The synthesis of the ‘Southern’ C-(1)—C-(8) fragment required the stereoselective 
introduction of the C-(4) methyl group. This was achieved through a sequence of 
methylenation, selective dihydroxylation and a substrate controlled hydrogenation 
reactions. Introduction of the C-(7) and C-(8) anti diol chemistry was attempted with 
both dihydroxylation and allylboration chemistry. Although both methodologies afforded 
the desired reactivity, the diastereoselective outcomes were insufficient for a total 
synthesis route. Stepwise introduction of the C-(7) and C-(8) stereocentres was shown to 
be achievable through the stereoselective reduction of an intermediate enone, thereby 
delivering allylic alcohol 455. The C-(8) stereochemistry was introduced through a 
stereoselective dihydroxylation, the resulting diol 457 proved to be amenable to a 
change in project strategy by providing the precursor to aldehyde 461. 
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Nucleophilic addition of Yang’s C-(9)—C-(17) fragment into aldehyde 461 allowed, with 
subsequent modification, access to the ‘Southern’ C-(1)—C-(17) fragment of the 
macrolide ring 466. This synthesis was recently published in tandem with that of the 
‘Northern’ fragment.212 
  
In summary, a stereoselective formation of the C-(18)—C-(34) fragment of 
amphidinolide C, the C-(18)—C-(34) fragment of amphidinolide F and the C-(1)—C-(8) 
fragment common to both macrolides has been achieved. Two of the nine stereocentres 
discussed in the work originate from the use of D-malic acid as the starting material for 
a common intermediate species. The remaining stereocentres were introduced through 
substrate controlled reactions, with the only exception being the C-(29) hydroxyl of 
amphidinolide C, which was introduced through Sharpless epoxidation resolution 
chemistry. The combined efforts of the Clark group have yielded two fragments 
corresponding to the complete carbon skeletons of amphidinolides C, C2, C3 and F, with 
union of ‘Northern’ and ‘Southern’ fragments the last hurdle to be overcome in a total 
synthesis of these fascinating natural products.
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General comments  
Air and/or moisture sensitive reactions were performed under an atmosphere of Argon 
in flame dried apparatus. Organic solvents were dried using Pure Solv™ solvent 
purification systems. All reagents were purchased from commercial suppliers and used 
without further purification, unless otherwise stated. All reactions were monitored by 
thin layer chromatography using Merck silica gel 60 covered alumina plates F254. Thin 
layer chromatography plates were viewed under UV light or were visualised using either 
potassium permanganate solution or acidic ethanolic anisaldehyde solution. Column 
chromatography was performed under pressure using silica gel (Fluorochem LC60A, 35-
70 micron, 60A) as solid support and HPLC-graded solvents as eluent. Petroleum ether 
used for column chromatography was 40-60 °C fraction.  
IR spectra were recorded using a type IIa diamond single reflection element on a 
Shimadzu FTIR-8400 instrument. The IR spectrum of the compound (solid or liquid) was 
directly detected as a thin layer at ambient temperature.  
1H NMR spectra were recorded on a Bruker 400 MHz or 500 MHz Spectrospin 
spectrometer at ambient temperature. The carbon numbering used for the NMR signal 
assignment of the molecules corresponds to the amphidinolide numbering protocol 
assigned by Kobayashi;12 where possible, intermediates are assigned based upon 
concluding position within the amphidinolide structure. IUPAC numbering is used for the 
molecule names and generated using ChemAxon’s MarvinSketch 5.12.2 software. Data is 
reported as follows: chemical shift in ppm relative to CDCl3 (7.26) on the δ scale, 
integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, 
br = broad, ap = apparent, or a combination of these), coupling constant(s) J (Hz) and 
assignment. 13C NMR spectra were recorded on a Bruker 400 MHz or 500 MHz Spectrospin 
spectrometer at 100 MHz or 125 MHz at ambient temperature and multiplicities were 
obtained using a DEPT sequence. Data is reported as follows: chemical shift in ppm 
relative to CHCl3 (77.16) on the δ scale and assignment.  
High resolution mass spectra (HRMS) were obtained under EI, FAB, CI and ESI conditions 
by the analytical services of the University of Glasgow on a Jeol MStation JMS-700 
instrument. Low resolution mass spectra (LRMS) were carried out on the same 
instrument; the intensity of each peak is quoted as a percentage of the largest, where 
this information was available.  
Elemental analyses were carried out on an Exeter Analytical Elemental Analyser EA 440.  
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1,2:5,6-Di-O-isopropylidene-D-mannitol.213 (312)  
 
To a slurry of D-mannitol (50 g, 0.27 mol) in  1,2-dimethoxyethane (120 mL) was added 
2,2-dimethoxypropane (80 mL, 0.65 mol) and SnCl2 (50 mg, 0.26 mmol). The mixture 
was warmed to 95 °C until a clear solution was obtained (45 minutes approx.) and the 
heating continued for a further 30 minutes. The reaction was removed from heat and 
pyridine (100 µl) was added to the solution whilst warm; the reaction was then allowed 
to cool to rt. The volatile component was removed by distillation at 100 °C (1 atm). The 
crude material was slurried in CH2Cl2 (360 mL) for 1.5 h, filtered to remove the 
colourless solid [1,2-isopropylidene-D-mannitol 311 (5.4 g, 9%)] and the filtrate 
concentrated to a clear oil which crystallised on standing. Purification of the two-
component mixture was achieved by chromatography (pet. ether/EtOAc, 4:1 to 1:1) to 
provide the desired diacetal 312 as colourless solid (42 g, 58%) and 1,2:3,4:5,6-di-O-
isopropylidene-D-mannitol 313 (13.8  g, 17%) also as a colourless solid. Rf = 0.15 (pet. 
ether/EtOAc, 1:1); [α]16D  +3.1 (c = 0.96, CHCl3); Mp 120–122 °C [lit. 118-120 °C]
213; νmax 
(powder) 3394, 3279, 2978, 2886, 1373, 1258, 1204, 1065, 856, 656 cm−1; 1H NMR (400 
MHz, CDCl3) δ 4.20–4.13 (2H, m, CH‐C8), 4.14-4.08 (2H, m, CH‐C7), 3.97 (2H, dd, J = 
8.4, 5.4 Hz, CH‐C8), 3.79-3.69 (2H, m, CH‐C6), 2.77 (2H, d, J = 6.7 Hz, OH‐C6), 1.40 
(6H, s, CH3‐Me acetonide), 1.34 (6H, s, CH3‐ Me acetonide); 
13C NMR (100 MHz, CDCl3) δ 
109.7 (C‐C acetonide), 76.5 (CH‐C7), 71.4 (CH‐C6), 67.0 (CH‐C8), 27.0 (CH3‐Me 
acetonide), 25.5 (CH3‐Me acetonide); HRMS (CI+, isobutane) calcd for  C12H23O6 [M+H]
+ 
263.1494, found 263.1494 (Δ −0.3 ppm); LRMS (CI+, isobutane) m/z (intensity); 263.4 
(100%), 205.3 (45%), 147.2 (20%); Anal. calcd for C12H22O6 C 54.95%, H 8.45%, found C 
54.89%, H 8.52%. 
 
 
 
 
 
 Chapter 3: Experimental Section 
 
151 
 
(4R)-2,2-Dimethyl-1,3-dioxolane-4-carbaldehyde.213 (88) 
 
Sodium periodate (16 g, 76 mmol) was added to a stirred solution of diol 312 (10 g, 
38 mmol) in CH2Cl2 (75 mL) and saturated aqueous NaHCO3 (4 mL) at 0 °C; the ice bath 
was then removed and the mixture stirred for 3 h at rt. MgSO4 (4.9 g) was added to the 
reaction mixture, stirred for 20 minutes and removed by filtration. The solids were 
washed with further CH2Cl2 (20 mL) and the solution carefully concentrated at ambient 
temperature on a rotary evaporator. Distillation of the crude mixture in vacuo afforded 
the desired aldehyde 88 (8.6 g, 87%) as a clear, colourless oil. [α] 26D  +72.0 (c = 1.30, 
CHCl3); Bp 45-48 °C (13 mbar) [lit. 72-74 °C (44 mbar)]
213; νmax (liquid film) 3442, 2989, 
1734, 1373, 1211, 1065, 840, 601 cm−1; 1H NMR (400 MHz, CDCl3) δ 9.70 (1H, d, J = 1.9 
Hz, CH‐C6), 4.41–4.30 (1H, m, CH‐C7), 4.15 (1H, dd, J = 8.8, 7.4 Hz, CH‐C8), 4.08 (1H, 
dd, J = 8.8, 4.7 Hz, CH‐C8), 1.47 (3H, s, CH3‐Me acetonide), 1.40 (3H, s, CH3‐Me 
acetonide); 13C NMR (100 MHz, CDCl3) δ 202.1 (CH‐C6), 111.6 (C‐C acetonide), 80.2 (CH‐
C7), 65.9 (CH2‐C8), 26.6 (CH3‐Me acetonide), 25.4 (CH3‐Me acetonide); HRMS (CI+, 
isobutane) calcd for  C6H11O3 [M+H]
+ 131.0708, found 131.0711 (Δ +2.2 ppm); LRMS (CI+, 
isobutane) m/z (intensity); 131.2 (100%). 
Ethyl 3-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-oxopropanoate.215 (314)  
 
Aldehyde 88 (8.8 g, 68 mmol) in CH2Cl2 (2 mL) was added dropwise to a solution of ethyl 
diazoacetate (7.5 mL, 71 mmol) and SnCl2 (1.3 g, 6.8 mmol) in CH2Cl2 (290 mL) at rt. 
Upon complete addition the mixture was stirred for 1h before the reaction was 
quenched with brine (150 mL). The mixture was extracted with Et2O (2 × 150 mL), dried 
(MgSO4), filtered and concentrated to a yellow oil. Purification of the residue by 
chromatography (pet. ether to pet. ether/EtOAc, 19:1) afforded a keto-enol mixture of 
314 (8.2 g, 56%) as a clear, colourless oil. Rf = 0.39 (pet. ether, EtOAc, 4:1); [α]
25
D  +80.4 
(c = 1.03, CHCl3) [lit. [α]
26
D +73.7 (c = 1.5, CHCl3)]
215; νmax (liquid film) 2988, 2901, 1745, 
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1720, 1208, 1061, 843, cm−1; Ketone: 1H NMR (400 MHz, CDCl3) δ 4.52 (1H, dd, J = 7.8, 
5.2 Hz, CH‐C7), 4.23–4.16 (3H, m, CH‐C8 and CH2‐OEt), 4.09 (1H, dd, J = 8.8, 5.2 Hz, 
CH‐C8), 3.66 (1H, d, J = 16.4 Hz, CH2‐C5),  3.52 (1H, d, J = 16.4 Hz, CH2‐C5), 1.48 (3H, 
s, CH3‐Me acetonide), 1.38 (3H, s, CH3‐Me acetonide), 1.28 (3H, t, J = 7.2 Hz, CH3‐OEt); 
13C NMR (100 MHz, CDCl3) δ 204.4 (C‐C6), 167.3 (C‐C4), 111.6 (C‐C acetonide), 80.2 (CH‐
C7), 66.9 (CH2‐C8), 61.8 (CH2‐OEt), 46.1 (CH‐C5), 26.3 (CH3‐Me acetonide), 25.1 (CH3‐Me 
acetonide), 14.4 (CH3‐OEt); Enol: 
1H NMR (400 MHz, CDCl3) δ 11.99 (1H, s, OH‐C6), 5.37 
(1H, d, J = 0.8 Hz, CH‐C5), 4.56–4.52 (1H, m, CH‐C7), 4.28–4.18 (3H, m, CH‐C8 and CH2‐
OEt),  3.99 (1H, dd, J = 8.5, 5.8 Hz, CH‐C8), 1.48 (3H, s, CH3‐Me acetonide), 1.40 (3H, s, 
CH3‐Me acetonide), 1.28 (3H, t, J = 7.2 Hz, CH3‐OEt); 
13C NMR (100 MHz, CDCl3) δ 175.6 
(C‐C6), 173.1 (C‐C4), 111.0 (C‐C acetonide), 88.6 (CH‐C5), 74.8 (CH‐C7), 68.4 (CH2‐C8), 
60.7 (CH2‐OEt), 26.4 (CH3‐Me acetonide), 25.7 (CH3‐Me acetonide), 14.6 (CH3‐OEt); 
HRMS (CI+, isobutane) calcd for  C10H17O5  [M+H]
+ 217.1076, found 217.1078 (Δ +0.9 
ppm); LRMS (CI+, isobutane) m/z (intensity); 217.2 (100%), 199.2 (21%), 159.2 (30%). 
Ethyl 3-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-(R,S)-hydroxypropanoate. (315) 
 
NaBH4 (0.9 g, 25 mmol) was added to a solution of ketone 314a (4.9 g, 23 mmol) in 
EtOH (130 mL) at 0 °C and the mixture stirred for 15 minutes. The volatiles were 
removed in vacuo and the residue partitioned between Et2O (50 mL) and brine (50 mL). 
The organic phase was isolated and the aqueous back-extracted with further Et2O (2× 50 
mL). The combined organic extracts were dried (MgSO4), filtered and concentrated 
before purification of the residue by chromatography (pet. ether/EtOAc, 9:1 to 4:1) to 
give a diasteromeric mixture of alcohols 315a and 315b (4.1 g, 83%, dr 1:1) as a clear 
oil. 
Resolution of β-hydroxy esters through silyl ether derivatisation. 
 
To a stirred solution of diasteromeric alcohols  315 (0.11 g, 0.46 mmol) in DMF (5 mL) at 
rt was added chloro(dimethyl)phenylsilane  (0.11 mL, 0.69 mmol) and imidazole (0.62 g, 
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0.92 mmol). The mixture was stirred for 1.5 h, concentrated in vacuo and purified by 
chromatography (pet. ether/EtOAc, 97:3) to provide silyl ethers 316a (34 mg, 21%), 
316b (53 mg, 33%) and a diastereomeric mixture of both (31 mg, 19%) all as clear, 
colourless oils. 
Ethyl (3R)-3-{[dimethyl(phenyl)silyl]oxy}-3-[(4R)-2,2-dimethyl-1,3-dioxolan-4-
yl]propanoate. (316a) 
 
Rf = 0.40 (pet. ether, EtOAc, 9:1);[α]
25
D  +25.0 (c = 1.09, CHCl3); νmax (liquid film) 2984, 
2902, 1734, 1373, 1208, 1250, 1071, 823, 785, 731, 699 cm−1; 1H NMR (400 MHz, CDCl3) δ 
7.59–7.55 (2H, m, CH‐PhSi), 7.47–7.29 (3H, m, CH‐PhSi), 4.45–4.22 (1H, m, CH‐C6), 4.11–
4.00 (3H, m, CH2‐OEt and CH‐C7), 3.92 (1H, dd, J = 8.4, 6.9 Hz, CH‐C8), 3.77 (1H, dd, J 
= 8.4, 6.6 Hz, CH‐C8), 2.50 (1H, dd, J = 15.2, 4.0 Hz, CH‐C5), 2.42 (1H, dd, J = 15.2, 8.5 
Hz, CH‐C5), 1.38 (3H, s, CH3‐Me acetonide), 1.30 (3H, s, CH3‐Me acetonide), 1.21 (3H, t, 
J = 7.1 Hz, CH3‐OEt), 0.40 (3H, s, CH3‐SiMe), 0.39 (3H, s, CH3‐SiMe); 
13C NMR (125 MHz, 
CDCl3) δ 171.7 (C‐C4), 138.3 (C‐PhSi), 133.8 (CH-PhSi), 129.9 (CH‐PhSi), 128.1 (CH‐PhSi), 
109.9 (C‐C acetonide), 78.0 (CH‐C7), 70.6 (CH‐C6), 65.5 (CH2‐C8), 60.9 (CH2‐OEt), 38.4 
(CH2‐C5), 26.6 (CH3–Me acetonide), 25.3 (CH3-Me acetonide), 14.5 (CH3‐OEt), −0.8 (CH3‐
MeSi), −1.0 (CH3‐MeSi); HRMS (CI+, isobutane) calcd for C18H29O5Si [M+H]
+ 353.1784, 
found 353.1788 (Δ +1.1 ppm); LRMS (CI+, isobutane) m/z (intensity); 353.3 (5%), 219.2 
(100%), 179.2 (23%), 161.2 (44%), 133.2 (24). 
Ethyl (3S)-3-{[dimethyl(phenyl)silyl]oxy}-3-[(4R)-2,2-dimethyl-1,3-dioxolan-4-
yl]propanoate. (316b) 
 
Rf = 0.44 (pet. ether, EtOAc, 9:1);[α]
24
D  −5.2 (c = 1.07, CHCl3); νmax (liquid film) 2985, 
2908, 1735, 1373, 1250, 1072, 824, 787, 733, 702 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.58–
7.54 (2H, m, CH‐PhSi), 7.40–7.33 (3H, m, CH‐PhSi), 4.17 (1H, ddd, J = 7.8, 6.7, 4.1 Hz, 
CH‐C7), 4.05–3.91 (4H, m, CH2‐OEt, CH‐C6 and CH‐C8), 3.72 (1H, dd, J = 7.8, 5.5 Hz, 
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CH‐C8), 2.61 (1H, dd, J = 15.4, 4.1 Hz, CH‐C5), 2.46 (1H, dd, J = 15.4, 7.7 Hz, CH‐C5), 
1.34 (3H, s, CH3‐Me acetonide), 1.31 (3H, s, CH3‐Me acetonide), 1.20 (3H, t, J = 7.2 Hz, 
CH3‐OEt), 0.40 (3H, s, CH3‐SiMe), 0.40 (3H, s, CH3‐SiMe); 
13C NMR (100 MHz, CDCl3) δ 
171.7 (C‐C4), 138.2 (C‐PhSi), 133.7 (CH‐PhSi), 130.0 (CH‐PhSi), 128.1 (CH‐PhSi), 109.8 
(C‐C acetonide), 78.7 (CH‐C7), 71.2 (CH‐C6), 67.1 (CH2‐C8), 60.8 (CH2‐OEt), 40.3 (CH2‐
C5), 26.9 (CH3‐Me acetonide),  25.6 (CH3-Me acetonide), 14.5 (CH3‐OEt), −0.76 (CH3‐
SiMe), −0.86 (CH3‐SiMe); HRMS (CI+, isobutane) calcd for  C18H29O5Si [M+H]
+ 353.1784, 
found 353.1783 (Δ −0.2 ppm); LRMS (CI+, isobutane) m/z (intensity); 353.3 (8%), 337.3 
(47%), 295.2 (100%), 275.2 (53%), 217.2 (28%). 
Ethyl (3R)-3-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-hydroxypropanoate. (315a) 
 
TBAF (3.4 mL of a 1 M solution in THF, 3.4 mmol) was added dropwise to a stirred 
solution of 316a (1.1 g, 3.1 mmol) in THF (10 mL) at rt and the mixture was stirred for 
30 minutes. The reaction was quenched by the addition of H2O (5 mL) and the mixture 
was extracted with CH2Cl2 (3 × 10 mL). The organic phase was dried (MgSO4), filtered 
and concentrated to a clear oil. Purification of the residue by chromatography (pet. 
ether/EtOAc/Et3N, 80:20:1) yielded alcohol 315a (0.58 g, 86%) as a single diastereomer. 
Rf = 0.17 (pet. ether/EtOAc, 2:1);[α]
24
D  +15.7 (c = 1.14, CHCl3); νmax (liquid film) 3472, 
2986, 2901, 1729, 1373, 1250, 1067, 849, 609 cm−1; 1H NMR (400 MHz, CDCl3) δ 4.18 (2H, 
q, J = 7.1 Hz, CH2‐OEt), 4.12 (1H, td, J = 6.5, 4.6 Hz, CH‐C7), 4.08–4.00 (2H, m, CH‐C6 
and CH‐C8), 3.85 (1H, dd, J = 8.3, 6.5 Hz, CH‐C8), 2.81 (1H, d, J = 5.6 Hz, OH‐C6), 2.54 
(1H, dd, J = 16.0, 8.3 Hz, CH‐C5), 2.48 (1H, dd, J = 16.0, 4.5 Hz, CH‐C5), 1.44 (3H, s, 
CH3‐Me acetonide), 1.36 (3H, s, CH3‐Me acetonide), 1.27 (3H, t, J = 7.1 Hz, CH2‐OEt); 
13C NMR (125 MHz, CDCl3) δ 172.2 (C‐C4), 110.0 (C‐C acetonide), 78.0 (CH‐C7), 68.7 (CH‐
C6), 66.0 (CH2‐C8), 61.2 (CH2‐OEt), 38.6 (CH2‐C5), 26.7 (CH3‐Me acetonide), 25.5 (CH3‐
Me acetonide), 14.5 (CH3‐OEt); HRMS (CI+, isobutane) calcd for  C10H19O5 [M+H]
+  
219.1232, found 219.1230 (Δ −1.0 ppm); LRMS (CI+, isobutane) m/z (intensity); 219.2 
(100%), 161.2 (70%); Anal. calcd for C10H18O5 C 55.03%, H 8.31%, found C 54.95%, H 
8.48%. 
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Ethyl (3S)-3-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-hydroxypropanoate.216 (315b) 
 
The procedure used to prepare 315a provided 315b as a clear, colourless oil in 91% 
yield. Rf = 0.17 (pet. ether, EtOAc, 2:1); [α]
25
D  −13.5 (c = 0.95, CHCl3), [lit. [α]
22
D  −11.8 
(c = 0.6, CHCl3)]
216 ; νmax (liquid film) 3464, 2986, 2909, 1728, 1373, 1157, 1064, 848, 
787 cm−1; 1H NMR (400 MHz, CDCl3) δ 4.18 (2H, q, J = 7.1 Hz, CH2‐OEt), 4.12–4.05 (1H, 
m, CH‐C8), 4.02–3.92 (3H, m, CH‐C6, CH-C7 and CH‐C8), 3.15 (1H, d, J = 3.7 Hz, OH‐
C6), 2.70 (1H, dd, J = 16.7, 2.8 Hz, CH‐C5), 2.47 (1H, dd, J = 16.7, 8.6 Hz, CH‐C5), 1.41 
(3H, s, CH3‐Me acetonide), 1.34 (3H, s, CH3‐Me acetonide), 1.28 (3H,t, J = 7.1 Hz, CH3‐
OEt); 13C NMR (100 MHz, CDCl3) δ 173.2 (C‐C4), 109.9 (C‐C acetonide), 77.9 (CH‐C7), 
69.6 (CH‐C6), 67.0 (CH2‐C8), 61.2 (CH2‐OEt), 37.9 (CH2‐C5), 27.0 (CH3‐Me acetonide), 
25.5 (CH3-Me acetonide), 14.5 (CH3‐OEt); HRMS (CI+, isobutane) calcd for  C10H19O5 
[M+H]+  219.1232, found 219.1234 (Δ +0.6 ppm); LRMS (CI+, isobutane) m/z (intensity); 
219.2 (100%), 161.2 (65%), 133.2 (26%). 
Ethyl (3R)-3-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-(prop-2-en-1-yloxy)propanoate. 
(323) 
 
Pd2(dba)2 (10 mg, 0.011 mmol) and 1,4-bis(diphenylphosphino)butane (20 mg, 
0.046 mmol) were stirred together in degassed THF (2 mL) at rt for 5 minutes. A 
solution of alcohol 315a (0.10 g, 0.46 mmol) and allyl ethyl carbonate (0.24 g, 1.8 
mmol) in degassed THF (1 mL) was added to the catalyst complex and the mixture was 
heated at 65 °C for 18 h. On cooling to rt the reaction mixture was concentrated and 
the residue purified directly by chromatography (pet. ether/EtOAC, 20:1 to 9:1) to 
afford the title allylic ether 323 (89 mg, 75%) as a clear, yellow oil. Rf = 0.57 (pet. 
ether, EtOAc, 3:1);[α]
25
D  +23.2 (c = 1.04, CHCl3); νmax (liquid film) 2985, 2901, 1736, 
1373, 1257, 1180, 1064, 849 cm−1; 1H NMR (400 MHz, CDCl3) δ  5.88 (1H, ddt, J = 17.1, 
 Chapter 3: Experimental Section 
 
156 
 
10.4, 5.7 Hz, CH‐C1), 5.25 (1H, dd, J = 17.1, 1.6 Hz, CH‐C1’ trans), 5.15 (1H, dd, J = 
10.4, 1.6 Hz, CH‐C1’ cis), 4.26 (1H, dt, J = 6.7, 5.6 Hz, CH‐C7), 7.31 (2H, q, J = 7.1 Hz, 
CH2‐OEt), 4.11-4.17 (2H, m, CH2‐C2), 4.03–3.95 (2H, m, CH‐C6 and CH‐C8), 3.79 (1H, dd, 
J = 8.5, 6.6 Hz, CH‐C8), 2.53 (1H, dd, J = 15.7, 4.7 Hz, CH‐C5), 2.47 (1H, dd, J = 15.7, 
7.9 Hz, CH‐C5), 1.42 (3H, s, CH3‐Me acetonide), 1.35 (3H, s, CH3‐Me acetonide),  1.27 
(3H, t, J = 7.1 Hz, CH3‐OEt);
 13C NMR (100 MHz, CDCl3) δ 171.8 (C‐C4), 135.0 (CH‐C1), 
117.4 (CH2‐C1’), 109.9 (C‐C acetonide), 76.8 (CH2-C2), 76.2 (CH‐C7), 72.4 (CH‐C6), 65.5 
(CH2‐C8), 60.9 (CH2‐OEt), 36.4 (CH2‐C5), 26.8 (CH3‐Me acetonide), 25.4 (CH3‐Me 
acetonide), 14.5 (CH3‐OEt); HRMS (CI+, isobutane) calcd for  C13H23O5 [M+H]
+ 259.1545, 
found 259.1540 (Δ −2.2 ppm); LRMS (CI+, isobutane) m/z (intensity); 259.3 (63%), 201.2 
(100%); Anal. calcd for C13H22O5 C 55.03%, H 8.31%, found C 54.95%, H 8.48%. 
1,4-Dimethyl (2R)-2-hydroxybutanedioate.217 (325) 
 
Thionyl chloride (30 mL, 0.41 mol) was added dropwise over 30 minutes to a solution of 
D-malic acid (25 g, 0.19 mol) in methanol (466 mL) at 0 °C and the mixture was stirred 
for 18 hours at rt. The volatile material was then removed in vacuo and the resulting 
residue partitioned between CH2Cl2 (200 mL) and saturated aqueous NaHCO3 (200 mL). 
The organic phase was isolated and the aqueous back-extracted with further CH2Cl2 (100 
mL). The combined organic extracts were washed with brine (200 mL), dried (MgSO4) 
and concentrated to provide the title diester 325 (28 g, 92%) as a pale yellow oil. Rf = 
0.48 (EtOAc); [α]
23
D  +16.7 (c = 0.98, MeOH), [lit. [α]
25
D  +9.6 (c = 2.3, EtOH)]
218; νmax 
(liquid film) 3493, 2958, 1730, 1438, 1264, 1212, 1167, 1103 cm−1; 1H NMR (400 MHz, 
CDCl3) δ 4.54-4.47 (1H, m, CH‐C6), 3.81 (3H, s, CH3‐MeO), 3.71 (3H, s, CH3‐MeO), 3.22 
(1H, d, J = 5.6 Hz, OH‐C6), 2.87 (1H, dd, J = 16.5, 4.4 Hz, CH –C5), 2.79 (1H, dd, J = 
16.5, 6.1 Hz, CH‐C5); 13C NMR (100 MHz, CDCl3): δ 173.5 (C‐C4), 170.7 (C‐C7), 67.0 (CH‐
C6), 52.7 (CH‐MeO), 51.8 (CH3‐MeO), 38.2 (CH2‐C5); HRMS (CI+, isobutane) calcd for  
C6H11O5 [M+H]
+ 163.0606, found 163.0603 (Δ −2.1 ppm); LRMS (CI+, isobutane) m/z 
(intensity); 163.2 (100%), 131.2 (24%), 103.2 (30%); Anal. calcd for C6H10O5 C 44.45%, H 
6.22%, found C 44.27%, H 6.28%. 
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Methyl (3R)-3,4-dihydroxybutanoate.219 (328) 
 
BH3·Me2S (17 mL, 0.18 mol) was added dropwise to a stirred solution of α-hydroxyester 
325 (28 g, 0.18 mol) in THF (336 mL) at rt. After complete addition and cessation of gas 
evolution, the reaction was stirred for 30 minutes. NaBH4 (0.66 g, 18 mmol) was added 
to the solution in two equal portions at 0 °C, at an interval of five minutes, and the 
reaction stirred for 3 hours at rt. The reaction was quenched by the addition of 
methanol (200 mL) and stirred for 10 minutes. The resulting solution was concentrated 
in vacuo and purified by chromatography (EtOAc) to provide the diol 328 (19 g, 83%) as 
a clear colourless oil. Rf = 0.23 (EtOAc);[α]
22
D   +13.8 (c = 0.99, CHCl3) [lit. [α]
20
D   +13.8 
(c = 2.27, CHCl3)]
8; νmax (liquid film) 3379, 2955, 2886, 1720, 1442, 1165, 1034, 864 
cm−1; 1H NMR (400 MHz, CDCl3) δ 4.16–4.09 (1H, m, CH‐C6), 3.72 (3H, s, CH3‐MeO), 3.71–
3.64 (1H, m, CH‐C7), 3.57–3.48 (1H, m, CH‐C7), 3.40–3.33 (1H, m, OH‐C6), 2.57 (1H, dd, 
J = 16.5, 8.5 Hz, CH‐C5), 2.50 (1H, dd, J = 16.5, 4.1 Hz, CH‐C5), 2.46–2.33 (1H, m, OH‐
C7); 13C NMR (100 MHz, CDCl3): δ 173.2 (C‐C4), 68.6 (CH‐C6), 65.8 (CH2‐C7), 52.1 (CH3‐
MeO), 37.5 (CH2‐C5); HRMS (CI+, isobutane) calcd for  C5H11O4 [M+H]
+ 135.0657, found 
135.0656 (Δ −0.9 ppm); LRMS (CI+, isobutane) m/z (intensity); 135.2 (82%), 103.2 
(100%); Anal. calcd for C5H10O4 C 44.77%, H 7.51%, found C 44.45%, H 7.51%. 
Methyl (3R)-4-[(tert-butyldimethylsilyl)oxy]-3-hydroxybutanoate.219 (329a) 
 
To a stirred solution of the diol 328 (7.59 g, 56.6 mmol) in CH2Cl2 (60 mL) at 0 °C were 
added sequentially tert-butyldimethylsilyl chloride (8.96 g, 59.4 mmol), triethylamine 
(15.8 mL, 113 mmol) and DMAP (1.38 g, 11.3 mmol). The mixture was stirred for 16 h at 
rt and then diluted with CH2Cl2 (40 mL). The reaction was quenched by the addition of 
1MHCl (120 mL). The mixture was extracted with CH2Cl2 (3 × 75 mL) and the organic 
phases were combined, washed with brine (100 mL), dried (MgSO4) and concentrated 
under reduced pressure. The residue was purified by flash column chromatography (pet. 
ether/EtOAc, 20:1) to provide the silyl ether 329a (11.4 g, 80%) as a colourless oil. Rf = 
0.15 (pet. ether/EtOAc, 9:1); [α]
23
D +11.2 (c = 1.01, CHCl3), [lit [α]
23
D  +7.38 (c = 1.00, 
CH2Cl2)]
219; νmax (liquid film) 3472, 2932, 2862, 1736, 1250, 1173, 1119, 1065, 833, 779 
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cm–1; 1H NMR (400 MHz, CDCl3) δ 4.12–4.03 (1H, m, CH‐C6) 3.71 (3H, s, CH3‐MeO), 3.63 
(1H, dd, J = 10.0, 4.8 Hz, CH‐C7), 3.57 (1H, dd, J = 10.0, 5.7 Hz, CH‐C7), 2.85 (1H, d, J 
= 4.9 Hz, OH‐C6), 2.54 (1H, dd, J = 16.0, 5.2 Hz, CH2‐C5), 2.49 (1H, dd, J = 16.0, 7.4 Hz, 
CH2‐C5), 0.89 (9H, s, CH3‐
tBuSi), 0.06 (6H, s, CH3‐MeSi); 
13C NMR (100 MHz, CDCl3): δ 
172.7 (C‐C4), 68.7 (CH‐C6), 66.3 (CH2‐C7), 51.9 (CH3‐MeO), 37.9 (CH2‐C5), 26.0 (CH3‐
tBuSi), 18.4 (C‐tBuSi), −5.3 (CH3‐MeSi), −5.3 (CH3‐MeSi); HRMS (CI+, isobutane) calcd for 
C11H25O4Si [M+H]
+ 249.1522, found 249.1519 (−1.2 ppm); LRMS (CI+, isobutane) m/z 
(intensity) 249.2 (100%). Anal. calcd for C11H24O4Si C 53.19%, H 9.74%, found C 53.03%,H 
9.83%. 
Methyl (3R)-4-[(tert-butyldimethylsilyl)oxy]-3-(prop-2-en-1-yloxy)butanoate. (330a) 
 
To a solution of the alcohol 329a (5.02 g, 20.1 mmol) and allyl trichloroacetimidate 
(8.72 g, 40.3 mmol) in pet. ether (25 mL) at rt was added triflic anhydride (4 drops). 
After stirring for 5 days the mixture was filtered, concentrated and purified directly by 
chromatography (pet. ether/EtOAc, 97.5:2.5) to provide the allyl ether 330a (5.53 g, 
95%) as a pale yellow oil. Rf = 0.33 (pet. ether/EtOAc, 9:1);[α]
23
D  +11.2 (c = 1.01, 
CHCl3); νmax. (liquid film) 2932, 2862, 1744, 1250, 1080, 1003, 833, 779, 671 cm
−1; 1H 
NMR (400 MHz, CDCl3) δ 5.88 (1H , ddt, J = 17.1, 10.4, 5.7 Hz, CH2‐C1), 5.25 (1H, dq, J = 
17.1, 1.5 Hz, CH‐C1’ trans), 5.14 (1H, dq, J = 10.4, 1.5 Hz, CH‐C1’ cis), 4.14–4.03 (2H, 
m, CH2‐C2), 3.90–3.83 (1H, m, CH‐C6), 3.71 (1H, dd, J = 10.4 Hz, 9.5 Hz, CH‐C7), 3.68 
(3H, s, CH3‐MeO), 3.54 (1H, dd, J = 10.4 Hz, 6.1 Hz, CH‐C7), 2.61 (1H, dd, J = 15.6, 4.8 
Hz, CH‐C5), 2.48 (1H, dd, J = 15.6, 7.8 Hz, CH‐C5), 0.89 (9H, s, CH3‐
tBuSi), 0.05 (6H, s, 
CH3‐MeSi); 
13C NMR (100 MHz, CDCl3) δ 172.3 (C‐C4), 135.2 (CH‐C1), 117.0 (CH2‐C1’), 
76.5 (CH‐C6), 71.6 (CH2‐C2), 64.8 (CH2‐C7), 51.7 (CH3‐MeO), 37.5 (CH2‐C5), 26.0 (CH3‐
tBuSi), 18.4 (C‐tBuSi), −5.3 (CH3‐MeSi), −5.3 (CH3‐MeSi); Anal. calcd for C14H28O4Si C 
58.29%, H 9.78%, found C 58.19%, H 9.71%. 
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(3R)-4-[(tert-Butyldimethylsilyl)oxy]-3-(prop-2-en-1-yloxy)butanoic acid. (331a) 
 
To a stirred solution of the ester 330a (26.8 g, 92.9 mmol) in methanol (500 mL) at rt 
was added a 1 M aqueous solution of KOH (112 ml, 112 mmol). The solution was stirred 
for 5 h at rt and concentrated in vacuo. The residue was dissolved in CH2Cl2 (300 mL) 
and adjusted to pH 2 with 1 M aqueous HCl. The phases were separated and the aqueous 
phase was extracted with CH2Cl2 (2 × 250 mL). The organic phases were combined, dried 
(MgSO4) and concentrated. The residue was purified by chromatography (pet. 
ether/EtOAc, 4:1) to provide the desired carboxylic acid 331a (19.6 g, 77%) as a pale 
yellow oil. Rf = 0.27 (pet. ether/EtOAc, 1:1); [α]
24
D  +20.4 (c = 1.02, CHCl3); νmax (liquid 
film) 3086, 2862, 17482, 1713, 1466, 1257, 1080, 833, 772  cm−1; 1H NMR (400 MHz, 
CDCl3) δ 11.02 (1H, br s, CO2H), 5.89 (1H, ddt, J = 17.2, 10.4, 5.7 Hz, CH‐C1), 5.27 (1H, 
qd, J = 17.2, 1.8 Hz, CH‐C1’trans), 5.17 (1H, qd, J = 10.4, 1.8 Hz, CH‐C1’cis), 4.17–4.06 
(2H, m, CH2‐C2), 3.89–3.82 (1H, m, CH‐C6), 3.73 (1H, dd, J = 10.4, 5.0 Hz, CH‐C7), 3.58 
(1H, dd, J = 10.4, 6.0 Hz, CH‐C7), 2.68 (1H, dd, J = 15.9, 5.0 Hz, CH‐C5), 2.55 (1H, dd, J 
= 15.9, 7.4 Hz, CH‐C5), 0.89 (9H, s, CH3‐
tBuSi), 0.06 (6H, s, CH3‐MeSi); 
13C NMR (100 
MHz, CDCl3) δ 176.6 (C‐C4), 134.8 (CH‐C1), 117.4 (CH2‐C1’), 76.2 (CH‐C6), 71.6 (CH2‐
C2), 64.7 (CH2‐C7), 37.4 (CH2‐C5), 26.0 (CH3‐
tBuSi), 18.4 (C‐tBuSi), −5.3 (CH3‐MeSi), −5.3 
(CH3‐MeSi); HRMS (CI+, isobutane) calcd for C13H27O4Si [M+H]
+ 275.1678, found 275.1681 
( +0.7 ppm); LRMS (CI+, isobutane) m/z (intensity) 275.3 (6%), 143.2 (100%). Anal. 
calcd for C13H26O4Si C 56.90%, H 9.55%, found C 57.03%, H 9.64%. 
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Diazomethane (138) 
 
Note - Diazomethane was generated from Diazald® within a Sigma Aldrich Daizald kit 
with fire-polished Clear-Seal® joints. The kit was inspected for cracks and/or chips 
prior to each use. Each distillation was conducted behind a blast shield. 
Solid KOH (13.5 g, 241 mmol) was dissolved in water (52 mL) to which was added Et2O 
(67 mL) and 2-ethoxyethanol (67 mL). The flask was warmed to 70 ˚C in a water bath 
and a solution of Diazald (17.2 g, 80.2 mmol) in Et2O (134 mL) was added dropwise over 
30 minutes to the basic solution. The ethereal solution of diazomethane was distilled 
into a conical flask pre-chilled in an ice-bath. Upon completion of the diazomethane 
distillation, the solution was stored at 0 ˚C under an argon atmosphere until required. 
(4R)-5-[(tert-Butyldimethylsilyl)oxy]-1-diazo-4-(prop-2-en-1-yloxy)pentan-2-one. 
(326a) 
 
The reaction sequence was performed in duplicate and material was combined for 
work-up and purification. To a stirred solution of the carboxylic acid 331a (2.5 g, 
9.1 mmol) in ether (90 mL), at rt, was added triethylamine (1.3 ml, 9.1 mmol) and 
isobutylchloroformate (1.3 ml, 9.6 mmol). The reaction mixture was stirred vigorously 
for 2 h then filtered, to remove precipitates, and added to a freshly distilled ethereal 
solution of diazomethane (91.1 mmol) at 0 °C. The resultant solution was allowed to stir 
for 16 h at rt and quenched by the addition of acetic acid (4 mL). The solution was 
added carefully to a solution of saturated aqueous NaHCO3 (200 mL) and the ether layer 
isolated. The aqueous phase was back-extracted with ether (100 mL) and the organic 
phases were combined, dried (MgSO4) and concentrated. The residue purified by 
chromatography (pet. ether/EtOAc, 20:1 to 9:1) to provide the diazo ketone 326a (4.7 
g, 86%); [α]
25
D  
+39.6 (c = 1.02, CHCl3); νmax (liquid film) 2955, 2930, 2857, 2101, 1640, 
1362, 1346, 1111, 1091, 833, 814, 775 cm–1; 1H NMR(400 MHz, CDCl3) δ 5.88 (1H, ddt, J 
= 17.2, 10.4, 5.7 Hz, CH‐C1), 5.34 (1H, br s, CH‐C3), 5.25 (1H, dq, J = 17.2, 1.4 Hz, CH-
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C1’ trans), 5.15 (1H, dq, J = 10.4, 1.4 Hz, CH‐C1’ cis), 4.12 (1H, ddt, J = 12.6, 5.7, 1.4 
Hz, CH‐C2), 4.06 (1H, ddt, J = 12.6, 5.7, 1.4 Hz, CH‐C2), 3.92–3.84 (1H, m, CH‐C6), 3.68 
(1H, dd, J = 10.5, 5.1 Hz, CH‐C7), 3.58 (1H, dd, J = 10.5, 5.5 Hz, CH‐C7), 2.63–2.42 (2H, 
m, CH2‐C5), 0.89 (9H, s, CH3‐
tBuSi), 0.05 (6H, s, CH3‐MeSi); 
13C NMR (100 MHz, CDCl3) δ 
193.3 (C‐C4), 135.1 (CH‐C1), 117.0 (CH2‐C1’), 76.8 (CH‐C6), 71.6 (CH2‐C2), 64.9 (CH2‐
C7), 55.5 (CH‐C3), 43.7 (CH2‐C5), 26.0 (CH3‐
tBuSi), 18.4 (C‐tBuSi), −5.2 (CH3‐MeSi); LRMS 
(FAB) m/z (intensity) 299.0 (100%). Anal. calcd for C14H26N2O3Si C 56.34%, H 8.78%, N 
9.39% found C 56.29%, H 8.80%, N 9.41%. 
(2S,5R)-5-{[(tert-Butyldimethylsilyl)oxy]methyl}-2-(prop-2-en-1-yl)tetrahydrofuran-
3-one. (327a) 
 
Diazoketone 326a (1.9 g, 6.4 mmol) in THF (160 mL) was added dropwise to a stirred 
solution of Cu(acac)2 (0.33 g, 1.3 mmol) in THF (160 mL) at reflux. Following complete 
addition, the solution was heated for a further 40 minutes and cooled to rt. 
Concentration in vacuo afforded a residue which was purified directly by 
chromatography (pet. ether/EtOAc, 20:1) to provide the furanone 327a (1.64 g, 95%, 
dr>20:1) as a colourless oil. Rf = 0.59 (pet. ether/EtOAc, 4:1); [α]
21
D  −70.2 (c = 1.02, 
CHCl3);  νmax (liquid film) 2932, 2862, 2100, 1759, 1466, 1404, 1257, 1087, 833, 779 
cm−1; 1H NMR (400 MHz, CDCl3) δ  5.78 (1H, ddt, J = 17.1, 10.2, 6.9 Hz, CH‐C1), 5.26–
5.02 (2H, m, CH2‐C1’), 4.50–4.44 (1H, m, CH‐C6), 4.13 (1H, dd, J = 7.2, 4.5 Hz, CH‐C3), 
3.91 (1H, dd, J = 10.9, 3.0 Hz, CH‐C7), 3.66 (1H, dd, J = 10.9, 2.6 Hz, CH‐C7), 2.56–2.42 
(3H, m, CH‐C2 and CH2‐C5), 2.32–2.23 (1H, m, CH‐C2), 0.86 (9H, s, CH3‐
tBuSi), 0.05 (3H, 
s, CH3‐MeSi), 0.04 (3H, s, CH3‐MeSi); 
13C NMR (100 MHz, CDCl3) δ 215.5 (C‐C4), 133.3 
(CH‐C1), 118.1 (CH2‐C1’), 79.7 (CH‐C3), 75.8 (CH‐C6), 66.8 (CH2‐C7), 38.3 (CH2‐C2), 36.4 
(CH2‐C5), 25.8 (CH3‐
tBuSi), 18.2 (C‐tBuSi), −5.5 (CH3‐MeSi), −5.6 (CH3‐MeSi); HRMS (CI+, 
isobutane) calcd for C14H27O3Si [M+H]
+ 271.1729, found 271.1731 (Δ+0.4 ppm); LRMS 
(CI+, isobutane) m/z (intensity) 271.4 (100%). Anal. calcd for C14H26O3Si C 62.18%, H 
9.69% found C 62.20%, H 9.81%. 
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(2S,3S,5R)-5-{[(tert-Butyldimethylsilyl)oxy]methyl}-2-(prop-2-en-1-yl) 
tetrahydrofuran-3-ol. (341a) 
(2S,3R,5R)-5-{[(tert-Butyldimethylsilyl)oxy]methyl}-2-(prop-2-en-1-yl) 
tetrahydrofuran-3-ol (341b)  
 
Sodium borohydride (365 mg, 9.66 mmol) was added to a solution of ketone 327a (2.5 g, 
9.2 mmol) in ethanol (157 mL) at rt. After stirring for 15 minutes the volatiles were 
removed in vacuo and the residue was partitioned between CH2Cl2 and H2O (100 mL of 
each). The resulting diastereomeric mixture of the alcohols was extracted with CH2Cl2 
(2 × 100 mL) and the combined extracts were washed with brine. The organic phase was 
dried (MgSO4) and concentrated to give a colourless oil. The crude material was used in 
the subsequent step without purification and a small sample of the diastereomeric 
mixture of alcohols (dr 4:1) was purified (pet. ether/EtOAc 95:5 to 9:1) for 
characterisation purposes.  
341a (C20-C21-syn).220 Rf = 0.27 (pet. ether/EtOAc, 20:1); [α]
22
D  +6.4 (c = 1.12, CHCl3); 
νmax
 (liquid film) 3409, 2953, 2929, 2897, 2857, 1254, 1085, 833, 775 cm−1; 1H NMR (400 
MHz, CDCl3) δ 5.86 (1H, dddd, J = 17.2, 10.2, 7.2, 6.6 Hz, CH‐C18), 5.17 (1H, dq, J = 
17.2, 1.6 Hz, CH‐C18’ trans), 5.10–5.06 (1H, m, CH-C18’ cis), 4.32–4.24 (2H, m, CH‐C23 
and CH‐C21), 3.89 (1H, td, J = 7.1, 2.8 Hz, CH‐C20), 3.68 (1H, dd, J = 10.8, 4.3 Hz, CH‐
C24), 3.61 (1H, dd, J = 10.8, 4.1 Hz, CH‐C24), 2.50–2.34 (2H, m, CH2‐C19), 2.08 (1H, 
ddd, J = 13.4, 8.6, 4.7 Hz, CH‐C22), 1.99 (1H, ddd, J = 13.4, 7.0, 1.1 Hz, CH‐C22), 1.57 
(1H, d, J = 6.0 Hz, OH‐C21), 0.89 (9H, s, CH3‐
tBuSi), 0.05 (6H, s, CH3‐MeSi); 
13C NMR (100 
MHz, CDCl3) δ 134.9 (CH‐C18), 117.1 (CH2‐C18’), 82.1 (CH‐C20), 77.6 (CH‐C23), 73.5 
(CH‐C21), 65.7 (CH2‐C24), 37.2 (CH2‐C22), 33.9 (CH2‐C19), 26.1 (CH3‐
tBuSi), 18.5 (C‐
tBuSi), −5.2 (CH3‐MeSi), −5.2 (CH3‐MeSi); HRMS (CI+, isobutane) calcd for C14H29O3Si 
[M+H]+ 273.1886, found 273.1887 (Δ +0.3 ppm); LRMS (CI+, isobutane) m/z (intensity) 
273.4 (100%). Anal. calcd for C14H28O3Si C 61.72%, H 10.36% found C 61.32%, H 10.55%. 
341b (C20-C21-anti).Rf = 0.31 (pet. ether/EtOAc, 20:1); [α]
22
D  −40.7 (c = 1.06, CHCl3); 
νmax (liquid film) 3445, 2953, 2929,2857, 1472, 1254, 1088, 832, 776 cm
−1; 1H NMR (400 
MHz, CDCl3) δ 5.81 (1H, ddt, J = 17.2, 10.3, 7.0 Hz, CH‐C18), 5.12–5.05 (2H, m, CH2‐
C18’), 4.29–4.24 (1H, m, CH‐C23), 4.23 (1H, d, J = 10.9 Hz, OH‐C21), 4.10-4.01 (1H, m, 
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CH‐C20), 3.99 (1H, ap dd, J = 10.9, 5.8 Hz, CH‐C21), 3.86 (1H, dd, J = 10.9, 2.3 Hz, CH‐
C24), 3.53 (1H, dd, J = 10.9, 1.8 Hz, CH‐C24), 2.36 (1H, ddd, J = 14.1, 9.8, 5.8 Hz, CH‐
C22), 2.20–2.05 (2H, m, CH2‐C19), 1.86 (1H, dd, J = 14.1, 2.6 Hz, CH‐C22), 0.92 (9H, s, 
CH3‐
tBuSi), 0.12 (6H, s, CH3‐MeSi); 
13C NMR (100 MHz, CDCl3) δ 134.6 (CH‐C18), 117.3 
(CH2‐C18’), 87.7 (CH‐C20), 78.1 (CH‐C23), 74.6 (CH‐C21), 66.1 (CH2‐C24), 38.4 (CH2‐
C19), 35.6 (CH2‐C22), 26.1 (CH3‐
tBuSi), 18.7 (C‐tBuSi), −5.3 (CH3‐MeSi), −5.4 (CH3‐MeSi); 
HRMS (CI+, isobutane) calcd for C14H29O3Si [M+H]
+ 273.1886, found 273.1888, (Δ +0.9 
ppm); LRMS (CI+, isobutane) m/z (intensity) 273.4 (100%). Anal. calcd for C14H28O3Si C 
61.72%, H 10.36% found C 61.62%, H 10.51%. 
tert-Butyldimethyl{[(2R,5R)-5-(prop-2-en-1-yl)tetrahydrofuran-2-yl]methoxy}silane. 
(343) 
 
A diastereomeric mixture of the alcohols 341 (1.95 g, 7.16 mmol, dr 70:30) in THF 
(2  mL) was added dropwise to a stirred suspension of NaH (1.51 g of a 60% dispersion in 
mineral oil, 37.8 mmol) in THF (143 mL) at 55 °C. Following complete addition, the 
mixture was heated at reflux for 30 minutes and carbon disulfide (4.30 mL, 71.6 mmol) 
was added. The mixture was heated for a further 30 minutes and iodomethane (4.52 
mL, 71.6 mmol) was added dropwise. Heating was continued for an additional 2 h and 
the mixture was then cooled to rt and the reaction was quenched by slow addition of 
H2O (100 mL). The organic component was extracted with ether (3 × 120 mL) and the 
extracts were washed with brine (100 mL) then dried (MgSO4) and concentrated. The 
residual crude xanthate was used without further purification. 
The crude xanthate was dissolved in toluene (243 mL) and 1,1′- 
azobis(cyclohexanecarbonitrile) (1.38 g, 5.66 mmol) and n-Bu3SnH (5.80 mL, 21.5 mmol) 
were added sequentially. The mixture was placed in a pre-heated oil bath at 110 °C and 
and the mixture was heated at reflux for 2 h. The mixture was cooled to rt and 
concentrated in vacuo. The resultant dark residual material was purified directly by 
chromatography (pet. ether/EtOAc, 99:1) to give the tetrahydrofuran 343 contaminated 
with a malodorous impurity. A small amount of material was purified for 
characterization purposes and the rest was used in the subsequent step without further 
purification. Rf = 0.46 (pet. ether/EtOAc, 9:1); [α]
21
D −10.4 (c = 1.00, CHCl3);  νmax (liquid 
film) 2955, 2928, 2857, 1471, 1252, 1084, 833, 775, 667 cm−1; 1H NMR (400 MHz, CDCl3) 
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δ 5.81 (1H, ddt, J = 17.2, 10.2, 7.0 Hz, CH‐C18), 5.12–5.01 (2H, m, CH2‐C18’), 4.06 (1H, 
tt, J = 6.7, 5.0 Hz, CH‐C23), 4.01 (1H, ddt, J = 7.7, 6.4, 6.1 Hz, CH‐C20), 3.63 (1H, dd, J 
= 10.5, 4.6 Hz, CH‐C24), 3.55 (1H, dd, J = 10.5, 5.4 Hz, CH‐C24), 2.39–2.30 (1H, m, CH‐
C19), 2.25–2.16 (1H, m, CH‐C19), 2.04–1.93 (2H, m, CH‐C21 and CH‐C22), 1.80–1.68 (1H, 
m, CH‐C22), 1.62–1.51 (1H, m, CH‐C21), 0.89 (9H, s, CH3‐
tBuSi), 0.05 (6H, s, CH3‐MeSi); 
13C NMR (100 MHz, CDCl3) δ 135.3 (CH‐C18), 116.8 (CH2‐C18’), 79.4 (CH‐C23), 78.9 (CH‐
C20), 66.1 (CH2‐C24), 40.4 (CH2‐C19), 31.4 (CH2‐C21), 28.2 (CH2‐C22), 26.1 (CH3‐
tBuSi), 
18.5 (C‐tBuSi), −5.1 (CH3‐MeSi); HRMS (CI+, isobutane) calcd for  C14H29O2Si [M+H]
+ 
257.1937 found 257.1934 (Δ −1.00 ppm); LRMS (CI+, isobutane) m/z (intensity) 257.4 
(100%); Anal. calcd for C14H28O2Si C 65.57%, H 11.00% found C 65.81%, H 11.05%. 
2-[(2R,5R)-5-{[(tert-Butyldimethylsilyl)oxy]methyl}tetrahydrofuran-2-yl]ethan-1-ol. 
(344) 
 
Ozone was bubbled through a solution of the alkene 343 dissolved in a mixture of 
methanol and CH2Cl2 (50% v/v, 120 mL) until the solution turned a purple/blue color. 
The solution was purged with argon for 15 minutes to dissipate the colour, warmed to 
0 °C and sodium borohydride (1.60 g, 43.0 mmol) was then added slowly in small 
portions over 10 minutes. The mixture was then stirred for 1 h and the reaction was 
quenched by the addition of solid NH4Cl (4 g). The precipitated solids were removed by 
vacuum filtration and the solvent was evaporated to give an opaque white oil that was 
then purified by chromatography (pet. ether/EtOAc, 4:1 to 1:1) to afford alcohol 344 
(1.36 g, 73% over 4 steps) as a colourless oil. Rf = 0.39 (pet. ether/EtOAc, 1/1); [α]
23
D  
−2.9 (c = 0.99, CHCl3); νmax (liquid film) 3440, 2953, 2930, 2857, 1469, 1253, 1079, 834, 
775, 668 cm−1; 1H NMR (400 MHz, CDCl3) δ 4.19–4.06 (2H, m, CH‐C20 and CH‐C23), 3.84–
3.76 (2H, m, CH2‐C18), 3.59 (2H, d, J = 4.8 Hz, CH2‐C24), 2.96 (1H, dd, J = 6.6, 4.3 Hz, 
OH‐C18), 2.11–2.02 (1H, m, CH‐C21), 2.02–1.92 (1H, m, CH‐C22), 1.79–1.69 (3H, m, CH2‐
C19 and CH‐C22), 1.63–1.53 (1H, m, CH‐C21), 0.89 (9H, s, CH3‐
tBuSi), 0.06 (6H, s, CH3‐
MeSi); 13C NMR (100 MHz, CDCl3) δ 80.1 (CH‐C23), 79.6 (CH‐C20), 65.9 (CH2‐C24), 62.1 
(CH2‐C18), 37.4 (CH2‐C19), 32.4 (CH2‐C21), 27.8 (CH2‐C22), 26.1 (CH3‐
tBuSi), 18.5 (C‐
tBuSi), −5.2 (CH3‐MeSi); HRMS (CI+, isobutane) calcd for  C13H29O3Si [M+H]
+ 261.1886 
found 261.1883, (Δ −1.20 ppm); LRMS (CI+, isobutane) m/z (intensity) 261.4 (100%), 
203.3 (22%), 129.3 (14%); Anal. calcd for C13H28O3Si C 59.95%, H 10.84% found C 59.99%, 
H 10.89%. 
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tert-Butyl({[(2R,5R)-5-{2-[(tert-butyldiphenylsilyl)oxy]ethyl}tetrahydrofuran-2-
yl]methoxy})dimethylsilane. (347) 
 
A solution of alcohol 344 (0.26 g, 1.0 mmol), tert-butyldiphenylsilyl chloride (0.29 mL, 
1.1 mmol), Et3N (0.21 ml, 1.5 mmol) and DMAP (25 mg, 0.20 mmol) in CH2Cl2 (10 mL) 
was stirred for 17 h at rt. The reaction was quenched by the addition of 1 M aqueous HCl 
(10 mL) and the mixture was extracted with CH2Cl2 (3 × 10 mL). The organic extracts 
were then dried (MgSO4) and concentrated. Chromatographic purification of the residual 
material by chromatography (pet. ether/EtOAc, 99:1) afforded the desired silyl ether 
347 (466 mg, 92%) as a colourless oil. Rf = 0.47 (pet. ether/EtOAc, 3:1); [α]
21
D  −1.9 (c = 
0.98, CHCl3);  νmax (liquid film) 2955, 2929, 2856, 1471, 1256, 1082, 1006, 835, 775, 736, 
699, 613 cm−1;  1H NMR (400 MHz, CDCl3) δ 7.68–7.64 (4H, m, CH-PhSi), 7.44–7.34 (6H, m, 
CH-PhSi), 4.13–4.06 (1H, m, CH‐C20), 4.04 (1H, tt, J = 6.9, 5.0 Hz, CH‐C23), 3.80–3.70 
(2H, m, CH2‐C18), 3.62 (1H, dd, J = 10.5, 5.0 Hz, 1H, CH‐C24), 3.53 (1H, dd, J = 10.5, 
5.0 Hz, CH‐C24), 2.05–1.82 (3H, m, CH‐C21, CH‐C22 and CH‐C19), 1.76–1.63 (2H, m, CH‐
C19 and CH‐C22), 1.55–1.45 (1H, m, CH‐C21), 1.07 (9H, s, CH3‐
tBuSi), 0.92 (9H, s, CH3‐
tBuSi), 0.08 (6H, s, CH3‐MeSi); 
13C NMR (100 MHz, CDCl3) δ 135.7 (CH‐PhSi), 134.1 (C‐
PhSi), 134.1 (C‐PhSi), 129.7 (CH‐PhSi), 127.7 (CH‐PhSi), 79.0 (CH‐C23), 76.8 (CH‐C20), 
66.2 (CH2‐C24), 61.6 (CH2‐C18), 38.8 (CH2‐C19), 32.1 (CH2‐C21), 28.3 (CH2‐C22), 27.0 
(CH3‐
tBuSi), 26.1 (CH3‐
tBuSi), 19.3 (C‐tBuSi), 18.5 (C‐tBuSi), −5.1 (CH3‐MeSi); HRMS (CI+, 
isobutane) calcd for C29H47O3Si2 [M+H]
+ 499.3063 found 499.3062 (Δ −0.5 ppm); LRMS 
(CI+, isobutane) m/z (intensity) 499.6 (68%), 421.5 (100%). 
[(2R,5R)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}tetrahydrofuran-2-yl]methanol. 
(348) 
 
To a solution of the bis silyl ether 347 (0.10 g, 0.20 mmol) in a mixture of methanol and 
CH2Cl2 (2 ml, 50% v/v) at 0 °C was added camphor sulfonic acid (14 mg, 0.06 mmol). 
The mixture was stirred for 2 h and the reaction was quenched by the addition of 
triethylamine (0.01 mL). The mixture was concentrated in vacuo and the residual 
material was purified by chromatography (pet. ether/EtOAc, 3:1) to provide the alcohol 
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348 (66 mg, 86%) as a colourless oil. Rf = 0.35 (pet. ether/EtOAc, 9:1); [α]
22
D  −10.9 (c = 
0.96, CHCl3); νmax (liquid film) 3433, 3055, 2931, 2862, 1466, 1389, 1265, 1088, 818, 
702, 609 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.77–7.61 (4H, m, CH-PhSi), 7.49–7.31 (6H, m, 
CH-PhSi), 4.18–4.09 (1H, m, CH‐C20), 4.06 (1H, qd, J = 6.9, 3.2 Hz, CH‐C23), 3.84–3.72 
(2H, m, CH2‐C18), 3.66–3.57 (1H, m, CH‐C24), 3.51–3.43 (1H, m, CH‐C24), 2.08–1.50 
(7H, m, CH2-C19, CH2-C21, CH2-C22 and OH‐C24), 1.06 (9H, s, CH3‐
tBuSi); 13C NMR (100 
MHz, CDCl3) δ 135.7 (CH‐PhSi), 134.1 (C‐PhSi), 134.0 (C‐PhSi), 129.7 (CH‐PhSi), 127.7 
(CH‐PhSi), 78.8 (CH‐C23), 76.5 (CH‐C20), 65.2 (CH2‐C24), 61.4 (CH2‐C18), 38.6 (CH2‐
C19), 32.4 (CH2‐C21), 27.6 (CH2‐C22), 27.0 (CH3‐
tBuSi), 19.3 (C‐tBuSi); HRMS (CI+, 
isobutane) calcd for  C23H33O3Si [M+H]
+ 385.2199 found 385.2200 (Δ +0.3 ppm); LRMS 
(CI+, isobutane) m/z (intensity) 385.4 (76%), 327.3 (27%), 307.4 (100%), 229.3 (40%). 
1-[(2R,5R)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}tetrahydrofuran-2-yl]-3-
(trimethylsilyl)prop-2-yn-1-ol. (367) 
 
Alcohol 348 (50 mg, 0.14 mmol) was dissolved in CH2Cl2 (4 mL) and the solution was 
treated with a single portion of Dess-Martin periodinane (79 mg, 0.19 mmol) for 1 h at 
rt. The volatiles were removed in vacuo and the resulting residue suspended in ether (5 
mL). The precipitates were removed by filtration and the mixture was concentrated. 
The crude aldehyde 362 was dissolved in an ethereal solution of magnesium bromide, 
prepared by the dropwise addition of 1,2-dibromoethane (0.10 mL, 1.1 mmol) to 
magnesium turnings (27 mg, 1.1 mmol) in ether (0.8 mL) at rt. A solution of MeLi (0.35 
mL of a 1.6 M solution in THF, 0.56 mmol) was cooled to 0 °C in an ice bath and 
ethynyltrimethylsilane (0.09 mL, 0.6 mmol) was then added dropwise. The mixture was 
cooled to −30 °C and a second batch of ethereal magnesium bromide solution (prepared 
as before) was added and the mixture stirred for 5 minutes. The magnesium-aldehyde 
complex was added to the solution of the metallated alkyne at −78 °C and the mixture 
was stirred for an additional 30 minutes. The mixture was allowed to slowly warm to rt 
over 45 minutes and the reaction was quenched by addition of saturated aqueous NH4Cl 
solution (7 mL). The organics were extracted with ether (3 × 5 mL), dried (MgSO4) and 
concentrated. Purification of the residual material by chromatography afforded a 
mixture (70:30) of the diastereomeric alcohols 367ab (48 mg, 71%) as a colourless 
liquid. 
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Diastereomer separation by formation of cobalt hexacarbonyl complexes. 
 
A mixture of propargylic alcohols (0.21 g, 0.44 mmol, dr 1:1) and dicobalt octacarbonyl 
(0.18 g, 0.52 mmol) in CH2Cl2 (5 mL) was allowed to stir for 1.5 h at ambient 
temperature. The volatiles were removed in vacuo and the resulting brown residue was 
purified directly by chromatography (pet. ether/EtOAc, 97.5:2.5) to provide separate 
cobalt hexacarbonyl complexes of the diastereomeric propargylic alcohols. The 
complexes, thus formed, were dissolved individually in CH2Cl2 (5 mL) and treated with 
NMO (615 mg, 5.25 mmol). After stirring for 1 h at rt the resulting purple mixtures were 
concentrated and purified directly by chromatography (pet. ether/EtOAc, 3:1) to afford 
the alcohols 363a (92 mg, 43%) and 363b (87 mg, 42%) as colourless oils. 
(1R)-1-[(2R,5R)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}tetrahydrofuran-2-yl]-3-
(trimethylsilyl)prop-2-yn-1-ol. (367a) 
Rf = 0.21 (pet. ether/EtOAc, 9:1); [α]
24
D  −53.7 (c = 2.20, CHCl3); νmax (liquid film) 3410, 
3070, 2955, 2936, 2889, 2862, 1465, 1427, 1389, 1249, 1103, 1080, 845, 698, 609 cm−1; 
1H NMR (400 MHz, CDCl3) δ 7.69–7.64 (4H, m, CH-PhSi), 7.45–7.35 (6H, m, CH-PhSi), 
4.20–4.10 (2H, m, CH‐C20 and CH‐C24), 4.00 (1H, ap q, J = 6.8 Hz, CH‐C23), 3.82–3.71 
(2H, m, CH2‐C18), 2.44 (1H, d, J = 3.5 Hz, OH‐C24), 2.13–2.00 (2H, m, CH‐C21 and CH‐
C22), 1.90–1.68 (3H, m, CH2‐C19 and CH‐C22), 1.62–1.52 (1H, m, CH‐C21), 1.05 (9H, s, 
CH3-
tBuSi), 0.17 (9H, s, CH3‐MeSi); 
13C NMR (100 MHz, CDCl3) δ 135.7 (CH‐PhSi), 134.0 
(C‐PhSi), 129.8 (CH‐PhSi), 127.8 (CH‐PhSi), 103.5 (C‐C25), 90.7 (C‐C26), 81.7 (CH‐C23), 
77.1 (CH‐C20), 66.2 (CH‐C24), 61.3 (CH2‐C18), 38.5 (CH2‐C19), 32.1 (CH2‐C21), 28.3 
(CH2‐C22), 27.0 (CH3‐
tBuSi), 19.4 (C‐tBuSi), 0.0 (CH3‐MeSi); HRMS (CI+, isobutane) calcd 
for  C28H41O3Si2 [M+H]
+ 481.2594, found 481.2592 (Δ −0.4 ppm); LRMS (CI+, isobutane) 
m/z (intensity) 481.5 (94%), 403.4 (100%). 
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(1S)-1-[(2R,5R)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}tetrahydrofuran-2-yl]-3-
(trimethylsilyl)prop-2-yn-1-ol. (367b) 
Rf = 0.22 (pet. ether/EtOAc, 9:1); [α]
26
D  +14.8 (c = 2.20, CHCl3); νmax (liquid film) 3406, 
3075, 2955, 2936, 2889, 2862, 1469, 1427, 1388, 1249, 1099, 945, 841, 744, 698, 613 
cm−1; 1H NMR (400 MHz, CDCl3) δ 7.70–7.65 (4H, m, CH-PhSi), 7.45–7.36 (6H, m, CH-
PhSi), 4.41 (1H, dd, J = 5.9, 3.3 Hz, CH‐C24), 4.27 (1H, tt, J = 7.7, 5.8 Hz, CH‐C20), 
4.09 (1H, td, J = 7.4, 3.3 Hz, CH‐C23), 3.81–3.72 (2H, m, CH2‐C18), 2.34 (1H, dd, J = 
5.9, 1.3 Hz, OH‐C24), 2.12 (1H, dq, J = 11.7, 5.8 Hz, CH‐C21), 2.04–1.97 (2H, m, CH2‐
C22), 1.84 (1H, ddt, J = 13.2, 7.9, 5.7 Hz, CH‐C19), 1.72 (1H, dq, J = 13.2, 6.6 Hz, CH‐
C19), 1.62-1.53 (1H, m, CH‐C21), 1.05 (9H, s, CH3-
tBuSi), 0.16 (9H, s, CH3‐MeSi); 
13C 
NMR (100 MHz, CDCl3) δ 135.7 (CH‐PhSi), 134.0 (C‐PhSi), 134.0 (C‐PhSi), 129.7 (CH‐
PhSi), 127.8 (CH‐PhSi), 103.7 (C‐C25), 90.9 (C‐C26), 80.7 (CH‐C23), 78.3 (CH‐C20), 65.1 
(CH‐C24), 61.4 (CH2‐C18), 38.8 (CH2‐C19), 32.4 (CH2‐C21), 27.0 (CH3-
tBuSi), 26.7 (CH2‐
C22), 19.3 (C‐tBuSi), 0.0 (CH3-MeSi); HRMS (CI+, isobutane) calcd for C28H41O3Si2 [M+H]
+ 
481.2594 found 481.2593, (Δ −0.2 ppm); LRMS (CI+, isobutane) m/z (intensity) 481.5 
(93%), 403.4 (100%). 
(1R)-1-[(2R,5R)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl} tetrahydrofuran -2-yl]prop-
2-yn-1-ol. (378a) 
 
 
To a stirred solution of the TMS protected alkyne 367a (600 mg, 1.25 mmol) in wet 
methanol (34 mL) was added solid K2CO3 (431 mg, 3.12 mmol). The mixture was stirred 
for 2 h at rt after which time the volatiles were removed in vacuo and residual material 
was partitioned between CH2Cl2 (20 mL) and saturated NH4Cl solution (20 mL). The 
organic phase was isolated and the aqueous phase extracted with further CH2Cl2 (3 × 20 
mL). The combined organic extracts were dried (MgSO4) and filtered. Removal of 
solvent gave a residue which was purified by chromatography (pet. ether/EtOAc, 3:1) to 
afford the alkyne 378a (499 mg, 98%) as a colourless oil. Rf = 0.26 (pet. ether/EtOAc, 
3:1); [α]
26
D  −0.73 (c = 2.15, CHCl3); νmax (liquid film) 3428, 3299, 3064, 2931, 2883, 2860, 
1468, 1428, 1389, 1105, 941, 821, 741, 702 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.69–7.64 
(4H, m, CH-PhSi), 7.46–7.35 (6H, m,CH- PhSi), 4.21– 4.12 (2H, m, CH‐C20 and CH‐C24), 
4.04 (1H, ap q, J = 6.9 Hz, CH‐C23), 3.82–3.71 (2H, m, CH2‐C18), 2.48 (1H, br d, J = 4.2 
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Hz, OH‐C24), 2.42 (1H, d, J = 2.2 Hz, CH‐C26), 2.14–2.01 (2H, m, CH‐C21 and CH‐C22), 
1.90–1.68 (3H, m, CH2‐C19 and CH‐C22), 1.63–1.52 (1H, m, CH‐C21), 1.05 (9H, s, CH3-
tBuSi); 13C NMR (100 MHz, CDCl3) δ 135.7 (CH‐PhSi), 134.0 (C‐PhSi), 133.9 (C‐PhSi), 129.8 
(CH‐PhSi), 127.8 (CH‐PhSi), 82.1 (C‐C25), 81.4 (CH‐C23), 77.2 (CH‐C20), 73.8 (C‐C26), 
65.4 (CH‐C24), 61.2 (CH2‐C18), 38.4 (CH2 –C19), 32.1 (CH2‐C21), 28.2 (CH2‐C22), 27.0 
(CH3‐
tBuSi), 19.3 (C‐tBuSi); HRMS (CI+, isobutane) [M+H]+ calcd for C25H33O3Si  409.2199 
found 409.2200 (Δ +0.3 ppm); LRMS (CI+, isobutane) m/z (intensity) 409.4 (100%), 383.4 
(54%), 331.4 (66%), 305.4 (31%), 253.3 (22%). 
(1S)-1-[(2R,5R)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}tetrahydrofuran-2-yl]prop-2-
yn-1-ol. (378b) 
 
The procedure used to prepare 378a was used to provide 378b in 88% yield. Rf = 0.26 
(pet.ether/EtOAc, 3:1); [α] 25D  +1.0 (c = 1.75, CHCl3); νmax (liquid film) 3401, 3306, 2957, 
2931, 2857, 1427, 1085, 823 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.72–7.67 (4H, m, CH-
PhSi), 7.48–7.37 (6H, m, CH-PhSi), 4.42 (1H, ddd, J = 6.2, 3.5, 2.3 Hz, CH‐C24), 4.35–
4.27 (1H, m, CH‐C20), 4.10 (1H, td, J = 7.4, 3.5 Hz, CH‐C23), 3.84–3.73 (2H, m, CH2‐
C18), 2.40 (1H, d, J = 2.2 Hz, CH‐C26), 2.32 (1H, d, J = 6.2 Hz, OH‐C24), 2.17–2.08 (1H, 
m, CH‐C21), 2.07–1.97 (2H, m, CH2‐C21 and CH-C22), 1.90–1.81 (1H, m, CH‐C19), 1.79–
1.70 (1H, m, CH‐C19), 1.64–1.53 (1H, m, CH-C22), 1.05 (9H, s, CH3-
tBuSi); 13C NMR (100 
MHz, CDCl3) δ 135.7 (CH‐PhSi), 134.0 (C‐PhSi), 134.0 (C‐PhSi), 129.7 (CH‐PhSi), 127.8 
(CH‐PhSi), 82.0 (C‐C25), 80.6 (CH‐C23), 78.1 (CH‐C20), 74.2 (C‐C26), 64.7 (CH‐C24), 
61.3 (CH2‐C18), 38.7 (CH2‐C19), 32.4 (CH2‐C21), 27.0 (CH3‐
tBuSi), 26.9 (CH2‐C22), 19.4 
(C‐tBuSi); HRMS (CI+, isobutane) calcd for  C25H33O3Si [M+H]
+  409.2199 found 409.2201 (Δ 
+0.4 ppm); LRMS (CI+, isobutane) m/z (intensity) 409.4 (65%), 383.4 (51%), 351.4 (36%), 
331.4 (100%), 305.4 (66%), 253.3 (27%), 227.3 (15%), 199.2 (9%); Anal. calcd for 
C25H32O3Si C 73.49%, H 7.89% found C 73.38%, H 7.78%. 
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(2R,5R)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl} tetrahydrofuran -2-carboxylic acid. 
 
A single portion of Dess-Martin periodinane (1.37 g, 3.23 mmol) was added to a solution 
of alcohol 348 (1.04 g, 2.71 mmol) in CH2Cl2 (51 mL) and the mixture stirred for 2 h at 
rt. The reaction was quenched with saturated aqueous NaHCO3 (30 mL) and the mixture 
was extracted with CH2Cl2 (2 × 30 mL). The combined organic extracts were dried 
(MgSO4) and concentrated. The crude residue was passed through a plug of silica gel 
(pet. ether/EtOAC, 9:1) and the concentrated solution was used as isolated in the 
following step. 
To a solution of the aldehyde and 2-methyl-2-butene (2.30 mL, 21.7 mmol) in t-BuOH 
(13.5 mL) was added a prepared solution of NaClO2 (1.83 g, 16.2 mmol, 80% pure) and 
NaH2PO4.2H2O (2.76 g, 17.7 mmol) in H2O (27 mL). The mixture was stirred for 1.5 h at 
rt, concentrated in vacuo and partitioned between CH2Cl2 (30 mL) and H2O (30 mL). The 
organic phase was isolated and the aqueous phase was back-extracted with further 
CH2Cl2 (2 × 20 mL). The combined organic extracts were dried (MgSO4), filtered and 
concentrated to give a clear, colourless oil that was used directly in the following step. 
Rf = 0.15 (EtOAc);[α]
24
D  +16.1  (c = 1.15, CHCl3); νmax (liquid film) 2957, 2957, 2934, 
2875, 1734, 1468, 1428, 1267,  1107, 1082, 736, 704 cm−1; 1H NMR (500 MHz, CDCl3) δ 
7.69–7.63 (4H, m, CH‐PhSi), 7.47–7.36 (6H, m, CH‐PhSi), 4.47 (1H, dd, J = 8.0, 6.3 Hz, 
CH‐C23), 4.38–4.31 (1H, m, CH‐C20), 3.83–3.73 (2H, m, CH2‐C18), 2.41–2.32 (1H, m, CH‐
C22), 2.14–2.03 (2H, m, CH‐C21 and CH‐C22), 1.91–1.83 (1H, m, CH‐C19), 1.75 (1H, td, J 
= 13.5, 6.0 Hz, CH‐C19), 1.67–1.59 (1H, m, CH‐C21), 1.05 (9H, s, CH3-
tBuSi); 13C NMR 
(125 MHz, CDCl3) δ 176.5 (C‐C24), 135.7 (CH‐PhSi), 133.8 (C‐PhSi), 133.7 (C‐PhSi), 129.8 
(CH‐PhSi), 127.8 (CH‐PhSi), 78.9 (CH‐C20), 76.3 (CH‐C23), 61.0 (CH2‐C18), 38.2 (CH2‐
C19), 31.6 (CH2-C21), 30.1 (CH2‐C22), 27.0 (CH3‐
tBuSi), 19.3 (C‐tBuSi); HRMS (CI+, 
isobutane) calcd for C23H31O4Si [M+H]
+ 399.1991 found 399.1995,  (Δ +0.9 ppm). 
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(2R,5R)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}-N-methoxy-N-methyl 
tetrahydrofuran-2-carboxamide. (371) 
 
The crude carboxylic acid was dissolved in CH2Cl2 (21 mL) to which was added 
sequentially DIPEA (1.34 mL, 7.71 mmol), N,O-dimethylhydroxylamine (341 mg, 3.49 
mmol) and HBTU (1.51 g, 3.49 mmol) at rt. The mixture was stirred for 18 h and the 
reaction was quenched with 1 M HCl (15 mL). This mixture was extracted with CH2Cl2 (3 
× 20 mL) and the combined organic extracts were dried (MgSO4), filtered and 
concentrated. Purification of the resultant residue was achieved by chromatography 
(pet. ether/EtOAc, 2:1) to afford the title Weinreb amide 371 (949 mg, 79% over three 
steps) as a clear, colourless oil.  Rf = 0.15 (pet. ether/EtOAc, 1:1); [α]
24
D  −2.2 (c = 1.00, 
CHCl3); νmax (liquid film) 2957, 2933, 2875, 1677, 1469, 1428, 1109, 1078, 704 cm
−1; 1H 
NMR (400 MHz, CDCl3) δ 7.68–7.64 (4H, m, CH‐ PhSi), 7.44–7.34 (6H, m, CH‐ PhSi), 4.84–
4.77 (1H, m, CH‐C23), 4.35–4.25 (1H, m, CH–C20), 3.77 (2H,t, J = 6.7 Hz, CH2‐C18), 3.68 
(3H, s, CH3-MeO), 3.18 (3H, s, CH3‐MeN), 2.24–2.00 (3H, m, CH2‐C22 and CH‐C21), 2.00–
1.91 (1H, m, CH‐C19), 1.75 (1H, dq, J = 13.3, 6.7 Hz, CH‐C19), 1.61–1.51 (1H, m, CH‐
C21), 1.04 (9H, s, CH3-
tBuSi); 13C NMR (100 MHz, CDCl3) δ 174.1 (C‐C24), 135.6 (CH‐
PhSi), 134.0 (C‐PhSi), 133.9 (C‐PhSi), 129.6 (CH‐PhSi), 127.7 (CH‐ PhSi), 78.2 (CH‐C20), 
74.8 (CH‐C23), 61.5 (CH2‐C18), 61.4 (CH3‐MeO), 38.5 (CH2‐C19), 32.4 (CH3‐MeN), 31.7 
(CH2‐C21), 29.4 (CH2‐C22), 26.9 (CH3‐
tBuSi), 19.2 (C‐tBuSi); HRMS (CI+, isobutane) calcd 
for C25H36NO4Si [M+H]
+ 442.2413 found 442.2413 (Δ −0.1 ppm); LRMS (CI+, isobutane) m/z 
(intensity) 442.5 (72%), 363.4  (100%). 
1-[(2R,5R)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}tetrahydrofuran-2-yl]-3-
(trimethylsilyl)prop-2-yn-1-one. (370) 
 
To a solution of n-BuLi (1.1 mL of a 2.5 M soln. in hexanes, 2.8 mmol) in of THF (1 mL) 
at 0 °C was added dropwise trimethylsilylacetylene (0.45 mL, 3.2 mmol). The reaction 
mixture was stirred for 30 minutes and transferred to a solution of Weinreb amide 371 
(0.95 g, 2.2 mmol) in THF (60 mL) at −78 °C. The mixture was stirred for 1 h then the 
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reaction was quenched by the addition of 1 M aqueous HCl (10 mL) and the mixture was 
allowed to warm to rt. The solution was extracted with CH2Cl2 (3 × 30 mL), dried 
(MgSO4), filtered and concentrated. The crude residue was purified by chromatography 
(pet. ether/EtOAc, 20:1 to 9:1) to yield the desired ynone 370 (0.88 g, 86%) as a clear, 
colourless oil. Rf = 0.34 (pet. ether/EtOAc, 9:1); 
25
D  +7.8 (c = 1.00, CHCl3); νmax (liquid 
film) 2957, 2933, 2875, 1677, 1469, 1428, 1109, 1078, 704 cm−1; 1H NMR (400 MHz, 
CDCl3) δ 7.68–7.65 (4H, m, CH‐PhSi), 7.44–7.36 (6H, m, CH‐PhSi), 4.47 (1H, dd, J = 8.4, 
6.0 Hz, CH‐C23), 4.33 (1H, dq, J = 8.1, 6.3 Hz, CH‐C20), 3.77 (2H, t, J = 6.5 Hz, CH2‐
C18), 2.33–2.25 (1H, m, CH‐C22), 2.11–2.02 (2H, m, CH‐C21 and CH‐C22), 1.95 (1H, dq, 
J = 13.3, 6.5 Hz, CH‐C19), 1.74 (1H, dq, J = 13.3, 6.5 Hz, CH‐C19), 1.64–1.55 (1H, m, 
CH‐C21), 1.04 (9H, s, CH3-
tBuSi), 0.22 (9H, s, CH3-MeSi); 
13C NMR (100 MHz, CDCl3) δ 
189.0 (C‐C24), 135.7 (CH‐PhSi), 133.9 (C‐PhSi), 133.9 (C‐PhSi), 129.7 (CH‐PhSi), 127.8 
(CH‐PhSi), 101.8 (C‐C25), 100.3 (C‐C26), 83.7 (CH‐C23), 78.9 (CH‐C20), 61.4 (CH2‐C18), 
38.5 (CH2‐C19), 31.4 (CH2‐C21), 29.6 (CH2‐C22), 27.0 (CH3‐
tBuSi), 19.3 (C‐tBuSi), −0.7 
(CH3‐MeSi); HRMS (CI+, isobutane) calcd for C28H39O3Si2 [M+H]
+ 479.2437 found 479.2434,  
(Δ −0.8 ppm). 
1-[(2R,5R)-5-{2-[(tert-butyldiphenylsilyl)oxy]ethyl}tetrahydrofuran-2-yl]prop-2-yn-
1-one. (372) 
 
A solution of Weinreb amide 371 (160 mg, 0.36 mmol) in THF (10 mL) was cooled to 
−78 °C and ethynylmagnesium bromide (1.1 mL, 0.54 mmol) was added dropwise. The 
mixture was stirred for 2.5 h and the reaction was quenched with 1 M aqueous HCl 
(5 mL). The mixture was allowed to warm to rt and extracted with CH2Cl2 (2 × 10 mL). 
The combined organic extracts were dried (MgSO4), filtered and concentrated to afford 
a residue that was purified by chromatography (pet. ether/EtOAc, 9:1) to provide the 
desired ynone 372 as a clear, colourless oil (131 mg, 90%). Rf = 0.18 (pet. ether/EtOAc, 
9:1); 
27
D  +2.8 (c = 1.00, CHCl3); νmax (liquid film) 3269, 2956, 2932, 2878, 2092, 1677, 
1469, 1427, 1109, 1078, 704 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.70–7.64 (4H, m, CH‐
PhSi), 7.45–7.35 (6H, m, CH‐PhSi), 4.47 (1H, dd, J = 8.3, 6.1 Hz, CH‐C23), 4.41–4.30 (1H, 
m, CH‐C20), 3.85–3.71 (2H, m, CH2‐C18), 3.26 (1H, s, CH‐C26), 2.37–2.24 (1H, m, CH‐
C22), 2.13–2.01 (2H, m, CH‐C21 and CH‐C22), 1.94-1.87 (1H, m, CH‐C19), 1.76 (1H, td, J 
= 13.6, 6.1 Hz, CH‐C19), 1.66–1.55 (1H, m, CH‐C21), 1.08–1.02 (9H, m, CH3-
tBuSi); 13C 
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NMR (125 MHz, CDCl3) δ 189.0 (C‐C24), 135.9 (CH‐PhSi), 134.1 (C‐PhSi), 134.1 (C‐PhSi), 
130.0 (CH‐PhSi), 128.0 (CH‐PhSi), 83.8 (CH‐C23), 81.9 (CH‐C26), 80.1 (C‐C25), 79.0 (C‐
C20), 61.4 (CH2‐C18), 38.5 (CH2‐C19), 31.6 (CH2‐C21), 29.6 (CH2‐C22), 27.2 (CH3-
tBuSi), 
19.5 (C‐tBuSi). 
(1R)-1-[(2R,5R)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}tetrahydrofuran-2-yl]-5-
methylhex-4-en-2-yn-1-ol. (390) 
 
1-Bromo-2-methyl-1-propene (0.25 mL, 2.4 mmol) was added to a suspension of 
Pd(PPh3)4 (4.3 mg, 3.9 μmol) in pyrrolidine (0.70 mL) and the mixture was stirred until 
homogeneous. The alkyne 378 (32 mg, 0.78 mmol) in pyrrolidine (0.70 mL) was added 
to the solution and the reaction mixture was warmed to 50 °C in a pre-heated oil bath 
for 20 h. The mixture was cooled to rt and the reaction was quenched by the addition of 
saturated NH4Cl solution (3 mL) and extracted with ether (3 × 3 mL). The organic 
extracts were combined and dried (MgSO4). Purification of the residue by 
chromatography (pet. ether/ether, 1:1) afforded the enyne 390 (27 mg, 75%) of a 
colourless oil. Rf = 0.15 (pet.ether/ether, 3:1); [α]
21
D  +4.4 (c = 1.20, CHCl3); νmax (liquid 
film) 3414, 2958, 2930, 2858, 1471, 1428, 1389, 1100, 823, 704 cm−1; 1H NMR (500 MHz, 
CDCl3) δ 7.69–7.64 (4H, m, CH-PhSi), 7.45–7.36 (6H, m, CH-PhSi), 5.27–5.25 (1H, m, CH‐
C27), 4.34–4.30 (1H, m, CH‐C24), 4.19–4.12 (1H, m, CH‐C20), 4.03 (1H, ap q, J = 7.1 Hz, 
CH‐C23), 3.81–3.73 (2H, m, CH2‐C18), 2.44 (1H, d, J = 3.7 Hz, OH‐C24), 2.13–2.02 (2H, 
m, CH‐C21 and CH‐C22), 1.86–1.68 (3H, m, CH2‐C19 and CH‐C22), 1.87 (3H, s, CH3‐C29), 
1.79 (3H, s, CH3‐C35), 1.61–1.53 (1H, m, CH‐C21), 1.04 (9H, s, CH3-
tBuSi); 13C NMR (125 
MHz, CDCl3) δ 149.6 (C‐C28), 135.7 (CH‐PhSi), 134.0 (C‐PhSi), 134.0 (C‐PhSi), 129.8 (CH‐
PhSi), 127.8 (CH‐PhSi), 104.7 (CH‐C27), 89.0 (C‐C26), 83.8 (C‐C25), 81.9 (CH‐C23), 77.0 
(CH‐C20), 66.4 (CH‐C24), 61.3 (CH2‐C18), 38.5 (CH2‐C19), 32.2 (CH2‐C21), 28.4 (CH2‐
C22), 27.0 (CH3‐
tBuSi), 24.9 (CH3‐C29), 21.2 (CH3‐C35), 19.4 (C‐
tBuSi); HRMS (CI+, 
isobutane) calcd for  C29H39O3Si [M+H]
+  463.2668 found 463.2673, (Δ +0.9 ppm); LRMS 
(CI+, isobutane) m/z (intensity) 463.7 (17%), 445.3 (100%). 
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(1R,2E)-1-[(2R,5R)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}tetrahydrofuran-2-yl]-5-
methylhexa-2,4-dien-1-ol. (395) 
 
Lithium aluminium hydride (0.22 mL of a 1 M solution in THF, 0.22 mmol) was added 
dropwise to a stirred solution of alkyne 390 (50 mg, 0.11 mmol) in THF (2 mL) at 0 °C. 
The mixture was stirred at 0 °C for 1 h and then at 30 °C for an additional 1 h. The 
reaction was quenched at 0 °C by the addition of H2O (1 mL) followed sequentially by 
10% aq. NaOH (2 mL) and further H2O (3 ml). The mixture was diluted with Et2O (7 mL) 
and MgSO4 (200 mg) was added; the mixture was then stirred for 15 minutes. The solids 
were removed by filtration and washed with further Et2O. The filtrate was concentrated 
and the resultant residue was purified by chromatography (pet. ether/Et2O, 2:1) to 
yield the diene 395 (35 mg, 70%) as a colourless oil. Rf = 0.21 (pet.ether/ether, 3:1); 
[α] 21D  +3.6 (c = 1.50, CHCl3); νmax (liquid film) 3456, 2957, 2928, 2909, 2857, 1471, 1427, 
1081, 957, 822, 736 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.70–7.64 (4H, m, CH-PhSi), 7.45–
7.35 (6H, m, CH-PhSi), 6.53 (1H, ddd, J = 15.2, 11.0, 0.8 Hz, CH‐C26), 5.83 (1H, dd, J = 
11.0, 0.8 Hz, CH‐C27), 5.46 (1H, dd, J = 15.2, 6.9 Hz, CH‐C25), 4.18–4.10 (1H, m, CH‐
C20), 3.96–3.90 (1H, m, CH‐C24), 3.83–3.71 (3H, m, CH2‐C18 and CH‐C23), 2.53 (1H, d, J 
= 2.6 Hz, OH‐C24), 2.07–1.99 (1H, m, CH‐C21), 1.97–1.88 (1H, m, CH‐C22), 1.88–1.80 
(1H, m, CH‐C19), 1.79 (3H, s, CH3‐C29), 1.77 (3H, s, CH3‐C35), 1.76–1.70 (1H, m, CH‐
C19), 1.67–1.48 (m, 2H, CH‐C21 and CH‐C22), 1.07 (9H, s, CH3‐
tBuSi); 13C NMR (125 MHz, 
CDCl3) δ 136.2 (C‐C28), 135.8 (CH‐PhSi), 134.3 (C‐PhSi), 134.2 (C‐PhSi), 129.7 (CH‐PhSi), 
129.3 (CH‐C26), 128.8 (CH‐C25), 127.8 (CH‐PhSi), 124.8 (CH‐C27), 82.0 (CH‐C23), 76.6 
(CH‐C20), 75.7 (CH‐C24), 61.5 (CH2‐C18), 38.8 (CH2‐C19), 32.4 (CH2-C21), 28.2 (CH2‐
C22), 27.1 (CH3‐
tBuSi), 26.1 (CH3‐C29), 19.4 (C‐
tBuSi), 18.5 (CH3‐C35); HRMS (ESI+) calcd 
for C29H41O3Si [M]
+ 464.2747 found 464.2737, (Δ −2.0 ppm). 
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{[(1R)-1-[(2R,5R)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}tetrahydrofuran-2-yl]prop-
2-yn-1-yl]oxy}triethylsilane. (396) 
 
A solution of alcohol 395 (26 mg, 0.056 mmol), chloromethyl methyl ether (21 µl, 
0.28 mmol) and DIPEA (58 µl, 0.34 mmol) in CH2Cl2 (2 mL) was heated at 55 °C for 15 h. 
The mixture was cooled to rt and the reaction was quenched with saturated aqueous 
NH4Cl (3 mL) and extracted with CH2Cl2 (3 × 4 mL). The combined organic extracts were 
dried (MgSO4), filtered, concentrated and the residue was purified by chromatography 
(pet. ether/Et2O, 9:1) to afford the desired MOM ether 396 (24 mg, 84%). Rf = 0.36 (pet. 
ether/Et2O, 3:1);  [α]
26
D −35.6 (c = 1.10, CHCl3); νmax  (liquid film) 2957, 2931, 2884, 
2857, 2362, 1472, 1428, 1109, 1037, 823, 704 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.68–7.64 
(4H, m, CH‐PhSi), 7.44–7.35 (6H, m, CH‐PhSi), 6.45 (1H, dd, J = 15.2, 11.0 Hz, CH‐C26), 
5.83 (1H, d, J = 11.0 Hz, CH‐C27), 5.38 (1H, dd, J = 15.2, 7.6 Hz, CH‐C25), 4.72 (1H, d, 
J = 6.7 Hz, CH‐MOM), 4.58 (1H, d, J = 6.7 Hz, CH‐MOM), 4.16–4.08 (1H, m, CH‐C20), 
4.04–3.96 (2H, m, CH‐C23 and CH‐C24), 3.82–3.70 (2H, m, CH2‐C18), 3.36 (3H, s, CH3‐
MOM), 1.99 (1H, tdd, J = 8.3, 5.7, 3.2 Hz, CH‐C21), 1.94–1.86 (2H, m, CH‐C19 and CH‐
C22), 1.78 (3H, s, CH3‐C35), 1.76 (3H, s, CH3‐C29), 1.74–1.62 (2H, m, CH‐C-19 and CH‐
C22), 1.54–1.45 (1H, m, CH‐C21), 1.04 (9H, s, CH3  
tBuSi); 13C NMR (125 MHz, CDCl3) δ 
136.8 (C‐C28), 135.9 (CH‐PhSi), 134.3 (C‐PhSi), 131.2 (CH‐C26), 129.9 (CH‐PhSi), 127.9 
(CH‐PhSi), 126.8 (CH‐C25), 124.8 (CH‐C27), 93.9 (CH2‐MOM), 80.8 (CH‐C23), 79.4 (CH‐
C24), 77.0 (CH‐C20), 61.8 (CH2‐C18), 55.6 (CH3‐MOM), 38.9 (CH2‐C19), 32.4 (CH2‐C21), 
28.7 (CH2‐C22), 27.2 (CH3‐
tBuSi), 26.4 (CH3‐C29), 19.5 (C‐
tBuSi), 18.7 (CH3‐C35). 
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2-[(2R,5R)-5-[(1R,2E)-1-(Methoxymethoxy)-5-methylhexa-2,4-dien-1-
yl]tetrahydrofuran-2-yl]ethan-1-ol. (397) 
 
To a stirred solution of silyl ether 396 (24 mg, 47 µmol) in THF (1 mL) was added TBAF 
(52 µl of a 1 M soln. in THF, 52 µmol). The mixture was stirred for 4 h at rt and the 
reaction was quenched with saturated aqueous NH4Cl (2 mL). The reaction mixture was 
extracted with Et2O (3 × 5 mL). The combined extracts were washed with saturated 
aqueous NaHCO3 (5 mL) and brine (5 mL), dried (MgSO4) and concentrated. Purification 
of the residue by chromatography (pet. ether/ Et2O, 1:3) provided alcohol 397 (12 mg, 
99%) as a pale yellow oil. Rf = 0.22 (pet. ether/Et2O, 1:2);  [α]
26
D −47.0 (c = 1.20, CHCl3); 
νmax  (liquid film) 3426, 2917, 2882, 2853, 1035 cm
−1; 1H NMR (400 MHz, CDCl3) δ 6.45 
(1H, dd, J = 15.2, 11.0 Hz, CH‐C26), 5.82 (1H, dd, J = 11.0, 0.7 Hz, CH‐C27), 5.37 (1H, 
dd, J = 15.2, 8.0 Hz, CH‐C25), 4.72 (1H, d, J = 6.7 Hz, CH‐MOM), 4.57 (1H, d, J = 6.7 Hz, 
CH‐MOM), 4.16 (1H, dq, J = 8.3, 6.1 Hz, CH‐C20), 4.07 (1H, dd, J = 14.2, 6.5 Hz, CH‐
C23), 4.02 (1H, dd, J = 14.2, 8.0 Hz, CH‐C24), 3.81–3.75 (2H, m, CH2‐C18), 3.39 (3H, s, 
CH3‐MOM), 2.85 (1H, br s, OH‐C18), 2.09–2.01 (1H, m, CH‐C21), 1.97–1.88 (1H, m, CH‐
C22), 1.80–1.65 (3H, m, CH2‐C19 and CH‐C22), 1.78 (3H, s, CH3‐C35), 1.76 (3H, s, CH3‐
C29), 1.56 (1H, ddt, J = 11.9, 9.9, 8.2 Hz, CH‐C21); 13C NMR (100 MHz, CDCl3) δ 137.1 
(C‐C28), 131.4 (CH‐C26), 126.5 (CH‐C25), 124.7 (CH‐C27), 94.0 (CH2‐MOM), 81.4 (CH‐
23), 79.9 (CH‐C20), 79.3 (CH‐C24),62.1 (CH2‐C18), 55.7 (CH3‐MOM),  37.7 (CH2‐C19), 
32.6 (CH2‐C21), 28.4 (CH2‐C22), 26.3 (CH3‐C29), 18.7 (CH3‐C35). 
2-[(2R,5R)-5-[(1R,2E)-1-(Methoxymethoxy)-5-methylhexa-2,4-dien-1-
yl]tetrahydrofuran-2-yl]acetaldehyde. (398) 
 
Dess-Martin Periodinane (45 mg, 89 µmol) was added in one portion to a stirred solution 
of alcohol 397 (24 mg, 0.11 mmol) in CH2Cl2 (1.5 mL) and stirred for 1 h at rt. The 
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reaction was quenched by addition of saturated aqueous NaHCO3 (2 mL) and the mixture 
was extracted with Et2O (3 × 2 mL).  The combined organic extracts were dried (MgSO4), 
and concentrated to give a residue that was purified by chromatography (pet. 
ether/Et2O, 1:2) affording the title acetaldehyde 398 as a colourless, opaque oil (19 
mg, 80%). Rf = 0.29 (pet. ether/Et2O, 1:2); νmax (liquid film) 2916, 2887, 2848, 1725, 
1442, 1378, 1149, 1098, 1032cm−1; 1H NMR (400 MHz, CDCl3) δ 9.81 (1H, t, J = 2.2 Hz, 
CH‐C18), 6.46 (1H, dd, J = 15.2, 11.0 Hz, CH‐C26), 5.83 (1H, dd, J = 11.0, 0.7 Hz, CH‐
C27), 5.37 (1H, dd, J = 15.2, 8.2 Hz, CH‐C25), 4.73 (1H, d, J = 6.7 Hz, CH‐MOM), 4.58 
(1H, d, J = 6.7 Hz, CH‐MOM), 4.41 (1H, ddt, J = 8.4, 6.9, 5.7 Hz, CH‐C20), 4.08 (1H, dd, 
J = 14.1, 6.8 Hz, CH‐C23), 4.05–3.99 (1H, m, CH‐C24), 3.39 (3H, s, CH3‐MOM), 2.72 (1H, 
ddd, J = 16.4, 6.9, 1.9 Hz, CH‐C19), 2.57 (1H, ddd, J = 16.4, 5.7, 1.9 Hz, CH‐C19), 2.19–
2.10 (1H, m, CH‐C21), 2.01–1.92 (1H, m, CH‐C22), 1.78 (3H, s, CH3‐C29 or C35), 1.76 
(3H, s, CH3‐C29 or C35), 1.76–1.70 (1H, m, CH‐C22), 1.55 (1H, ddt, J = 12.1, 9.7, 8.4 Hz, 
CH‐C21); 13C NMR (100 MHz, CDCl3) δ 201.5 (CH‐C18), 137.2 (C‐C28), 131.6 (CH‐C26), 
126.4 (CH‐C25), 124.7 (CH‐C27), 93.9 (CH2‐MOM), 81.5 (CH‐C23), 79.3 (CH‐C24), 74.6 
(CH‐C20), 55.6 (CH3‐MOM), 49.8 (CH2‐C19), 32.5 (CH2‐C21), 28.6 (CH2‐C22), 26.3 (CH3‐
C29), 18.7 (CH3‐C35). 
tert-Butyldiphenyl{2-[(2R,5R)-5-{(R)-1-[(triethylsilyl)oxy]prop-2-yn-1-yl} tetrahydro 
furan-2-yl]ethoxy}silane. (379) 
 
To a stirred solution of propargylic alcohol 378 (62 mg, 0.15 mmol), Et3N (42 µl, 
0.30 mmol) and DMAP (1.6 mg, 0.26 µmol) in CH2Cl2 (2 mL) was added TESCl (33 µl, 
0.20 mmol). The mixture was stirred for 1.5 h at rt and the reaction was quenched by 
the addition aqueous 0.5 M HCl (3 mL). The reaction mixture was extracted with CH2Cl2 
(3 × 5 mL) and the combined organic extracts were washed with brine (10 mL), dried 
(MgSO4) and concentrated. Purification of the residue was achieved by chromatography 
(pet. ether/EtOAc, 20:1) yielding the desired silyl ether 379 (71 mg, 91%) as a clear, 
colourless oil. Rf = 0.45 (pet. ether/Et2O, 9:1); [α]
25
D  −9.3 (c = 0.99, CHCl3); νmax (liquid 
film) 3310, 2956, 2932, 2875, 1472, 1428, 1083, 824, 701 cm−1; 1H NMR (400 MHz, CDCl3) 
δ 7.69 – 7.61 (4H, m, CH‐PhSi), 7.44 –7.35 (6H, m, CH‐PhSi), 4.39 (1H, dd, J = 5.8, 2.1 
Hz, CH‐C24), 4.22-4.14 (1H, m, CH‐C20), 4.01 (1H, td, J = 7.0, 5.8 Hz, CH-C23), 3.79–
3.70 (2H, m, CH2‐C18), 2.33 (1H, d, J = 2.1 Hz, CH‐C26), 2.10 –2.00 (2H, m, CH‐C21 and 
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CH‐C22), 1.99–1.83 (2H, m, CH‐C19 and CH‐C22), 1.69 (1H, m, CH‐C19), 1.54–1.45 (1H, 
m, CH‐C21), 1.04 (9H, s, CH3‐
tBuSi), 0.96 (9H, t, J = 7.9 Hz, CH3‐EtSi), 0.64 (6H, q, J = 
7.9 Hz, CH2‐EtSi); 
13C NMR (125 MHz, CDCl3) δ 135.9 (CH‐PhSi), 134.3 (C‐PhSi), 129.9 
(CH‐PhSi), 127.9 (CH‐PhSi), 83.8 (C‐C25), 81.5 (CH‐C23), 77.6 (CH‐C20), 73.4 (CH‐C26), 
66.1 (CH‐C24), 61.7 (CH2‐C18), 38.9 (CH2‐C19), 32.5 (CH2‐C21), 28.1 (CH2‐C22), 27.2 
(CH3‐
tBuSi), 19.5 (C‐tBuSi), 7.0 (CH3‐EtSi), 5.1 (CH2‐EtSi). 
{[(1R,2E)-1-[(2R,5R)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}tetrahydrofuran-2-yl]-
3-(tributylstannyl)prop-2-en-1-yl]oxy}triethylsilane. (380) 
 
To a stirred solution of alkyne 379 (30 mg, 57 μmol) in THF (0.5 mL) at 0 °C was added 
Pd(PPh3)2Cl2 (0.4 mg, 0.6 μmol) and n-Bu3SnH (17 μL, 63 μmol). The reaction was stirred 
for 15 minutes before direct purification by column chromatography (pet. ether/Et3N, 
99:1) to afford vinyl stannane 380 (35 mg, 74%) as a clear, colourless oil. Rf = 0.35 (pet. 
ether); [α] 24D  +0.62 (c = 0.97, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 7.69–7.63 (4H, m, CH-
PhSi), 7.44 –7.34 (6H, m, PhSi), 6.21 (1H, dd, J = 19.1, 1.2 Hz, CH-C26), 5.98 (1H, dd, J 
= 19.1, 5.4 Hz, CH-C25), 4.09–4.00 (2H, m, CH-C20 and CH-C24), 3.90-3.96 (1H, m, CH-
C23), 3.75 (2H, t, J = 6.5 Hz, CH2-C18), 1.98–1.90 (1H, m, CH-C21), 1.90–1.80 (2H, m, 
CH-C19 and CH-C22), 1.73–1.64 (2H, m, CH-C19 and CH-C22), 1.52–1.41 (7H m, CH-C21 
and CH2-
nBuSn), 1.35–1.24 (6H, m, CH2-
nBuSn), 1.04 (9H, s, CH3-
tBuSi), 0.93 (9H, t, J = 
7.9 Hz, CH2-EtSi), 0.90–0.85 (15H m, CH2-
nBuSn and CH3-
nBuSn), 0.58 (6H, q, J = 7.9 Hz, 
CH2-EtSi); 
13C NMR (125 MHz, CDCl3) δ 147.7 (CH-C25), 135.7 (CH-PhSi), 134.1 (C-PhSi), 
134.0 (C-PhSi), 129.6 (CH-PhSi), 129.3 (CH-C26), 127.7 (CH-PhSi), 81.9 (CH-C23), 78.4 
(CH-C24), 76.8 (CH-C20), 61.7 (CH-C18), 38.9 (CH2-C19), 32.4 (CH-C21), 29.3 (
nBuSn), 
27.4 (nBuSn), 27.0 (CH3-
tBuSi), 19.3 (C- tBuSi), 13.9 (nBuSn), 9.6 (nBuSn), 7.0 (CH3-EtSi), 
5.08 (CH2-EtSi); HRMS (ESI+, MeOH:H2O) calcd for C43H74O3Si2Sn [M+Na]
+  837.4096, found 
837.4091, (Δ +4.7 ppm). 
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(1R,4E)-1-[(2R,5R)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}tetrahydrofuran-2-yl]-5-
methyl-7-methylidene-1-[(triethylsilyl)oxy]undec-4-en-2-yn-6-ol. (402) 
 
To a stirred solution of vinyl iodide 80rac (30 mg, 0.11 mmol), Pd(PPh3)4 (3.0 mg, 0.024 
mmol) Et3N (0.65 mL) and CuI (1.2 mg, 0.049 mmol) in THF (2 mL) was added alkyne 
375 (25 mg, 0.049 mmol) in THF (0.5 mL) dropwise. The mixture was stirred at rt for 16 
h and the reaction was quenched by the addition of 0.5 M aqueous HCl (2 mL). The 
organic component was extracted with CH2Cl2 (2 × 5 mL), dried (MgSO4) and 
concentrated. The resultant brown residue was purified by chromatography (pet. 
ether/EtOAc, 3:1) to afford the enyne 402 (12 mg, 45%) as a brown oil. Rf = 0.60 (pet. 
ether/Et2O, 1:1); νmax (liquid film) 3439, 2956, 2931, 2875, 2364, 1461, 1429, 1110, 
1085, 739, 704 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.68–7.64 (4H, m, CH‐PhSi), 7.44–7.35 
(6H, m, CH‐PhSi), 5.65 (1H, d, J = 0.9 Hz, CH‐C27), 5.11 (1H, s, CH‐C41), 4.96 (1H, s, 
CH‐C41), 4.59-4.51 (1H, m, CH‐C24), 4.50 (1H, s, CH‐C29), 4.16 (1H, td, J = 12.3, 6.2 
Hz, CH‐C20), 4.04 (1H, td, J = 12.9, 6.9 Hz, CH‐C23), 3.75 (2H, t, J = 6.5 Hz, CH2‐C18), 
2.10–2.01 (2H, m, CH‐C21 and CH‐C22), 1.99–1.81 (4H, m, CH‐C19, CH‐C22 and CH2‐
C31), 1.75 (3H, s, CH3‐C40), 1.74–1.64 (1H, m, CH‐C19), 1.61 (1H, br s, OH‐C29), 1.50 
(1H, dq, J = 11.3, 8.8 Hz, CH‐C21), 1.44–1.35 (2H, m, CH2‐C32), 1.36–1.26 (2H, m, CH2‐
C33), 1.04 (9H, s, CH3‐
tBuSi), 0.96 (9H, t, J = 7.9 Hz, CH3‐EtSi), 0.89 (3H, t, J = 7.3 Hz, 
CH3‐C34), 0.64-0.59 (6H, m, CH2‐EtSi); 
13C NMR (125 MHz, CDCl3) δ 150.7 (C‐C30), 149.2 
(C‐C28), 135.9 (CH‐PhSi), 135.9 (CH‐PhSi), 134.3 (C‐PhSi), 134.3 (C‐PhSi), 129.9 (CH‐
PhSi), 129.8 (CH‐PhSi), 128.0 (CH‐PhSi), 111.4 (CH2‐C41), 106.8 (CH‐C27), 93.4 (C‐C25), 
82.6 (C‐C26), 81.8 (CH‐C23), 79.3 (CH‐C29), 77.5 (CH‐C20), 66.9 (CH‐C24), 61.8 (CH2‐
C18), 38.9 (CH2‐C19), 32.5 (CH2‐C21), 31.5 (CH2‐C31), 30.4 (CH2‐C32), 28.3 (CH2‐C22), 
27.2 (CH3‐
tBuSi), 22.9 (CH2‐C33), 19.5 (C‐
tBuSi), 15.5 (CH3‐C40), 14.3 (CH3‐C34), 7.1 
(CH3‐EtSi), 5.1 (CH2‐EtSi); HRMS (FAB+, NOBA, NaI) calcd for  C41H62O4Si2Na [M+Na]
+ 
697.4085, found 697.4073, (Δ −1.6 ppm). 
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2-Methylidenehexanal.221 (79) 
 
Hexanal (24.0 mL, 20.0 g, 200 mmol), dimethylamine hydrochloride (19.6 g, 240 mmol) 
and formaldehyde (19.4 g, 240 mmol, 37% w/w soln. in H2O) were heated together at 
55 °C for 16 hours. The mixture was cooled to rt and extracted with Et2O (3 x 50 mL) 
and concentrated to afford the desired aldehyde 79 (19.6g, 87%) as a clear, pale yellow 
oil.  Rf = 0.42 (pet. ether/EtOAC, 9:1); νmax (liquid film) 2957, 2929, 2862, 1696, 1463, 
945 cm−1; 1H NMR (500 MHz, CDCl3) δ 9.53 (s, 1H, CH-C29), 6.24 (1H, d, J = 0.5 Hz, CH-
C41), 5.98 (1H, J = 0.5 Hz CH‐C41), 2.24 (2H, t, J = 7.6 Hz, CH2‐C31), 1.45–1.35 (2H, m, 
CH2‐C32), 1.35–1.23 (2H, m, CH2‐C33), 0.91 (3H, t, J = 7.2 Hz, CH3‐C34); 
13C NMR (125 
MHz, CDCl3) δ 194.9 (CH‐C29), 150.6 (C‐C30), 134.0 (CH2‐C41), 30.0 (CH2‐C32), 27.6 
(CH2‐C31), 22.4 (CH2‐C33), 13.9 (CH2‐C34); LRMS (CI+, isobutane) m/z (intensity) 113.2 
(100%) 101.2 (20%) 83.2 (10%) 71.1 (18%) 69.1 (9%) 61.0 (5%). 
(±)-4-Methylidene-1-(trimethylsilyl)oct-1-yn-3-ol. (rac-80) 
 
Isopropylmagnesium bromide (116 mL of a 2.0 M solution in THF, 0.23 mol) was added 
dropwise to a stirred solution of trimethylsilylacetylene (24.6 g, 251 mmol) in THF 
(50 mL) at 0 ºC. After complete addition of the Grignard reagent, the mixture was 
warmed to rt for 2 h before being added to a stirred solution of 2-methylidenehexanal 
79 (20.0 g, 179 mmol) in THF, (50 mL) at 0 ºC. The mixture was stirred for 30 minutes 
and then warmed to rt and stirred for a further 2 h. The reaction was quenched with a 
saturated aqueous solution of NH4Cl (100 mL).The mixture was extracted with Et2O (3 × 
100 mL) and the organic extracts were combined and dried (Na2SO4) then concentrated 
in vacuo. The residue was purified by chromatography (pet. ether/EtOAc, 100:1 to 50:1) 
to afford the propargylic alcohol rac-80 (30.2 g, 81%) as a pale yellow oil. 
 
 
 
 Chapter 3: Experimental Section 
 
181 
 
(3S)-4-Methylidene-1-(trimethylsilyl)oct-1-yn-3-ol.28 (80) 
 
To a solution of racemic allyl alcohol rac-80 (12.7 g, 60.6 mmol) and (+)-DET (1.55 mL, 
9.08 mmol) in CH2Cl2 (454 mL), was added powdered 4 Å molecular sieves (3.8 g). The 
mixture was cooled to −30 ºC and freshly distilled Ti(Oi-Pr)4 (1.79 mL g, 6.06 mmol) was 
added. The mixture was stirred for 2 h before addition of TBHP (3.0 mL of a 5.6 M 
solution in CH2Cl2, 17 mmol). The resulting solution was placed at −20 ºC until 
1H NMR 
showed > 65% conversion of starting material to product. The reaction was quenched by 
the addition of aqueous 1 M NaOH (250 mL) and extracted with CH2Cl2 (3 × 250 mL). The 
combined organic extracts were washed with brine (250 mL), dried (MgSO4) 
concentrated in vacuo. The residue was purified by flash chromatography (pet. 
ether/EtOAc, 20:1) to give of enantiopure allyl alcohol 80 (4.51 g, 35%, 98% ee) as a 
colourless oil. [α] 25D  +3.6 (c = 1.01, CHCl3); Rf = 0.54, (pet. ether/EtOAc, 4:1); νmax 
(liquid film) 2958, 2931, 2173, 1379, 1249, 1041, 1008, 906, 839, 759, 731, 698, 671, 
626 cm1; 1H NMR (400 MHz, CDCl3) δ 5.27 (1H, s, CH-C41), 4.94 (1H, s, CH-C41), 4.81 
(1H, d, J = 6.3 Hz, CH-C29), 2.19 (2H, t, J = 7.6 Hz, CH2-C31), 1.92–1.86 (1H, m, OH-
C29), 1.54–1.45 (2H, m, CH2-C32), 1.41-1.31 (2H, m, CH2-C33), 0.92 (3H, t, J = 7.3 Hz, 
CH3-C34), 0.18 (9H, s, CH3-MeSi);
 13C NMR (100 MHz, CDCl3) δ 148.2 (C‐C30), 111.5 (CH2‐
C41), 104.8 (C‐C27), 90.9 (C‐C28), 66.2 (CH‐C29), 31.6 (CH2‐C31), 30.2 (CH2‐C32), 22.6 
(CH2‐C33), 14.1 (CH2‐C34), -0.1 (CH3‐C1 TMS); LRMS (CI+, isobutane) m/z (intensity) 
211.2 (20%) 193.2 (100%), 151.2 (72%). 
[(3S)-3-[(tert-Butyldimethylsilyl)oxy]-4-methylideneoct-1-yn-1-yl]trimethylsilane.28 
(384) 
 
To a solution of alcohol 80 (0.40 g, 1.9 mmol) in CH2Cl2 (27 mL) was added imidazole 
(0.30 g, 4.4 mmol), DMAP (23 mg, 0.19 mmol) and tert-butyldimethylsilyl chloride (1.3 
g, 0.87 mmol) at 0 ºC, the reaction mixture was allowed to warm to rt and stirred for 25 
h. The reaction was quenched by the addition of 1 M aqueous HCl (20 mL) and the 
mixture was extracted with CH2Cl2 (3 × 20 mL). The extracts were combined, washed 
with brine, dried (MgSO4) and concentrated. The resulting residue was purified by 
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chromatography (pet. ether/Et2O, 99:1) to give the desired silyl ether 384 (0.61 g, 98%) 
as a colourless oil. Rf = 0.76 (pet. ether/ether, 40:1); [α]
29
D  −40.9 (c = 1.05, CHCl3); νmax 
(liquid film) 2958, 2929, 2857, 1653, 1464, 1249, 1070, 1029, 834, 775, 759 cm1;  1H 
NMR (500 MHz, CDCl3) δ 5.23 (1H, s, CH-C41), 4.87–4.85 (1H, m, CH-C29), 4.80 (1H, s, 
CH-C41), 2.14 (2H, dd, J = 8.2, 7.2 Hz, CH2-C31), 1.53–1.43 (2H, m, CH2-C32), 1.39-1.30 
(2H, m, CH2-C33), 0.92 (9H, s, CH3-
tBuSi), 0.91 (3H, t, J = 7.3 Hz, CH3-C34), 0.16 (9H, s, 
CH3-MeSi), 0.15 (3H, s, CH3-MeSi), 0.13 (3H, s, CH3-MeSi); 
13C NMR (125 MHz, CDCl3) δ 
148.5 (C‐C30), 110.4 (CH2‐C41), 105.9 (C‐C27), 89.9 (C‐C28), 66.6 (CH‐C29), 31.5 (CH2‐
C31), 30.2 (CH2‐C32), 26.0 (CH3‐
tBuSi), 22.7 (CH2‐C33), 18.5 (C‐
 tBuSi), 14.1 (CH2‐C34), -
0.1 (CH3‐MeSi), −4.2 (CH3‐MeSi), −4.6 (CH3‐MeSi). 
tert-Butyldimethyl{[(3S)-4-methylideneoct-1-yn-3-yl]oxy}silane.28 (385)  
 
To a solution of the TMS-protected alkyne 384 (892 mg, 2.75 mmol) in wet MeOH (25 
mL) was added K2CO3 (950 mg, 6.85 mmol) at rt. The mixture was stirred for 2 h and 
then concentrated in vacuo. The residue was partitioned between CH2Cl2 (20 mL) and 
1 M aqueous HCl (20 ml) and the organic phase isolated. The aqueous solution was 
extracted with CH2Cl2 (3 × 20 mL) and the combined organic extracts were then dried 
(MgSO4) and concentrated. The resulting crude material was purified by chromatography 
(pet. ether/EtOAc, 99:1) to provide the alkyne 385 (652 mg, 94%) as a colourless oil. Rf 
= 0.65 (pet. ether/EtOAc, 20:1);[α] 20D –29.1 (c = 1.02, CHCl3); νmax (liquid film) 3313, 
2957, 2929, 2859, 1464, 1252, 1071, 835, 776 cm−1; 1H NMR (500 MHz, CDCl3) δ 5.22 (1H, 
s, CH-C41), 4.89–4.87 (1H, m, CH-C29), 4.81 (1H, s, CH-C41), 2.44 (1H, d, J = 2.2 Hz, 
CH-C27), 2.23–2.11 (2H, m, CH2-C31), 1.52–1.42 (2H, m, CH2-C32), 1.40–1.30 (2H, m, 
CH2-C33), 0.92 (3H, t, J = 7.2 Hz, CH3-C34), 0.92 (9H, s, CH3-
tBuSi), 0.15 (3H, s, CH3-
MeSi), 0.12 (3H, s, CH3-MeSi); 
13C NMR (125 MHz, CDCl3) δ 148.5 (C‐C30), 110.4 (CH2‐
C41), 84.2  (C‐C28), 73.0 (CH‐C27), 66.1 (CH‐C29), 31.2 (CH2‐C31), 30.1 (CH2‐C32), 25.9 
(CH3‐
tBu TBS), 22.7 (CH2‐C33), 18.5 (C‐
 tBuSi), 14.1 (CH2‐C34), −4.6 (CH3‐MeSi), −5.0 
(CH3‐MeSi); HRMS (CI+, isobutane) calcd for C15H29OSi [M+H]
+ 253.1987, found 253.1983 
(Δ −2.0 ppm); LRMS (CI+, isobutane) m/z (intensity) 253.3 (100%), 195.2 (63%), 121.2 
(64%); Anal. calcd for C15H28OSi C 71.36%, H 11.18%, found: C 71.37%, H 11.24%. 
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 (3S)-3-Hydroxy-4-methylideneoctan-2-one. (408) 
 
To a solution of alkyne 80 (1.2 g, 5.7 mmol) in acetone (57 mL), was added in one 
portion, a predissolved solution of yellow HgO (0.62 g, 2.9 mmol) in 0.75 M aqueous 
H2SO4 (27 mL). The mixture was warmed to 60 °C for 30 minutes, cooled to rt and the 
reaction was quenched by the addition of 1 M aqueous HCl (10 mL). The mixture was 
extracted with CH2Cl2 (3 x 15 mL), dried (MgSO4) and concentrated. Flash 
chromatography purification of the residue (pet. ether/Et2O, 3:1) provided ketone 408 
(0.77 g, 86%)  as a clear colourless oil Rf = 0.32 (pet. ether/Et2O, 1:1); [α]
26
D +340.5 (c = 
1.18, CHCl3);  νmax (liquid film) 3457, 2958, 2930, 2864, 1714, 1357, 1182, 1084 cm
−1; 1H 
NMR (500 MHz, CDCl3) δ 5.22 (1H, s, CH-C41), 5.12 (1H, s, CH-C41), 4.59 (1H, d, J = 4.4 
Hz, CH-C29), 3.84 (1H, d, J = 4.4 Hz, OH-C29), 2.18 (3H, s, CH3-C40), 2.15–1.98 (1H, m, 
CH-C31), 1.84–1.74 (1H, m, CH-C31), 1.47-1.36 (2H, m, CH2-C32), 1.35-1.25 (2H, m, 
CH2-C33), 0.89 (3H, t, J = 7.3 Hz, CH3-C34); 
13C NMR (125 MHz, CDCl3) δ 208.4 (C–C28), 
146.8 (C–C30), 115.9 (CH2–C41), 82.7 (CH–C29), 30.1 (CH2–C31), 29.9 (CH2–C32), 24.9 
(CH3–C40), 22.6 (CH2–C33), 14.0 (CH3–C34); HRMS (CI+, isobutane) calcd for C9H16O2 
[M+H]+ 157.1228, found 157.1232 (Δ +2.0 ppm);  LRMS (CI+, isobutene) m/z (intensity); 
157.3 (100%), 139.2 (42%). 
(3S)-4-Methylidene-3-[(triethylsilyl)oxy]octan-2-one. (409) 
 
Chloro triethylsilane (1.2 mL, 7.4 mmol) was added dropwise, at 0 °C, to a solution 
containing alcohol 408 (0.77 g, 4.9 mmol), DIPEA (1.3 mL, 7.4 mmol) and DMAP (0.60 g, 
4.9 mmol) in CH2Cl2 (10 mL). Upon complete addition the solution was warmed to rt and 
stirred for 90 minutes. The reaction was quenched by addition of H2O (20 mL) and 
extracted with CH2Cl2 (2 x 20 mL). The combined organic extracts were washed with 
brine (10 mL), dried (MgSO4) and concentrated. The resultant residue was purified by 
chromatography (pet. ether/Et2O, 99:1) to provide the title silyl ether 409 (1.3 g, 98%) 
as a pale yellow oil. Rf = 0.51 (pet. eth./Et2O, 20:1); [α]
27
D −140.2 (c = 0.96, CHCl3);  νmax 
(liquid film) 2955, 2938, 2877, 1719, 1237, 1070, 1003, 726 cm−1; 1H NMR (500 MHz, 
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CDCl3) δ 5.33 (1H, s, CH-C41), 5.06–4.95 (1H, m, CH-C41), 4.38 (1H, s, CH-C329), 2.11 
(3H, s, CH3-C40), 2.01-1.97 (1H, m, CH-C31), 1.95–1.87 (1H, m, CH-C31), 1.51–1.24 (4H, 
m, CH2-C32 and CH2-C33), 0.94 (9H, t, J = 7.9 Hz, CH3-EtSi), 0.89 (3H, t, J = 7.2 Hz, CH3-
C34), 0.60 (6H, q, J = 7.9 Hz, CH2-EtSi); 
13C NMR (125 MHz, CDCl3) δ 209.5 (C-C28), 146.9 
(C-C30), 111.6 (CH2-C41), 82.2 (CH-C29), 31.4 (CH2-C31), 29.9 (CH2-C32), 23.7 (CH3-
C40), 22.6 (CH2-C33), 14.1 (CH3-C34), 6.8 (CH3- EtSi), 4.8 (CH2- EtSi). 
Diethyl (3-(trimethylsilyl)prop-2-yn-1-yl)phosphonate.222 (414) 
 
To a solution of diethyl phosphite (5.7 mL, 44 mmol) in THF (14 mL) was added 
dropwise  NaHMDS (44 mL of a 1 M soln. in THF, 44 mmol) at −10 °C and stirred for 1 h. 
Propargyl bromide (7.2 mL, 44 mmol) was added dropwise to the solution and the 
mixture was stirred for a further 1 h. The reaction was quenched by the addition of H2O 
(50 mL) and the mixture was extracted with Et2O (2 × 50 mL). The combined organic 
extracts were dried (MgSO4), filtered and concentrated. Purification of the residue by 
flash chromatography (pet. ether/Et2O, 9:1 to 1:4) provided 414 (7.6 g, 69%) as a pale 
yellow oil; Rf = 0.25 (Et2O); νmax (liquid film) 2982, 2961, 2933, 2900, 2179, 1248, 1019, 
837, 759, 640 cm−1; 1H NMR (500 MHz, CDCl3) δ 4.23–4.15 (4H, m, CH2‐OEt), 2.80 (1H, d, 
J = 22.3 Hz, CH2‐C27), 1.36 (1H, t, J = 7.1 Hz, CH3‐OEt), 0.16 (9H, s, CH3-MeSi); 
13C NMR 
(125 MHz, CDCl3) δ 96.1 (C‐C26), 88.3 (C‐C25), 63.2 (CH2‐OEt), 63.1 (CH2‐OEt), 19.6 (d, 
J = 144.7 Hz, CH2‐C27), 16.5 (CH3‐OEt), 0.0 (CH3-MeSi); HRMS (EI+) calcd for C10H21O3PSi 
[M]+ 248.0998, found 248.0989, (Δ −3.3 ppm);  LRMS (EI+) m/z (intensity); 248.0 (12%), 
233.3 (100%), 205.0 (30%), 177.0 (84%).    
Triethyl({[(3E,5S)-4-methyl-6-methylidene-1-(trimethylsilyl)dec-3-en-1-yn-5-
yl]oxy})silane. (410) 
 
To a solution of diethyl (3-(trimethylsilyl)prop-2-yn-1-yl)phosphonate 414 (2.4 g, 9.7 
mmol) in THF (10 mL) at −78 °C was added dropwise NaHMDS (7.3 mL of a 1 M soln. in 
THF, 7.3 mmol). The reaction was then stirred for 30 minutes before the dropwise 
addition of a precooled solution of ketone 409 (1.3 g, 4.8 mmol) in THF (10 mL). The 
reaction was stirred for a further 30 minutes and the reaction was quenched by the 
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addition of H2O (15 mL). The mixture was warmed to rt and extracted with Et2O (3 x 
15mL). The combined organic extracts were washed with brine (20 mL) and dried 
(MgSO4). The solution was filtered, concentrated and the residue was purified by 
chromatography (pet. ether/Et2O, 99:1) to provide the title enyne 410 (1.4 g, 82%) as a 
clear, colourless oil. Rf = 0.73 (pet. Ether/Et2O, 20:1); [α]
27
D  +2.1 (c = 1.00, CHCl3);
 νmax 
(liquid film) 2956, 2877, 2137, 1458, 1248, 1103, 1073, 839, 725 cm−1; 1H NMR (500 MHz, 
CDCl3) δ 5.72-5.69 (1H, m, CH-C27), 5.07 (1H, s, CH-C41), 4.87 (1H, s, CH-C41), 4.44 
(1H, s, CH-C29), 1.98–1.87 (1H, m, CH-C31), 1.81–1.76 (1H, m, CH-C31), 1.74 (3H, s, 
CH3-C40), 1.42–1.34 (2H, m, CH2-C32), 1.34–1.24 (2H, m, CH2-C33), 0.93 (9H, t, J = 7.9 
Hz, CH3-EtSi), 0.89 (3H, t,  J = 7.2 Hz, CH3-C34), 0.57 (6H, q, J = 7.9 Hz, CH2-EtSi), 0.01 
(9H, s, CH3-MeSi); 
13C NMR (125 MHz, CDCl3) δ 153.1 (C-C28), 149.3 (C-C30), 110.6 (CH2-
C41), 105.3 (CH-C27), 103.2 (C-C26), 97.8 (C-C25) 79.7 (CH-C29), 29.9 (CH2-C32), 29.7 
(CH2-C31), 25.6 (CH2-C33), 15.3 (CH3-C40), 14.0 (CH3-C34), 6.8 (CH3-EtSi), 4.7 (CH2-
EtSi), 0.1 (CH2-TMS); HRMS (CI+, isobutane) calcd for C21H41OSi2 [M+H]
+ 365.2696, found 
365.2698, (Δ +0.2 ppm);  LRMS (CI+, isobutane) m/z (intensity); 365.4 (25%), 233.3 (9%), 
113.2 (32%), 73.1 (100%); Anal. calcd for C21H40OSi2 C 69.16%, H 11.05%, found C 68.93%, 
H 11.12%. 
(3E,5S)-4-Methyl-6-methylidenedec-3-en-1-yn-5-ol. (411) 
 
To a solution of silyl alkyne 410 (0.31 g, 0.84 mmol) in THF (5 mL) at rt was added TBAF 
(1.8 mL of a 1 M solution in THF, 1.8 mmol). The mixture was stirred for 30 minutes and 
the reaction was quenched by the addition of H2O (5 mL). The mixture was extracted 
with Et2O (3 x 5mL), the combined extracts washed with brine (10 mL), dried (MgSO4), 
and concentrated. Purification of the residue by chromatography (pet. ether/Et2O, 20:1 
to 9:1) provided the title compound 411 (0.14 g, 91%) as  of clear, colourless oil; Rf = 
0.30 (pet. eth./Et2O, 3:1); [α]
25
D  +4.8 (c = 1.02, CHCl3);
 νmax (liquid film) 3359,  3310, 
2957, 2872, 2860, 2103, 1648, 1024, 904, 633, cm−1; 1H NMR (500 MHz, CDCl3) δ 5.67-
5.65 (1H, m, CH-C27), 5.13 (1H, s, CH-C41), 4.99-4.97 (1H, m, CH-C41), 4.54 (1H, d, J = 
3.0 Hz, CH-C29), 3.11 (1H, d, J = 2.2 Hz, CH-C25), 1.98 (1H, dt, J = 15.6, 7.7 Hz, CH-
C31), 1.87 (1H, dt, J = 15.6, 7.7 Hz, CH-C31), 1.81 (3H, s, CH3-C40), 1.67 (1H, m, C29-
OH), 1.48–1.37 (2H, m, CH2-C32), 1.37–1.27 (2H, m, CH2-C33), 0.90 (3H, t, J = 7.3 Hz, 
CH3-C34);
 13C NMR (125 MHz, CDCl3) δ 152.8 (C–C28), 148.9 (C–C30), 111.5 (CH2–C41), 
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105.6 (CH–C27), 81.5 (CH–C25), 81.2 (C–C26), 79.1 (CH-C29), 31.2 (CH2–C31), 30.2 (CH2–
C32), 22.7 (CH2–C33), 15.5 (CH3–C40), 14.1 (CH3–C34); HRMS (CI+, isobutane) calcd for 
C12H19O [M+H]
+ 179.1436, found 179.1434 (Δ −0.2 ppm); LRMS (CI+, isobutene) m/z 
(intensity); 179.2 (12%), 161.2 (100%). 
Mosher Ester Preparation—General Procedure 
To a solution of secondary alcohol (0.012 mmol) dissolved CH2Cl2 (1 mL) was added Et3N 
(3.0 µL, 0.018 mmol) and a single crystal of DMAP. (S)-MTPA chloride (3.6 mg, 0.014 
mmol) was added to the solution and the mixture stirred overnight at rt. The reaction 
was quenched by the addition of water (1mL) and extracted with Et2O (2 × 2 mL). The 
organic layer was washed sequentially with 1 M HCl (1 mL), NaHCO3 sat. aq. (1 mL) and 
brine (1 mL). The solution was dried over MgSO4, and concentrated. The (R)-MTPA ester 
was purified by flash chromatography on silica gel and analysed by 1H-NMR on isolation. 
The (S)-MTPA ester was prepared from (R)-MTPA chloride using an identical procedure.  
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Mosher Ester Analysis of 411 
 
   Δδ SR (=δS−δR) 
 
δ S-ester 
 (PPM) 
δ R-ester 
 (ppm) 
ppm Hz (400 MHz) 
CH-C25 3.16 3.13 0.03 +12 
CH-C27 5.80 5.81 0.13 +4 
CH3-C40 1.84 1.74 0.10 +40 
CH-C41 4.98 5.05 −0.07 −28 
CH-C41 5.01 5.16 −0.15 −60 
CH2-C31 1.82 1.91 −0.09 −36 
CH2-C32 1.36 1.42 −0.06 −24 
CH2-C33 1.25 1.30 −0.05 −20 
CH2-C34 0.87 0.89 −0.025 −8 
 
(S)-MTPA ester: 1H NMR (400 MHz, CDCl3) δ 7.54–7.45 (2H, m, CH-Ph MTPA), 7.44–7.34 
(3H, m, CH-Ph MTPA), 5.80 (1H, s, CH-C27), 5.00-4.97 (1H, m, CH-C41), 5.01 (1H, s, CH-
C41), 4.98 (1H, s, CH-C29), 3.54 (3H, s, MeO MTPA), 3.16 (1H, d, J = 2.2 Hz, CH-C25), 
1.84 (3H, s, CH3-C40), 1.84-1.79 (2H, m, CH2-C31), 1.42–1.30 (2H, m, CH2-C32), 1.30–
1.17 (2H, m, CH2-C33), 0.87 (2H, t, J = 7.2 Hz, CH3–C34). 
(R)-MTPA ester:  1H NMR (400 MHz, CDCl3) δ 7.55–7.45 (2H, m, CH-Ph MTPA), 7.44–7.36 
(3H,m, CH-Ph MTPA), 5.81 (1H, s, CH-C27), 5.07-5.04 (1H, m, CH-C41), 5.16 (1H,s, CH-
C41), 5.05 (1H, s, CH-C29), 3.54 (3H, s, CH3-MeO MTPA), 3.13 (1H, d, J = 2.2 Hz, CH-
C25), 1.93-1.90 (2H, m, CH2-C31), 1.74 (3H, s, CH3-C40), 1.47–1.35 (2H, m, CH2-C32), 
1.37–1.18 (2H, m, CH2-C33), 0.89 (3H, t, J = 7.3 Hz, CH3–C34). 
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tert-Butyldimethyl{[(3E,5S)-4-methyl-6-methylidenedec-3-en-1-yn-5-yl]oxy}silane.28 
(412) 
 
To a solution of allylic alcohol 411 (0.36 g, 2.0 mmol) in DMF (10 mL) was added 
imidazole (0.27 g, 4.0 mmol) and TBSCl (0.36 g, 2.4 mmol) and the mixture stirred for 
36 h at rt. The reaction was quenched by the addition of H2O (5 mL) and the mixture 
was extracted with pet. ether (3 x 10 mL). The combined organic extracts were washed 
sequentially with aqueous 1 M HCl (15 mL) and saturated aqueous NaHCO3 (15 mL) and 
dried (MgSO4). The solution was concentrated and the residue was purified by 
chromatography (pet. ether to pet. ether/Et2O, 3:1) to provide the title compound 412 
as a clear colourless oil (0.45 g, 77%) and recovered starting material (49 mg, 14%); Rf = 
0.40 (pet. eth); [α] 28D  +8.2 (c = 1.00, CHCl3);
 νmax (liquid film) 3315, 2929, 2858, 2109, 
1647, 1427, 1252, 1091, 869, 834, 774, 675 cm−1; 1H NMR (500 MHz, CDCl3) δ 5.66-5.63 
(1H, m, CH-C27), 5.07 (1H, s, CH-C41), 4.89 (1H, d, J = 1.2 Hz, CH-C41), 4.44 (1H, s, 
CH-C29), 3.08 (1H, d, J = 2.2 Hz, CH-C25), 1.97–1.87 (1H, m, CH-C31), 1.83–1.76 (1H,m, 
CH-C31), 1.76 (3H, s, CH3-C40), 1.45–1.35 (2H, m, CH2-C32), 1.35–1.24 (2H, m, CH2-
C33), 0.87 (3H, t, J = 7.2 Hz, CH3–C34), 0.89 (9H, s, CH3-
tBuSi), 0.03 (3H, s, CH3-MeSi), 
0.02 (3H, s, CH3-MeSi); 
13C NMR (125 MHz, CDCl3) δ 153.9 (C–C28), 149.2 (C–C30), 111.1 
(CH2–C41), 104.5 (CH–C27), 81.7 (C–C26), 80.9 (CH–C25), 80.2 (CH–C29), 30.1 (CH2–C31), 
29.9 (CH2–C32), 25.9 (CH3–
tBuSi), 22.7 (CH2–C33), 18.4 (C–
tBuSi), 15.4 (CH3–C40), 14.2 
(CH3–C34), −4.9 (CH3−MeSi), −5.0 (CH3−MeSi); HRMS (CI+, isobutane) calcd for C18H33OSi 
[M+H]+ 293.2300, found 293.2307, (Δ +0.6 ppm); LRMS (CI+, isobutene) m/z (intensity); 
293.4 (100%), 279.4 (41%), 253.3 (58%), 161.2 (46%); Anal. calcd for C18H32OSi C 73.90%, 
H 11.03%, found C 74.16%, H 11.15%. 
[(2R,5R)-5-{2-[(4-Methoxyphenyl)methoxy]ethyl}tetrahydrofuran-2-yl]methanol. 
(350) 
 
To a suspension of NaH (7.5 mg, 0.18 mmol) in THF (3mL) was added alcohol 344 (24 
mg, 0.092 mmol) in THF (0.5 mL). The suspension was stirred for 5 minutes at rt before 
addition of TBAI (3.3 mg, 0.009 mmol) and PMBCl (16 mL, 0.11 mmol). The mixture was 
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stirred for 16 hours and the reaction was quenched by the addition of H2O (3 mL). The 
reaction mixture was extracted with Et2O (3 x 5 mL), washed with brine (10 mL), dried 
(MgSO4) and concentrated. The crude residue was dissolved in THF (2 mL) and TBAF (0.1 
mL of a 1 M solution in THF, 0.1 mmol) was added and the mixture stirred for 30 minutes 
at rt. The reaction was quenched with H2O (2 mL) and the mixture extracted with Et2O 
(3 x 2 mL). The combined organic extracts were dried (MgSO4), filtered and 
concentrated and the crude residue purified by column chromatography (pet. eth/Et2O, 
9:1) to afford alcohol 350 (17 mg, 49% over two steps) as a clear, colourless oil. Rf = 
0.25 (Et2O); [α]
24
D  −21.9 (c = 0.96, CHCl3); νmax (liquid film) 3440, 2937, 2866, 1612, 
1512, 1244, 1081, 1031, 818cm−1; 1H NMR (400 MHz, CDCl3) δ 
1H NMR (400 MHz, CDCl3) δ 
7.26 (2H, d, J = 8.7 Hz, CH‐PMB Ar), 6.88 (2H, d, J = 8.7 Hz, CH‐PMB Ar), 4.44 (2H, s, 
CH2‐PMB alkyl), 4.13–4.03 (2H, m, CH‐C20 and CH‐C23), 3.80 (3H, s, CH3‐PMB alkyl), 
3.62 (1H, ddd, J = 11.4, 7.1, 3.3 Hz, CH-C24), 3.56 (1H, m, CH-C18), 3.54 (1H, m, CH-
C18), 3.52–3.44 (1H, m, CH‐C24), 2.10–2.01 (1H, m, CH‐C21), 2.01–1.82 (2H, m, CH‐C22 
and CH‐C19), 1.77 (1H, dtd, J = 12.4, 7.0, 5.4 Hz, CH‐C19), 1.71–1.51 (2H, m, CH‐C21 
and CH‐C22); 13C NMR (125 MHz, CDCl3) δ 159.3 (C-PMB Ar), 130.8 (C‐PMB Ar), 129.4 
(CH-PMB Ar), 113.9 (CH-PMB Ar), 79.0 (CH-C23), 76.8 (CH-C20), 72.8 (CH3‐PMB alkyl), 
67.4 (CH2‐C24), 65.2 (CH2-C18), 55.4 (CH3‐PMB alkyl), 36.0 (CH2‐C19), 32.4 (CH2‐C21), 
27.6 (CH2‐C22); HRMS (EI+) calcd for C15H21O4 [M]
+ 266.1518, found 266.1515, (Δ −0.3 
ppm). 
(2S)-2-{2-[(4-Methoxyphenyl)methoxy]ethyl}oxirane.25 (52) 
 
m-CPBA (18 g, 0.11 mol) was added portionwise over 15 minutes to a solution of alkene 
352 (10 g, 52 mmol) in CH2Cl2 (120 mL) at 0 °C, on warming to rt the mixture was 
stirred for 14 h. The resultant precipitates were removed by filtration and washed with 
cold CH2Cl2 (50 mL). The filtrate was concentrated and pet. ether (150 mL) was added 
to the flask and the mixture stirred for a further 30 minutes at rt. Filtration and 
concentration yielded a yellow solid that was purified by chromatography (pet. 
ether/Et2O, 9:1 to 4:1) to afford the intermediate racemic epoxide (6.4 g, 59%) as a 
yellow oil.  
To a solution of (S,S)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-
1,2-cyclohexanediaminocobalt (II) (0.15 g, 0.25 mmol) in CH2Cl2 (3.1 mL) was added 
AcOH (28 µl, 0.50 mmol), under an open atmosphere, and the mixture was stirred for 30 
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minutes at rt.  Concentration of the mixture in vacuo afforded a black residue, which 
was then dried for 20 minutes under high vacuum and dissolved in THF (7 mL). The 
catalyst solution was added to the concentrated epoxide (5.3 g, 25 mmol) and stirred 
until uniform mixing was achieved. The mixture was cooled to 0 °C and H2O (0.25 mL, 
14 mmol) was added dropwise over 15 minutes, the mixture was then stirred for 72 h at 
rt and purified directly by chromatography (pet. ether/Et2O, 9:1 to 4:1) to yield the 
enantiopure epoxide 52 (2.1 g, 39%, ee >90%) as a clear, colourless oil (Rf = 0.32 (pet. 
ether/Et2O, 1:1); 
24
D  −14.9 (c = 1.02, CHCl3) [lit. [α]
26
D  −13.9 (c = 1.0, CHCl3)]
14; νmax 
(liquid film) 2998, 2933, 2837, 1611, 1512, 1244, 1086, 1032, 818 cm−1; 1H NMR (500 
MHz, CDCl3) δ 7.26 (2H,d, J = 8.6 Hz, CH‐PMB Ar), 6.88 (2H,d, J = 8.6 Hz, CH‐PMB Ar), 
4.46 (2H,s, CH2‐PMB alkyl), 3.81 (3H,s, CH3‐PMB alkyl), 3.62–3.57 (2H,m, CH2‐C18), 3.08–
3.04 (1H,m, CH‐C20), 2.78 (1H,dd, J = 4.8, 4.1 Hz, CH‐C21), 2.52 (1H, dd, J = 4.8, 2.7 
Hz, CH‐C21), 1.93–1.87 (1H,m, CH‐C19), 1.77 (1H,m, CH‐C19); 13C NMR (125 MHz, CDCl3) 
δ 159.6 (C‐PMB Ar), 130.8 (C‐PMB Ar), 129.6 (CH‐PMB Ar), 114.2 (CH‐PMB Ar), 73.1 (CH2‐
PMB alkyl), 67.1 (CH2‐C18), 55.6 (CH3‐PMB alkyl), 50.4 (CH‐C20), 47.4 (CH2‐C21), 33.3 
(CH2‐C19). 
(3R)-1-[(4-Methoxyphenyl)methoxy]hept-6-en-3-ol.25 (353) 
  
Allylmagnesium chloride (6.7 mL of a 2 M solution, 13.4 mmol) was added dropwise, 
over 10 minutes to a stirred solution of epoxide 52 (1.8 g, 1.9 mmol) in THF (81 mL) at 
0 °C. The mixture was stirred for 1 hand  the reaction was quenched with saturated 
aqueous NH4Cl (50 mL). The mixture was extracted with Et2O (3 × 50 mL), washed with 
brine (75 mL), dried (MgSO4) and concentrated. The resultant residue was purified by 
column chromatography (pet. ether/Et2O, 9:1 to 3:1) to afford the desired secondary 
alcohol 353 (1.9 g, 86%) as a clear oil. Rf = 0.19 (pet. ether/Et2O, 1:1); 
24
D  +12.7 (c = 
1.01, CHCl3); νmax (liquid film) 2998, 2933, 2837, 1611, 1512, 1244, 1086, 1032, 818 
cm−1; 1H NMR (400 MHz, CDCl3) δ 7.25 (2H, d, J = 8.7 Hz, CH‐PMB Ar),  6.88 (2H, d, J = 
8.7 Hz, CH‐PMB Ar), 5.84 (1H, ddt, J = 17.1, 10.2, 6.7 Hz, CH‐C23), 5.03 (1H, ddd, J = 
17.1, 3.4, 1.6 Hz, CH‐C24 trans), 4.96 (1H, ddd, J = 10.2, 3.4, 1.2 Hz, CH‐C24 cis), 4.45 
(2H, s, CH2‐PMB alkyl), 3.85–3.78 (1H, m, CH‐C20), 3.80 (3H, s, CH3‐PMB alkyl), 3.73–
3.67 (1H, m, CH‐C18), 3.66–3.59 (1H, m, CH‐C18), 2.92 (1H, d, J = 3.2 Hz, OH‐C20), 
2.26–2.06 (2H, m, CH2‐C22), 1.76–1.71 (2H, m, CH2‐C19), 1.64–1.46 (2H, m, CH2‐C21); 
13C NMR (100 MHz, CDCl3) δ 159.4 (C‐PMB Ar), 138.8 (CH‐C23), 130.2 (C‐PMB Ar), 129.5 
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(CH‐PMB Ar), 114.7 (CH‐C24), 114.0 (CH‐PMB Ar), 73.1 (CH2‐PMB alkyl), 71.1 (CH‐C20), 
69.1 (CH2‐C18), 55.4 (CH3‐PMB alkyl), 36.7 (CH2‐C21), 36.5 (CH2‐C19), 30.1 (CH2‐C22); 
HRMS (EI+) [M]+ calcd for C15H22O3 250.1569, found 250.1574 (Δ +1.1 ppm). 
[(2R,5R)-5-{2-[(4-Methoxyphenyl)methoxy]ethyl}tetrahydrofuran-2-yl]methanol. 
(350) 
 
To a solution of Co(NMP)2 358 (0.43 g, 0.76 mmol)
223 in i-PrOH (76 mL) under an O2 
atmosphere was added alkenol 349 (1.9 g, 7.6 mmol) in i-PrOH (5 mL) and t-BuOOH. 
The mixture was heated at 55 °C for 17 h, cooled to rt and MeI (0.47 mL, 7.6 mmol) was 
added to the mixture. The reaction was quenched by the addition of H2O (50 mL), and 
the mixture was extracted with CH2Cl2 (4 × 50 mL). The combined organic extracts were 
dried (MgSO4), concentrated to give a residue that was purified by column 
chromatography (pet. ether/Et2O, 4:1 to 1:1) to afford tetrahydrofuran 346 (1.3 g, 65%) 
as a clear oil. The 1H, 13C NMR and optical rotation data matches the previously 
characterised sample.   
(2R,5R)-5-{2-[(4-Methoxyphenyl)methoxy]ethyl}tetrahydrofuran-2-carboxylic acid. 
 
Dess-Martin periodinane (0.94 g, 2.2 mmol) was added to a solution of alcohol 350 (0.45 
g, 1.7 mmol) of CH2Cl2 (22 mL). The mixture was stirred for 2 h at rt and the reaction 
was quenched with NaHCO3 (10 mL). The mixture was extracted with Et2O (3 × 30 mL) 
and the combined layers were dried (MgSO4) and concentrated before filtration through 
a silica gel pad (pet. ether/Et2O, 1:1) to provide a clear, colourless oil. The product was 
dissolved in a solution of t-BuOH (8.5 mL) and 2-methyl-2-butene (1.4 mL, 13.6 mmol) 
to which was added dropwise a solution of NaClO2 (0.92 g, 10.2 mmol) and 
NaH2PO4.2H2O (1.7 g, 11.1 mmol) in H2O (17 mL). The mixture was stirred for 2 h at rt 
and then the reaction was concentrated in vacuo and partitioned between CH2Cl2 
(10 mL) and H2O (10 mL). The organic phase was isolated and the aqueous phase was 
back-extracted with further CH2Cl2 (3 × 10 mL). The combined organic extracts were 
dried (MgSO4) and concentrated to provide the intermediate carboxylic acid (0.33 g, 69% 
over two steps) as a clear, colourless oil. Rf = 0.14 (Et2O); [α]
25
D  +12.5 (c = 1.02, CHCl3);  
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νmax (liquid film) 2938, 2932, 2870, 1723, 1512, 1245, 1080, 818, 751 cm
−1; 1H NMR (500 
MHz, CDCl3) δ 7.25 (2H, d, J = 8.7 Hz, CH‐PMB Ar), 6.88 (2H, d, J = 8.7 Hz, CH‐PMB Ar), 
4.52–4.47 (1H, m, CH‐C23), 4.44 (2H, s, CH2‐PMB alkyl), 4.33–4.26 (1H, m, CH‐C20), 3.81 
(3H, s, CH3‐PMB alkyl), 3.60–3.53 (2H, m, CH2‐C18),  2.43–2.34 (1H, m, CH‐C22), 2.14–
2.04 (2H, m, CH‐C21 and CH‐C22), 1.93–1.78 (2H, m, CH2‐C19), 1.70–1.61 (1H, m, CH‐
C21); 13C NMR (125 MHz, CDCl3) δ 174.6 (C‐C24), 159.6 (C‐PMB Ar), 130.7 (C‐PMB Ar), 
129.4 (CH‐PMB Ar), 114.1 (CH‐PMB Ar), 79.2 (CH‐C20), 76.6 (CH‐C23), 73.0 (CH2‐PMB 
alkyl), 66.9 (CH2‐C18), 55.5 (CH3‐PMB alkyl), 35.5 (CH2‐C19), 31.7 (CH2‐C21), 30.0 (CH2‐
C22); HRMS (EI+, isobutane) calcd for C15H20O5 [M+H]
+ 280.1311, found 280.1314, (Δ +1.2 
ppm). 
(2R,5R)-N-Methoxy-5-{2-[(4-methoxyphenyl)methoxy]ethyl}-N-
methyltetrahydrofuran-2-carboxamide. (416) 
 
A solution of the carboxylic acid (0.32 g, 1.1 mmol), N,O-dimethyhydroxylamine.HCl 
(0.21 g, 2.2 mmol), HBTU (0.43 g, 2.2 mmol) and DIPEA (0.84 mL, 4.8 mmol) in CH2Cl2  
(13 mL) was stirred for 16 h at rt. The reaction was quenched by the addition of 
saturated aqueous NH4Cl (10 mL) and the mixture was extracted with CH2Cl2 (2 × 10 
mL). The combined extracts were dried (MgSO4), concentrated and the resultant residue 
was purified by column chromatography (pet. ether/Et2O 1:1 to Et2O) to afford of the 
Weinreb amide 416 (0.33 g, 88%) as a clear, colourless oil. Rf = 0.27 (Et2O); [α]
24
D −3.63 
(c = 1.17, CHCl3);  νmax (liquid film) 2938, 2857, 1674, 1513, 1247, 1079, 1033, 819 cm
−1; 
1H NMR (500 MHz, CDCl3) δ 7.25 (2H, d, J = 8.7 Hz, CH‐PMB Ar), 6.87 (2H, d, J = 8.7 Hz, 
CH‐PMB Ar), 4.85–4.79 (1H, m, CH‐C23), 4.43 (1H, s, CH2‐PMB alkyl), 4.42 (1H, s, CH2‐
PMB alkyl),4.28 (1H, ddd, J = 13.1, 7.3, 5.7 Hz, CH‐C20), 3.80 (3H, s, CH3‐PMB alkyl), 
3.70 (3H, s, CH3‐MeO), 3.62–3.53 (2H, m, CH2‐C18), 3.19 (3H, s, CH3‐MeN), 2.24–2.16 
(1H, m, CH‐C22), 2.16–2.02 (2H, m, CH‐C21 and CH‐C22), 1.93 (1H, ddd, J = 12.8, 10.3, 
6.4 Hz, CH‐C19), 1.82 (1H, dtd, J = 12.8, 7.3, 5.7 Hz, CH‐C19),  1.62–1.53 (1H, m, CH‐
C21); 13C NMR (125 MHz, CDCl3) δ 173.2 (C-C24) 159.4 (C-PMB Ar), 131.0 (C-PMB Ar), 
129.3 (CH‐PMB Ar), 114.0 (CH‐PMB Ar), 78.4 (CH‐C20), 75.1 (CH‐C23), 72.9 (CH2‐PMB 
alkyl), 67.7 (CH2‐C18), 61.5 (CH3‐MeO), 55.5 (CH3‐PMB alkyl), 35.9 (CH2‐C19), 31.8 (CH3‐
MeN and CH2‐C21), 29.4 (CH2‐C22); HRMS (CI+, isobutane) calcd for C17H26NO5 [M+H]
+  
324.1811, found 324.1806, (Δ−1.4 ppm);  LRMS (CI+, isobutene) m/z (intensity); 324.3 
(17%), 292.2 (16%), 241.2 (16%), 216.2 (10%), 204.2 (20%), 172.2 (28%), 121.1 (100%). 
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(4E,6S)-6-[(tert-Butyldimethylsilyl)oxy]-1-[(2R,5R)-5-{2-[(4-methoxyphenyl) 
methoxy]ethyl}tetrahydrofuran-2-yl]-5-methyl-7-methylideneundec-4-en-2-yn-1-
one. (414) 
 
To a stirred solution of alkyne 412 (0.36 g, 1.2 mmol) in of THF (4 mL) at 0 °C was 
added dropwise n-BuLi (0.37 mL of a 2.5 M solution in hexane, 1.2 mmol). The reaction 
was stirred 30 minutes and transferred to a precooled −78 °C solution of Weinreb amide 
416 (0.20 g, 0.62 mmol) in of THF (4 mL). The solution was stirred for a further 30 
minutes and the reaction was quenched with a saturated aqueous solution of NH4Cl (5 
mL). The mixture was extracted with Et2O (2 x 10 mL), the combined organic phases 
were washed with brine, dried (MgSO4) and concentrated. The crude residue was 
purified by chromatography (pet. ether to pet. ether/Et2O, 2:1) to provide ynone 418 as 
a clear, colourless oil (0.33 g, 95%).Rf = 0.46 (pet. ether/Et2O, 2:1); [α]
25
D  +19.2 (c = 
1.00, CHCl3);  νmax (liquid film) 2954, 2929, 2857, 1664, 1614, 1513, 1247, 1086, 867, 
835, 776 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.25 (2H, d, J = 8.7 Hz, CH‐PMB Ar), 6.87 (2H, 
d, J = 8.7 Hz, CH‐PMB Ar), 5.86 (1H, s, CH‐C27), 5.08 (1H, s, CH‐C41), 4.93 (1H, d, J = 
1.3 Hz, CH‐C41),  4.55–4.49 (2H, m, CH‐23 and CH‐C29), 4.44 (2H, d, J = 5.4 Hz, CH2‐
PMB alkyl), 4.33–4.25 (1H, m, CH‐C20), 3.80 (3H, s, CH3‐PMB alkyl), 3.63–3.53 (2H, m, 
CH2‐C18), 2.35–2.25 (1H, m, CH‐C22), 2.14–2.03 (2H, m, CH‐C21 and CH‐C22), 2.00–1.90 
(2H, m, CH‐C19 and CH‐C31), 1.86 (3H, s, CH3‐C40), 1.85–1.75 (2H, m, CH‐C19 and CH‐
C31), 1.68–1.56 (1H, m, CH‐C21), 1.46–1.36 (2H, m, CH2‐C32), 1.36–1.25 (2H, m, CH2‐
C33), 0.91 (9H, s, CH3‐
tBuSi), 0.90 (3H, t, J = 7.2 Hz, CH3‐C34), 0.04 (3H, s, CH3‐MeSi), 
0.04 (3H, s, CH3‐MeSi);
 13C NMR (125 MHz, CDCl3) δ 189.3 (C‐C24), 161.0 (C‐C28), 159.5 
(C-PMB Ar), 148.9 (C‐C30), 130.9 (C‐PMB Ar), 129.3 (CH‐PMB Ar), 114.1 (CH‐PMB Ar), 
112.1 (CH2‐C41), 103.5 (CH‐C27), 92.9 (C‐C25), 90.9 (C‐C26), 83.9 (CH‐C29), 80.5 (CH‐
C23), 78.9 (CH‐C20), 72.9 (CH2‐PMB alkyl), 67.5 (CH2‐C18), 55.5 (CH3‐PMB alkyl), 35.9 
(CH2‐C19), 31.5 (CH2‐C21), 30.2 (CH2‐C32), 29.8 (CH2‐C31), 29.7 (CH2‐C22), 25.9 (CH3‐
tBuSi), 22.7 (CH2‐C33), 18.4 (C‐
tBuSi), 16.5 (CH3‐C40), 14.1 (CH3‐C34), −4.8 (CH3‐MeSi), 
−5.0 (CH3‐MeSi); HRMS (CI+, isobutane) calcd for C33H51O5Si [M+H]
+ 555.3506, found 
555.3511, (Δ +0.9 ppm);  LRMS (CI+, isobutene) m/z (intensity); 555.3 (100%). 
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(1S,4E,6S)-6-[(tert-Butyldimethylsilyl)oxy]-1-[(2R,5R)-5-{2-[(4-methoxyphenyl) 
methoxy]ethyl}tetrahydrofuran-2-yl]-5-methyl-7-methylideneundec-4-en-2-yn-1-ol. 
(417b) 
 
Dess-Martin periodinane (0.21 g, 0.48 mmol) was added as a single portion to a stirred 
solution of alcohol 350 (0.10 g, 0.38 mmol) in CH2Cl2 (5 mL) at rt. The mixture was 
stirred for 2 h and the reaction was quenched by the addition of a saturated aqueous 
NaHCO3 (5 mL). The mixture was extracted with Et2O (3 × 5 mL) and the organic 
extracts were dried (MgSO4) and concentrated. The residue was purified by 
chromatography (pet. ether/Et2O, 1:1) to afford the corresponding aldehyde.  
The aldehyde was dissolved in THF (1.5 mL) and cooled to -78 °C. n-BuLi (0.16 mL of a 
2.5 M solution in hexanes, 0.40 mmol) was added dropwise to a solution of alkyne 412 
(0.12 g, 0.40 mmol) in THF (2 mL) at 0 °C and the mixture was stirred for 15 minutes 
before cooling to −78 °C. A solution of the aldehyde in THF (1.5 mL) was added 
dropwise to the alkyne anion and the mixture was stirred for a further 15 minutes 
before the reaction was quenched by the addition of saturated aqueous NH4Cl (3 mL). 
On warming to rt the mixture was extracted with Et2O (3 × 5mL) and the organic 
extracts were washed with brine (10 mL), dried (MgSO4) and concentrated. The residue 
was purified by chromatography (pet. ether/Et2O, 2:1) to afford a diastereomeric 
mixture of propargylic alcohols (0.15 g, 71%, dr C-23-C24 anti:syn, 3:2). Partial 
separation of the isomers by chromatography (pet. ether/Et2O, 4:1) allowed for 
isolation of the pure C23,C24-anti diastereomer 417b.  Rf = 0.25 (pet. ether/Et2O, 1:1); 
[α]
25
D  +13.1 (c=2.05, CHCl3);  νmax (liquid film) 3491, 2955, 2929, 2857, 2364, 1613, 1513, 
1247, 1080, 871, 835, 775, 732 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.25 (2H, d, J = 8.6 Hz, 
CH‐PMB Ar), 6.87 (2H, d, J = 8.6 Hz, CH‐PMB Ar), 5.65 (1H, s, CH‐C27),  5.07 (1H, s, CH‐
C41), 4.87 (1H, d, J = 1.4 Hz, CH‐C41), 4.61-4.55 (1H, m, CH‐C24), 4.43 (3H, s, CH2‐PMB 
alkyl and CH‐C29), 4.22 (1H, tt, J = 7.7, 5.5 Hz, CH‐C20), 4.16 (1H, td, J = 7.3, 3.4 Hz, 
CH‐C23), 3.80 (3H, s, CH3‐PMB alkyl), 3.54 (2H, t, J = 6.5 Hz, CH2‐C18), 2.36 (1H, d, J = 
5.4 Hz, OH‐C24), 2.15–2.07 (1H, m, CH‐C21), 2.07–1.99 (2H, m, CH2‐C22), 1.96–1.83 (2H, 
m, CH‐C19 and CH‐C31), 1.81–1.73 (2H, m, CH‐C19 and CH‐C31), 1.71 (3H, s, CH3‐C40), 
1.66–1.53 (1H, m, CH‐C21), 1.38 (2H, m, CH2‐C32), 1.34–1.23 (2H, m, CH2‐C33), 0.89 
(3H, t, J = 7.2 Hz, CH3‐C34), 0.89 (9H, s, CH3‐
tBuSi), 0.01 (6H, s, CH3‐MeSi); 
13C NMR 
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(125 MHz, CDCl3) δ 159.3 (C‐ PMB Ar), 152.6 (C‐C30), 149.2 (C‐C28), 130.7 (C‐PMB Ar), 
129.4 (CH‐PMB Ar), 113.9 (CH‐PMB Ar), 111.0 (CH2‐C41), 104.9 (CH‐C27), 90.7 (C‐C26), 
83.8 (C‐C25), 81.0 (CH‐C23), 80.1 (CH‐C29), 78.4 (CH‐C20), 72.8 (CH2‐PMB alkyl), 67.4 
(CH2‐C18), 65.3 (CH‐C24), 55.4 (CH3‐PMB alkyl), 36.0 (CH2‐C19), 32.4 (CH2‐C21), 30.1 
(CH2‐C32), 30.0 (CH2‐C31), 26.8 (CH2‐C22), 25.9 (CH3‐
tBuSi), 22.7 (CH2‐C33), 18.4 (C‐
tBuSi), 15.4 (CH3‐C40), 14.2 (CH3‐C34), −4.9 (CH3‐MeSi), −5.0 (CH3‐MeSi); HRMS (FAB+, 
NOBA) calcd for C33H53O5Si [M+H]
+ 557.3662, found 557.3662, (Δ +0.0 ppm). 
(1S,2E,4E,6S)-6-[(tert-Butyldimethylsilyl)oxy]-1-[(2R,5R)-5-{2-[(4-methoxyphenyl) 
methoxy]ethyl}tetrahydrofuran-2-yl]-5-methyl-7-methylideneundeca-2,4-dien-1-ol. 
(419b) 
 
To a solution of propargylic alcohol 417b (68 mg, 0.12 mmol) in Et2O (2 mL) at 0 °C was 
added Red-Al (74 mg of a >65% wt. solution in toluene, 0.24 mmol) and the solution 
stirred for 45 minutes. The reaction was quenched by addition of saturated aqueous 
NH4Cl (5 mL) and the mixture was extracted with Et2O (2 × 10 mL). The combined 
organic extracts were washed with brine (10 mL), dried (MgSO4), filtered and 
concentrated. The crude residue was purified (pet. ether/Et2O, 1:1) to provide of the 
desired dienol 419b (59 mg, 88%) as a clear, colourless oil (88%). Rf = 0.23 (pet. 
ether/Et2O, 1:1); [α]
23
D  −7.3 (c = 1.01, CHCl3);  νmax (liquid film) 3432, 2955, 2929, 2857, 
1613, 1513, 1247, 1074, 834, 774, 732 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.26 (2H, d, J = 
8.7 Hz, CH‐PMB Ar), 6.88 (2H, d, J = 8.7 Hz, CH‐PMB Ar), 6.52 (1H, ddd, J = 15.2, 11.0, 
1.2 Hz, CH‐C26), 6.07 (1H, d, J = 11.0 Hz, CH‐C27), 5.59 (1H, dd, J = 15.2, 6.6 Hz, CH‐
C25), 5.10 (1H, s, CH‐C41), 4.85 (1H, s, CH‐C41), 4.44 (2H, s, CH2‐PMB alkyl), 4.40 (1H, 
s, CH‐C29), 4.32-4.39 (1H, m, CH‐C24), 4.14 (1H, tdd, J = 11.4, 6.8, 4.5 Hz, CH‐C20), 
4.04–3.98 (1H, m, CH‐C23), 3.80 (3H, s, CH3‐PMB alkyl), 3.55 (2H, t, J = 6.5 Hz, CH2‐
C18), 2.20 (1H, br s, OH‐C24), 2.11–2.02 (1H, m, CH‐C21), 1.93–1.83 (4H, m, CH‐C19, 
CH2‐C22 and CH‐C31), 1.83–1.72 (2H, m, CH‐C19 and CH‐C31), 1.60 (3H, d, J = 0.8 Hz, 
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CH3‐C40), 1.59–1.50 (1H, m, CH‐C21), 1.42–1.34 (2H, m, CH2‐C32), 1.33–1.24 (2H, m, 
CH2‐C33), 0.89 (9H, s, CH3‐
tBuSi), 0.88 (3H, t, J = 7.4 Hz, CH3‐C34), 0.02 (3H, s, CH3‐
MeSi), 0.01 (3H, s, CH3‐MeSi); 
13C NMR (125 MHz, CDCl3) δ 159.3 (C‐PMB Ar), 149.7 (C‐
C30), 139.6 (C‐C28), 130.7 (C‐PMB Ar), 130.3 (CH‐C25), 129.4 (CH‐PMB Ar), 128.4 (CH‐
C26), 124.9 (CH‐C27), 113.9 (CH‐PMB Ar), 109.9 (CH2‐C41), 81.5 (CH‐23), 80.8 (CH‐C29), 
77.8 (CH‐C20), 73.6 (CH‐C24), 72.8 (CH2‐PMB alkyl), 67.4 (CH2‐C18), 55.4 (CH3‐PMB 
alkyl), 36.2 (CH2‐C19), 32.4 (CH2‐C21), 30.9 (CH2‐C31), 30.2 (CH2‐C32), 26.0 (CH3‐
tBuSi), 
25.7 (CH2‐22), 22.7 (CH2‐C33), 18.4 (C‐
tBuSi), 14.2 (CH3‐C34), 12.2 (CH3‐C40), −4.9 (CH3‐
MeSi), −4.9 (CH3‐MeSi); HRMS (CI+, isobutane) calcd for C33H55O5Si [M+H]
+ 559.3819, 
found 559.3808, (Δ −1.9 ppm). 
(2E,4E,6S)-6-[(tert-Butyldimethylsilyl)oxy]-1-[(2R,5R)-5-{2-[(4-methoxyphenyl) 
methoxy]ethyl}oxolan-2-yl]-5-methyl-7-methylideneundeca-2,4-dien-1-one. (420) 
 
Dienol 419 (0.19 g, 0.34 mmol, dr 1:1) was dissolved in CH2Cl2 (6 mL) to which was 
added Dess-Martin periodinane (0.17 g, 0.40 mmol) and mixture allowed to stir for 1 h 
at rt. The reaction was quenched with saturated aqueous NaHCO3 (5 mL) and the 
mixture was extracted with Et2O (2 × 10 mL). The combined organic extracts were dried 
(MgSO4) and concentrated. Purification of the residue by chromatography (pet. 
ether/Et2O, 4:1) yielded the title dienone 420 (0.16 g, 87%) as a clear, colourless oil. Rf 
= 0.25 (pet. ether/Et2O, 3:1); [α]
24
D  +15.1 (c = 0.98, CHCl3);  νmax (liquid film) 2954, 
2929, 2857, 1681, 1613, 1585, 1247, 1079, 835, 775, cm−1; 1H NMR (400 MHz, CDCl3) δ 
7.64 (1H, dd, J = 15.2, 11.8 Hz, CH‐C26), 7.26 (2H, d, J = 8.7 Hz, CH2‐PMB Ar), 6.88 (2H, 
d, J = 8.7 Hz, CH2‐PMB Ar), 6.52 (1H, d, J = 15.2 Hz, CH‐C25), 6.32 (1H, dd, J = 11.8, 
0.8 Hz, CH‐C27), 5.11 (1H, s, CH‐C41), 4.90 (1H, d, J = 1.0 Hz, CH‐C41), 4.57–4.50 (1H, 
m, CH‐C23), 4.47 (1H, s, CH‐C29), 4.45 (2H, s, CH2‐PMB alkyl), 4.44 (2H, s, CH2‐PMB 
alkyl), 4.23 (1H, ddd, J = 13.1, 7.2, 5.8 Hz, CH‐C20), 3.80 (3H, s, CH3‐PMB alkyl), 3.59 
(2H, t, J = 6.5 Hz, CH2‐C18), 2.32–2.21 (1H, m, CH‐C22), 2.09–1.72 (6H, m, CH2‐C19, CH‐
C21, CH‐C22 and CH2‐C31), 1.76 (3H, d, J = 1.0 Hz, CH3‐C40), 1.66–1.55 (1H, m, CH‐
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C21), 1.43–1.33 (2H, m, CH2‐C32), 1.33–1.23 (2H, m, CH2‐C33), 0.90 (9H, s, CH3‐
tBuSi), 
0.87 (3H, t, J = 7.2 Hz, CH3‐C34), 0.03 (3H, s, CH3–MeSi), 0.02 (3H, s, CH3‐MeSi); 
13C NMR 
(100 MHz, CDCl3) δ 201.6 (C‐C24), 159.3 (C‐PMB Ar), 151.7 (C‐C30), 149.1 (C‐C28), 140.0 
(CH‐C26), 130.7 (C‐PMB Ar), 129.4 (CH‐PMB Ar), 124.0 (CH‐C25), 123.9 (CH‐C27), 113.9 
(CH‐PMB Ar), 111.0 (CH2‐C41), 82.7 (CH‐C23), 80.9 (CH‐C29), 78.4 (CH‐C20), 72.9 (CH2‐
PMB alkyl), 67.4 (CH2‐C18), 55.4 (CH3‐PMB alkyl), 35.8 (CH2‐C19), 31.7 (CH2‐C21), 30.4 
(CH2‐C32), 30.1 (CH2‐C31), 29.7 (CH2‐C22), 25.9 (CH3‐
tBuSi), 22.7 (CH2‐C33), 18.4 (C‐
tBuSi), 14.1 (CH3‐C34), 13.4 (CH3‐C40), −4.9 (CH3‐MeSi), −4.9 (CH3‐MeSi); HRMS (CI+, 
isobutane) calcd for C33H53O5Si [M+H]
+  557.3662, found 557.3661,( Δ −0.9 ppm);  LRMS 
(CI+, isobutene) m/z (intensity); 557.5 (100%), 425.4 (32%), 243.3 (39%). 
(1R,2E,4E,6S)-6-[(tert-Butyldimethylsilyl)oxy]-1-[(2R,5R)-5-{2-[(4-methoxyphenyl) 
methoxy]ethyl}tetrahydrofuran-2-yl]-5-methyl-7-methylideneundeca-2,4-dien-1-ol. 
(419a) 
 
To a solution of dienone 420 (0.16 g, 0.30 mmol) and CeCl3.7H2O (0.15 g, 0.41 mmol) in 
methanol (34 mL) at −78 °C was added, in one portion, NaBH4 (16 mg, 0.41 mmol). The 
reaction mixture was stirred for 30 minutes, concentrated and partitioned between Et2O 
(10 mL) and saturated aqueous NH4Cl (10 mL). The organic layer was isolated and the 
aqueous phase back-extracted with further Et2O (2 × 10 mL). The combined organic 
extracts were dried (MgSO4) and concentrated to afford dienol 419a (0.16 g, 100%, 
dr>10:1) as a clear, colourless oil. Rf = 0.33 (pet. ether/Et2O, 1:1); [α]
24
D  −9.8 (c = 1.90, 
CHCl3);  νmax (liquid film) 3438, 2954, 2929, 2857, 1612, 1513, 1247, 1073, 834, 774, 
cm−1; 1H NMR (500 MHz, CDCl3) δ 7.26 (2H, d, J = 8.6 Hz, CH‐PMB Ar), 6.88 (2H, d, J = 
8.6 Hz, CH‐PMB Ar), 6.54 (1H,ddd, J = 15.1, 11.0, 0.8 Hz, CH‐C26), 6.07 (1H, d, J = 11.0 
Hz, CH‐C27), 5.57 (1H, dd, J = 15.1, 7.2 Hz, CH‐C25), 5.11 (1H, s, CH‐C41), 4.85 (1H, s, 
CH‐C41), 4.44 (2H, s, CH2‐PMB alkyl), 4.40 (1H, s, CH‐C29), 4.09 (1H, dt, J = 7.6, 6.5 Hz, 
CH‐C20), 3.96 (1H, t, J = 7.2 Hz, CH‐C24), 3.87 (1H, ap q, J = 7.2 Hz, CH‐C23), 3.80 (3H, 
s, CH3‐PMB alkyl), 3.56-3.53 (2H, m, CH2‐C18), 2.62 (1H, br s, OH‐C24), 2.11–2.00 (1H, 
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m, CH‐C21), 2.00–1.72 (5H, m, CH2‐C19, CH‐C22 and CH2‐C31), 1.71–1.50 (2H, m, CH‐
C21 and CH‐C22), 1.60 (3H, s, CH3‐C40), 1.42–1.33 (2H, m, CH2‐C32), 1.33–1.22 (2H, m, 
CH2‐C33), 0.89 (9H, s, CH3‐
tBuSi), 0.87 (3H, t, J = 7.2 Hz, CH3‐C34), 0.02 (3H, s, CH3‐
MeSi), 0.00 (3H, s, CH3‐MeSi); 
13C NMR (125 MHz, CDCl3) δ 159.5 (C‐PMB Ar), 149.9 (C‐
C30), 140.0 (C‐C28), 130.9 (C-PMB Ar), 130.7 (CH‐C25), 129.6 (CH‐PMB Ar), 129.2 (CH‐
C26), 125.1 (CH‐C27), 114.1 (CH‐PMB Ar), 110.1 (CH2‐C41), 82.1 (CH‐C23), 81.0 (CH‐
C29), 76.9 (CH‐C20), 75.9 (CH‐C24), 73.0 (CH2‐PMB alkyl), 67.6 (CH2‐C18), 55.6 (CH3‐
PMB alkyl), 36.1 (CH2‐C19), 32.6 (CH2‐C21), 31.1 (CH2‐C31), 30.4 (CH2‐C32), 28.4 (CH2‐
C22), 26.2 (CH3‐
tBuSi), 22.9 (CH2‐C33), 18.6 (C‐
tBuSi), 14.4 (CH3‐C34), 12.4 (CH3‐C40), 
−4.67 (CH3‐MeSi), −4.72 (CH3‐MeSi); HRMS (EI+) calcd for C33H52O4Si [M−H2O]
+  540.3630, 
found 540.3639,( Δ +0.7 ppm). 
(5S,6E,8E,10R)-12,12-Diethyl-5-(hex-1-en-2-yl)-10-[(2R,5R)-5-{2-[(4-
methoxyphenyl)methoxy]ethyl}tetrahydrofuran-2-yl]-2,2,3,3,6-pentamethyl-4,11-
dioxa-3,12-disilatetradeca-6,8-diene. (407) 
 
To a stirred solution of alcohol 419a (47 mg, 0.08 mmol) and 2,6-lutidine (29 µl, 0.25 
mmol) in CH2Cl2 (2 mL) at rt was added TES triflate (23 µl, 0.10 mmol). The solution was 
stirred for 2 h and the reaction was quenched with 0.5 M aqueous HCl (5 mL). The 
mixture was extracted with Et2O (2 × 5 mL), the combined organic layers were dried 
(MgSO4) and concentrated to a crude residue that was purified by chromatography (pet. 
ether/Et2O, 3:1) to yield of the title compound 407 (43 mg, 76%) as a clear colourless 
oil and unreacted starting alcohol (10 mg, 21%). Rf = 0.36 (pet. ether/Et2O, 9:1); [α]
25
D  
−9.5 (c = 1.00, CHCl3);  νmax  (liquid film) 2954, 2929, 2875, 2857, 1613, 1513, 1247, 
1078, 834, 774, cm−1; 1H NMR (500 MHz, CDCl3) δ 7.26 (2H, d, J = 8.7 Hz, CH‐PMB Ar), 
6.87 (2H, d, J = 8.7 Hz, CH‐PMB Ar), 6.46 (1H, ddd, J = 15.2, 11.0, 1.2 Hz, CH‐C26), 
6.05 (1H, d, J = 11.0 Hz, CH‐C27), 5.65 (1H, dd, J = 15.2, 6.2 Hz, CH‐C25), 5.12 (1H, s, 
CH‐C41), 4.85 (1H, s, CH‐C41), 4.45 (1H, d, J = 11.5 Hz, CH‐PMB alkyl), 4.41 (1H, d, J = 
11.5 Hz, CH‐PMB alkyl), 4.40 (1H, s, CH‐C29), 4.16 (1H, t, J = 5.5 Hz, CH‐C24), 4.04-3.97 
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(1H, m, CH‐C20), 3.97-3.92 (1H, m, CH‐C23), 3.80 (3H, s, CH3‐PMB alkyl), 3.60–3.50 (2H, 
m, CH2‐C18), 2.00–1.93 (1H, m, CH‐C21), 1.92–1.67 (6H, m, CH2‐C19, CH2‐C22 and CH2‐
C31), 1.58 (3H, d, J = 0.9 Hz, CH3‐C40), 1.53–1.44 (1H, m, CH‐C21), 1.42–1.34 (2H, m, 
CH2‐C32), 1.33–1.24 (2H, m, CH2‐C33), 0.95 (9H, t, J = 7.9 Hz, CH3‐EtSi), 0.89 (9H, s, 
CH3‐
tBuSi), 0.87 (3H, t, J = 7.2 Hz, CH3‐C34), 0.60 (6H, q, J = 7.9 Hz, CH2‐EtSi), 0.01 
(3H, s, CH3-MeSi), 0.00 (3H, s, CH3-MeSi); 
13C NMR (125 MHz, CDCl3) δ 159.3 (C‐PMB Ar), 
149.8 (C‐C30), 138.4 (C‐C28) 132.3 (CH‐C25), 130.9 (C-PMB Ar), 129.4 (CH‐PMB Ar), 
127.4 (CH‐C26), 125.5 (CH‐C27), 113.9 (CH‐PMB Ar), 109.7 (CH2‐C41), 82.1 (CH‐C23), 
80.8 (CH‐C29), 77.0 (CH‐C20), 75.8 (CH‐C24), 72.8 (CH2‐PMB alkyl), 67.8 (CH2‐C18), 55.7 
(CH3-PMB alkyl), 36.1 (CH2‐C19), 32.4 (CH2‐C21), 31.1 (CH2‐C31), 30.3 (CH2‐C32), 27.6 
(CH2‐22), 26.0 (CH3‐
tBuSi), 22.7 (CH2‐C33), 18.4 (C‐
tBuSi), 14.2 (CH3‐C34), 12.0 (CH3‐
C40), 7.0 (CH3‐EtSi), 5.1 (CH2‐EtSi), −4.9 (CH3‐MeSi), −4.9 (CH3‐MeSi); HRMS (EI+) [M]
+ 
calcd for C39H68O5Si2 672.4605, found 672.4612, (Δ +1.0 ppm). 
tert-Butyldimethyl{[(2R,5S)-4-methylidene-5-(prop-2-en-1-yl)tetrahydrofuran-2-
yl]methoxy}silane. (423) 
 
t-BuOK (25 mL of a 2 M solution in THF, 50 mmol) was added to a suspension of 
methyltriphenylphosphonium bromide (18 g, 50 mmol) in THF (83 mL) at rt and stirred 
for 1 h. A solution of the ketone 327a (4.5 g, 17 mmol) in THF (65 mL) was added to the 
suspension of the ylide at rt and the mixture was stirred for 30 minutes. The reaction 
was quenched by the addition of H2O (100 mL) and the mixture was extracted with 
EtOAc (3 × 200 mL). The organic extracts were dried (MgSO4) and concentrated in 
vacuo, and the residue was purified by chromatography (pet. ether/EtOAc, 20:1) to 
provide the desired diene 423 (4.5 g, 100%) as a colourless oil. Rf = 0.49 (pet. 
ether/EtOAc, 20:1); [α]
22
D −53 (c = 0.99, CHCl3); νmax. (liquid film) 3078, 2954, 2929, 
2858, 1667, 1641, 1471, 1254, 1077, 834, 814, 775, cm−1; 1H NMR (400 MHz, CDCl3) δ 
5.86 (1H, ddt, J = 17.1, 10.2, 6.9 Hz, CH‐C1), 5.14–5.04 (2H, m, CH2-C1’), 5.00 (1H, q, J 
= 2.2 Hz, CH‐C35), 4.86 (1H, q, J = 2.2 Hz, CH‐C35), 4.50–4.43 (1H, m, CH‐C3), 4.18–
4.11 (1H, m, CH‐C6), 3.64 (1H, dd, J = 10.4, 4.6 Hz, CH‐C7), 3.53 (1H, dd, J = 10.4, 6.1 
Hz, CH‐C7), 2.69–2.61 (1H, m, CH‐C5), 2.54–2.46 (1H, m, CH‐C5), 2.41–2.25 (2H, m, CH2‐
C2), 0.88 (9H, s, CH3-
tBuSi), 0.05 (6H, s, CH3-MeSi); 
13C NMR (100 MHz, CDCl3) δ 150.8 
(C‐C4), 134.8 (CH‐C1), 117.2 (CH2‐C1’), 105.2 (CH2‐C35), 80.1 (CH‐C3), 78.1 (CH‐C6), 
65.5 (CH2‐C7), 40.3 (CH2‐C2), 35.2 (CH2‐C5), 26.0 (CH3‐
tBuSi), 18.5 (C‐tBuSi), −5.2 (CH3‐
 Chapter 3: Experimental Section 
 
200 
 
MeSi); HRMS (CI+, isobutane) calcd for C15H29O2Si [M+H]
+ 269.1937, found 269.1933 (Δ 
−1.3 ppm). Anal. calcd for C15H28O2Si C 67.11%, H 10.51%, found C 67.10%, H 10.57%. 
3-[(2S,5R)-5-{[(tert-Butyldimethylsilyl)oxy]methyl}-3-methylidenetetrahydrofuran-
2-yl]propane-1,2-diol. (424) 
 
OsO4 (0.88 mL of a 4% aqueous solution, 0.15 mmol) was added to a solution of diene 
423 (2.2 g, 8.2 mmol) and NMO (1.2 g, 10 mmol) in a mixture of THF (100 mL) and H2O 
(11 mL), and the mixture was stirred for 16 h at rt. The reaction was quenched by the 
addition of solid Na2SO3 (3.2 g) and the mixture was allowed to stir for 30 minutes 
before being partitioned between CH2Cl2 (125 mL) and H2O (100 mL). The organic phase 
was extracted with CH2Cl2 (2 × 100 mL), dried (MgSO4)and concentrated. The residue 
was purification by chromatography (pet. ether/EtOAc, 1:1 to 1:3) to give a 
diasteromeric mixture of diols 424 (1.6 g, 64%, dr = 1:1) as a colourless oil. Analyses 
were conducted on a diastereomeric mixture of C-1 alcohols. Rf = 0.21 (pet. 
ether/EtOAc, 1:1); νmax. (liquid film) 3387, 3078, 2954, 2931, 2862, 1667, 1249, 1072, 
833, 779, cm−1; 1H NMR (400 MHz, CDCl3) δ 5.03 (0.5H, q, J = 2.2 Hz, CH‐C35), 5.01 
(0.5H, q, J = 2.2 Hz, CH‐C35), 4.86 (0.5H, q, J = 2.2 Hz, CH‐C35), 4.84 (0.5H, q, J = 2.3 
Hz, CH‐C35), 4.71–4.62 (1H, m, CH‐C3), 4.23–4.15 (1H, m, CH‐C6), 4.03–3.91 (1H, m, 
CH‐C1), 3.87 (0.5H, d, J = 1.6 Hz, OH‐C1), 3.69–3.50 (4H, m, CH2‐C1’ and CH2‐C7), 3.15 
(0.5H, d, J = 4.1 Hz, OH‐C1), 2.73–2.60 (1H, m, CH2‐C5), 2.58–2.45 (1H, m, CH2‐C5), 
2.37 (0.5H, t, J = 5.9 Hz, OH‐C1’), 2.20 (0.5H, t, J = 6.2 Hz, OH‐C1’), 1.92 (0.5H, dd, J = 
8.2, 3.3 Hz, CH‐C2), 1.88 (0.5H, dd, J = 8.2, 3.3 Hz, CH‐C2), 1.78–1.63 (1.5H, m), 0.89 
(4.5H, s, CH3-
tBuSi), 0.88 (4.5H, s, CH3-
tBuSi), 0.06 (3H, s, CH3-MeSi), 0.05 (3H, s, CH3-
MeSi); 13C NMR (100 MHz, CDCl3) δ 150.8 (C‐C4), 150.5 (C‐C4), 105.4 (CH‐C35), 105.3 
(CH‐C35), 80.3 (CH‐C3), 78.4 (CH‐C6), 78.4 (CH‐C6), 78.2 (CH‐C3), 71.6 (CH‐C1), 70.0 
(CH‐C1), 67.0 (CH2‐C1’), 66.6 (CH2‐C1’), 65.4 (CH2‐C7), 65.3 (CH2‐C7), 38.3 (CH2‐C2), 
37.7 (CH2‐C2), 34.9 (CH2‐C5), 34.5 (CH2‐C5), 26.0 (CH3‐
tBuSi), 18.4 (C‐tBuSi), −5.2 (CH3‐
MeSi); HRMS (CI+, isobutane) calcd for C15H31O4Si [M+H]
+ 303.1991, found 303.1996 (Δ 
+1.4 ppm). Anal. calcd for C15H30O4Si C 59.56%, H 10.00%, found C 59.26%, H 9.95%. 
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2-[(2S,5R)-5-{[(tert-Butyldimethylsilyl)oxy]methyl}-3-methylidenetetrahydrofuran-
2-yl]acetaldehyde. (425) 
 
Sodium periodate (3.5 g, 16 mmol) was added to a stirred solution of the diol 424 (2.5 
g, 8.3 mmol) in a mixture of THF (141 mL) and H2O (35 mL) and the mixture was stirred 
for 1.5 h at rt. The mixture was diluted with H2O and extracted with Et2O (2 × 75 mL). 
The organic extracts were dried (MgSO4) and concentrated, and the resulting crude 
aldehyde was used in the following step. A small sample was purified by chromatography 
(pet. ether/EtOAc, 4:1) for characterization purposes. νmax. (liquid film) 2953, 2931, 
2894, 2857, 1666, 1727, 1254, 1076, 836, 775, cm−1; 1H NMR (400 MHz, CDCl3) δ 9.79 
(1H, t, J = 2.3 Hz, CH–C1), 5.06 (1H, q, J = 2.2 Hz, CH–C35), 4.93–4.88 (1H, m, CH-C3), 
4.87 (1H, q, J = 2.2 Hz, CH–C35), 4.18 (1H, dddd, J = 7.3, 5.6, 5.2, 4.5 Hz, CH–C6), 3.64 
(1H, dd, J = 10.6, 4.5 Hz, CH–C7), 3.60 (1H, dd, J = 10.6, 5.2 Hz, CH–C7), 2.73–2.64 (3H, 
m, CH2–C2 and CH–C5), 2.62–2.54 (1H, m, CH–C5), 0.88 (9H, s, CH3-
tBuSi), 0.05 (3H, s, 
CH3-MeSi), 0.05 (3H, s, CH3-MeSi); 
13C NMR (100 MHz, CDCl3) δ 201.3 (C–C1), 150.3 (C–
C4), 105.9 (CH2–C35), 78.5 (CH–C6), 75.8 (CH–C3), 65.5 (CH2–C7), 49.3 (CH2–C5), 34.7 
(CH2–C2), 26.0 (CH3‐
tBuSi), 18.5 (C‐tBuSi), −5.2 (CH3‐MeSi), −5.2 (CH3‐MeSi). 
2-[(2S,5R)-5-{[(tert-Butyldimethylsilyl)oxy]methyl}-3-methylidenetetrahydrofuran-
2-yl]ethan-1-ol. (426) 
 
 
The crude aldehyde 425 was dissolved in wet EtOH (92 mL) and solid NaBH4 (0.33 g, 8.7 
mmol) was added. The mixture was stirred for 1 h at rt, concentrated and then 
partitioned between CH2Cl2 (50 mL) and H2O (50 mL). The phases were separated and 
the aqueous phase was extracted with further CH2Cl2 (2 × 25 mL). The combined organic 
extracts were dried (MgSO4) and concentrated. The residue was purified by 
chromatography (pet. ether/EtOAc, 3:1) to provide the alcohol 426 (1.8 g, 80% over two 
steps) as a colourless oil. Rf = 0.19 (pet. ether/EtOAc, 4:1); [α]
26
D −42.8 (c = 1.00, CHCl3); 
νmax. (liquid film) 3426, 3078, 2931, 2855, 1667, 1466, 1249, 1065, 833, 772 cm
−1; 1H 
NMR (400 MHz, CDCl3) δ 5.01 (1H, q, J = 2.2 Hz, CH–C35), 4.84 (1H, q, J = 2.2 Hz, CH–
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C35), 4.65–4.59 (1H, m, CH–C3), 4.17 (1H, dddd, J = 7.1, 6.1, 5.1, 5.0 Hz, CH–C6), 3.88–
3.76 (2H, m, CH2–C1), 3.63 (1H, dd, J = 10.6, 5.0 Hz, CH2–C7), 3.59 (1H, dd, J = 10.6, 
5.1 Hz, CH2–C7), 2.84 (1H, dd, J = 7.0, 4.2 Hz, OH–C1), 2.69–2.61 (1H, m, CH–C5), 2.55–
2.47 (1H, m, CH–C5), 1.89–1.74 (2H, m, CH2–C2), 0.88 (9H, s, CH3‐
tBuSi), 0.05 (6H, s, 
CH3-MeSi); 
13C NMR (100 MHz, CDCl3) δ 151.0 (C–C4), 105.1 (CH2–C35), 81.0 (CH–C6), 78.2 
(CH–C3), 65.3 (CH2–C7), 61.7 (CH2–C1), 37.1 (CH–C2), 34.8 (CH2–C5), 26.0 (CH3‐
tBuSi), 
18.4 (C‐tBuSi), −5.2 (CH3‐MeSi); HRMS (CI+, isobutane) calcd for C14H29O3Si [M+H]
+ 
273.1886, found 273.1885 (Δ −0.4 ppm); Anal. calcd for C14H28O3Si C 61.72%, H 10.36%, 
found C 61.71%, H 10.41%. 
2-[(2S,3R,5R)-5-{[(tert-Butyldimethylsilyl)oxy]methyl}-3-methyltetrahydrofuran-2-
yl]ethan-1-ol.21 (433) 
 
Crabtree’s catalyst (0.25 g, 0.27 mmol) was dissolved in CH2Cl2 (160 mL) under an 
atmosphere of argon. The argon was evacuated and replaced with H2; purging/H2 
replacement was repeated twice more. The mixture stirred for under the hydrogen 
atmosphere until a visible lessening in color intensity was observed (~10 min), at which 
point the alkene 426 (1.00 g, 3.67 mmol) in CH2Cl2 (6 mL) was added dropwise to the 
solution of the catalyst. After 2 h, an aliquot (0.3 mL) was removed from the reaction 
vessel, dried in vacuo and analyzed by 1H NMR to ensure that alkene reduction had 
occurred. The reaction mixture was used directly in the following step; an aliquot was 
purified for characterization purposes. Rf = 0.21 (pet. ether/EtOAc, 4:1); [α]
25
D −14.0 (c = 
1.01, CHCl3). νmax. (liquid film) 3425, 2956, 2928, 2903, 2857, 1473, 1251, 1103, 1049, 
938, 833, 814, 774 cm−1; 1H NMR (500 MHz, CDCl3) δ 4.08 (1H, ddt, J = 9.1, 6.6, 4.7 Hz, 
CH-C6), 3.83–3.74 (2H, m, CH2-C1), 3.62 (2H, d, J = 4.7 Hz, CH2-C7), 3.57 (1H, td, J = 
9.1, 2.8 Hz, CH-C3), 2.82 (1H, dd, J = 7.0, 4.0 Hz, OH–C1),  2.10 (1H, dt, J = 12.2, 6.6 
Hz, CH2-C5), 1.95–1.88 (1H, m, CH-C4), 1.88–1.82 (1H, m, CH2-C2), 1.65 (1H, dddd, J = 
14.0, 9.1, 8.0, 4.7 Hz, CH2-C2), 1.41 (1H, ddd, J = 12.2, 10.9, 9.1 Hz, CH2-C5), 1.02 (3H, 
d, J = 6.5 Hz, CH3-C35), 0.91 (9H, s, CH3‐
tBuSi), 0.07 (6H, s, CH3-MeSi); 
13C NMR (125 
MHz, CDCl3) δ 86.0 (CH-C3), 79.1 (CH-C6), 66.2 (CH2-C7), 62.0 (CH2-C1), 40.4 (CH-C4), 
37.0 (CH2-C5), 35.7 (CH2-C2), 26.1 (CH3‐
tBuSi), 18.5 (C‐tBuSi), 16.2 (CH3 –C35), −5.1 
(CH3‐MeSi), −5.2 (CH3‐MeSi); HRMS (CI+, isobutane) calcd for C14H31O3Si [M+H]
+ 275.2042, 
found 275.2041 (Δ −0.5 ppm).   
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tert-Butyl({[(2R,4R,5S)-5-{2-[(tert-butyldiphenylsilyl)oxy]ethyl}-4-
methyltetrahydrofuran-2-yl]methoxy})dimethylsilane. (434) 
 
The H2 amosphere was replaced with argon before the sequential addition of Et3N (0.47 
mL, 3.39 mmol), TBDPSCl (1.05 mL, 4.03 mmol) and DMAP (0.12 g, 0.94 mmol). The 
resulting mixture was stirred for 36 h at rt and then concentrated. The residue was 
partitioned between CH2Cl2 (50 mL) and 1 M aqueous HCl (50 mL), the phases were 
separated and the organic extracts were further extracted with CH2Cl2 (50 mL). The 
combined organic layers were dried (MgSO4) and concentrated. The reaction mixture 
was used directly in the following step; an aliquot was purified for characterization 
purposes. Rf = 0.55 (pet. ether/EtOAc, 4:1); [α]
24
D −12.8 (c = 1.02, CHCl3); νmax. (liquid 
film) 2955, 2929, 2885, 2857, 1472, 1428, 1252, 1107, 834, 776, 737, 700 cm−1; 1H NMR 
(400 MHz, CDCl3) δ 7.69–7.65 (4H, m, CH-PhSi), 7.44–7.34 (6H, m, CH-PhSi), 3.98 (1H, 
ddt, J = 9.0, 6.3, 5.0 Hz, CH-C6), 3.87–3.75 (2H, m, CH2-C1), 3.62 (1H, dd, J = 10.5, 5.0 
Hz, CH-C7), 3.55 (1H, dd, J = 10.5, 5.0 Hz, CH-C7), 3.53 (1H, dd, J = 8.7, 3.2 Hz, CH–
C3), 2.10 (1H, dt, J = 12.2, 6.7 Hz, CH-C5), 1.90–1.78 (2H, m, CH-C4 and CH–C2), 1.72–
1.62 (1H, m, CH-C2), 1.36 (1H, ddd, J = 12.2, 10.8, 9.0 Hz, CH-C5), 1.04 (9H, s, CH3‐
tBuSi), 1.00 (3H, d, J = 6.5 Hz, CH3-C35), 0.88 (9H, s, CH3‐
tBuSi), 0.04 (6H, s, CH3-MeSi); 
13C NMR (100 MHz, CDCl3) δ 135.7 (CH–PhSi), 134.3 (C–PhSi), 134.2 (C–PhSi), 129.6 (CH–
PhSi), 127.7 (CH–PhSi), 82.3 (CH–C3), 78.5 (CH–C6), 66.4 (CH2–C7), 61.6 (CH2–C1), 40.0 
(CH–C4), 37.7 (CH2–C5), 37.3 (CH2–C2), 27.0 (CH3‐
tBuSi), 26.1 (CH3‐
tBuSi), 19.3 (C‐tBuSi), 
18.5 (C‐tBuSi), 16.5 (CH3-C35), −5.0 (CH3‐MeSi), −5.1 (CH3‐MeSi); Anal. calcd for 
C30H48O3Si2 C 70.26%, H 9.43% found C 70.38%, H 9.56%. 
[(2R,4R,5S)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}-4-methyltetrahydrofuran-2-
yl]methanol. (435) 
 
The crude bis-silyl ether 434 was dissolved in a mixture of CH2Cl2 (50 mL) and MeOH (50 
mL) and cooled to −10 °C. Solid CSA (0.16 g, 0.68 mmol) was added and the resulting 
mixture was stirred for 3 h. The reaction was quenched by the addition of Et3N (0.40 
mL, 2.9 mmol) and warmed to rt. The volatiles were removed in vacuo and the residue 
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was purified by flash chromatography (pet. ether/EtOAc, 9:1 to 3:1) to provide the 
alcohol 435 (0.98 g, 66% over 3 steps). Rf = 0.22 (pet. ether/EtOAc, 3:1); [α]
24
D −17.4 (c = 
1.00, CHCl3); νmax. (liquid film) 3435, 2956, 2930, 2857, 1473, 1427, 1111, 1083, 823, 
737, 700 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.70–7.65 (4H, m, CH-PhSi), 7.45–7.35 (6H, m, 
CH-PhSi), 4.03 (1H, dtd, J = 9.3, 6.3, 3.2 Hz, CH–C6), 3.86–3.77 (2H, m, CH2-C1), 3.61 
(1H, ddd, J = 11.5, 7.1, 3.2 Hz, CH–C7), 3.58 (1H, td, J = 8.8, 3.1 Hz, CH-C3), 3.49–3.41 
(1H, m, CH–C7), 2.10–2.02 (1H, m, CH-C5), 1.96–1.80 (2H, m, CH-C4 and CH–C2), 1.70–
1.60 (1H, m, CH-C2), 1.33 (1H, ddd, J = 12.1, 10.7, 9.3 Hz, CH-C5), 1.05 (9H, s, CH3‐
tBuSi), 1.02 (3H, d, J = 6.5 Hz, CH3-C35); 
13C NMR (100 MHz, CDCl3) δ 135.7 (CH–PhSi), 
134.1 (C-PhSi), 134.1 (C-PhSi), 129.7 (CH–PhSi), 127.8 (CH–PhSi), 82.1 (CH-C3), 78.4 (CH-
C6), 65.4 (CH2-C7), 61.3 (CH2–C1), 40.2 (CH-C4), 37.2 (CH2–C2), 36.7 (CH2-C5), 27.0 
(CH3‐
tBuSi), 19.4 (C–tBuSi), 16.5 (CH3-C35); HRMS (CI+, isobutane) calcd for C24H35O3Si 
[M+H]+ 399.2355, found 399.2354, (Δ −0.5 ppm). 
(2R,4R,5S)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}-4-methyltetrahydrofuran-2-
carbaldehyde. (436) 
 
Dess-Martin periodinane (96 mg, 0.22 mmol) was added to a solution of alcohol 435 (45 
mg, 0.11 mmol) in CH2Cl2 (6 mL) at rt and the reaction mixture was stirred for 2 hours at 
rt. The reaction was quenched by the addition of saturated aqueous NaHCO3 (5 mL) and 
the mixture was extracted with CH2Cl2 (2 x 5 mL). The combined organic extracts were 
dried (MgSO4), concentrated and used crude in the following step.
1H NMR (400 MHz, 
CDCl3) δ 9.62 (1H, d, J = 2.2 Hz, CH‐C7), 7.70–7.65 (4H,m, CH‐PhSi), 7.45 – 7.36 (6H, m, 
CH‐PhSi), 4.22 (1H, td, J = 8.2, 2.2 Hz, CH‐C6), 3.85 (2H, dd, J = 7.3, 5.4 Hz, CH2‐C1), 
3.69 (1H,td, J = 8.5, 3.2 Hz, CH‐C3), 2.33 (1H, dt, J = 12.6, 7.6 Hz, CH-C5), 1.99–1.83 
(3H, m, CH2‐C2 and CH‐C4), 1.60–1.52 (1H, m, CH-C5), 1.05 (9H, s, CH3‐
tBuSi), 1.03 (3H, 
d, J = 6.6 Hz, CH3‐C35); 
13C NMR (100 MHz, CDCl3) δ 203.4 (C‐C7), 135.7 (CH‐PhSi), 135.7 
(CH‐PhSi), 134.0 (C‐PhSi), 133.9 (C‐PhSi), 129.7 (CH‐PhSi), 127.8 (CH‐PhSi), 84.0 (CH‐
C3), 81.8 (CH‐C6), 61.1 (CH2‐C1), 39.4 (CH‐C4), 36.8 (CH2‐C2), 36.2 (CH2‐C5), 27.0 (CH3‐
tBuSi), 19.4 (C‐ tBuSi), 16.4 (CH3‐C35). 
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Methyl (2Z)-3-[(2R,4R,5S)-5-{2-[(tert-butyldiphenylsilyl)oxy]ethyl}-4-
methyltetrahydrofuran-2-yl]prop-2-enoate. (437) 
 
To a solution of methyl P,P-bis(2, 2, 2-trifluoroethyl)phosphonoacetate (23 μL, 0.11 
mmol) and 18-crown-6 (0.15 g, 0.55 mmol) in THF (1.5 mL) cooled to −78 oC was added 
a solution of KHMDS (0.18 mL of a 0.6 M solution in THF, 0.11 mmol). The reaction 
mixture was stirred for 10 minutes before the addition of the crude aldehyde 436 (0.22 
mmol) in THF (2 mL). Stirring was continued for 1 hour at −78 oC before the mixture was 
warmed to rt and quenched with aqueous saturated NH4Cl (5 mL). The mixture was 
extracted with Et2O (3 x 5 mL), dried (MgSO4) and concentrated to provide a clear oil 
containing Z/E isomers in a ratio of 99:1.The mixture was purified on SiO2 (pet. 
ether/EtOAc 30/1) to provide Z-unsaturated ester 437 (38 mg, 77%) as a clear, 
colourless oil. Rf = 0.38 (pet. ether/ EtOAc, 9:1);[α]
29
D  −6.4 (c = 2.05, CHCl3); νmax 
(liquid film) 2955, 2923, 2856, 1720, 1427, 1196, 1178, 1105, 1088, 1007, 822, 700, 613 
cm−1;  1H NMR (500 MHz, CDCl3) δ 7.69–7.66 (4H, m, CH‐PhSi), 7.44–7.34 (6H, m, CH-
PhSi), 6.29 (1H, dd, J = 11.7, 7.3 Hz, CH-C7), 5.74 (1H, dd, J = 11.7, 1.5 Hz, CH-C8), 
5.40–5.34 (1H, m, CH-C6), 3.85–3.80 (2H, m, CH2‐C1), 3.70 (3H, s, CH3‐MeO), 3.68 (1H, 
td, J = 8.6, 3.2 Hz, CH‐C3), 2.51 (1H, dt, J = 12.1, 6.7 Hz, CH-C5), 2.00–1.89 (1H, m, 
CH-C4), 1.85 (1H, dtd, J = 13.9, 7.4, 3.2, CH-C2) 1.68 (1H, dtd, J = 13.9, 8.6, 5.5 Hz, 
CH-C2), 1.28 (ddd, J = 12.1, 10.3, 7.5 Hz, 1H, CH-C5), 1.05 (9H, s, CH3‐
tBuSi), 1.02 (3H, 
d, J = 6.5 Hz, CH3‐C35); 
13C NMR (125 MHz, CDCl3) δ 166.5 (C-C9), 152.8 (CH-C7), 135.7 
(CH‐PhSi), 134.2 (C‐PhSi), 134.2 (C‐PhSi) 129.6 (CH‐PhSi), 127.8 (CH‐PhSi), 118.3 (CH‐
C8), 82.6 (CH‐C3), 74.9 (CH‐C6), 61.4 (CH2‐C1), 51.4 (CH3‐OMe), 41.5 (CH2‐C5), 40.1 
(CH‐C4), 37.2 (CH2‐C2), 27.0 (CH3‐
tBuSi), 19.4 (C‐tBuSi), 16.6 (CH3‐C35); HRMS (CI+, 
isobutane) [M+H]+ calcd for  C27H37O4Si 453.2461, found 453.2462 (Δ +0.1 ppm); LRMS 
(CI+, isobutane) m/z (intensity); 453.5 (76%), 375.4 (100%). 
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Methyl (2E)-3-[(2R,4R,5S)-5-{2-[(tert-butyldiphenylsilyl)oxy]ethyl}-4-
methyltetrahydrofuran-2-yl]prop-2-enoate. 
 
The E isomer was isolated from mixtures resulting from the reaction of aldehyde 436 
and methyl (triphenylphosphoranylidene)acetate (Scheme 104). Rf = 0.25 (pet. ether/ 
EtOAc, 9:1);[α] 24D  +9.8 (c = 2.15, CHCl3); νmax (liquid film) 2955, 2929, 2857, 1724, 
1427, 1269, 1109, 1088, 823, 700, 613 cm−1;  1H NMR (500 MHz, CDCl3) δ 7.71–7.67 
(4H,m, CH‐PhSi), 7.47–7.31 (6H, m, CH‐ PhSi), 6.92 (1H, dd, J = 15.6, 5.2 Hz, CH–C7), 
6.02 (1H, dd, J = 15.6, 1.5 Hz, CH‐C8), 4.55–4.49 (1H, m, CH‐C6), 3.83 (2H, dd, J = 7.4, 
5.5 Hz, CH2‐C1), 3.74 (3H, s, CH3‐OMe), 3.68 (1H, td, J = 8.8, 3.1 Hz, CH‐C3), 2.30 (1H, 
dt, J = 12.1, 6.7 Hz, CH‐C5), 1.94 (1H, ddt, J = 10.4, 8.8, 6.7 Hz, CH‐C4), 1.87 (1H, dtd, 
J = 13.9, 7.4, 3.1 Hz, CH‐C2), 1.67 (1H, ddt, J = 13.9, 8.6, 5.4 Hz, CH‐C2), 1.42–1.34 
(1H, m, CH‐C5), 1.05 (9H, s, CH3-
tBuSi), 1.02 (3H, d, J = 6.5 Hz, CH3‐C35); 
13C NMR (125 
MHz, CDCl3) δ 166.9 (C‐C9), 149.5 (CH‐C7), 135.7 (CH‐ PhSi), 134.2 (C‐PhSi), 134.2 (C‐
PhSi), 129.7 (CH‐PhSi), 127.8 (CH‐PhSi), 119.3 (CH‐C8), 82.7 (CH‐C3), 76.7 (CH‐C6), 61.2 
(CH2‐C1), 51.7 (CH3‐OMe), 41.4 (CH2‐C5), 40.4 (CH‐C4), 37.2 (CH2‐C2), 27.0 (CH3‐
tBuSi), 
19.4 (C-tBuSi), 16.4 (CH3‐C35); HRMS (CI+, isobutane) [M+H]
+ calcd for  C27H37O4Si 
453.2461, found 453.2465 (Δ +0.8 ppm); LRMS (CI+, isobutane) m/z 
(intensity); 453.5 (26%), 375.4 (100%).
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Methyl (2S,3R)-3-[(2R,4R,5S)-5-{2-[(tert-butyldiphenylsilyl)oxy]ethyl}-4-
methyltetrahydrofuran-2-yl]-2,3-dihydroxypropanoate. (440) 
Methyl (2R,3S)-3-[(2R,4R,5S)-5-{2-[(tert-butyldiphenylsilyl)oxy]ethyl}-4-
methyltetrahydrofuran-2-yl]-2,3-dihydroxypropanoate. (441) 
 
OsO4 (5.0 μL of a 4% aqueous solution 0.86 μmol) was added to a solution of α,β-
unsaturated ester 437 (19 mg, 0.043 mmol) and NMO (6.1 mg, 0.051 mmol) in a solution 
of in THF (1 mL) and H2O (0.1 mL). The mixture was stirred for 3 days at rt and 
quenched by the addition of solid Na2SO3 (22 mg). On stirring for 30 minutes the solution 
was diluted with CH2Cl2 (3 mL) and H2O (2 mL), the organic phase isolated and the 
aqueous phase back-extracted with further CH2Cl2 (2 × 5 mL). The solution was dried 
(MgSO4), filtered and concentrated before purification by chromatography (pet. 
ether/EtOAc, 3:1) to afford 7,8-anti diols 440 (9 mg, 43%) and 441 (8 mg, 38%) both as 
clear oils. 
440: Rf = 0.29 (pet. ether/EtOAc, 2:1);[α]
25
D  −16.8 (c = 1.15, CHCl3); νmax (liquid film) 
3464, 2955, 2930, 2858, 1739, 1429, 1269, 1107, 1082, 823, 738 cm−1;  1H NMR (400 
MHz, CDCl3) δ 7.69–7.62 (4H, m, CH‐PhSi), 7.44 –7.35 (6H, m, CH‐PhSi), 4.26 (1H, dd, J = 
9.4, 4.2 Hz, CH-C8), 4.00 (1H, ddd, J = 9.7, 6.1, 3.6 Hz, CH-C6), 3.80–3.76 (2H, m, CH2‐
C1), 3.74 (3H, s, CH3‐MeO), 3.74–3.68 (1H, m, CH-C7), 3.61 (1H, td, J = 8.8, 3.0 Hz, CH-
C3), 3.27 (1H, d, J = 9.4 Hz, OH-C8), 2.62 (1H, d, J = 8.2 Hz, OH-C7), 2.10 (1H, dt, J = 
12.3, 6.1 Hz, CH-C5), 1.93–1.78 (2H, m, CH-C2 and CH-C4), 1.65 –1.56 (2H, m, CH-C2 
and CH-C5), 1.04 (9H, s, CH3‐
tBuSi), 1.02 (3H, d, J = 6.5 Hz, CH3‐C35); 
13C NMR (100 
MHz, CDCl3) δ 172.9 (C-C9), 135.7 (CH‐PhSi), 134.0 (C‐PhSi), 134.0 (C‐PhSi), 129.8 (CH‐
PhSi), 129.8 (CH‐PhSi), 127.8 (CH‐PhSi), 127.8 (CH‐PhSi), 83.3 (CH‐C3), 77.8 (CH‐C6), 
73.7 (CH-C7), 73.6 (CH-C8), 61.2 (CH2-C1), 52.5 (CH3-MeO), 39.9 (CH-C4), 37.4 (CH2-C5), 
37.1 (CH2-C2), 27.0 (CH3‐
tBuSi), 19.3 (C‐tBuSi), 16.2 (CH3‐C35); HRMS (CI+, isobutane) 
 Chapter 3: Experimental Section 
 
208 
 
calcd for C27H39O6Si [M+H]
+ 487.2516, found 487.2517 (Δ +0.2 ppm); LRMS (CI+, 
isobutane) m/z (intensity); 487.4 (100%), 409.4 (40%), 375.4 (26%), 331.3 (53%). 
441: Rf = 0.18 (pet. ether/EtOAc, 2:1);[α]
25
D  −23.6 (c = 0.95, CHCl3); νmax (liquid film) 
3441, 2955, 2929, 2857, 1738, 1429, 1259, 1225, 1107, 1084, 822, 736 cm−1;  1H NMR 
(400 MHz, CDCl3) δ 7.68–7.63 (4H, m, CH‐PhSi), 7.45–7.35 (6H, m, CH‐PhSi), 4.34-4.25 
(1H, m, CH-C8), 3.99 (1H, ddd, J = 9.0, 7.8, 6.4 Hz, CH-C6), 3.80–3.68 (3H, m, CH2-C1 
and CH-C7), 3.67 (3H, s, CH3-MeO), 3.51 (1H, td, J = 8.8, 3.1 Hz, CH-C3), 3.21 (1H, d, J 
= 5.3 Hz, OH-C7), 2.38 (1H, d, J = 7.2 Hz, OH-C8), 2.25 (1H, dt, J = 12.7, 6.4 Hz, CH-
C5), 1.92–1.83 (1H, m, CH-C4), 1.83–1.72 (1H, m, CH-C2), 1.66–1.47 (2H, m, CH-C2 and 
CH-C5), 1.04 (9H, s, CH3‐
tBuSi), 1.01 (3H, d, J = 6.5 Hz, CH3‐C35); 
13C NMR (100 MHz, 
CDCl3) δ 173.1 (C-C9), 135.7 (CH‐PhSi), 135.7 (CH‐PhSi), 134.1 (C‐PhSi), 129.7 (CH‐PhSi), 
127.8 (CH‐PhSi), 82.8 (CH‐C3), 77.3 (CH‐C6), 75.5 (CH-C7), 72.7 (CH-C8), 61.4 (CH2‐C1), 
52.6 (CH3-MeO), 40.1 (CH-C4), 38.7 (CH2-C5), 37.2 (CH2-C2), 27.0 (CH3‐
tBuSi), 19.3 (C‐
tBuSi), 16.4 (CH3‐C35); HRMS (CI+, isobutane) calcd for  C27H39O6Si [M+H]
+ 487.2516, 
found 4487.2514 (Δ −0.5 ppm); LRMS (CI+, isobutane) m/z (intensity); 487.4 (88%), 
409.4 (44%), 375.4 (30%), 331.3 (100%). 
(2R,4R,5S)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}-4-methyltetrahydrofuran-2-
carboxylic acid. 
 
Dess-Martin periodinane (498 mg, 1.18 mmol) was added in a single portion to a stirred 
solution of alcohol 435 (390 mg, 0.98 mmol) in CH2Cl2 (18 mL). The mixture was stirred 
at rt for 1.5 h, quenched with saturated aqueous NaHCO3 (20 mL) and extracted with 
CH2Cl2 (2 × 25 ml). The combined organic extracts were dried (MgSO4), filtered, 
concentrated and the residue used directly in the following step. 
To a solution of aldehyde and 2-methyl-2-butene (0.83 mL, 7.8 mmol) in t-BuOH (4.8 
mL) was added dropwise a solution of NaClO2 (0.67 g, 80% purity, 6.0 mmol) and 
NaH2PO4·2H2O (1.0 g, 6.4 mmol) in H2O (9.7 mL). The mixture was stirred at rt for 1 h, 
concentrated and partitioned between CH2Cl2 (20 mL) and H2O (15 mL). The aqueous 
phase was isolated and extracted with further CH2Cl2 (20 mL). The combined organic 
extracts were dried (MgSO4) and concentrated to give the title carboxylic acid which 
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was used directly in the following step. Rf = 0.12 (pet. ether/EtOAc, 1:1); [α]
25
D +11.9 (c 
= 2.70, CHCl3); νmax. (liquid film) 3050, 2957, 2930, 2857, 1721, 1427, 1107, 1088, 937, 
823, 736, 700 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.68–7.64 (4H, m, CH-PhSi), 7.46–7.37 
(6H, m, CH-PhSi), 4.42-4.33 (1H, m, CH‐C6), 3.84–3.77 (3H, m, CH2‐C1 and CH‐C3), 2.53 
(1H, dt, J = 12.8, 7.4 Hz, CH‐C5), 2.03–1.94 (1H, m, CH‐C4), 1.87 (dtd, J = 14.4, 7.4, 3.1 
Hz, 1H, CH‐C2), 1.74–1.63 (2H, m, CH‐C2 and CH‐C5), 1.05 (9H, s, CH3‐
tBuSi), 1.04 (3H, 
d, J = 6.6 Hz, CH3‐C35); 
13C NMR (125 MHz, CDCl3) δ 174.5 (C‐C7), 135.7 (CH–PhSi), 133.8 
(C–PhSi), 133.8 (C–PhSi), 129.9 (CH‐PhSi), 129.8 (CH‐PhSi), 127.9 (CH‐PhSi), 127.8 (CH‐
PhSi), 84.4 (CH‐C3), 75.8 (CH‐C6), 60.8 (CH2‐C1), 39.9 (CH‐C4), 38.6 (CH2‐C5), 36.6 
(CH2‐C2), 27.0 (CH3‐
tBuSi), 19.3 (C‐tBuSi), 16.1 (CH3‐C35); HRMS (CI+, isobutane) calcd 
for C24H33O4Si [M+H]
+ 413.2148, found 413.2151, (Δ +0.7 ppm). 
(2R,4R,5S)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}-N-methoxy-N,4-
dimethyltetrahydrofuran-2-carboxamide. (453) 
 
To a solution of the intermediate carboxylic acid (crude 0.98 mmol) in CH2Cl2 (8 mL) was 
added sequentially DIPEA (0.48 mL, 2.7 mmol), N,O-dihydroxylamine hydrochloride 
(0.12 g, 1.3 mmol) and HBTU (0.55 g, 1.3 mmol). The resulting mixture was stirred for 
19 h at rt and the reaction was quenched with 1 M HCl (10 mL). The mixture was 
extracted with CH2Cl2 (2 × 20 mL) and the organic phases were combined and washed 
with brine (20 mL), then dried (MgSO4) and concentrated. Purification of the residue by 
chromatography (pet. ether/EtOAc, 9:1 to 4:1) afforded the desired the Weinreb amide 
453 (0.33 g, 75% over three steps) as a colourless oil. Rf = 0.16 (pet. ether/EtOAc, 3:1). 
[α]
23
D −10.3 (c = 1.24, CHCl3). νmax. (liquid film) 3050, 2958, 2933, 2857, 1672, 1467, 
1427, 1109, 1089, 740, 705, 613 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.69–7.64 (4H, m, CH-
PhSi), 7.43–7.33 (6H, m, CH-PhSi), 4.79–4.70 (1H, m, CH‐C6), 3.90–3.78 (2H, m, CH2‐C1), 
3.73 (1H, td, J = 8.5, 3.5 Hz, CH‐C3), 3.64 (3H, s, CH3‐MeO), 3.18 (3H, s, CH3‐MeN), 2.34 
(1H, dt, J = 12.2, 7.4 Hz, CH‐C5), 1.96–1.85 (2H, m, CH‐C4 and CH‐C2), 1.80–1.70 (2H, 
m, CH‐C2 and CH‐C5), 1.04 (9H, s, CH3‐
tBuSi), 1.03 (3H, d, J = 6.5 Hz, CH3‐C35); 
13C NMR 
(125 MHz, CDCl3) δ 174.1 (C‐C7), 135.7 (CH‐PhSi), 135.6 (CH‐PhSi), 134.2 (C‐PhSi), 134.0 
(C‐PhSi), 129.6 (CH‐PhSi), 127.7 (CH‐PhSi), 127.7 (CH‐PhSi), 83.5 (CH‐C3), 74.2 (CH‐C6), 
61.5 (CH2‐C1), 61.5 (CH3‐MeO), 39.7 (CH‐C4), 38.1 (CH2‐C5), 36.8 (CH2‐C2), 32.5 (CH3‐
MeN), 27.0 (CH3‐
tBuSi), 19.3 (C‐tBuSi), 16.1 (CH3‐C35); HRMS (CI+, isobutane) calcd for 
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C26H38NO4Si [M+H]
+ 456.2570, found 456.2571 (Δ +0.2 ppm).  
1-[(2R,4R,5S)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}-4-methyltetrahydrofuran-2-
yl]prop-2-en-1-one. (454) 
 
To a solution of Weinreb amide 453 (2.5 g, 5.5 mmol) in THF (150 mL) at −78 °C was 
added dropwise vinylmagnesium bromide (7.2 mL of a 1 M solution in THF, 7.2 mmol). 
The mixture was stirred for 1 h and the reaction was then quenched by the addition of 
1 M aqueous HCl (75 mL). The mixture was allowed to warm slowly to rt and the organic 
component was extracted with CH2Cl2 (3 × 100 mL). The combined organic extracts 
were washed with brine (150 mL), dried (MgSO4) and then concentrated. Purification of 
the residue by chromatography (pet. ether/EtOAc, 9:1) afforded the title enone 454 
(2.2 g, 86%) as a colourless oil. Rf = 0.16 (pet. ether/EtOAc, 20:1); [α]
25
D +20.5 (c = 1.50, 
CHCl3); νmax. (liquid film) 3071, 2932, 2862, 1697, 1612, 1466, 1427, 1396, 1103, 702, 
609 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.70–7.66 (4H, m, CH-PhSi), 7.45–7.35 (6H, m, CH-
PhSi), 6.74 (1H, dd, J = 17.5, 10.6 Hz, CH‐C8), 6.38 (1H, dd, J = 17.5, 1.7 Hz, CH‐C9 
trans), 5.76 (1H, dd, J = 10.6, 1.7 Hz, CH‐C9 cis), 4.50 (1H, dd, J = 8.8, 7.6 Hz, CH‐C6), 
3.88–3.83 (2H, m, CH2‐C1), 3.72 (1H, td, J = 8.5, 3.3 Hz, CH‐C3), 2.39 (1H, dt, J = 12.5, 
7.6 Hz, CH‐C5), 2.00–1.85 (2H, m, CH‐C4 and CH‐C2), 1.70 (1H, ddt, J = 13.9, 8.5, 5.4 
Hz, CH‐C2), 1.59 (1H, ddd, J = 12.5, 10.3, 8.8 Hz, CH-C5), 1.05 (9H, s, CH3 ‐
tBuSi), 1.02 
(3H, d, J = 6.6 Hz, CH3‐C35); 
13C NMR (100 MHz, CDCl3) δ 201.3 (C‐C7), 135.7 (CH‐PhSi), 
135.7 (CH‐PhSi), 134.1 (C‐PhSi), 134.0 (C‐PhSi), 131.6 (CH‐C8), 129.7 (CH‐PhSi), 129.7 
(CH2‐C9), 127.8 (CH‐PhSi), 83.7 (CH‐C3), 81.6 (CH‐C6), 61.1 (CH2‐C1), 39.7 (CH‐C4), 
38.3 (CH2‐C5), 36.8 (CH2‐C2), 27.0 (CH3‐
tBuSi), 19.4 (C‐tBuSi), 16.3 (CH3‐C35); HRMS 
(CI+, isobutane) calcd for C26H35O3Si [M+H]
+ 423.2355, found 423.2359 (Δ +0.9 ppm). 
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(1R)-1-[(2R,4R,5S)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}-4-
methyltetrahydrofuran-2-yl]prop-2-en-1-ol. (455) 
 
To a solution of enone 454 (0.26 g, 0.63 mmol) and CeCl3.7H2O (0.25 g, 0.68 mmol) in 
MeOH (63 mL) at −78 °C was added solid NaBH4 (26 mg, 0.68 mmol) in a single portion. 
The mixture was stirred for 1 h at −78 °C and then warmed to rt and concentrated in 
vacuo. The residue was partitioned between CH2Cl2 (20 mL) and H2O (20 mL), the 
organic phase isolated and the aqueous phase was extracted with further CH2Cl2 (2 × 20 
mL). The combined organic extracts were washed with brine (30 mL), dried (MgSO4) and 
concentrated to afford the desired allylic alcohol 455 (0.27 g, 99%, dr > 9:1) as a 
colourless oil. Rf = 0.40 (pet. ether/EtOAc, 3:1); [α]
24
D −12.0 (c = 1.00, CHCl3); νmax. 
(liquid film) 3466, 3071, 2958, 2930, 2858, 1427, 1109, 1089, 1027, 994, 926, 823, 739, 
703 cm−1. 1H NMR (400 MHz, CDCl3) δ 7.69–7.65 (4H, m, CH-PhSi), 7.45–7.36 (6H, m, CH-
PhSi), 5.76 (1H, ddd,  J = 17.2, 10.5, 6.1 Hz, CH‐C8), 5.36 (1H, dt, J = 17.2, 1.5 Hz, CH‐
C9 trans), 5.19 (1H, dt, J = 10.5, 1.5 Hz, CH‐C9 cis), 3.93–3.87 (1H, m, CH‐C7), 3.84–
3.74 (3H, m, CH2‐C1 and CH‐C6), 3.59 (1H, td, J = 8.9, 2.9 Hz, CH‐C3), 2.48 (1H, d, J = 
3.0 Hz, OH‐C7), 2.10–2.02 (1H, m, CH‐C5), 1.95–1.82 (2H, m, CH‐C2 and CH‐C4), 1.63 
(1H, ddt, J = 13.9, 8.9, 5.2 Hz, CH‐C2), 1.32 (1H, ddd, J = 12.2, 10.8, 9.1 Hz, CH‐C5), 
1.05 (9H, s, CH3‐
tBuSi), 1.01 (3H, d, J = 6.5 Hz, CH3‐C35); 
13C NMR (125 MHz, CDCl3) δ 
136.7 (CH‐C8), 135.7 (CH‐PhSi), 134.1 (C‐PhSi), 134.0 (C‐PhSi), 129.7 (CH‐PhSi), 127.8 
(CH‐PhSi), 117.1 (CH2‐C9), 82.1 (CH‐C3), 81.0 (CH‐C6), 76.3 (CH‐C7), 61.2 (CH2‐C1), 
40.4 (CH‐C4), 37.5 (CH2‐C5), 37.0 (CH2‐C2), 27.0 (CH3‐
tBuSi), 19.4 (C‐tBuSi), 16.4 (CH3‐
C35); HRMS (CI+, isobutane) calcd for C26H37O3Si 425.2512 [M+H]
+, found 425.2509 (Δ –
0.7 ppm). 
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Mosher Analysis of Alcohol 455 
 
   Δδ SR (=δS−δR) 
 
δ S-ester 
(PPM) 
δ R-ester 
(ppm) 
ppm Hz (400 MHz) 
CH-C9 trans 5.42 5.26 0.16 +64 
CH-C9 cis 5.31 5.22 0.09 +36 
CH-C8 5.84 5.65 0.19 +76 
CH-C6 4.02 4.01 0.01 +4 
CH-C5 1.97 2.06 -0.09 -36 
CH-C5 1.23 1.29 -0.06 -24 
CH-C4 1.84 1.90 -0.06 -24 
CH3-C35 0.92 1.00 -0.08 -32 
CH-C3 3.49 3.54 -0.05 -20 
CH-C2 1.78 1.82 -0.04 -16 
CH-C2 1.62 1.66 -0.04 -16 
CH2-C1 3.75 3.76 -0.01 -4 
tBu-C1 tBuSi 1.03 1.03 0.00 0 
 
(S)-MTPA ester: 1H NMR (400 MHz, CDCl3) δ 7.68-7.63 (4H, m, CH-PhSi), 7.54–7.50 (2H, 
m, CH-Ph MTPA), 7.43–7.33 (6H, m, CH-PhSi), 7.33–7.27 (3H, m, CH-Ph MTPA), 5.84 (1H, 
ddd, J = 17.5, 10.6, 7.1 Hz, CH–C8), 5.46–5.38 (2H, m, CH–C7 and CH–C9 trans), 5.31 
(1H, d, J = 10.6 Hz, CH–C9 cis), 4.02 (1H, td, J = 9.2, 6.4 Hz, CH–C6), 3.81–3.69 (2H, m, 
CH2–C1), 3.49 (1H, dd, J = 8.9, 3.0 Hz, CH–C3), 3.46 (3H, d, J = 0.8 Hz, CH3–MeO MTPA), 
2.02–1.94 (1H, m, CH–C5), 1.87 – 1.81 (1H, m, CH–C4), 1.81–1.75 (1H, m, CH–C2), 1.67–
1.58 (1H, m, CH–C2), 1.28–1.18 (1H, m, CH–C5), 1.03 (9H, s, CH3-
tBuSi), 0.92 (3H, d, J = 
6.5 Hz, CH3–C35). 
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(R)-MTPA ester: 1H NMR (400 MHz, CDCl3) δ 7.66–7.62 (m, 4H, PhSi), 7.56–7.52 (m, 2H, 
Ph MTPA), 7.43–7.33 (6H, m, PhSi), 7.33–7.28 (3H, m, Ph MTPA), 5.65 (1H, ddd, J = 17.3, 
10.6, 6.8 Hz, CH–C8), 5.37 (1H, t, J = 7.4 Hz, CH–C7), 5.26 (1H, dt, J = 17.3, 1.2 Hz, CH–
C9 trans), 5.22 (1H, dt, J = 10.6, 1.2 Hz, CH–C9 cis), 4.05–3.97 (1H, m, CH–C6), 3.82–
3.69 (2H, m, CH2–C1), 3.54 (1H, td, J = 9.0, 2.9 Hz, CH–C3), 3.47 (3H, d, J = 1.0 Hz, CH3–
MeO MTPA), 2.10–2.01 (1H, m, CH–C5), 1.93–1.86 (1H, m, CH–C4), 1.86–1.78 (1H, m, CH–
C2), 1.71–1.60 (1H, m, CH–C2), 1.33–1.24 (1H, m, CH–C5), 1.03 (9H, s, CH3-
tBuSi), 1.00 
(3H, d, J = 6.5 Hz, CH3–C35). 
tert-Butyl({2-[(2S,3R,5R)-5-[(1R)-1-[(4-methoxyphenyl)methoxy]prop-2-en-1-yl]-3-
methyltetrahydrofuran-2-yl]ethoxy})diphenylsilane. (456) 
 
To a stirred solution of allylic alcohol 455 (0.10 g, 0.24 mmol) and p-
methoxybenzyltrichloroacetimidate (99 mg, 0.35 mmol) in CH2Cl2 (10 mL) was added 
La(OTf)3 (7.2 mg, 0.012 mmol) and the mixture stirred at rt for 6 h. The reaction was 
quenched by the addition of H2O (5 mL) and the mixture extracted with CH2Cl2 (3 × 5 
mL), washed with brine (10 mL) and dried (MgSO4). Concentration afforded a residue 
that was purified by chromatography (pet. ether/EtOAc, 98:2) to yield the title ether 
456 (0.11 g, 82%) as a colourless oil. Rf = 0.72 (pet. ether/EtOAc, 3:1); [α]
24
D −19.1 (c = 
0.98, CHCl3); νmax. (liquid film) 3071, 2956, 2931, 2857, 1612, 1513, 1246, 1108, 1084, 
1035, 999, 926, 822, 739, 703 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.70–7.65 (4H, m, CH–
PhSi), 7.43–7.33 (6H, m, CH–PhSi), 7.24 (2H, d, J = 8.7 Hz, CH‐PMB Ar), 6.81 (2H, d, J = 
8.7 Hz, CH‐PMB Ar), 5.79–5.69 (1H, m, CH‐C8), 5.30–5.24 (2H, m, CH2‐C9), 4.59 (1H, d, J 
= 11.9 Hz, CH-PMB alkyl), 4.40 (1H, d, J = 11.9 Hz, CH-PMB alkyl), 4.00 (1H, dt, J = 9.4, 
6.4 Hz, CH‐C6), 3.89–3.78 (2H, m, CH2‐C1), 3.77 (3H, s, CH3-PMB alkyl), 3.75–3.70 (1H, 
m, CH‐C7), 3.54 (1H, td, J = 8.4, 3.3 Hz, CH‐C3), 1.99 (1H, dt, J = 12.3, 6.4 Hz, CH‐C5), 
1.90–1.78 (2H, m, CH‐C2 and CH‐C4), 1.69 (1H, ddt, J = 13.7, 8.4, 5.8 Hz, CH‐C2), 1.42–
1.28 (1H, m, CH‐C5), 1.04 (9H, s, CH3‐
tBuSi), 0.98 (3H, d, J = 6.5 Hz, CH3‐C35); 
13C NMR 
(100 MHz, CDCl3) δ 159.1 (C‐PMB Ar), 135.7 (CH‐PhSi), 135.6 (CH‐C8), 134.3 (C‐PhSi), 
134.2 (C‐PhSi), 131.0 (C‐PMB Ar), 129.6 (CH‐PhSi), 129.6 (CH‐PhSi), 129.3 (CH‐PMB Ar), 
127.7 (CH‐PhSi), 118.6 (CH2‐C9), 113.8 (CH‐PMB Ar), 82.5 (CH‐C7), 82.3 (CH‐C3), 79.9 
(CH‐C6), 70.2 (CH2‐PMB alkyl), 61.6 (CH2‐C1), 55.4 (CH3‐PMB alkyl), 39.7 (CH‐C4), 37.4 
(CH2‐C5), 37.1 (CH2‐C2), 27.0 (CH3-
tBuSi), 19.4 (C‐tBuSi), 16.4 (CH3‐C35); HRMS (CI+, 
isobutane) calcd for C34H45O4Si [M+H]
+ 545.3087, found 545.3079 (Δ –1.5 ppm).  
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(2R,3R)-3-[(2R,4R,5S)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}-4-methyl 
tetrahydrofuran-2-yl]-3-[(4-methoxyphenyl)methoxy]propane-1,2-diol. (457) 
 
A solution of alkene 456 (82 mg, 0.15 mmol) and NMO (19 mg, 0.16 mmol) dissolved in a 
mixture of THF (2.0 mL) and H2O (0.2 mL) was treated with OsO4 (17 µl of a 4% aqueous 
solution, 3.0 µmol) and the solution was stirred for 18 h at rt. The reaction was 
quenched by the addition of solid Na2SO3 (60 mg) and the mixture was stirred for 30 
minutes. The mixture was extracted with CH2Cl2 (3 × 10 mL) and this was washed with 
brine (15 mL), dried (MgSO4) and concentrated. The crude residue was purified by 
chromatography (pet. ether/EtOAc, 3:1 to EtOAc) to afford the title diol 457 (76 mg, 
88%) as a viscous yellow oil. Rf = 0.21 (pet. ether/EtOAc, 1:1); [α]
23
D −1.3 (c = 0.96, 
CHCl3); νmax. (liquid film) 3404, 2954, 2931, 2855, 1612, 1514, 1247, 1105, 1084, 1035, 
823, 737, 701, 688 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.68–7.62 (4H, m, CH‐PhSi), 7.44–
7.32 (6H, m, CH‐PhSi), 7.23 (2H, d, J = 8.7 Hz, CH‐PMB Ar), 6.85 (2H, d, J = 8.7 Hz, CH‐
PMB Ar), 4.63 (1H, d, J = 11.2 Hz, CH-PMB alkyl),  4.55 (1H, d, J = 11.2 Hz, CH-PMB 
alkyl), 4.14 (1H, dt, J = 10.0, 5.5 Hz, CH‐C6), 3.82–3.74 (3H, m, CH2‐C1 and CH‐C8), 
3.79 (3H, s, CH3-PMB alkyl), 3.71–3.63 (3H, m, CH‐C3 and CH2‐C9), 3.54 (1H, t, J = 5.5 
Hz, CH‐C7), 3.28 (1H, d, J = 6.3 Hz, 1H, OH‐C8), 2.32 (1H, dd, J = 6.7, 5.8 Hz, OH‐C9), 
2.03 (1H, dt, J = 12.2, 5.5 Hz, CH‐C5), 1.94–1.77 (2H, m, CH‐C2 and CH‐C4), 1.67–1.58 
(1H, m, CH‐C2), 1.56–1.48 (1H, m, CH‐C5), 1.02 (3H, d, J = 6.5, CH3‐C35),  1.04 (9H, s, 
CH3‐
tBuSi); 13C NMR (125 MHz, CDCl3) δ 159.5 (C-PMB Ar), 135.7 (CH‐PhSi), 134.1 (C‐
PhSi), 134.0 (C‐PhSi), 130.5 (C‐PMB Ar), 129.7 (CH‐PMB Ar), 129.7 (CH‐PhSi), 127.8 (CH‐
PhSi), 114.0 (CH‐PMB Ar), 82.7 (CH‐C3), 80.5 (CH‐C7), 79.0 (CH‐C6), 73.7 (CH2‐PMB 
alkyl), 71.5 (CH‐C8), 63.9 (CH2‐C9), 61.3 (CH2‐C1), 55.4 (CH3‐PMB alkyl), 39.7 (CH‐C4), 
37.2 (CH2‐C2), 37.0 (CH2‐C5), 27.0 (CH3‐
tBuSi), 19.3 (C‐tBuSi), 16.4 (CH3‐C35); Anal. 
calcd for C34H46O6Si C 70.55%, H 8.17%, found C 70.61%, H 8.01%. 
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tert-butyl[(2R,3R)-3-[(2R,4R,5S)-5-{2-[(tert-butyldiphenylsilyl)oxy]ethyl}-4-
methyltetrahydrofuran-2-yl]-2-hydroxy-3-[(4-methoxyphenyl)methoxy] 
propoxy]dimethylsilane. (458) 
 
To a solution of diol 457 (69 mg, 0.12 mmol) in CH2Cl2 (2 mL) was added sequentially 
Et3N (25 µl, 0.18 mmol), DMAP (1.5 mg, 0.012 mmol) and TBSCl (20 mg, 0.13 mmol) and 
the mixture was stirred for 24 h at rt. The reaction was quenched with 1 M aqueous HCl 
(5 mL), extracted with CH2Cl2 (2 × 5 mL) and dried (MgSO4). On filtration and 
concentration, the residue was purified by chromatography (pet. ether/EtOAc, 99:1 to 
9:1) to yield the silyl ether 458 (44 mg, 53%) as a clear colourless oil. Rf = 0.29 (pet. 
ether: EtOAc, 9:1); [α] 23D  −8.5 (c = 1.85, CHCl3); νmax (liquid film) 3480, 2951, 2931, 
2860, 1248, 1078, 1035, 829, 699, 611 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.68–7.63 (4H, 
m, CH‐PhSi), 7.42–7.32 (6H, m, CH‐PhSi), 7.24 (2H, d, J = 8.7 Hz, CH‐PMB Ar), 6.83 (2H, 
d, J = 8.7 Hz, CH‐PMB Ar), 4.59 (2H, s, CH2‐PMB), 4.19 (1H, ddd, J = 10.0, 6.2, 4.2 Hz, 
CH‐C6), 3.85–3.76 (3H, m, CH2‐C1 and CH‐C8), 3.79 (3H, s, CH3‐PMB), 3.68 (2H,m, CH2‐
C9), 3.67-3.64 (1H, td, J = 8.6, 3.3 Hz, CH‐C3), 3.42 (1H,dd, J = 5.0, 4.2 Hz, CH‐C7), 
3.07 (1H,d, J = 5.8 Hz, OH‐C8), 2.00 (1H, dt, J = 12.0, 6.2 Hz, CH‐C5), 1.90–1.77 (2H, m, 
CH‐C2 and CH‐C4), 1.70–1.61 (1H, m, CH‐C2), 1.61–1.53 (1H, m, CH‐C5), 1.03 (9H, s, 
CH3‐
tBuSi), 1.00 (3H, d, J = 6.5 Hz, CH3‐C35), 0.88 (9H, s, CH3‐
tBuSi), 0.05 (3H,s, CH3‐
MeSi), 0.04 (3H, s, CH3‐MeSi); 
13C NMR (125 MHz, CDCl3) δ 159.3 (C-PMB Ar), 135.7 (CH‐
PhSi), 134.2 (C‐PhSi), 134.1 (C‐PhSi), 130.9 (C-PMB Ar), 129.7 (CH‐PMB Ar), 129.6 (CH‐
PhSi), 127.7 (CH‐PhSi), 113.8 (CH‐PMB Ar), 82.5 (CH‐C3), 79.6 (CH‐C7), 78.6 (CH‐C6), 
73.2 (CH2‐PMB alkyl), 72.2 (CH‐C8), 64.3 (CH2‐C9), 61.5 (CH2‐C1), 55.4 (CH3‐PMB alkyl), 
39.8 (CH‐C4), 37.3 (CH2‐C2), 37.3 (CH2‐C5),  27.0 (CH3-
tBuSi), 26.1 (CH3-
tBuSi), 19.3 (C‐
tBuSi), 18.4 (C‐tBuSi), 16.4 (CH3‐C35), −5.2 (CH3‐MeSi), −5.2 (CH3‐MeSi); HRMS (FAB, 
NOBA) calcd for C40H61O6Si2 [M+H]
+ 693.4006, found 693.4011, (Δ +0.7 ppm). 
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Mosher Ester Analysis of Alcohol 458 
 
   Δδ SR (=δS – δR) 
 
δ S-ester 
 (PPM) 
δ R-ester 
 (ppm) 
ppm 
Hz  
(500 MHz) 
CH3-C9 MeSi 0.05 0.02 0.03 +15 
CH3-C9 MeSi 0.04 0.02 0.02 +10 
CH3-C9
 tBuSi 0.85 0.83 0.02 +10 
CH-C9 4.00 3.96 0.04 +20 
CH-C9  3.87 N/A N/A NA 
CH-C7 3.43 3.61 -0.18 -90 
CH-C7 PMB-CH2 4.34 4.57 -0.23 -115 
CH-C7 PMB-CH2 4.29 4.53 -0.24 -120 
CH-C7 PMB-CH3 3.76 3.78 -0.02 -10 
CH-C7 PMB-Ar 7.03 7.17 -0.14 -70 
CH-C7 PMB-Ar 6.74 6.8 -0.06 -30 
CH-C6 3.91 4.04 -0.13 -65 
CH-C5 1.93 2.02 -0.09 -45 
CH-C5 1.45 1.51 -0.06 -30 
CH-C4 Not assignable 
CH3-C35 0.97 0.99 -0.02 -10 
CH-C3 3.55 3.57 -0.02 -10 
CH-C2 Not assignable 
CH-C2 1.62 1.64 -0.02 -10 
CH3-C1
 tBuSi 1.03 1.04 -0.01 -5 
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(S)-MTPA ester: 1H NMR (500 MHz, CDCl3) δ 7.67–7.64 (4H, m, CH-PhSi), 7.64–7.59 
(2H,m, CH-Ph MTPA), 7.43–7.31 (9H, m, CH-PhSi and CH–Ph MTPA), 7.03 (2H,d, J = 8.6 
Hz, CH-PMB Ar), 6.74 (2H, d, J = 8.6 Hz, CH-PMB Ar), 5.22 (1H, dt, J = 7.3, 3.3 Hz, CH–
C8), 4.34 (1H, d, J = 10.9 Hz, CH-PMB alkyl), 4.29 (1H, d, J = 10.9 Hz, CH–PMB alkyl), 
4.00 (1H,dd, J = 11.8, 2.8 Hz, CH–C9), 3.95-3.86 (1H, m, CH–C6), 3.87 (1H,dd, J = 11.8, 
7.3 Hz, CH–C9), 3.85–3.77 (2H, m, CH2–C1), 3.76 (3H, s, CH3-PMB alkyl), 3.62 (3H, s, CH3–
MeO MTPA), 3.55 (1H, td, J = 8.8, 2.9 Hz, CH–C3), 3.43 (1H, dd, J = 5.0, 3.3 Hz, CH–C7), 
1.93 (1H, dt, J = 11.6, 6.6 Hz, CH–C5), 1.84 –1.75 (2H, m, CH–C2 and C4), 1.66–1.58 (1H, 
m, CH–C2), 1.49–1.41 (1H, m, CH–C5), 1.03 (9H, s, CH3-
tBuSi), 0.97 (3H, d, J = 6.4 Hz, 
CH3–C35), 0.85 (9H, s, CH3 -
tBuSi), 0.05 (3H, s, CH3-MeSi), 0.04 (3H,s, CH3-MeSi). 
(R)-MTPA ester: 1H NMR (500 MHz, CDCl3) δ 7.67–7.63 (4H, m, CH-PhSi), 7.58–7.55 (2H, 
m, CH–Ph MTPA), 7.42–7.31 (9H, m, CH-PhSi and CH–Ph MTPA), 7.17 (2H, d, J = 8.6 Hz, 
CH-PMB Ar), 6.80 (2H, d, J = 8.6 Hz, CH-PMB Ar), 5.21 (1H,dt, J = 7.3, 3.5 Hz, CH–C8), 
4.57 (1H, d, J = 11.1 Hz, CH-PMB alkyl), 4.53 (1H, d, J = 11.1 Hz, CH-PMB alkyl), 4.04 
(1H, dt, J = 9.8, 5.7 Hz, CH–C6), 3.96 (1H, dd, J = 11.6, 3.5 Hz, CH–C9), 3.88–3.79 (3H, 
m, CH2–C1 and CH–C9), 3.78 (3H, s, CH3-PMB alkyl), 3.64–3.58 (1H, m, CH–C7), 3.57 (1H, 
td, J = 8.8, 2.9 Hz, CH–C3), 3.49 (3H, s, CH3–MeO MTPA), 2.02 (1H, dt, J = 11.8, 6.6 Hz, 
CH–C5), 1.88–1.78 (2H, m, CH–C2 and CH–C4), 1.68–1.60 (1H, m, CH–C2), 1.54–1.48 (1H, 
m, CH–C5), 1.04 (9H, s, CH3-
tBuSi TBDPS), 0.99 (3H, d, J = 6.5 Hz, CH3–C35), 0.83 (9H, s, 
CH3-
tBuSi), -0.02 (3H, s, CH3-MeSi), -0.02 (3H, s, CH3-MeSi). 
(2S)-2-[(2R,4R,5S)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}-4-
methyltetrahydrofuran-2-yl]-2-[(4-methoxyphenyl)methoxy]acetaldehyde. (461) 
 
Sodium periodate (73 mg, 0.34 mmol) was added to a solution of diol 457 (0.10 g, 0.17 
mmol) in a mixture of THF (2.6 mL) and H2O (0.30 mL) at rt. The mixture was stirred for 
30 minutes at rt and then diluted with H2O (3 mL). The mixture was extracted with 
CH2Cl2 (4 × 4 mL) and the organic extracts were dried (MgSO4). The mixture was 
concentrated to afford the crude aldehyde which was used directly in the following 
step. Rf = 0.41 (pet. ether/EtOAc, 1:1). νmax. (liquid film) 2957, 2931, 2857, 1731, 1612, 
1513, 1248, 1105, 1034, 1008, 909, 822, 732, 700 cm−1; 1H NMR (400 MHz, CDCl3) δ 9.67 
(1H, d, J = 1.7 Hz, CH-C8), 7.70–7.63 (4H, m, CH‐PhSi), 7.45–7.33 (6H, m, CH‐PhSi), 7.26 
(2H, d, J = 8.6 Hz, CH-PMB Ar), 6.86 (2H, d, J = 8.6 Hz, CH-PMB Ar), 4.68 (1H, d, J = 
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11.7 Hz, CH-PMB alkyl), 4.56 (1H, d, J = 11.7 Hz, CH-PMB alkyl), 4.24 (1H, ddd, J = 9.3, 
6.3, 4.5 Hz, CH‐C6), 3.80 (3H, s, CH3-PMB alkyl), 3.82–3.71 (3H, m, CH2‐C1 and CH‐C7), 
3.64 (1H, td, J = 8.6, 3.1 Hz, 1H, CH‐C3), 2.06 (1H, dt, J = 12.2, 6.7 Hz, CH‐C5), 1.89–
1.79 (2H, m, CH‐C4 and CH‐C2), 1.69–1.52 (2H, m, CH‐C2 and CH‐C5), 1.05 (9H, s, CH3‐
tBuSi), 1.02 (3H, d, J = 6.5 Hz, CH3‐C35); 
13C NMR (100 MHz, CDCl3) δ 203.7 (C‐C8), 159.6 
(C-PMB Ar), 135.7 (CH‐PhSi), 134.2 (C‐PhSi), 134.1 (C‐PhSi), 129.9 (CH‐PhSi), 129.7 (CH‐
PMB Ar), 129.5 (C‐PMB Ar), 127.7 (CH‐PhSi), 114.0 (CH‐PMB Ar), 84.9 (CH‐C7), 82.8 (CH‐
C3), 77.7 (CH‐C6), 73.0 (CH2‐PMB alkyl), 61.3 (CH2‐C1), 55.4 (CH3‐PMB alkyl), 39.6 (CH‐
C4), 37.0 (CH2‐C2), 36.7 (CH2‐C5), 27.0 (CH3-
tBuSi TBDPS), 19.3 (C‐tBuSi), 16.2 (CH3‐
C35). 
(1R,2R)-1-[(2R,4R,5S)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}-4-methyl 
methyltetrahydrofuran -2-yl]propane-1,2,3-triol. (442) 
 
Palladium on carbon (14 mg, 10% wt.%) was added to a solution of PMB ether 457 (137 
mg, 0.24 mmol) in methanol (2.5 mL) under a nitrogen atmosphere. The flask was 
purged and refilled with hydrogen and the process repeated two times. The mixture was 
stirred for 16 h at rt and the reaction mixture was filtered through celite, concentrated 
and purified by chromatography (pet. ether/Et2O, 1:3) to afford triol 442 (35 mg, 32%) 
as a clear oil. Rf = 0.22 (Et2O); [α]
28
D  −18.3 (c = 1.70, CHCl3); νmax. (liquid film) 3401, 
2957, 2930, 2857, 1473, 1427, 1072, 700 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.70–7.64 (4H, 
m, CH-PhSi), 7.45–7.35 (6H, m, PhSi), 4.06 (1H, ddd, J = 9.8, 6.2, 3.8 Hz, CH-C6), 3.85–
3.77 (2H, m, CH2-C1), 3.72 (2H, t, J = 5.3 Hz, CH2-C9), 3.66–3.60 (2H, m, CH-C3 and CH-
C8), 3.53 (1H, ddd, J = 7.2, 5.5, 3.8 Hz, CH-C7), 2.66 (1H, d, J = 7.3 Hz, OH-C8), 2.46 
(1H, d, J = 7.2 Hz, OH-C7), 2.31-2.22 (1H, m, OH-C9), 2.07 (1H, dt, J = 12.4, 6.2 Hz, 
CH-C5), 1.97–1.90 (1H, m, CH-C4), 1.89–1.82 (1H, m, CH-C2), 1.69–1.59 (2H, m, CH-C2 
and CH-C5), 1.07 (9H, s, CH3-
tBuSi), 1.04 (3H, d, J = 6.5 Hz, CH3-C35); 
13C NMR (125 
MHz, CDCl3) δ 135.8 (CH-PhSi), 134.2 (C-PhSi), 134.2 (C-PhSi), 129.8 (CH-PhSi), 127.8 
(CH-PhSi), 83.2 (CH-C3), 78.1 (CH-C6), 74.1 (CH-C7), 73.3 (CH-C8), 64.1 (CH2-C9), 61.3 
(CH2-C1), 40.2 (CH-C4), 37.6 (CH2-C5), 37.4 (CH2-C2), 27.1 (CH3-
tBuSi), 19.4 (C-tBuSi), 
16.3 (CH3-C35); HRMS (CI+, isobutane) calcd for C26H39O5Si [M+H]
+ 459.2567, found 
459.2561 (Δ −1.3 ppm). 
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(1R,2R)-1-[(2R,4R,5S)-5-{2-[(tert-Butyldiphenylsilyl)oxy]ethyl}-4-methyl 
methyltetrahydrofuran -2-yl]propane-1,2,3-triol. (442) 
 
LiAlH4 (2.0 mg, 0.53 mmol) was added to a stirred solution of ester 441 (17 mg, 0.035 
mmol) in THF (1 ml) at rt. The mixture was stirred for 1 h and was quenched by the 
sequential addition of H2O (0.1 mL), 10% aqueous NaOH (0.1 mL), H2O (0.1 mL) and 
MgSO4 (0.2 g). The solution was filtered and the 
1H NMR spectra of the compound 
matched that of the previously characterised material.   
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